Final programme - eshre 2013

London - United Kingdom 7 to 10 July 2013 FINAL PROGRAMME

Prolutex ® / Lubion TMAqueous solution of progesteronefor subcutaneous administrationThe new choice foreffective luteal supportPlease, check availability and specifications of marketing authorisation in your country.For further details see full prescribing information.Evidence of life

Contents007 Welcome009 Committees013 General Information019 Business & Committee Meetings023 Agenda of the 2013 Annual General Assembly of ESHRE Members024 Agenda of the 2013 Annual Assembly of the Paramedical Group027 Social Programme029 Sponsorship Acknowledgements030 Pre-Congress Courses030 Pre-Congress Course 1: Fertility preservation - The next frontier031 Pre-Congress Course 2: Is male fertility decreasing? The latest news suggests not…033 Pre-Congress Course 3: Risk factors for recurrent pregnancy loss - more pieces of the puzzle035 Pre-Congress Course 4: Cryopreservation - What is hot and what is cold?036 Pre-Congress Course 5: Impact of pelvic pain and uterine bleeding on quality of life037 Pre-Congress Course 6: High standard psychosocial care in your clinic; how to implementnew guidelines038 Pre-Congress Course 7: Ovarian stimulation for ART: how to achieve efficacy and safety?040 Pre-Congress Course 8: Genetic and epigenetic causes of infertility - can we minimize the risks?042 Pre-Congress Course 9: The impact of reproductive surgery on repeated implantation failure043 Pre-Congress Course 10: Pluripotent stem cells, cancer and fertility preservation: science fact orscience fiction?044 Pre-Congress Course 11: Responsible innovation in medically assisted reproduction046 Pre-Congress Course 12: Total quality management (TQM) in an IVF Centre048 Pre-Congress Course 13: Precision medicine: Paving the way to new reproductive disease taxonomies,diagnostics and therapeutics049 Pre-Congress Course 14: Academic Authorship Programme - The A to Z of research: doing a study,presenting a poster, giving a talk, writing it up050 Pre-Congress Course 15: Optimizing IVF outcomeProgramme book3

052 Overview Monday, 8 July 2013Session 01:Session 02:Session 03:Session 04:Session 05:Session 06:Session 07:Session 08:Session 09:Session 10:Session 11:Session 12:Session 13:Session 14:Session 15:Session 16:Session 17:Session 18:Session 19:Session 20:Session 21:Session 22:Keynote lectures sessionFrom oocyte to blastocystThe impact of new clinical evidence in (early) pregnancyPCOSSperm factors influencing ART outcomeEndometriosisFemale infertility: new developmentsAdvances in fertility preservation for severe diseasesESHRE data reporting on PGD cycles and oocyte donationFertility Society of Australia exchange lectureParamedical invited session - NursingRegulation of sperm motility by the female tract and oocyte: messages and signals (MHR session)Gathering evidence in early pregnancy research - Making trials happenParamedical selected oral session - LaboratoryEmbryo and culture environmentI nnovations in reproductive geneticsPromises of AMHLifestyle dangers for men’s fertilityPsychology and counsellingThe ovary in female infertilityAssessing the polycystic ovary (Clinical tutorial)Advanced methods of assessing sperm quality078 Overview Tuesday, 9 July 2013Session 23:Session 24:Session 25:Session 26:Session 27:Session 28:Session 29:Session 30:Session 31:Session 32:Session 33:Session 34:Session 35:Session 36:Session 37:Session 38:Session 39:Session 40:Session 41:Session 42:Session 43:Session 44:Session 45:Session 46:Session 47:European and Global ART Monitoring (presentation of the EIM and ICMART data reports)Culture media. Growing faster growing better?ASRM exchange session - Genetic and metabolic consequences for fertility in men and womenParamedical invited session - Laboratory: The embryo-endometrial interface - role in implantation/developmental successGenes and chromosomes in oocytes and embryosLive surgery sessionOvarian stimulationFertility preservation for medical and non-medical indicationsPGD/PGSStem cells and translational researchChlamydia trachomatis and tubal infertility, modern insights and lessons from outside reproductivemedicineWhy sex is goodParamedical selected oral sessionViral disease in reproductionHistorical lectureManaging relationship through infertility (Organised by Fertility Europe)Paramedical invited session - LaboratoryEmbryo metabolismKeys for success for embryo cryopreservationEthical aspects of ARTSpermatogenesis - the new knowledgeLong term outcome of ARTClinical female infertilityEpigenetics in reproductive healthReproductive surgery4

Session 48:Session 49:Session 50:Session 51:Challenges of AMH studiesProtecting and choosing good spermReproduction and societyFertility awareness112 Overview Wednesday, 10 July 2013Session 52:Session 53:Session 54:Session 55:Session 56:Session 57:Session 58:Session 59:Session 60:Session 61:Session 62:Session 63:Session 64:Session 65:Session 66:Session 67:Session 68:Session 69:Session 70:Session 71:Session 72:Future infertility managementAre human embryonic stem cells ready for regenerative medicine?New findings in reproductive oncologyASRM/Society of Reproductive Biologists and Technologists Exchange Symposium: Optimizingthe culture and selection of human embryo in 2013From experimental to established: ESHRE guidelines and position papersTime lapse: the real revolution for embryo assessment?Basics of reproductive endocrinologyEndometriumPerinatal outcome after ARTEffects of interventions on embryo qualityQuality management and regulation in the ART labNew ART interventions may, under certain circumstances, be introduced without a clinical trial? (Debate)Endometriosis-associated painParamedical invited session - Nursing (Debate): Patients have the right for an anonymous donorEmbryo quality: does it predict pregnancy?Scientific challenges in early pregnancy achievementThe impact of genetics in andrologyClinical endocrinologyChallenges in cryopreservationSurgeryAwards and closing ceremony137 Poster discussion sessions140 Posters185 Author indexProgramme book5

COMMITTEESExecutive Committee(2011-2013)−−−−−−−−−−ChairmanAnna Veiga (Spain)Chairman ElectJuha Tapanainen (Finland)MembersCarlos Calhaz-Jorge (Portugal)Jacques De Mouzon (France)Ursula Eichenlaub-Ritter (Germany)Roy Farquharson (United Kingdom)Anis Feki (Switzerland)Cornelis Lambalk (The Netherlands)Milan Macek Jr. (Czech Republic)Cristina Magli (Italy)Antonis Makrigiannakis (Greece)Jolieneke Schoonenberg-Pomper (The Netherlands)Françoise Shenfield (United Kingdom)Miodrag Stojkovic (Serbia)Anne-Marie Suikkari (Finland)Etienne Van den Abbeel (Belgium)Immediate Past ChairmanLuca Gianaroli (Italy)Coordinator SIG’sFrançoise Shenfield (United Kingdom)Paramedical Board−−−−−−−−ChairmanHelle Bendtsen (Denmark)Past-ChairmanJolieneke Schoonenberg-Pomper (The Netherlands)MembersEline Dancet (Belgium)Yves Guns (Belgium)Inge Rose Jorgensen (Denmark)Helen Kendrew (United Kingdom)Uschi Van den Broeck (Belgium)Leonie Van Den Hoven (The Netherlands)Cecilia Westin (Sweden)Central OfficeChristine BauquisVeerle De RijbelVeerle GoossensKaren MarisCatherine PlasErika Mar Rodriguez RaesHeidi RoijemansBruno Van den EedeIne Van WassenhoveNathalie VermeulenCOMMITTEESProgramme book9

Committee of National Representatives(2011 - 2013)Vasco Almeida (Portugal)Birol Aydin (Macedonia)Basak Balaban (Turkey)Anette Bergh (Norway)Zeev Blumenfeld (Israel)Pierre Boyer (France)Giovanni Coticchio (Italy)Gabriel De Candolle (Switzerland)Alfonso L. De La Fuente (Spain)José Joaquim Domingues Nunes (Portugal)Jeremy Don (Israel)Bogdan Doroftei (Romania)Thomas Ebner (Austria)Geraldine Emerson (Ireland)Gregoris Grimbizis (Greece)Maurizio Guido (Italy)Bjorn Heindryckx (Belgium)Christina Hnida (Denmark)José Antonio Horcajadas Almansa (Spain)Julius Hreinsson (Sweden)Katalin Kanyo (Hungary)Borut Kovacic (Slovenia)Péter Kovács (Hungary)Markus S. Kupka (Germany)Rafal Kurzawa (Poland)Kalliopi Loutradi (Greece)Sirpa Makinen (Finland)Alice Malenovska (Czech Republic)Tania Milachich (Bulgaria)Laure C. Morin - Papunen (Finland)Milan Mrazek (Czech Republic)Andreea Sandra Mustata (Romania)Lyubov Mykhaylyshyn (Ukraine)Nan Brigitte Oldereid (Norway)Julia Paget (United Kingdom)Michael Pelekanos (Cyprus)Manuel Pensis (Switzerland)Zoranco Petanovski (Macedonia)Ireneusz Polac (Poland)Nebojsa Radunovic (Serbia)Catherine Rongieres (France)Pia Saldeen (Sweden)Ertan Saridogan (United Kingdom)Kirsten Louise Tryde Schmidt (Denmark)Jesper M.J. Smeenk (The Netherlands)Anna Smirnova (Russia C.I.S.)Patrik Stanic (Croatia)Nada Tabs (Serbia)Tania Nikolova Timeva (Bulgaria)Krinos M. Trokoudes (Cyprus)Bulent Urman (Turkey)Aafke Van Montfoort (The Netherlands)Frank Vandekerckhove (Belgium)Peter H. Vogt (Germany)Hrvoje Vrcic (Croatia)Eda Vrtacnik-Bokal (Slovenia)Anthony Walsh (Ireland (Rep.)Ludwig Wildt (Austria)Sergey Yakovenko (Russia C.I.S.)10

International Scientific CommitteeNational CommitteeHelle Bendtsen (Denmark)Paul Devroey (Belgium)Petra De Sutter (Belgium)Wybo Dondorp (The Netherlands)Gerard Dunselman (The Netherlands)Johannes Evers (The Netherlands)Joep Geraedts (The Netherlands)Luca Gianaroli (Italy)Mariette Goddijn (The Netherlands)Georg Griesinger (Germany)Joyce Harper (United Kingdom)Sheena Lewis (United Kingdom)Kersti Lundin (Sweden)Edgar Mocanu (Ireland)Willem Ombelet (Belgium)Guido Pennings (Belgium)Helen Picton (United Kingdom)Enrico Semprini (Italy)Karen Sermon (Belgium)Françoise Shenfield (United Kingdom)Johan Smitz (Belgium)Vassilios Tanos (Cyprus)Juha Tapanainen (Finland)Anna Veiga (Spain)Chris Verhaak (The Netherlands)David BairdAdam BalenSiladitya BhattacharyaHeidi BirchJacky BoivinPeter BrinsdenIan CookeHilary CritchleyRachel CuttingsMelanie DaviesLynn FraserStephen HillierHenry LeeseSheena LewisClare Lewis-JonesTin-Chiu LiNicholas MacklonHarry MooreAllan PaceyAnthony RuhterfordLocal CommitteeRoy FarquharsonJoyce HarperJulia PagetErtan SaridoganFrançoise Shenfield (Chair)COMMITTEESProgramme book11

GENERAL INFORMATION−−Political StatementThe aim of ESHRE is to provide a forum for the exchange and discussion of new clinicaland scientific ideas. The Society, in good faith, assumes that all participants will respectthe non-political nature of our annual meeting.−−Registration andInformation DeskThe registration and general information desks will be located in the entrance hall ofthe congress centre and will be open at the following hours:Sunday, 7 July 08.00 - 20.00 (registrations pre-congress courses)12.00 - 20.00 (registrations main program)Monday, 8 July 08.00 - 19.00Tuesday, 9 July 08.00 - 19.00Wednesday, 10 July 08.00 - 15.00GENERAL INFORMATION−−Hotels DeskAny queries regarding accommodation should be directed to MCI who will be managingthe hotels desk in the registration area throughout the Meeting.Hotels and tours desk opening hours at the venue:Sunday, 7 July 08.00 - 20.00Monday, 8 July 08.00 - 19.00Tuesday, 9 July 08.00 - 19.00Wednesday, 10 July 08.00 - 15.00−−LanguageEnglish is the official language of the meeting. There will be no simultaneous translation.−−Badge Colour Codes• YELLOW: access to pre-congress courses only• RED: access to main program only (not to the pre-congress courses)• GREEN: access only to the exhibit and other congress facilities, but no access to anyof the scientific sessions (i.e. pre-congress courses as well as main program)−−Slide PreviewSlide preview facilities will be available in the slide preview room, which is located inthe registration area. Presenters are kindly requested to submit their slides on a portablemedium at least 60 minutes before presentation!−−ESHRE Internet zonePay a visit to our cyber facility “The ESHRE Internet Zone”, which is located on the exhibit hall.“The Zone” is an internet facility with various functions such as:• Use of the internet. Browsers shall always launch with www.eshre.eu as homepage.Internet pages cannot be printed.• A meeting tool where a participant can consult the scientific programme of themeeting, click on titles of presentations and read the related abstract (individual pdf’sto be provided for by OUP and which are stored on a local server) plus the possibilityto create a personal itinerary with print option, will also be available.• A second meeting tool where a participant can print a personalised certificate ofattendance and a receipt of payment if of course the participant’s registration recordshows a 0-balanceComputer access will only be possible with a username and password (access details areprinted on the participant’s badge).−−Certificates ofAttendanceCertificates of attendance can be printed out at the “ESHRE Zone”Programme book13

−−E-Posters/Paper PostersWe will stage a digital and paper “poster” exhibition. Both poster exhibitions will be inthe “poster area” (exhibit hall).The complete administration, organization and set-up of the electronic exhibition will behandled through an electronic poster system (e-Poster System) which has beendeveloped by IT experts specialised in congress management.The presentation of electronic posters onsite will be accomplished by a number ofwork- stations connected to a central server. A high performance search engine willallow searching by authors, poster titles, full text, keyword search and many morecriteria. You will enjoy the ability to e-mail certain posters of your interest to your homeor work computer (in PDF format). In addition, visitors of the “E-poster area” will havethe opportunity to view last year’s poster presentation as well.−−Getting Aroundin LondonTaxis, Licensed Private Hire Vehicles and Minicabs in LondonLondon’s Black Cabs can be hailed in the street or at designated ranks situated inprominent places, including many mainline rail, Tube and bus stations. They can also bebooked by telephone. If the yellow TAXI sign at the front is illuminated, the cab isavailable for hire. Black cabs are legally obliged to take on any job for journeys upto 12 miles (20 miles for cabs at the Heathrow Airport taxi ranks), or up to one hourduration. Fares are metered, and there is a minimum charge of £ 2.20. Black cabs arelicensed to carry up to five people (six in the special Metrocabs and Mercedes Vitos) plusluggage. There are no additional charges for extra passengers or items of luggage.Private hire vehicles and minicabs must be booked at an office, by telephone or email.Reputable, licensed minicab companies can offer a cheaper alternative to the black cab.While their fares are generally reasonable, they are not on a meter, instead you shouldask how much the trip will cost when you make a booking.If you want to book a private hire vehicle or minicab by telephone then most hotels andhostels will have a list of reputable, licensed operators. You will also find minicab officeson most high streets.Unbooked minicabs are illegal. You may be approached by minicab drivers seekingpassengers or offering a service; avoid this as these are unsafe, unlicensed, uninsuredand illegal and you put yourself in danger if you use these services.Useful number/contacts• Cabwise: text CAB to 60835 (see above for details)• Findaride: find details of licensed private hire and minicab operators in any partof London• To comment or complain about taxi and private hire services email, visit or call TfLon 0845 300 7000−−Public TransportTransport for LondonA London Oyster card is the fastest, smartest and most cost-effective way to pay forsingle journeys on the bus (£ 1.35 per fare), Tube (from £ 2 per fare depending onthe zone), DLR, tram, London Overground, Thames Clippers and most National Railservices. If you make lots of journeys, the Oyster card will automatically cap the day’scharges at the price of an equivalent 1-Day Travelcard.Cards can be bought at all stations, the visitlondon web site, or group bought by yourevent organiser. For general information on how to use your Oyster go tohttp://visitorshop.tfl.gov.uk/Tube and Docklands Light Railway (DLR)London’s Underground rail network or ‘the Tube’ as it is universally known to Londoners,is normally the quickest and easiest way of travelling around London.14

Greater London is served by 12 Tube lines, along with the Docklands Light Railway(DLR) and an interconnected local train network. Trains generally run between 5am andmidnight, Monday to Saturday. Operating hours are reduced on Sunday. Plan your routeonline with Transport for London’s Journey Planner.BusesLondon buses are a quick, convenient and cheap way to travel around. And you’ll getplenty of sightseeing opportunities en route. The Central London bus guide will besufficient for most travelers. This map is available from travel information centres atlarger Tube stations or to download from Travel Maps.London is a 24-hour city so buses run throughout the night. Night bus services cover theperiod between the close of the Tube and the start of daytime bus services. In addition,many London bus routes run for 24 hours.If you’re not familiar with the routes, head to Trafalgar Square (the hub for night buses)or check any bus-stop information board.There is a flat fare throughout the bus network, £ 1.35 with a pre-pay Oyster card and£ 2.20 if you are paying by cash. Travelcards are valid on buses.GENERAL INFORMATIONCyclesLondon’s Barclays Cycle Hire scheme is a public bike sharing scheme for shorterjourneys around the capital. Bike docking stations across the capital give you access toaround 6,000 bikes at 400 locations in London’s Zone One travel area.−−Lunches andRefreshmentsDuring the congress, lunches will be provided to all registered participants. Coffee andlunches will be served throughout the exhibition area.Monday, 8 July 09.30 - 10.00 coffee13.00 - 14.00 lunch16.30 - 17.00 coffeeTuesday, 9 July 09.30 - 10.00 coffee13.00 - 14.00 lunch16.30 - 17.00 coffeeWednesday, 10 July 09.30 - 10.00 coffee13.00 - 14.00 lunch−−ElectricityThe electrical power supply in the United Kingdom is 230 volts. Suitable adapters areneeded for all European plugs.−−Insurance & LiabilityESHRE does not accept liability for individual medical, travel or personal insurance,and participants are strongly advised to take out their own personal insurance policies intheir country of origin. Participation in all excursions, tours etc. is at personal risk.−−Questions?In case you have more questions regarding the meeting, please turn to the informationdesk in the entrance hall.−−Legal disclaimer -Privacy policyBy using the participant’s badge, you accept the following terms of use,which are applicable:PrivacyPersonal Data (more specific your name, address, company or institute working for,email address, telephone number, fax number) provided to ESHRE by the participantby email and/or by contact form and/or registration, will be (i) transmitted on theparticipant’s badge you will receive and (ii) treated by ESHRE confidentially and inconformity with the Belgian Privacy Law. The controller of the data processing is:ESHRE - The European Society for Human Reproduction and Embryology, Meerstraat,n° 60, in 1852 Grimbergen, Belgium - Bruno van den Eede, Managing Director.Programme book15

The Personal Data is collected and may be used by ESHRE for information andpromotional campaigns. In compliance with the law of 8 December 1992 on theprotection of privacy, upon request, you may object free of charge to the use of your datafor this promotional campaign purpose.Other than that, Personal Data is not processed or transmitted by ESHRE to third partiesoutside ESHRE without the consent of the relevant individual, unless ESHRE is requiredto do this by virtue of mandatory legal requirements or rulings by the courts or officialbodies.In compliance with the law of 8 December 1992 on the protection of privacy, uponrequest, ESHRE will remove the participant’s Personal Data from its database.Furthermore, upon request, registered participants may access and/or correct anyerroneous Personal Data. Any request concerning a participant’s Personal Data shouldbe made to: The European Society for Human Reproduction and Embryology, Meerstraat,n° 60, in 1852 Grimbergen, Belgium.Personal Data provided to ESHRE shall be transmitted on the participant’s badge youwill receive. By scanning this participant’s badge at the booth you are visiting on theexhibition, your Personal Data shall be transmitted and / or processed to the respectiveexhibitor. ESHRE does not have or assume any responsibility for Personal Data given bya visitor to one of the exhibitors of a trade show or event as a result of the scanning ofthe visitors badge or otherwise.DisputesAll disputes involving this legal disclaimer shall be governed by Belgian law. In the eventof disputes only the courts of Gent shall be competent.By using the participant’s badge, you signify your assent to the ESHRE policy. If you do notagree to this policy, please do not use this badge.16

GENERAL INFORMATIONProgramme book17

Business & Committee MeetingsSince this Final Programme went into print, rooms that were originally allocated to the business and committeemeetings listed below may have changed. Please check on-site signage at all times for up-to-date informationand directions.Friday 5 July 201309.00 - 17.00 ICMART Board Meeting ..................................................South Gallery 1914.00 - 19.00 ESTEEM meeting .......................................................South Gallery 20Saturday 6 July 201308.00 - 17.30 IFFS Committee Meeting .................................................South Gallery 2009.00 - 12.00 ESHRE Executive Committee Meeting ...................................South Gallery 21+2211.00 - 14.00 SAG Meeting ...........................................................South Gallery 2311.30 - 17.30 International Infertility Counselling Organisation .............................South Gallery 3313.00 - 15.30 ESHRE International Scientific Committee Meeting ........................South Gallery 21+2214.30 - 15.30 Tutorial PGD Data Collection .............................................South Gallery 2315.30 - 17.00 ESHRE SIG & TF Sub-Committee Meeting. ...............................South Gallery 21+2216.00 - 19.00 PGD Consortium Meeting ................................................South Gallery 23BUSINESS & COMMITEE MEETINGSSunday 7 July 201308.00 - 17.30 IFFS Committee Meeting .................................................South Gallery 2015.00 - 18.00 ICMART Board Meeting ..................................................South Gallery 1917.00 - 17.30 SIG Embryology Business Meeting .........................................Capital Suite 7+817.00 - 18.00 SIG Stem Cells Business Meeting. ..........................................Capital Suite 1017.00 - 18.45 Paramedical Board Meeting ................................................Capital Suite 517.15 - 18.00 SIG Andrology Business Meeting. ...........................................Capital Suite 1217.30 - 19.00 Molecular Human Reproduction Associate Editors’ Meeting ................. South Gallery21+22Programme book19

Monday 8 July 201308.00 - 17.30 IFFS Committee Meeting .................................................South Gallery 2009.00 - 17.30 Fertility Europe Members’ Meeting. .....................................South Gallery 21+2209.30 - 10.00 FSA Award Selection Committee Meeting .....................................Capital Suite 609.30 - 10.00 PG Award Selection Committee Meeting ......................................Capital Suite 609.30 - 10.00 Basic Science Oral Award Selection Committee Meeting .........................Capital Suite 609.30 - 10.00 Clinical Science Oral Award Selection Committee Meeting .......................Capital Suite 609.30 - 10.00 Basic Science Poster Award Selection Committee Meeting .......................Capital Suite 609.30 - 10.00 Clinical Science Poster Award Selection Committee Meeting .....................Capital Suite 612.00 - 14.00 Human Reproduction Associate Editors’ Meeting ...............................Capital Suite 213.00 - 14.00 ESHRE CNR Meeting ......................................................Capital Suite 413.00 - 14.00 ICMART Contributors meeting. ............................................South Gallery 1913.00 - 14.00 Paramedical Group Annual Assembly. ................................................S8-B13.00 - 17.00 Editorial Meeting of the Cochrane Menstrual Disorders + Subfertility Group .......South Gallery 1714.00 - 16.30 European Donorquota .....................................................Capital Suite 516.30 - 17.00 FSA Award Selection Committee Meeting .....................................Capital Suite 616.30 - 17.00 PG Award Selection Committee Meeting ......................................Capital Suite 616.30 - 17.00 Basic Science Oral Award Selection Committee Meeting .........................Capital Suite 616.30 - 17.00 Clinical Science Oral Award Selection Committee Meeting .......................Capital Suite 616.30 - 17.00 Basic Science Poster Award Selection Committee Meeting .......................Capital Suite 616.30 - 17.00 Clinical Science Poster Award Selection Committee Meeting .....................Capital Suite 6Tuesday 9 July 201307.30 - 08.30 Fertility and Sterility Breakfast meeting .......................................Capital Suite 609.00 - 17.30 Fertility Europe Members’ Meeting. ........................................South Gallery 1912.00 - 14.00 Human Reproduction Update Associate Editors’ Meeting. ...................South Gallery 21+2213.00 - 14.00 ESHRE/ASRM Liaison Committee Meeting ...................................London Suite 413.00 - 14.00 Board Meeting SIG Stem Cells ..............................................Capital Suite 513.00 - 14.00 SIG Safety and Quality Business Meeting ......................................Capital Hall B13.00 - 14.00 SIG Reproductive Genetics Business Meeting ..........................................S8-A13.00 - 14.00 SIG Reproductive Endocrinology Business Meeting ............................ Capital Suite A13.00 - 16.00 EIM Consortium Meeting ...................................................Capital Suite 216.30 - 17.00 FSA Award Selection Committee Meeting .....................................Capital Suite 616.30 - 17.00 PG Award Selection Committee Meeting ......................................Capital Suite 616.30 - 17.00 Basic Science Oral Award Selection Committee Meeting .........................Capital Suite 616.30 - 17.00 Clinical Science Oral Award Selection Committee Meeting .......................Capital Suite 616.30 - 17.00 Basic Science Poster Award Selection Committee Meeting .......................Capital Suite 616.30 - 17.00 Clinical Science Poster Award Selection Committee Meeting .....................Capital Suite 620

Wednesday 10 July 201307.30 - 18.00 MMR Survey Meetings ................................................South Gallery 21+2209.30 - 11.00 Endometriosis Guidelines meeting ...........................................Capital Suite 513.00 - 14.00 Board Meeting SIG Early Pregnancy ..........................................Capital Suite 514.15 - 14.45 FSA Award Selection Committee Meeting .....................................Capital Suite 614.15 - 14.45 PG Award Selection Committee Meeting ......................................Capital Suite 614.15 - 14.45 Basic Science Oral Award Selection Committee Meeting .........................Capital Suite 614.15 - 14.45 Clinical Science Oral Award Selection Committee Meeting .......................Capital Suite 614.15 - 14.45 Basic Science Poster Award Selection Committee Meeting .......................Capital Suite 614.15 - 14.45 Clinical Science Poster Award Selection Committee Meeting .....................Capital Suite 616.30 - 19.00 Embryo Certification Committee meeting .....................................Capital Suite 5Thursday 11 July 201309.00 - 12.00 ESHRE’s Debriefing meeting ...........................................South Gallery 21+2209.00 - 17.00 Psychology guidelines meeting ........................................London Suite LoungeBUSINESS & COMMITEE MEETINGSProgramme book21

Agenda of the 2013 Annual GeneralAssembly of ESHRE Members−−DATE: Tuesday, 9 July 2013−−TIME: from 18.00 to 19.00−−PLACE: ExCeL Centre, London, venue of the 29th Annual Meeting - Room S8-B1. Minutes of the last meeting (held in Istanbul and published in Focus on Reproduction, September 2012)2. Matters arising3. Membership of the Society• Society activities• Annual meetings• Campus meetings• Special Interest Groups and Task Forces• Human Reproduction journals4. Paramedical Group5. Financial report6. Ratification of the new Executive Committee• Kersti Lundin (SE) to become the new Chairman-Elect• Ursula Eichenlaub-Ritter (DE), Antonis Makrigiannakis (GR), Miodrag Stojkovic (RS), Anne-Maria Suikkari (FI),Etienne Van den Abbeel (BE), Milan Macek (CZ) to step down• Carlos Calhaz-Jorge (PT), Jacques de Mouzon (FR), Roy Farquharson (GB), Anis Feki (CH), Niels Lambalk (NL)and Cristina Magli (IT) to be re-appointed for a second term of two years• Petra De Sutter (BE), Andres Salumets (EE), Grigoris Grimbizis (GR), Tatjana Motrenko (ME) andGeorg Griesinger (DE) to be appointed as new members• Retirement of the Chairman, Anna Veiga (ES), and installation of the new Chairman, Juha Tapanainen (FI)7. Election of the Honorary Members for 20148. Any other business9. Date of the next Annual General AssemblyAGENDAProgramme book23

Agenda of the 2013 Annual Assemblyof THE PARAMEDICAL GROUP−−DATE: Monday, 8 July 2013−−TIME: from 13.00 to 14.00−−PLACE: ExCeL Centre, London, venue of the 29th Annual Meeting - Room S8-B1. What is ESHRE?2. The paramedical group3. Membership of the Society4. Society Activities, Campus Courses, PCC5. ESHRE Nurse Certification6. Annual Meeting London 2013 – Paramedical Program7. The Royal College of Nursing, Fertility Nursing Forum reception8. Any other business9. Date of the next Annual General Assembly24

AGENDAProgramme book25

E R IExclusive publisher ofESHRE Final ProgramIB2A COMMUNICATION GROUPPRINTING, DIGITAL AND INTERACTIVE COMMUNICATIONWE HELP YOU SUCCEEDINGAdvertising● Support for your publications● Publishing● Layout - Printing - Routing● Visual IdentityEVENTS ORGANISATION● Conferences● Trade showMULTIMEDIA● Web site● CD Rom● Corporate communicationTrust us with your projectsContact us today : contact@ib2a.frTél. : 33 (0)1.55.12.31.20 - 33 (0)6.07.57.51.82E R IERI SAS16, rue Louis Dupré94100 SAINT MAURFRANCESCE15, rue Louis Braille94100 SAINT MAURFRANCEAgence et Régie publicitaireIB2A3, rue Sacrot94160 SAINT MANDÉFRANCE

SOCIAL PROGRAMMEOpening Ceremony and Welcome Reception at the Meeting VenueSunday, 7 July 2013 / 19.00 - 22.00 / Auditorium (Opening Ceremony) & Exhibit Hall (Welcome Reception)All participants and their accompanying persons are warmly invited to join us for the Opening Ceremony that takesplace in the Auditorium of ExCel. It will be an entertaining and eventful introduction to the meeting. After the OpeningCeremony, we will officially open the industrial exhibit and invite our delegates to the Welcome Reception inthe Exhibit Hall.Tuesday Evening Congress Party at the Science MuseumTuesday, 9 July 2013 / 20.30 - 23.00We invite all delegates and their accompanying persons to take part in the “Tuesday Evening Congress Party”.Participation is optional and tickets for this unique event will be 120 Euro/person.It will be an ideal moment to meet up with old friends and to make new acquaintances.The party will be held at the Science Museum.SOCIAL PROGRAMMEHow to get to the party?The Main Entrance to the Museum is on Exhibition Road in South Kensington, London, SW7 2DD.By UndergroundThe nearest tube station (10 minutes walk) is South Kensington on the District, Circle and Piccadilly lines. A pedestriansubway runs directly from the ticket barrier at South Kensington station to the Main Entrance of the Museum.Gloucester Road tube station is a 15 minute walk away and is based on the Circle, District and Piccadilly line.By BusBus routes 14, 49, 70, 74, 345, 360, 414, 430 and C1 stop outside South Kensington Underground Station, from whereit is a five minute walk north to the Museum’s Main Entrance.Bus routes 9, 10, 52, 452 and 70 stop outside the Royal Albert Hall on Kensington Gore, from where it is a five minutewalk south to the Museum’s Main Entrance.Tickets for this unique event may still be available on-site. Cost = 120 Euro / personAwards and Closing Ceremony at the Meeting VenueWednesday, 10 July 2013 / 15.30 - 16.30 / Capital Suite AThe Closing and Award Ceremony will be held after the last session of the meeting. During this Ceremony, the winnersof the 2013 ESHRE Awards for the best poster and oral communications will be presented. The chairpersons of thevarious Award Committees will present the awards, together with representatives of the award sponsors. At the end ofthis Ceremony we will say goodbye and make a new appointment for our meeting in Munich in the year 2014.Attendance is free of charge to registered participants.Programme book27

Sponsorship acknowledgementsESHRE acknowledges the support of the following Primary Corporate MembersAuxogyn, Inc.Labotect GmbHMerck Serono S.A.SPONSORSHIPMerck Sharp & Dohme Corp.ESHRE acknowledges the support of the following Regular Corporate Members• RI - Research Instruments Ltd.Programme book29

COURSE 1Sunday, 7 July−−Room Capital Suite 12 (Hands-on session: Capital Suite 03)−−−−Fertility preservation - The next frontierOrganised by the Paramedical GroupCourse coordinators: Jolieneke Schoonenberg-Pomper (The Netherlands) and Helle Bendtsen (Denmark)Course description: An advanced course for nurses and lab technicians focusing on the different aspects of fertilitypreservation.Target audience: Nurses and lab techniciansCourse programmeChairman: Helle Bendtsen (Denmark) and Helen J. Kendrew (United Kingdom)09.00 - 09.10 Introduction - Helle Bendtsen (Denmark)09.10 - 09.40 Role of the nurse in England - Rebecca Goulding (United Kingdom)09.40 - 09.50 Discussion09.50 - 10.20 Risk of premature ovarian failure - Ina Beerendonk (The Netherlands)10.20 - 10.30 Discussion10.30 - 11.00 Coffee break11.00 - 11.25 Fertility preservation in women affected by malignant diseases; when (indication),and how (procedures) - Kirsten Louise Tryde Schmidt (Denmark)11.25 - 11.35 Discussion11.35 - 12.00 Oocyt Cryopreservation - alternative technique to embryo freezing - Laura Francesca Rienzi (Italy)12.00 - 12.10 Discussion12.10 - 12.30 Hands-on session vitrification - companies will show different vitrification devices for oocytes -Helle Bendtsen (Denmark)12.10 - 12.30 Hands-on session vitrification - companies will show different vitrification devices for oocytes -Cecilia Westin (Sweden)12.10 - 12.30 Hands-on session vitrification - companies will show different vitrification devices for oocytes -Yves Guns (Belgium)12.30 - 13.30 Lunch13.30 - 14.05 Oocyte banking in an egg-donation programme - Elisabeth Clare Larsen (Denmark)14.05 - 14.15 Discussion14.15 - 14.50 Oocyte cryopreservation: applications and outcomes in the U.S.A. - Nicole Noyes (U.S.A.)14.50 - 15.00 Discussion15.00 - 15.30 Coffee break15.30 - 16.00 Counseling for social freezing - Julie Nekkebroeck (Belgium)16.00 - 16.10 Discussion16.10 - 16.40 Ethical issue of social freezing - Françoise Shenfield (United Kingdom)16.40 - 17.00 Discussion30

COURSE 2Sunday, 7 July−−Room Capital Suite 04−−−−Is male fertility decreasing? The latest news suggests not…Organised by the Special Interest Group AndrologyCourse coordinators: Sheena E.M. Lewis (United Kingdom) and Jackson Kirkman Brown (United Kingdom)Course description: This course will present the latest research on male reproductive health and debatetwo issues: whether male fertility is declining and secondly if ART is a solution to Europe’s demographic demise1. The impact on ART on falling birth rates on European Society2. The economic benefits of ART on European Society3. Factors causing the increase in couples seeking ART year on year4. The health of children conceived with surgically retrieved spermTarget audience: Clinicians, paramedical staff, embryologists and andrologists with an interest in male reproductionand the differing schools of thought on male fertility public health issuesCourse programmeIs male REPRODUCTIVE HEALTH decreasing?Chairman: Sheena E. M. Lewis (Ireland)09.00 - 09.20 Recent semen data from France - Joelle Le Moal (France)09.20 - 09.40 Male reproductive health: Its impacts in relation to general wellbeing and low European fertilityrates - Stefan Schlatt (Germany)09.40 - 10.00 Trends in global semen parameters - Harry Fisch (U.S.A.)10.00 - 10.30 Discussion10.30 - 11.00 Coffee breakPRE-CONGRESS COURSESFACTORS THAT MAY CAUSING the increase in couples seeking ART EACH yearChairman: Stefan Schlatt (Germany)11.00 - 11.30 Effect of lifestyle and environment - Richard Sharpe (United Kingdom)11.30 - 11.45 Discussion11.45 - 12.15 Increasing patient age - Lone Schmidt (Denmark)12.15 - 12.30 Discussion12.30 - 13.30 LunchDEBATE: We believe THAT ART is an IMPORTANT PART of the SOLUTION TO Europe’s demographic demiseChairman: Jackson Kirkman-Brown (United Kingdom)13.30 - 14.00 For the motion - Søren Ziebe (Denmark)14.00 - 14.30 Against the motion - Egbert R. te Velde (The Netherlands)14.30 - 15.00 Discussion15.00 - 15.30 Coffee breakProgramme book31

Chairman: Willem Ombelet (Belgium)15.30 - 16.00 Costs matter, but so do benefits: The economic benefits of ART to Society -Georgina Chambers (Australia)16.00 - 16.15 Discussion16.15 - 16.45 How will ART children from infertile fathers affect the health of European Society in the future?The latest child health data - Anja Pinborg (Denmark)16.45 - 17.00 Discussion32

COURSE 3Sunday, 7 July−−Room Capital Suite 11−−−−Risk factors for recurrent pregnancy loss - more pieces of the puzzleOrganised by the Special Interest Group Early PregnancyCourse coordinators: Mariëtte Goddijn (The Netherlands)Course description: This pre-congress course will address the risk factors involved in recurrent pregnancy lossand focuses on potential therapeutic consequencesTarget audience: Reproductive gynaecologists and physiciansCourse programmePregnancies of UNKNOWN LOCATION (PUL)Chairman: Siobhan Quenby (United Kingdom)09.00 - 09.20 Diagnosis solutions for pregnancy of unknown location (PUL) - The role of ultrasound -Emma Kirk (United Kingdom)09.20 - 09.40 Diagnosis solutions for pregnancy of unknown location (PUL) - The role of hCG measurements -Kurt Barnhart (U.S.A.)09.40 - 10.00 How PULs affect future pregnancy outcomes: new ESHRE guidelines -Astrid Marie Kolte (Denmark)10.00 - 10.30 Interactive discussion with the speakers and audience: which diagnostic tests to use; how to informpatients about their prognosis10.30 - 11.00 Coffee breakPRE-CONGRESS COURSESThyroid abnormalities and EARLY PREGNANCYChairman: Mariette Goddijn (The Netherlands)11.00 - 11.30 When to screen for thyroid function abnormalities? - Rosa Vissenberg (The Netherlands)11.30 - 12.00 Thyroid antibodies and miscarriage: Clinical trial - Arri Coomarasamy (United Kingdom)12.00 - 12.30 Discussion with the speakers and audience: diagnostic tests in setting of scientific studies;RCT design12.30 - 13.30 LunchSOCIETAL and life style FACTORSChairman: to be announced13.30 - 13.50 Life style factors increase the risk of recurrent miscarriage - William H. Kutteh (U.S.A.)13.50 - 14.10 The impact of genetic testing for couples with recurrent miscarriage -Fleur Vansenne (The Netherlands)14.10 - 14.30 The influence of advanced maternal age: major cause of recurrent pregnancy loss -Mary Stephenson (U.S.A.)14.30 - 15.00 Discussion with speakers and audience: how to fight bad habits15.00 - 15.30 Coffee breakProgramme book33

New thoughtsChairman: Mariette Goddijn (The Netherlands)15.30 - 16.00 NK cells - Siobhan Quenby (United Kingdom)16.00 - 16.30 NICE guidelines 2012 - dissemination and implementation - Caroline Overton (United Kingdom)16.30 - 17.00 Discussion with speakers and audience: early pregnancy research networks - bridging the ‘pond’ -Mariette Goddijn (The Netherlands)16.30 - 17.00 Discussion with speakers and audience: early pregnancy research networks - bridging the ‘pond’ -Mary Stephenson (U.S.A.)34

COURSE 4Sunday, 7 July−−Room Capital Suite 07/08−−−−Cryopreservation - What is hot and what is cold?Organised by the Special Interest Group EmbryologyCourse coordinators: Kersti Lundin (Sweden) and Cristina Magli (Italy)Course description: This course is aimed to give an update on current and possible future practices in shortand long-term cryopreservation, as well as analyse risks, utilisation rates, and outcomeTarget audience: IVF lab technologists, clinical embryologists, scientists and cliniciansCourse type: AdvancedCourse programmeChairman: Kersti Lundin (Sweden) and Cristina Magli (Italy)Burning ASPECTS of CRYOPRESERVATION09.00 - 09.30 Cryobiology with focus on gametes and embryos - Henri Woelders (The Netherlands)09.30 - 09.45 Discussion09.45 - 10.15 Cross-contamination of samples in liquid nitrogen - statistical probability or absolute certainty? -Ana Cristina Cobo Cabal (Spain)10.15 - 10.30 Discussion10.30 - 11.00 Coffee breakPRE-CONGRESS COURSESCRYOPRESERVATION , OPTIMISATION of METHODOLOGY11.00 - 11.30 Is there still a place for slow freezing in ART - David H. Edgar (Australia)11.30 - 11.45 Discussion11.45 - 12.15 Fresh versus frozen oocytes - are we reaching the optimum? - Maria Jose De Los Santos (Spain)12.15 - 12.30 Discussion12.30 - 13.30 LunchChairman: Maria Jose De Los Santos (Spain) and D. Edgar (Australia)Long term CRYOPRESERVATION13.30 - 14.00 Cryopreservation and utilization of ovarian tissue; when, where and how -Christiani Amorim (Belgium)14.00 - 14.15 Discussion14.15 - 14.45 Cryopreservation of testicular tissue; when, where and how - G. Verheyen (Belgium)14.45 - 15.00 Discussion15.00 - 15.30 Coffee breakA cold LOOK AT CRYOPRESERVATION15.30 - 16.00 Epigenetic events in early embryos & possible effects of culture conditions -Petra Hajkova (United Kingdom)16.00 - 16.15 Discussion16.15 - 16.45 Freeze-dried sperm preservation: are we looking at the future? - Luca Gianaroli (Italy)16.45 - 17.00 Discussion17.00 - 17.30 Business meeting Special Interest Group EmbryologyProgramme book35

COURSE 5Sunday, 7 July−−Room Capital Suite 13−−−−Impact of pelvic pain and uterine bleeding on quality of lifeOrganised by the Special Interest Group Endometriosis/EndometriumCourse coordinators: Hilary Critchley (United Kingdom)Course description: Multidisciplinary content addressing:−−what we know now about pain and uterine bleeding−−what we need to know to improve treatment outcomes−−how to prioritise basic research that can be translated into patient benefit−−the impact of pelvic pain and menstrual bleeding disturbances on quality of life for women. This topic will encompass (but not exclusively) the clinical conditions of endometriosis, fibroids, and HMB (heavy menstrual bleeding) -the focus will be upon symptoms and impact of interventions on the patient from a multidisciplinary perspective.−−medical, surgical, and complementary therapy outcomes will be addressed in terms of morbidity, mortality, qualityof life (pain & bleeding), and fertility.−−future research priorities proposed by each speaker for discussion at the end of each presentationTarget audience: All providers of care for women with the complaints of pelvic pain and unacceptable menstrualbleeding. This will include care-providers of women with endometriosis, fibroids, and HMB: including clinicians,scientists (especially those with an interest in bleeding and pain mechanisms) and psychologists with an interest inquality of life and the impact of pelvic pain and bleeding. We welcome the attendance of those who provide multi-/cross-discipline care provision.Course programmeChairman: Andrew Horne (United Kingdom)09.00 - 09.30 Pain and bleeding and quality of life - the evidence - Cindy M. Farquhar (New Zealand)09.30 - 09.45 Discussion09.45 - 10.15 From basic research to clinical management - are we improving women’s quality of life? -Peter Rogers (Australia)10.15 - 10.30 Discussion10.30 - 11.00 Coffee break11.00 - 11.30 Endometrialgia: neuronal pathways in the perception of endometriosis-associated pain(ipv: Neuronal pathways in the perception of endometriosis-associated pain: novel therapeuticopportunities) - Thomas Lundeberg (Sweden)11.30 - 11.45 Discussion11.45 - 12.15 Pelvic pain and bleeding - the impact on female sexuality - Brigitte Leeners (Switzerland)12.15 - 12.30 Discussion12.30 - 13.30 Lunch13.30 - 14.00 Medical management and patient benefit - Khalid Khan (United Kingdom)14.00 - 14.15 Discussion14.15 - 14.45 Pelvic surgery and patient benefit - Philippe Koninckx (Belgium)14.45 - 15.00 Discussion15.00 - 15.30 Coffee break15.30 - 16.00 Psychologically-informed pain management and pain self-management - Amanda Williams (UK)16.00 - 16.15 Discussion16.15 - 16.45 Quality of life outcomes and trial regulation: influence on future clinical study design -Stephen Kennedy (United Kingdom)16.45 - 17.00 Discussion36

COURSE 6Sunday, 7 July−−Room Capital Suite 09−−−−High standard psychosocial care in your clinic; how to implement new guidelinesOrganised by the Special Interest Group Psychology and CounsellingCourse coordinators: Chris Verhaak (The Netherlands) and Uschi Vandenbroeck (Belgium)Course description: Supported by the ESHRE guideline group, new guidelines for psychosocial care are developedby psychologists, counsellors, nurses and gynaecologists. The guidelines are focused on implementing psychosocialcare in different aspects of daily clinical care. The workshop is aimed to facilitate implementing the guidelines in dailypractice.Target audience: Doctors and nurses, psychologists and counselorsCourse programmeChairman: Christianne Verhaak (The Netherlands) and Uschi Van den Broeck (Belgium)09.00 - 09.30 Tackling the burden of ART, a practical guide for clinical staff -Jacky Boivin (United Kingdom)09.30 - 09.45 Discussion09.45 - 10.15 Guidelines and then: how to implement psychosocial care in daily practice -Nathalie Vermeulen (Belgium)10.15 - 10.30 Discussion10.30 - 11.00 Coffee break11.00 - 11.30 The implementation of tailored expectant management in reproductive medicine -Noortje Van Den Boogaard (The Netherlands)11.30 - 11.45 Discussion11.45 - 12.15 How can mental health professionals work with other clinic staff to implement psychosocialsupport? - Sofia Gameiro (Portugal)12.15 - 12.30 Discussion12.30 - 13.30 Lunch13.30 - 14.00 How doctors could implement psychosocial care - Christos Venetis (Greece)14.00 - 14.15 Discussion14.15 - 14.45 How to support patients in the waiting period? - Deborah Lancastle (United Kingdom)14.45 - 15.00 Discussion15.00 - 15.30 Coffee break15.30 - 16.00 Screening on distress in ART patients; theoretical background and practical implications -Angelique van Dongen (The Netherlands)16.00 - 16.15 Discussion16.15 - 16.45 Supporting patients in changing lifestyle. Rotterdam Lifestyle interventions -Geranne Jiskoot (The Netherlands)16.45 - 17.00 DiscussionPRE-CONGRESS COURSESProgramme book37

COURSE 7Sunday, 7 July−−−−−−Room Capital Hall BOvarian stimulation for ART: how to achieve efficacy and safety?Organised by the Special Interest Group Reproductive EndocrinologyCourse coordinators: Georg Griesinger (Germany)Course description: Ovarian stimulation remains an essential part of ART. Inter-individual variation in ovarianresponse represents a significant clinical and economical challenge. Undoubtedly, there is a need to reliably predictovarian response to stimulation, to tailor stimulation protocols optimizing the probability of pregnancy and keep at thesame time the risks of complications and costs at a minimum.Special emphasis needs to be given on how to avoid excessive response and predict the occurrence of ovarianhyperstimulation syndrome (OHSS), as well as on maximizing tolerability of treatment from a patient’s perspective.Topics to be covered include ovarian stimulation strategies; primary, secondary and tertiary prevention of OHSS;development of protocols for patients with diminished ovarian reserve; ovarian reserve testing and its practicalimplications; mild stimulation and financial implications; segmentation of IVF treatment; impact of ovarian stimulationon the endometrium; and emergency stimulation for oncofertility patients.Target audience: Physicians and scientists in reproductive medicineCourse type: AdvancedCourse programmeSESSION 1: Cost IMPLICATIONS of OVARIAN STIMULATION in EXPECTED normal respondersChairman: Daniela Romualdi (Italy)09.00 - 09.15 Introduction and E-system voting09.15 - 09.45 Conventional stimulation & cryopreservation of surplus oocytes or embryos is the most costeffectivetreatment - Filippo Ubaldi (Italy)09.45 - 10.15 Repetitive natural cycles or mild stimulation offer most benefit per Euro spent -Michael von Wolff (Germany)10.15 - 10.30 E-system voting & Discussion10.30 - 11.00 Coffee breakSESSION 2: Poor response TO OVARIAN STIMULATION: three short SKETCHES and a mini-DEBATEChairman: Frank J. Broekmans (The Netherlands)11.00 - 11.15 Is the clinical impact of a poor response female age dependant? - Simone Broer (The Netherlands)11.15 - 11.30 Is manipulating intra-ovarian androgen conditions effective in upgrading ovarian response? -Renato Fanchin (France)11.30 - 11.45 Will application of stimulation dosages over 225 IU per day prevent a poor response? -Frank J. Broekmans (The Netherlands)11.45 - 12.30 Mini - Debate: A first cycle poor responder after adequate FSH dosing should not be allowedfurther ART treatment11.45 - 12.00 Pro - Petra De Sutter (Belgium)12.00 - 12.15 Con - Pia Saldeen (Sweden)12.15 - 12.30 E-system voting12.30 - 13.30 Lunch38

PRE-CONGRESS COURSESSession 3: Excessive responseChairman: Georg Griesinger (Germany)13.30 - 13.40 Introduction and E-system voting13.40 - 14.00 How should we stimulate patients with polycystic ovaries - Efstratios Kolibianakis (Greece)14.00 - 15.00 Debate: Excessive ovarian response affects oocyte quality, endometrial receptivityand child health14.00 - 14.22 Pro - Nicholas Macklon (United Kingdom)14.22 - 14.44 Con - Karin Middelburg (The Netherlands)14.45 - 15.00 E-system voting & Discussion15.00 - 15.30 Coffee breakSESSION 4: INDIVIDUALISATION of OVARIAN STIMULATION: CAN it IMPACT the OUTCOME?Chairman: Efstratios Kolibianakis (Greece)15.30 - 15.45 Introduction and E-system voting15.45 - 16.15 Maximising success rates by stimulation individualization -Ernesto Sr. Bosch (Spain)16.15 - 16.45 Individualisation of ovarian stimulation has little impact on outcome -Georg Griesinger (Germany)16.45 - 17.00 E-system voting & DiscussionProgramme book39

COURSE 8Sunday, 7 July−−Room Capital Suite 14−−−−Genetic and epigenetic causes of infertility - can we minimize the risks?Organised by the Special Interest Group Reproductive GeneticsCourse coordinators: Ursula Eichenlaub-Ritter (Germany), Joyce Harper (United Kingdom),Wendy Dean (United Kingdom) and Tania Milachich (Bulgaria)Course description: The link between reproduction and genetics has been studied extensively, having benefittedimmensely from the human genome project. What is now apparent is that epigenetics may play an equally importantrole in reproductive potential. In the post genomic era, whole genome scanning may become routine practice beforecouples try to conceive. This will be an exciting time but not without ethically difficult issues to resolve. This workshop isdesigned to update delegates on our current knowledge of genetic testing and epigenetics in relation to fertility.The course will cover some of the latest findings relating to the female, the male and the embryo. One of the questionswill be - can we minimise genetic and epigenetic risks? This is an advanced course and so a basic knowledge ingenetics and embryology is necessary.Target audience: Scientist, embryologists and medics interested in genetics, PGD specialists, geneticistsCourse type: AdvancedCourse programmeChairman: Joyce Harper (United Kingdom)INTRODUCTION09.00 - 09.30 Genes and genetic testing - where are we today? - Alan H. Handyside (United Kingdom)09.30 - 09.45 Discussion09.45 - 10.15 Epigenetics and fertility - Wendy Dean (United Kingdom)10.15 - 10.30 Discussion10.30 - 11.00 Coffee breakFemale11.00 - 11.30 Genome scanning to identify genes in PCOS and early onset menopause -Joop S.E. Laven (The Netherlands)11.30 - 11.45 Discussion11.45 - 12.15 Epigenetics in the oocyte - Thomas Haaf (Germany)12.15 - 12.30 Discussion12.30 - 13.30 LunchMale13.30 - 14.00 Genetic factors for male infertility - Stephane Viville (France)14.00 - 14.15 Discussion14.15 - 14.45 Paternal DNA packaging in sperm - more than the sum of its parts? DNA, histones, protamines,and epigenetics - David Miller (United Kingdom)14.45 - 15.00 Discussion15.00 - 15.30 Coffee break40

PRE-CONGRESS COURSESEmbryos15.30 - 16.00 Epigenetic mechanisms in the preimplantation embryo - Robert Feil (France)16.00 - 16.15 DiscussionPREGNANCY and minimizing the risks16.15 - 16.45 Links between the genome and the epigenome in utero - Gudrun Moore (United Kingdom)16.45 - 17.00 DiscussionProgramme book41

COURSE 9Sunday, 7 July−−Room Capital Suite 10−−−−The impact of reproductive surgery on repeated implantation failureOrganised by the Special Interest Group Reproductive SurgeryCourse coordinators: Vasilios Tanos (Cyprus) and Tin-Chiu Li (United Kingdom)Course description: This advanced course aims to review the aetiology of implantation failure dealing withcongenital and acquired pathology as well as the impact of reproductive surgery in diagnosis and treatment.Daily practice problems and dilemmas about implantation failure and how reproductive surgery can solve them will beextensively analysed and discussed. The importance of imaging techniques and endoscopic procedures as diagnosticand treatment tools, improving implantation will be also reported. Presentations of surgical procedures and evidencebased data how implantation and endometrial receptivity can be increased will be demonstrated.Target audience: Gynaecologists, Embryologists, RadiologistsCourse type: AdvancedCourse programme09.00 - 09.30 Overview of recurrent implantation failure following IVF treatment - Zi-Jiang Chen (China)09.30 - 09.45 Discussion09.45 - 10.15 The role of imaging techniques in the investigation of the pathology affecting implantationTVU 2D / 3D, Hydrosography, MRI - Tarek El-Toukhy (United Kingdom)10.15 - 10.30 Discussion10.30 - 11.00 Coffee break11.00 - 11.30 New insights of subtle congenital uterine malformation on implantation -Marco Gergolet (Italy)11.30 - 11.45 Discussion11.45 - 12.15 Overview on the uterine congenital anomalies and their impact on implantation failure -Gregoris Grimbizis (Greece)12.15 - 12.30 Discussion12.30 - 13.30 Lunch13.30 - 14.00 Intramural fibroids and implantation failure - Mostafa Metwally (United Kingdom)14.00 - 14.15 Discussion14.15 - 14.45 Adenomyosis and implantation failure: the oocyte or the uterus? - Stephan Gordts (Belgium)14.45 - 15.00 Discussion15.00 - 15.30 Coffee break15.30 - 16.00 Surgery of hydrosalpinges and implantation rate (salpiggectomy/salpigostomy/ligation/essure) -Vasilios Tanos (Cyprus)16.00 - 16.15 Discussion16.15 - 16.45 The importance of minor endometrial pathology and endometrial scratching in repeatedimplantation failure. When a treatment is indicated - Tin-Chiu Li (United Kingdom)16.45 - 17.00 Discussion42

COURSE 10Sunday, 7 July−−Room Capital Suite 16−−−−Pluripotent stem cells, cancer and fertility preservation: science fact or science fiction?Organised by the Special Interest Group Stem Cells and Task Force Fertility Preservation in Severe DiseasesCourse coordinators: Rita Vassena (Spain), Anis Feki (Switzerland), Helen Picton (UK) and Karen Sermon (Belgium)Course description: This advanced course will try to unveil the link between pluripotent stem cells and cancer,and how this has repercussions on fertility preservation. The course will cover the current knowledge on stem cells ingonads, how these stem cells are related to cancer of reproductive organs and how this affects cancer treatmentas well as infertility treatmentTarget audience: Stem cell biologists, fertility specialists with an interest in fertility preservation after cancertreatmentCourse type: AdvancedCourse programmeChairman: Anis Feki (Switzerland) and Helen M. Picton (United Kingdom)09.00 - 09.30 Stem cells in ovarian tissue- the case for and against - Evelyn E. Telfer (United Kingdom)09.30 - 09.45 Discussion09.45 - 10.15 Female fertility preservation and reproductive outcome - Claus Yding Andersen (Denmark)10.15 - 10.30 Discussion10.30 - 11.00 Coffee breakPRE-CONGRESS COURSESChairman: Rita Vassena (Spain) and Karen Sermon (Belgium)11.00 - 11.30 Stem cells in testis and their role in fertility preservation - Ans van Pelt (The Netherlands)11.30 - 11.45 Discussion11.45 - 12.15 Advances in male germ cells preservation and transplantation - Christine Wyns (Belgium)12.15 - 12.30 Discussion12.30 - 13.45 LunchChairman: Anis Feki (Switzerland) and Rita Vassena (Spain)13.45 - 14.20 Epigenetics of pluripotent cells - John Huntriss (United Kingdom)14.20 - 14.40 Discussion15.00 - 15.30 Coffee breakChairman: Helen M. Picton (United Kingdom) and Karen Sermon (Belgium)15.30 - 16.00 Stimulation protocols in cancer patients - Juan Garcia Velasco (Spain)16.00 - 16.15 Discussion16.15 - 16.45 Cancer stem cells and their role in male germline cancers- James Korkola (U.S.A.)16.45 - 17.00 Discussion17.00 - 18.00 Business meeting of the SIG Stem CellsProgramme book43

COURSE 11Sunday, 7 July−−Room Capital Suite 02−−−−Responsible innovation in medically assisted reproductionOrganised by the Special Interest Groups Ethics and Law & Safety and Quality in ARTCourse coordinators: Wybo Dondorp (The Netherlands), Guido De Wert (The Netherlands), Petra De Sutter(Belgium) and Willianne Nelen (The Netherlands)Aim: To present an overview of issues, challenges and responsibilities relevant to the safety and quality of innovationsin medically assisted reproduction.Background: Also in the light of reported subtle health effects in children born with the help of reproductivetechnologies, there is a growing awareness in the field that safety as a crucial aspect of innovation needs moresystematic attention than it has sometimes received in the past. Relevant questions include (but are not limited to) therelation between practice adaption and research, the usefulness of research in animal models and embryos, theimportance of registries and follow-up studies, the level of risk that should be regarded as acceptable and how thevarious stakeholders (including ESHRE) can contribute to making the field more accountable in this regard.Target audience: Congress participants who as researchers, embryologists or clinicians have a professional interestin the safety and quality of new reproductive technologies, participants with a general interest in the ethics of assistedreproduction, policy makers, etc.Course type: AdvancedCourse programmeChairman: Willianne Nelen (The Netherlands)09.00 - 09.30 Possible subtle adverse health outcomes of medically assisted reproduction (MAR): a review -Arianna D’Angelo (United Kingdom)09.30 - 09.45 Discussion09.45 - 10.15 Innovation in MAR: lessons from the past (ICSI), challenges for the present (oocyte vitrification),perspectives on the future (artificial gametes) - Heidi Mertes (Belgium)10.15 - 10.30 Discussion10.30 - 11.00 Coffee break11.00 - 11.30 What animal research may contribute to safety and quality in MAR? - Thomas D’Hooghe (Belgium)11.30 - 11.45 Discussion11.45 - 12.15 In vitro-maturation of oocytes: is there a case for preclinical embryo research? -Guido De Wert (The Netherlands)12.15 - 12.30 Discussion12.30 - 13.30 Lunch Chairman: Veerle Provoost (Belgium)13.30 - 14.00 When should practice adaptation be research? The case of culture media in IVF -John Dumoulin (The Netherlands)14.00 - 14.15 Discussion14.15 - 14.45 The health of the future child: what level of risk is acceptable in MAR? -Nils-Eric Sahlin (Sweden)14.45 - 15.00 Discussion15.00 - 15.30 Coffee break15.30 - 16.00 Registries and follow-up studies: a joint responsibility of the field - Maryse Bonduelle (Belgium)44

PRE-CONGRESS COURSES16.00 - 16.15 Discussion16.15 - 16.45 Multidisciplinary forum debate aimed at formulating policy conclusions -Petra De Sutter (Belgium)16.15 - 16.45 Multidisciplinary forum debate aimed at formulating policy conclusions -Wybo J. Dondorp (The Netherlands)16.45 - 17.00 DiscussionProgramme book45

course 12Sunday, 7 July−−Room Capital Suite 17−−−−Total quality management (TQM) in an IVF CentreOrganised by the Task Force Management of Fertility Units in conjunction with the Special Interest GroupsAndrology/Embryology/Reproductive Surgery & Safety and Quality in ARTCourse coordinators: Paul Devroey (Belgium) and Luca Gianaroli (Italy)Course description: Total quality management or TQM is an integrative philosophy of management for continuouslyimproving the quality of services and processes. Through the years, this concept has become fundamental inHealthcare, a field in which a high standard of treatment should constantly be pursued. This Course focuses on allprocesses performed within Fertility Units and how they can be influenced and improved by TQM in order to providepatients with the best and most safe treatments and procedures available. The course will also investigate how TQMcan be a useful tool to improve efficacy and efficiency, also with reference to financial and administrative aspects.Target audience:−−Clinicians−−Embryologists−−Professionals involved in Quality Control and Total Quality Management−−Managers of Fertility Units and public and academic hospitalsCourse type: AdvancedCourse programme08.45 - 09.00 Introduction: What is TQM? - Luca Gianaroli (Italy)Part I: IMPACT of TOTAL quality MANAGEMENT in:Chairman: Luca Gianaroli (Italy)09.00 - 09.30 Andrology lab - David Mortimer (Canada)09.30 - 09.45 Discussion09.45 - 10.15 Embryology - Arne Sunde (Norway)10.15 - 10.30 Discussion10.30 - 11.00 Coffee breakChairman: Paul Devroey (Belgium)11.00 - 11.30 Reproductive surgery - Rudi L. Campo (Belgium)11.30 - 11.45 Discussion11.45 - 12.15 Complications related to ART - Jan Gerris (Belgium)12.15 - 12.30 Discussion12.30 - 13.30 Lunch46

PRE-CONGRESS COURSESPart II: The CYCLE of TQMChairman: Amparo Ruiz Jorro (Spain)13.30 - 14.00 Patient pathway and patient satisfaction - Bart C.J.M. Fauser (The Netherlands)14.00 - 14.15 Discussion14.15 - 14.45 How to implement TQM - Tonko Mardesic (Czech Republic)14.45 - 15.00 Discussion15.00 - 15.30 Coffee breakChairman: Timur Gürgan (Turkey)15.30 - 16.00 The cost of quality: Example of the IVI approach to the continuous improvement -Carlos Blanes (Spain)16.00 - 16.15 Discussion16.15 - 16.45 The role of the European Tissue Directive on TQM - Edgar Vasile Mocanu (Ireland)16.45 - 17.00 Discussion17.00 - 17.15 Closing remarks - Veljko Vlaisavljevic (Slovenia)Programme book47

Course 13Sunday, 7 July−−Room Capital Suite 15−−−−Precision medicine: Paving the way to new reproductive disease taxonomies, diagnostics and therapeuticsOrganised by the American Society for Reproductive MedicineObjectives: This Pre-Congress Course will focus on the meaning of precision medicine and discuss its application tomale and female infertility and to classification, diagnosis, and targeted therapies for diseases of the reproductive tract.Target audience: Reproductive Endocrinologists, Andrologists, General Gynecologists, Urologists, and AlliedReproductive Health ProfessionalsLearning objectives: At the conclusion of this course, participants should be able to:1. Define precision medicine and discuss its relevance to integrating patient genetic, clinical, and diseaseinformation, and translating this to development of diagnostics and targeted therapies in reproduction2. List the types and sources of data and information available to put into knowledge networks and the role ofbiomedical informatics in these processes.3. Describe resources (databases), genetic abnormalities, and clinical phenotypes are involved in male and femaleinfertility and reproductive disorders, including, polycystic ovary syndrome, premature ovarian insufficiency,endometriosis and hypothalamic amenorrheaCourse programmeChairman: Linda C. Giudice (U.S.A.)09.00 - 09.30 Precision medicine: what it is and its relevance to infertility phenotypes, diagnosis and treatment -Linda C. Giudice (U.S.A.)09.30 - 09.45 Discussion09.45 - 10.15 Genetics and phenotypes in male infertility: databases and new diagnostics/therapeutics -Dolores J. Lamb (U.S.A.)10.15 - 10.30 Discussion10.30 - 11.00 Coffee break11.00 - 11.30 Genetics and phenotypes in premature ovarian insufficiency and oocyte aging: databasesand new diagnostics/therapeutics - Antonio Pellicer (Spain)11.30 - 11.45 Discussion11.45 - 12.15 Genetics and phenotypes in polycystic ovary syndrome: databases and new diagnostics/therapeuticsRoger Lobo (U.S.A.)12.15 - 12.30 Discussion12.30 - 13.30 Lunch13.30 - 14.00 Genetics and phenotypes in endometriosis: databases and new diagnostics/therapeutics -Serdar E. Bulun (U.S.A.)14.00 - 14.15 Discussion14.15 - 14.45 Genetics and phenotypes in hypothalamic amenorrhea: databases and new diagnostics/therapeuticsRichard Reindollar (U.S.A.)14.45 - 15.00 Discussion15.00 - 15.30 Coffee break15.30 - 16.00 Genetics and phenotypes of embryos in culture: databases and new diagnostics for embryoselection - Antonio Pellicer (Spain)16.00 - 16.15 Discussion16.15 - 16.45 Resources of patient information - Craig Niederberger (U.S.A.)16.45 - 17.00 Discussion48

Course 14Sunday, 7 July−−Room Capital Suite 06−−−−Academic Authorship Programme - The A to Z of research: doing a study, presenting a poster, giving a talk,writing it upOrganised by the Editors of Human Reproduction JournalsLearning objectives: After attending the course the participant should be familiar with the principles of studydesign - including those for treatment and diagnostic test studies. Considerable focus will be directed to the keycomponents of a manuscript, with practical exercises designed to equip participants with the knowledge required toprepare their work for publication, either as a poster or as an oral presentation, and finally as an original publication ina scientific journal.Course format: There will be just five lectures; the rest of the day being devoted to small-group exercises withfeedback to all participants following each exercise.Target audience: Young clinicians and scientists, people at the onset of the writing and presentation phase of theiracademic career, and all those who wish to familiarize themselves with present day ideas about designing a study andpublishing its outcome.Faculty:C. Barratt, Editor-in-Chief MHRH. Beard, Managing Editor MHRM. Brown/Ph. Bishop, Senior Publisher, Clinical Medicine, Oxford University PressH. Evers, Editor-in-Chief Human Reproduction (Course chair)F. Petraglia, Editor-in-Chief Human Reproduction UpdateR. Sharpe, Deputy Editor Human ReproductionE. Somigliana, Deputy Editor Human ReproductionA. van Steirteghem, Editor Emeritus, Human ReproductionM. van Wely, Deputy Editor Human Reproduction UpdateK. Watkins, Assistant Managing Editor ESHRE JournalsA. Williams, Managing Editor ESHRE JournalsPRE-CONGRESS COURSESCourse programme09.00 - 09.10 Introduction to the course - Johannes Evers (The Netherlands)09.10 - 09.40 Principles of study design, treatment - Johannes Evers (The Netherlands)09.40 - 09.50 Discussion09.50 - 10.20 Principles of study design, diagnosis - Madelon Van Wely (The Netherlands)10.30 - 11.00 Coffee break10.20 - 10.30 Discussion11.00 - 11.30 Presenting a poster - Chris Barratt (United Kingdom)11.30 - 12.30 Group work on poster presentation + report to group - Chris Barratt (United Kingdom)12.30 - 13.30 Lunch13.30 - 14.00 Giving a talk - Edgardo Somigliana (Italy)14.00 - 15.00 Group work on oral presentation + report to group - Edgardo Somigliana (Italy)15.00 - 15.30 Coffee break15.30 - 16.00 Writing a study up for a scientific journal - Richard Sharpe (United Kingdom)16.00 - 17.00 Group work on writing a manuscript + report to group - Richard Sharpe (United Kingdom)17.00 - 17.10 Conclusions of the course - Felice Petraglia (Italy)Programme book49

course 15Sunday, 7 JulyRoom Capital Suite 01Optimizing IVF outcomeOrganised by the Middle East Fertility SocietyCourse coordinators: Mohamed Aboulghar (Egypt)Course description, teaching aims and course description:How to optimize IVF results based on high quality evidence.Course description and characteristics: This is an advanced course in IVF.Steps to optimize IVF before starting the procedure by identification of the conditions which may negatively affect theresults of IVF, it should recognized and treated. The optimum stimulation protocol for IVF will be discussed. Optimizingculture conditions for oocytes and embryos is essential for generating high quality embryos. Optimum cultureconditions will be explained. The number of embryos transferred with emphasis on the current and future role of singleembryo transfer is essential for a current IVF program. Results of single embryo transfer will be evaluated.The technique of embryo transfer is critical to the success of IVF. The methodology of embryo transfer, how to choosethe embryo transfer catheter in addition to the importance of mock embryo transfer will be discussed.The prevention of the most serious complication of ovulation induction which is ovarian hyperstimulation syndrome isan important step to ensure safety of IVF. Implantation is the critical step for improving pregnancy rate, explanation ofthe unclear aspects of implantation will be discussed and possible future steps to improve implantation rate will beexplored. Vitrification which gained widespread use in cryopreservation of embryos and oocytes became the method ofchoice for freezing embryos. Details and advantages will be explained.Target audience: Physicians, ART specialists, registrars in Ob/Gyn, Fellows in assisted reproduction, embryologistsand biologistsCourse programmeChairman: Mohamed A. Aboulghar (Egypt)09.00 - 09.30 Identification and management of conditions detrimental to IVF outcome -Mohamed A. Aboulghar (Egypt)09.30 - 09.45 Discussion09.45 - 10.15 Optimizing the stimulation protocol for IVF - Bart C.J.M. Fauser (The Netherlands)10.15 - 10.30 Discussion10.30 - 11.00 Coffee break11.00 - 11.30 Is single embryo transfer going to be the future? - Siladitya Bhattacharya (United Kingdom)11.30 - 11.45 Discussion11.45 - 12.15 Optimizing culture conditions - Antonio Capalbo (Italy)12.15 - 12.30 Discussion12.30 - 13.30 Lunch13.30 - 14.00 Prevention of OHSS - Mohamed A. Aboulghar (Egypt)14.00 - 14.15 Discussion14.15 - 14.45 Techniques and Technologies for Embryo Transfer: Does it Really Matter - Johnny Awwad (Lebanon)14.45 - 15.00 Discussion15.00 - 15.30 Coffee break15.30 - 16.00 Improving Implantation - The endometrial factor matters - Carlos Simon Valles (Spain)16.00 - 16.15 Discussion16.15 - 16.45 Optimizing the outcome of cryopreservation - Safaa Al-Hasani (Germany)50

PRE-CONGRESS COURSESProgramme book51

Overview MONDAY, 8 July 201308.00 - 09.00Session 01: Keynote lectures session Auditorium−−−−Prof. Robert Edwards: the man and his visio - Victor Gomel (Canada)The Human Reproduction Keynote Lecture - Trophectodermmorphology: an important parameter for predicting live birth after singleblastocyst transfer - Aisling Ahlstrom (Sweden)Auditorium09.30 - 10.00Coffee breakEXHIBIT HALL10.00 - 11.30SESSION 02: From oocyte to blastocystSESSION 03: The impact of new clinical evidence in (early) pregnancySession 04: PCOSSession 05: Sperm factors influencing ART outcomeSession 06: EndometriosisSession 07: Female infertility: new developmentsAuditoriumCapital Hall ACapital Suite ACapital Hall BS8 - AS8 - B11.45 - 13.00Ferring Company SymposiumAuditorium11.45 - 12.45Session 08: Advances in fertility preservation for severe diseases−−Reproductive outcome after fertility preservation in girls and women -Dror Meirow (Israel)−−Advances in fertility preservation for boys and men -Stefan Schlatt (Germany)Capital Hall A11.45 - 12.45Session 09: ESHRE data reporting on PGD cycles and oocyte donation−−Data from the ESHRE PGD Consortium - Joanne Traeger (Synodinos,Greece)−−Introduction to the study of the ESHRE Cross Border Reproductive Care(CRBC) task force (TF) - Françoise Shenfield (United Kingdom)−−Oocyte donors in Europe: who are they? - Jacques De Mouzon (France)−−Reasons for donation among oocyte donors in 11 European countries -Guido Pennings (Belgium)Capital Suite A11.45 - 12.15Session 10: Fertility Society of Australia exchange lecture−−Embryos with good morphology but abnormal cell divisions havesignificantly lower implantation potential - Joe Conaghan (U.S.A.)Capital Hall B11.45 - 12.45Session 11: Paramedical invited session - Nursing−−Fertility assessment and counselling in normal women and men -Anders Nyboe Andersen, Denmark−−Psychological stress in women who have conceived pregnancies viain-vitro fertilization - Eleanor Lowndes Stevenson (U.S.A.)S8 - B13.00 - 14.00Lunch break and Poster viewing and discussion at the Speakers' Cornerin the poster area.Exhibit hall14.00 - 15.15MSD Company SymposiumAuditorium52

14.00 - 15.00Session 12: Regulation of sperm motility by the female tract and oocyte:Capital Hall Amessages and signals (MHR session)−−Controlling how sperm swim: Ca 2+ signals, Ca 2+ stores and Ca 2+channels - Stephen Publicover (United Kingdom)−−The non-genomic action of progesterone in human sperm -an ionotropic rather than metabotropic mechanism -U.B. Kaupp (Germany)14.00 - 15.00Session 13: Gathering evidence in early pregnancy research -Capital Suite AMaking trials happen−−Pregnancy of unknown location. Solving the puzzle -Davor Jurkovic (United Kingdom)−−The secret of successful trials - Siobhan Quenby (United Kingdom)14.00 - 15.00Session 14: Paramedical selected oral session - LaboratoryS8 - B15.15 - 16.30Session 15: Embryo and culture environmentAuditoriumSession 16: Innovations in reproductive geneticsCapital Hall ASession 17: Promises of AMHCapital Suite ASession 18: Lifestyle dangers for men’s fertilityCapital Hall BSession 19: Psychology and counsellingS8 - ASession 20: The ovary in female infertilityS8 - B16.30 - 17.0017.00 - 18.00Coffee breakSession 21: Assessing the polycystic ovary (Clinical tutorial)Exhibit hallAuditoriumMONDAY−−Defining the PCOS by ultrasound of the ovary - Sophie Jonard (France)−−Defining the PCOS by biochemistry - pitfalls and practice -Julian Barth (United Kingdom)17.00 - 18.00Session 22: Advanced methods of assessing sperm qualityCapital Hall A−−The role of sperm DNA testing in the clinic -Aleksander Giwercman (Sweden)−−The clinical andrological perspective on diagnosis and treatment ofmale infertility - Kevin McEleny (United Kingdom)Programme book53

Monday 8 July 2013Invited session08.30 - 09.30 AuditoriumSession 01: Keynote lectures sessionChairman: A. Veiga (Spain)Chairman: J. Evers (The Netherlands)08.30 o-001 prof. Robert Edwards: the man and his visionV. Gomel (Canada)09.00 o-002 the Human Reproduction Keynote Lecture - Trophectoderm morphology: an important parameterfor predicting live birth after single blastocyst transferA. Ahlstrom, C. Westin, M. Wikland, T. Hardarson (Sweden)54

Monday 8 July 2013Selected oral communication session10.00 - 11.30 AuditoriumSession 02: From oocyte to blastocystChairman: K. Lundin (Sweden)Chairman: TBA10.00 o-003 does the duration of compaction differ in fragmented cleavage stage embryos that becomeeuploid or aneuploidy blastocystsS. Montgomery, S. Duffy, N. Bowman, M. Sedler, A. Campbell, S. Fishel (United Kingdom)10.15 o-004 dna profiling of culture medium as a novel, non-invasive tool for embryo assessmentP. Scaruffi, S. Stigliani, P.L. Venturini, P. Anserini (Italy)10.30 o-005 oocyte dysmorphisms negatively influence the morphology of the inner-cell mass andtrophectoderm and developmental competence of the blastocystR.C. Ferreira, R.C.S. Figueira, D.P.A.F. Braga, A.S. Setti, A. Iaconelli Jr., E. Borges Jr. (Brazil)10.45 o-006 direct embryo tagging system: a novel tool to reduce the risk of mix-ups in human assistedreproduction technologiesS. Novo, O. Penon, C. Nogués, L. Barrios, J. Santaló, M. Duch, R. Gómez-Martínez, L. Pérez-García,J.A. Plaza, E. Ibáñez (Spain)11.00 o-007 transfer of day 4 vitrified-warmed embryos yields equally good clinical outcomes as compared toblastocysts vitrified on days 5 or 6J. Menezes, P.G.L. Lalitkumar, P. Borg, K. Vaegter, M. Wramsby, H. Wramsby (Sweden)MONDAY11.15 o-008 the effects of mice maternal obesity on embryo quality and on embryo vitrification injuryW. Ma, X. Liang, X. Huang, X. Yang, L. Wei (China)Programme book55

Monday 8 July 2013Selected oral communication session10.00 - 11.30 Capital Hall ASession 03. The impact of new clinical evidence in (early) pregnancyChairman: M. Goddijn (The Netherlands)Chairman: R.G. Farquharson (United Kingdom)10.00 O-009 No benefit of low molecular weight heparin in recurrent pregnancy loss - results of the ETHIG II studyN. Rogenhofer, E. Schleussner, G. Kamin, G. Seeliger, B. Toth for the ETHIG Investigator Group (Germany)10.15 o-010 How does IVF and the number of embryos transferred affect first trimester growthS.D. Sur, B.K. Campbell, N.J. Raine-Fenning (United Kingdom)10.30 o-011 transfer of single frozen blastocyst reduces the risk of ectopic pregnancyY.A. Wang, E.A. Sullivan, M. Chapman (Australia)10.45 o-012 semiquantitative digital home pregnancy test in comparison to standardised ultrasoundassessment of gestational age: a randomised studyS. Johnson, S. Godbert, J. Larsen, P. Buchanan, T. Alonzo, M. Zinaman (United Kingdom)11.00 o-013 increased density of uterine natural killer cells in the peri-implantation endometrium isassociated with inadequate decidualization, local cortisol deficiency, and impaired induction ofmetabolic enzymesR. Venkatakrishnan, S. Sucurovic, J.J. Brosens, S. Quenby, K. Kuroda (United Kingdom)11.15 o-014 first pregnancies with a simplified IVF procedure: a crucial step to universal and accessibleinfertility careE.P.F. Klerkx, M. Janssen, J. van Blerkom, R. Campo, W. Ombelet (Belgium)56

Monday 8 July 2013Selected oral communication session10.00 - 11.30 Capital Suite ASession 04: PCOSChairman: D. Romualdi (Italy)Chairman: A. Balen (United Kingdom)10.00 o-015 menstrual disorders at age 16 are associated with an increased risk of polycystic ovary syndromeand infertility at age 26L. Morin - Papunen, S. West, P. Pinola, A. Bloigu, A. Pouta, M.R. Järvelin, S. Franks, H. Lashen,J.S. Tapanainen (Finland)10.15 o-016 serum anti-Mullerian hormone concentrations reflect the presence of symptoms in women withpolycystic ovary syndromeR. Homburg, A. Ray, P. Bhide, A. Gudi, A. Shah, P. Timms, K. Grayson (United Kingdom)10.30 o-017 integral reproductive hormone profiles before and after laparoscopic ovarian laser evaporation inPCOS; a prospective controlled studyM.L. Hendriks, T. König, T. Korsen, R. Schats, P.G.A. Hompes, R. Homburg, E.M. Kaaijk,J.W.R. Twisk, C.B. Lambalk (The Netherlands)10.45 o-018 the role of subclinical thyroid dysfunction in the gluco-insulinemic homeostasis in women withpolycystic ovary syndrome: an euglycemic-hyperinsulinemic clamp studyS. De Cicco, A. Lanzone, D. Gagliano, V. Immediata, C. Tartaglia, A. Zumpano, E. Cirella,D. Romualdi, M. Guido (Italy)11.00 o-019 maternal characteristics and pregnancy outcomes among women undergoing AssistedReproductive Technology (ART) by infertility diagnosis: polycystic ovary syndrome versus tubalobstructionV. Grigorescu, Y. Zhang, D. Kissin, E. Sauber-Schatz, M. Sunderam, R. Kirby, H. Diop, P. McKane,D. Jamieson (U.S.A.)MONDAY11.15 o-020 the influence of sex steroids on the neuronal correlates of working memory in women withPolycystic Ovarian SyndromeR. Soleman, B.P.C. Kreukels, D.J. Veltman, P.T. Cohen-Kettenis, P.G.A. Hompes, M.L. Drent,C.B. Lambalk (The Netherlands)Programme book57

Monday 8 July 2013Selected oral communication session10.00 - 11.30 Capital Hall BSession 05: Sperm factors influencing ART outcomeChairman: N. Garrido Puchalt (Spain)Chairman: S.E.M. Lewis (Ireland)10.00 o-021 does the extent of sperm DNA fragmentation affect IVF or ICSI outcome: a systematic review andmeta analysisA. Osman, H. Alsomait, S. Seshadri, Y. Khalaf, T. El Toukhy (United Kingdom)10.15 o-022 novel detection of intratubular germ cell neoplasia in non-obstructive azoospermia using OCT3/4and PLAP in AgarCytos of testicular sperm extraction specimensM. Hessel, L. Ramos, A.F.C. Hulsbergen, K.W.M. d'Hauwers, D.D.M. Braat,C.A. Hulsbergen-van de Kaa (The Netherlands)10.30 o-023 evaluating the etiopathogenic factors of DNA damage in sperm with large nuclear vacuolesF. Bourroul, J.B.A. Oliveira, C.G. Petersen, L.D. Vagnini, A.M. Nascimento, A.L. Mauri, F.C. Massaro,A. Nicoletti, A. Pontes, M. Cavagna, R.L.R. Baruffi, J.G. Franco Jr. (Brazil)10.45 o-024 Punalpin ® increases the numbers of motile sperm in men with reduced semen quality:a prospective, randomized, controlled, double-blinded trialM.D. Kaspersen, H.B. Jakobsen, I. Giversen, L.P. Christensen, J. Fedder (Denmark)11.00 o-025 is morphologically selected sperm injection with ejaculated spermatozoa useful fornon-selected patientsN. Inoue, A. Yoshida, S. Tanigiwa, K. Seida, H. Suzuki, M. Tanaka (Japan)11.15 O-026 Motile sperm organellar morphology examination (MSOME): interest to predict clinical outcome of ICSII. Heilikman, K. Pocate, R. Porcher, V. Barraud-Lange, N. Sermondade, C. Dupont, J.P. Wolf,C. Sifer (France)58

Monday 8 July 2013Selected oral communication session10.00 - 11.30 S8 - ASession 06: EndometriosisChairman: TBAChairman: C. Becker (United Kingdom)10.00 o-027 endometriosis symptom variation by mutually adjusted demographic characteristics in acohort of 1000 womenL.F. Carvalho, S.A. Missmer, K.F. Correia, L.F.C. Fernandes, M.S. Abrão (Brazil)10.15 o-028 interleukin-8 in follicular fluid - a promising prognostic marker for IVF success in women withendometriosisR. Chattopadhyay, A.K. Singh, S. Roychoudhury, S. Ghosh, G. Bose, K. Chaudhury, M. Chakravarty,B.N. Chakravarty (India)10.30 o-029 Low molecular weight heparin versus cardioaspirin in embryo implantation in women undergoingICSI without inherited trombophilia: a randomized pilot studyI. Pergolini, E. Gravotta, M.R. Rampini, D. Marconi, P. Alfano, B. Gilio, C. Verlengia, E. Alviggi,A. Colicchia (Italy)10.45 o-030 pre-treatment with danazol before IVF in women with endometriosis: a controlled trialD. Marconi, M. Sbracia, M.R. Rampini, I. Pergolini, P. Alfano, C. Verlengia, E. Alvigi, B. Giglio,A. Colicchia (Italy)11.00 o-031 endometriotic ovarian cysts do not negatively affect the rate of spontaneous ovulationC. Scala, U. Leone Roberti Maggiore, E. Tafi, A. Racca, P.L. Venturini, V. Remorgida, S. Ferrero (Italy)MONDAY11.15 o-032 identification of sex-specific pleiotropic loci underlying endometriosis and obesity-related traitsN. Rahmioglu, S. Macgregor, H. Harris, G.W. Montgomery, S.A. Missmer, C.M. Lindgren,K.T. Zondervan (United Kingdom)Programme book59

Monday 8 July 2013Selected oral communication session10.00 - 11.30 S8 - BSession 07: Female infertility: new developmentsChairman: TBAChairman: TBA10.00 o-033 thin endometrium: an enigma or an obstacle for implantation? – analysis in donor oocyterecipients.L. Dain, D. Bider, J. Levron, V. Zinchenko, S. Westler, M. Dirnfeld (Israel)10.15 o-034 sirt1, the main component of sirtuin family, protects mouse oocytes from oxidative stress and isderegulated with agingG. Di Emidio, S. Falone, M. Vitti, M. Santonocito, M. Vento, P.g.artini, C. Di Pietro,F. Amicarelli, C. Tatone (Italy)10.30 o-035 investigating the role of kisspeptin signalling in ovulation and placentationA. Herreboudt, W.H. Colledge (United Kingdom)10.45 o-036 Comparative proteomic analysis of proteins identified at three different stages of ovarian folliclesduring in vitro development in miceA. Anastácio, C. Pionneau, S. Chardonnet, T. Almeida Santos, C. Poirot (France)11.00 o-037 preliminary comparative effectiveness of IVF with single embryo transfer or IVF in the modifiednatural cycle and IUI with hyperstimulation; a randomized trial (INeS trial)A.J. Bensdorp, R.I. Tjon-Kon-Fat, C. Koks, G.J.E. Oosterhuis, A. Hoek, P.G.A. Hompes,F.J. Broekmans, H.R. Verhoeve, J.P. de Bruin, R. van Golde, S. Repping, B.J. Cohlen, B.W.J. Mol,F. Veen van der, M. Wely van (The Netherlands)11.15 o-038 the risk of congenital heart malformations in children born after assisted reproductivetechnology: a nordic cohort study from the conartas groupA.A. Henningsen, M. Gissler, K.G. Nygren, R. Skjaerven, A. Tiitinen, U.B. Wennerholm,L.B. Romundstad, A. Nyboe Andersen, O. Lidegaard, J.L. Forman, A. Pinborg (Denmark)60

MONDAYMonday 8 July 2013Company symposium11.45 - 13.00 AuditoriumFerring Company SymposiumProgramme book61

Monday 8 July 2013Invited session11.45 - 12.45 Capital Hall ASession 08: Advances in fertility preservation for severe diseasesChairman: L. Gianaroli (Italy)Chairman: P. Barri (Spain)11.45 o-039 reproductive outcome after fertility preservation in girls and womenD. Meirow (Israel)12.15 o-040 advances in fertility preservation for boys and menS. Schlatt (Germany)62

MONDAYMonday 8 July 2013Invited session11.45 - 12.45 Capital Suite ASession 09: ESHRE data reporting on PGD cycles and oocyte donationChairman: J. Geraedts (The Netherlands)Chairman: TBA11.45 o-041 data from the ESHRE PGD ConsortiumJ. Traeger-Synodinos, E. Coonen, V. Goossens (Greece)12.15 o-042 introduction to the study of the ESHRE Cross Border Reproductive Care (CRBC) task force (TF)F. Shenfield (United Kingdom)12.20 o-043 oocyte donors in Europe: who are they?J. De Mouzon, F. Shenfield, A. Ruiz, V. Goossens, A.P. Ferraretti, T. Mardesic, G. Pennings (France)12.30 o-044 reasons for donation among oocyte donors in 11 European countriesG. Pennings, F. Shenfield, J. de Mouzon, A. Ruiz, A.P. Ferraretti, T. Mardesic, V. Goossens (Belgium)Programme book63

Monday 8 July 2013Invited session11.45 - 12.15 Capital Hall BSession 10: Fertility Society of Australia exchange lectureChairman: A. Suikkari (Finland)Chairman: TBA11.45 o-045 embryos with good morphology but abnormal cell divisions have significantly lowerimplantation potentialJ. Conaghan (USA)64

MONDAYMonday 8 July 2013Invited session11.45 - 12.45 S8 - BSession 11: Paramedical invited session - NursingChairman: TBAChairman: TBA11.45 o-046 fertility assessment and counselling in normal women and menA. Nyboe Andersen, H.W. Hvidman (Denmark)12.15 o-047 psychological stress in women who have conceived pregnancies via in-vitro fertilizationE. Lowndes Stevenson (U.S.A.)Programme book65

Monday 8 July 2013Company symposium14.00 - 15.15 AuditoriumMSD Company symposium Advances in Controlled Ovarian Stimulation: corifollitropin alfa (ELONVA)Chairman: Nicholas Macklon14.00 evolution of Controlled Ovarian Stimulation over the Past Four DecadesN. Macklon (United Kingdom)14.10 emergence of Corifollitropin Alfa into Clinical PracticeN. Macklon (United Kingdom)14.25 the PURSUE Trial: Results in Older WomenR. Boostanfar (USA)14.50 translating Knowledge from Clinical Trials to Clinical PracticeCh. Blockeel (Belgium)66

MONDAYMonday 8 July 2013Invited session14.00 - 15.00 Capital Hall ASession 12: Regulation of sperm motility by the female tract and oocyte: messages and signals (MHR session)Chairman: L. Björndahl (Sweden)Chairman: C. Barratt (United Kingdom)14.00 o-048 Controlling how sperm swim: Ca 2+ signals, Ca 2+ stores and Ca 2+ channelsS. Publicover, J. Correia, W. Alasmari, C. Barratt (United Kingdom)14.30 o-049 the non-genomic action of progesterone in human sperm - an ionotropic rather thanmetabotropic mechanismU.B. Kaupp (Germany)Programme book67

Monday 8 July 2013Invited session14.00 - 15.00 Capital Suite ASession 13: Gathering evidence in early pregnancy research - Making trials happenChairman: B.C. Tarlatzis (Greece)Chairman: TBA14.00 o-050 pregnancy of unknown location. Solving the puzzleD. Jurkovic (United Kingdom)14.30 o-051 the secret of successful trialsS. Quenby (United Kingdom)68

MONDAYMonday 8 July 2013Selected oral communication session14.00 - 15.00 S8 - BSession 14: Paramedical selected oral session - LaboratoryChairman: L. Van Den Hoven (The Netherlands)Chairman: V.N. Bolton (United Kingdom)14.00 o-052 Comparison of different enzymatic isolation protocols for human ovarian follicles suitable for aclinical cleanroom settingS. Lierman, K. Tilleman, W.H. De Vos, P. De Sutter (Belgium)14.15 o-053 sperm selection in TESE: which parameters affect the pregnancy rate after ICSI?J. Robben, M. Hessel, K.W.M. D'Hauwers, J.M.T. Rikkert, K. Fleischer, D.D.M. Braat,L. Ramos (The Netherlands)14.30 o-054 impact of spermatozoon position in the oocyte after ICSI on survival, fertilization and top-qualityblastocyst development in the humanM. Abraham, N. Franceus, A. De Vos, P. Haentjens, H. Tournaye, G. Verheyen,H. Van de Velde (Belgium)14.45 o-055 evaluation of the frozen embryo stock and destination of the frozen embryos in a large scalecryopreservation programB. Desmet, S. Vitrier, W. Meul, L. Van Landuyt, H. Tournaye, G. Verheyen (Belgium)Programme book69

Monday 8 July 2013Selected oral communication session15.15 - 16.30 AuditoriumSession 15: Embryo and culture environmentChairman: C.E. Plancha (Portugal)Chairman: R. Sturmey (United Kingdom)15.15 o-056 metabolic profiles of spent culture media does not predict pregnancy outcomeK. Kirkegaard, A.S.P. Svane, J.J. Hindkjær, N.C. Nielsen, H.J. Ingerslev (Denmark)15.30 o-057 oxygen regulates in vitro growth and metabolism of preantral ovarian follicles from adult miceD.A. Gook, K. Riordan, D.H. Edgar, J.R. Sheedy, D.K. Gardner (Australia)15.45 o-058 Complex protein supplements used for embryo culture contain high levels of amino acids andmetals and delay timing of early cleavage events in mouse embryosH. Wolff, J. Fredrickson, N. Baumann, T. Moyer, D. Matern, D. Morbeck (U.S.A.)16.00 o-059 apolipoprotein B in follicular fluid, a new predictive factor of success parameters in assistedreproductive technologyE. Scalici, K. Astruc, C. Jimenez, L. Duvillard, T. Gautier, M.N. Huot, S. Girod, E. Schmutz,L. Lagrost, P. Sagot, V. Drouineaud (France)16.15 o-060 Leptin stimulates activation of stat3 in human blastocystsS.L. Drury, D. Taylor, S.C. Gadd, G.M. Hartshorne (United Kingdom)70

Monday 8 July 2013Selected oral communication session15.15 - 16.30 Capital Hall ASession 16: Innovations in reproductive geneticsChairman: S. Viville (France)Chairman: A.H. Handyside (United Kingdom)15.15 o-061 Breakthrough/innovative approach: first genetic matching assay in an oocyte donation programusing preconceptional screening arrays (Recombine)J. Aizpurua, N. Szlarb, I. Moragues, B. Ramos, S. Rogel (Spain)15.30 o-062 Clinical application of massively parallel sequencing on chromosomal abnormalities detection ofhuman blastocystsJ. Li, X.Y. Yin, K. Tan, Y.Q. Tan, F. Chen, L.E.I. Zhang, G. Lin, H. Jiang, W. Wang (China)15.45 o-063 a novel embryo screening technique provides new insights into embryo biology and yields the firstpregnancies following genome sequencingD. Wells, K. Kaur, J. Grifo, S. Anderson, J. Taylor, E. Fragouli, S. Munne (United Kingdom)16.00 o-064 targeted sequencing of SNPs results in highly accurate non-invasive detection of fetal aneuploidyof chromosomes 13, 18, 21, X, and Y: a validation studyB. Levy, M. Banjevic, M. Hill, B. Zimmermann, A. Ryan, S. Sigurjonsson, N. Wayham, P. Lacroute,M. Dodd, B. Hoang, J. Tong, P. Vu, M.P. Hall, Z. Demko, M. Rabinowitz (U.S.A.)16.15 o-065 development and validation of rapid and cost-effective blastocyst comprehensive chromosomeanalysis methods utilising quantitative real-time PCR and microbead-based technologiesK. Spath, E. Fragouli, M. Konstantinidis, M. Poli, D. Wells (United Kingdom)MONDAYProgramme book71

Monday 8 July 2013Selected oral communication session15.15 - 16.30 Capital Suite ASession 17: Promises of AMHChairman: TBAChairman: R. Fleming (United Kingdom)15.15 o-066 is ovarian reserve a good marker of spontaneous conception in infertile women?A retrospective study of natural conception in 1551 women trying to conceiveO. Chausiaux, R. Ganyani, S. Morris, S. Baker, J. Hayes, C. Long, G. Williams,S. Husheer (United Kingdom)15.30 o-067 amH levels at age 16 are predictive of future cycle irregularity and hyperandrogenism in girlsP. Pinola, L. Morin-Papunen, D.B. Dunger, K. Ong, A. Bloigu, A. Pouta, M.R. Järvelin, S. Franks,J.S. Tapanainen, H. Lashen (Finland)15.45 o-068 anti-Müllerian hormone is not associated with cardiometabolic risk factors in adolescent femalesE. Anderson, A. Fraser, W. McNally, N. Sattar, H. Lashen, R. Fleming, S.M. Nelson,D.A. Lawlor (United Kingdom)16.00 o-069 serum AMH levels and circulating progenitor cells in women with type 1 diabetes; the role ofvascular function in ovarian agingA.C. de Kat, F. Yarde, H. Gremmels, M.C. Verhaar, F.J. Broekmans (The Netherlands)16.15 o-070 prenatal exposures and anti-Müllerian hormone in female adolescents: the Avon longitudinalstudy of parents and childrenA. Fraser, W. McNally, N. Sattar, E. Anderson, H. Lashen, R. Fleming, D.A. Lawlor,S.M. Nelson (United Kingdom)72

Monday 8 July 2013Selected oral communication session15.15 - 16.30 Capital Hall BSession 18: Lifestyle dangers for men's fertilityChairman: J.A. Castilla Alcala (Spain)Chairman: R. Cutting (United Kingdom)15.15 o-071 the effects of age on sperm quality: an evaluation of 1,500 semen samplesD.C.C. Pedroso, J.B.A. Oliveira, C.G. Petersen, A.L. Mauri, A.M. Nascimento, L.D. Vagnini,A. Nicoletti, F.C. Massaro, M. Cavagna, A.M.V.C. Martins, R.L.R. Baruffi, J.G. Franco Jr. (Brazil)15.30 o-072 early life influences on testicular function in adulthood using the western australian pregnancy(raine cohort)R. Hart, D.A. Doherty, D.J. Handelsman, R. McLachlan, N.E. Skakkebaek, J.A. Keelan,R.J. Norman (Australia)15.45 o-073 the role of paternal age on assisted reproduction outcomeN. Dokuzeylül, M. Onal, M. Acet, M. Basar, S. Kahraman (Turkey)16.00 o-074 prevalence and clearance of human papillomavirus in semen samples of infertile patients and roleon sperm parametersA. Garolla, D. Pizzol, M. Ghezzi, R. Selice, A. Bertoldo, M. Menegazzo, C. Foresta (Italy)16.15 o-075 the prevalence and awareness of relevant modifiable lifestyle factors within a population of sixhundred patients presenting for infertility treatment comparing questionnaire and interview dataC. Jordan, P. Broderick (Australia)MONDAYProgramme book73

Monday 8 July 2013Selected oral communication session15.15 - 16.30 S8 - ASession 19: Psychology and counsellingChairman: J.M.J. Smeenk (The Netherlands)Chairman: L.E. Bunting (United Kingdom)15.15 o-076 depression, relationship satisfaction and sexual functioning improve after laparoscopic surgeryfor moderate and severe endometriosis with and without bowel resectionU. Van den Broeck, C. Meuleman, C. Tomassetti, A. D'Hoore, A. Wolthuis, B. Van Cleynenbreugel,I. Vergote, F. Penninckx, P. Enzlin, T. D'Hooghe (Belgium)15.30 o-077 the impact of marital stability and re-partnering on infertility-related stress trajectories over 5years of unsuccessful fertility treatmentM. Martins, P. Costa, B.D. Peterson, M.E. Costa, L. Schmidt (Portugal)15.45 o-078 the relation between dropout and patient-centredness in fertility careA.G. Huppelschoten, A.J.C.M. van Dongen, I.C.P. Philipse, C.J.C.M. Hamilton, C. Verhaak,W.L.D.M. Nelen, J.A.M. Kremer (The Netherlands)16.00 o-079 it takes two to tango: predictive factors in both men and women for IVF treatment dropoutL. Bastings, J.M.J. Smeenk, D.D.M. Braat, C.M. Verhaak (The Netherlands)16.15 o-080 Children of surrogate mothers: psychological well-being, family relationships and experiences ofsurrogacyV. Jadva, S. Imrie, S. Golombok (United Kingdom)74

Monday 8 July 2013Selected oral communication session15.15 - 16.30 S8 - BSession 20: The ovary in female infertilityChairman: TBAChairman: P. Brinsden (United Kingdom)15.15 o-081 significantly reduced ovarian reserve in female offspring of consanguine parentsH. Fatemi, T. seher, S. biesemanns, M. al azemi, E. Thiering, J. Heinrich, J. Gutermuth (Belgium)15.30 o-082 Can birth hypoxia affect ovarian follicular reserveP. Temple-Smith, E. Pereleshina, D. LaRosa, S. Ellery, R. Snow, D. Walker, S. Catt,H. Dickinson (Australia)15.45 o-083 Comparative study about ART outcome in patients with Turner´s syndrome or partial X monosomyusing own oocytes with preimplantational genetic screening or ovum donationJ. Giles, C. Vidal, C. Rubio, F. Cruz, C. Gallo, A. Pellicer, N. Garrido (Spain)16.00 o-084 Caffeine intake does not affect female ovarian reserve. Analysis of a cohort of 1963 consecutiveblood samples evaluating hormonal ovarian statusA. Dalleac, M. Cohen-Bacrie, S. Belloc, F. Olivennes, P. Zitoun, A. Hazout, P. Cohen-Bacrie,J. De Mouzon (France)16.15 o-085 association of urinary phthalate (UrP) metabolite concentrations with ovarian response and earlyin-vitro fertilization (IVF) outcomesI. Souter, K.W. Smith, P.L. Williams, S. Ehrlich, R. Hauser (U.S.A.)MONDAYProgramme book75

Monday 8 July 2013Invited session17.00 - 18.00 AuditoriumSession 21: Assessing the polycystic ovary (Clinical tutorial)Chairman: R. Homburg (Israel)Chairman: J.S.E. Laven (The Netherlands)17.00 o-086 defining the PCOS by ultrasound of the ovaryS. Jonard, D. Dewailly (France)17.30 o-087 defining the PCOS by biochemistry - pitfalls and practiceJ.H. Barth (United Kingdom)76

MONDAYMonday 8 July 2013Invited session17.00 - 18.00 Capital Hall ASession 22: Advanced methods of assessing sperm qualityChairman: A. Van Steirteghem (Belgium)Chairman: R. Menkveld (South Africa)17.00 o-088 the role of sperm DNA testing in the clinicA. Giwercman, M. Bungum, K. Oleszczuk (Sweden)17.30 o-089 the clinical andrological perspective on diagnosis and treatment of male infertilityK. McEleny (United Kingdom)Programme book77

Overview TUESDAY, 9 July 201308.30 - 09.30Session 23: European and Global ART Monitoring (presentation of the EIMand ICMART data reports)−−−−Assisted reproductive technology in Europe, 2010: results generatedfrom European registers by ESHRE. Preliminary results -Anna Pia Ferraretti (Italy)ICMART World Report: Preliminary data for 2009 - David Adamson (U.S.A.)−−ICMARTs role in national registries: the South Africa story -Silke J. Dyer (South Africa)Auditorium08.30 - 09.30Session 24: Culture media. Growing faster growing better?−−−−What makes a medium a good medium - Daniel Brison (United Kingdom)Time for being proactive - Aafke Van Montfoort (The Netherlands)Capital Hall A08.30 - 09.30Session 25: ASRM exchange session - Genetic and metabolicconsequences for fertility in men and women−−Genetic and other controversies in the infertile male -−−Dolores J. Lamb (U.S.A.)Metabolic alterations affecting fertility in women - Roger Lobo (U.S.A.)Capital Suite A08.30 - 09.30Session 26: Paramedical invited session - Laboratory: The embryo-endometrialinterface - role in implantation/developmental success−−−−The contribution of the embryo - Hilde Van de Velde (Belgium)The contribution of the endometrium - Nicholas Macklon (United Kingdom)S8 - B09.30 - 10.00Coffee breakExhibit hall10.00 - 11.30Session 27: Genes and chromosomes in oocytes and embryosAuditorium10.00 - 13.00Session 28: Live surgery sessionCapital Hall A10.00 - 11.30Session 29: Ovarian stimulationSession 30: Fertility preservation for medical and non-medical indicationsSession 31: PGD/PGSSession 32: Stem cells and translational researchCapital Suite ACapital Hall BS8 - AS8 - B11.45 - 13.00Merck-Serono Company Symposium: Breakthrough innovation in ART:Science and technologies beyond drugs to maximize success for the benefitof the patientsAuditorium11.45 - 12.45Session 33: Chlamydia trachomatis and tubal infertility, modern insightsand lessons from outside reproductive medicine−−How does Chlamydia trachomatis cause tubal infertility? -Jolande A. Land (The Netherlands)−−Can screening programmes reduce the risk of tubal infertility? -Nicola Low (Switzerland)Capital Suite A11.45 - 12.45Session 34: Why sex is good−−Evolution of sexual reproduction - Sjoerd Repping (The Netherlands)−−Meiosis: A highly risky cell division - James Turner (United Kingdom)Capital Hall B78

11.45 - 12.45Session 35: Paramedical selected oral session - NursingS8 - B13.00 - 14.00Lunch break and Poster viewing and discussion at the Speakers' Corner inExhibit hallthe poster area.14.00 - 15.15IBSA Company SymposiumAuditorium14.00 - 15.00Session 36: Viral disease in reproductionCapital Hall A−−Screening for CMV: fertility, prenatally, postnatally - Sophie Alain (France)−−HPV vaccine and reproduction - Denise Nardelli Haefliger (Switzerland)14.00 -15.0014.00 - 15.00Session 37: Historical lecture−−The history of reproduction through ART - a visual journey from caves tochromosomes - Edward G. Hughes (Canada)Session 38: Managing relationship through infertility (Organised byCapital Suite ACapital Hall BCOMMITTEESFertility Europe)−−Decision-making, ending treatment and the couple relationship:a counsellor’s perspective - Sheila Pike (United Kingdom)−−Love, sex and infertility. The art of growing as a couple when dealingwith infertility - Helga Sol Olafsdottir (Iceland)−−Surviving Infertility: How I never became a dad, but still going strongwith my wife - Erikjan Bor (The Netherlands)−−Ending fertility treatment- when, why and how should clinicians adviseour patients? - Tim Child (United Kingdom)14.00 - 15.00Session 39: Paramedical invited session - LaboratoryS8 - B−−Cumulus cells and gene expression, markers for oocyte competence -Marie Louise Groendahl (Denmark)−−Is there a future for sperm morphology? - Alex Wetzels (The Netherlands)TUESDAY15.15 - 16.30Session 40: Embryo metabolismAuditoriumSession 41: Keys for success for embryo cryopreservationCapital Hall ASession 42: Ethical aspects of ARTCapital Suite ASession 43: Spermatogenesis - the new knowledgeCapital Hall BSession 44: Long term outcome of ARTS8 - ASession 45: Clinical female infertilityS8 - B16.30 - 17.00Coffee breakExhibit hall17.00 - 18.00Session 46: Epigenetics in reproductive healthAuditoriumSession 47: Reproductive surgeryCapital Hall ASession 48: Challenges of AMH studiesCapital Suite ASession 49: Protecting and choosing good spermCapital Hall BSession 50: Reproduction and societyS8 - ASession 51: Fertility awarenessS8 - B18.00 - 19.00Annual General Assembly of MembersS8 - BProgramme book79

Tuesday 9 July 2013Invited session08.30 - 09.30 AuditoriumSession 23: European and Global ART Monitoring (presentation of the EIM and ICMART data reports)Chairman: A.N. Andersen (Denmark)Chairman: J. De Mouzon (France)08.30 o-090 assisted reproductive technology in Europe, 2010: results generated from European registers byESHRE. Preliminary resultsA. Ferraretti, V. Goossens, S. Bhattacharya, J.A. Castilla, J. de Mouzon, V. Korsak, A.N. Andersen,M. Kupka (Italy)09.00 o-091 iCMART World Report: Preliminary data for 2009D. Adamson, F. Zegers-Hochschild, O. Ishihara, E. Sullivan, R. Mansour, K.G. Nygren, M. Banker,J. de Mouzon, S. Dyer (U.S.A.)09.15 o-092 iCMARTs role in national registries: the South Africa storyS.J. Dyer (South Africa)80

TUESDAYTuesday 9 July 2013Invited session08.30 - 09.30 Capital Hall ASession 24: Culture media. Growing faster growing better?Chairman: A. Sunde (Norway)Chairman: J. Dumoulin (The Netherlands)08.30 o-093 what makes a medium a good mediumD.R. Brison (United Kingdom)09.00 o-094 time for being proactiveA.P.A. Van Montfoort (The Netherlands)Programme book81

Tuesday 9 July 2013Invited session08.30 - 09.30 Capital Suite ASession 25: ASRM exchange session - Genetic and metabolic consequences for fertility in men and womenChairman: J.S. Tapanainen (Finland)Chairman: L.C. Giudice (U.S.A.)08.30 o-095 genetic and other controversies in the infertile maleD. Lamb (U.S.A.)09.00 o-096 metabolic alterations affecting fertility in womenR. Lobo (U.S.A.)82

TUESDAYTuesday 9 July 2013Invited session08.30 - 09.30 S8 - BSession 26: Paramedical invited session - Laboratory: The embryo-endometrial interface - role inimplantation/developmental successChairman: TBAChairman: TBA08.30 o-097 the contribution of the embryoH. Van de Velde (Belgium)09.00 o-098 the contribution of the endometriumN. Macklon (United Kingdom)Programme book83

Tuesday 9 July 2013Selected oral communication session10.00 - 11.30 AuditoriumSession 27: Genes and chromosomes in oocytes and embryosChairman: C. Magli (Italy)Chairman: G.M. Hartshorne (United Kingdom)10.00 o-099 assessment of telomere DNA length in human oocytes and cleavage stage embryos:impact on aneuploidy risk and implantation potentialS. Jaroudi, M. Konstantinidis, S. Alfarawati, E. Fragouli, D. Wells (United Kingdom)10.15 o-100 detailed transcriptomic analysis of human mature oocytes reveals the impact of cryopreservationtechniques at the gene expression levelV. Bianchi, S.J. Souraya Jaroudi, D.B. Dilair Baban, S.K. Samantha Knight, A.B. Andrea Borini,E.F. Elpida Fragouli, D.W. Dagan Wells (Italy)10.30 o-101 increasing the probability of selecting chromosomally normal embryos by studying their kineticsN. Basile, F. Bronet, M.C. Nogales, E. Martínez, M. Ariza, D. Agudo, M. Florensa, M. Riqueros,M. Meseguer (Spain)10.45 o-102 Blastocyst formation, cell proliferation, and NANOG expression are not comprised by cleavagestage vitrification using a closed systemL. Hyslop, N. Prathalingam, E. Clapham, L. Nowak, E. Dunkley, J. Fenwick, S. Byerley, A. Murdoch,M. Herbert (United Kingdom)11.00 o-103 factors correlated with aneuploidy in human preimplantation embryosK.M. Wong, J. Van Echten-Arends, J.C. Korevaar, F. van der Veen, S. Repping,S. Mastenbroek (The Netherlands)11.15 o-104 microRNAs: new candidates in the regulation of human cumulus-oocyte complexS. Assou, D. Haouzi, A. Ferrieres, H. Dechaud, S. Hamamah (France)84

TUESDAYTuesday 9 July 2013Invited session10.00 - 13.00 Capital Hall ASession 28: Live surgery sessionChairman: V. Tanos (Cyprus)Chairman: TBAProgramme book85

Tuesday 9 July 2013Selected oral communication session10.00 - 11.30 Capital Suite ASession 29: Ovarian stimulationChairman: E. Kolibianakis (Greece)Chairman: TBA10.00 o-105 Cumulative live birth rates following minimal ovarian stimulation/natural cycle IVF and singleembryo transfer in unselected infertile patients: a 3-year, single-centre, Japanese cohort studyD. Bodri, S. Kawachiya, M. Kondo, R. Kato, T. Matsumoto (Japan)10.15 O-106 The effect of the type of ovarian stimulation protocol on PGD results: a prospective randomised trialW. Verpoest, V. Vloeberghs, C. Staessen, A. Devos, M. De Rycke, M. Bonduelle, H. Tournaye,C. Blockeel (Belgium)10.30 o-107 kisspeptin - a novel physiological trigger for oocyte maturation in IVF treatmentA. Abbara, C.N. Jayasena, G.M. Nijher, A.N. Comninos, G. Christopoulos, D. Ashby, M.A. Ghatei,S.R. Bloom, A. Carby, G. Trew, W.S. Dhillo (United Kingdom)10.45 o-108 a phase III assessor-blinded randomised multi-centre study to compare efficacy and safety oftwo r-hfsH formulations (afoLIA [Bemfola ® ] vs Gonal-f ® ) in women for assisted reproductivetreatmentB. Imthurn, M. Rettenbacher, E. Bemfola Study Group (Switzerland)11.00 o-109 Continued treatment with clomiphene citrate in subfertile women with World Health Organizationtype II anovulation who are not pregnant after six ovulatory cyclesN.S. Weiss, S. Braam, T.E. König, M.L. Hendriks, C.J. Hamilton, C. Koks, E.M. Kaaijk, M. van Wely,P.G.A. Hompes, C.B. Lambalk, B.W. Mol (The Netherlands)11.15 o-110 increased breast cancer risk after multiple implantation in IVF: a cohort studyE. Groeneveld, I.M. Krul, M. Spaan, A.W. van den Belt-Dusebout, T.M. Mooij, M.J. Lambers,J.W.R. Twisk, M. Hauptmann, P.G.A. Hompes, F.E. van Leeuwen, C.B. Lambalk, on behalf of theOMEGA-project group (The Netherlands)86

Tuesday 9 July 2013Selected oral communication session10.00 - 11.30 Capital Hall BSession 30: Fertility preservation for medical and non-medical indicationsChairman: J.E.J. Smitz (Belgium)Chairman: H.M. Picton (United Kingdom)10.00 o-111 Cyclophosphamide triggers follicle activation causing ovarian reserve 'burn out'; AS101 preventsfollicle loss and preserves fertilityH. Roness, L. Kalich-Philosoph, A. Carmely, M. Fishel-Bartal, H. Ligumsky, S. Paglin,I. Wolf, H. Kanety, B. Sredni, D. Meirow (Israel)10.15 o-112 oocyte banking for anticipated gamete exhaustion (age): a follow-up studyD. Stoop, E. Maes, N.P. Polyzos, G. Verheyen, H. Tournaye, J. Nekkebroeck (Belgium)10.30 o-113 rapid warming increases survival rate of slow frozen (SF) oocytes; randomised controlled studyon sibling human oocytesL. Parmegiani, G.E. Cognigni, S. Bernardi, E. Troilo, A. Arnone, A.M. Maccarini, S. Lanzilotti,A. Rastellini, M. Filicori, G. Di Emidio, M. Vitti, C. Tatone (Italy)10.45 o-114 Bioengineered/biosynthetic supporting matrices for culturing human primordial follicles withphosphatidylinositol-trisphosphate (pip3)elevating substancesR. Abir, G. Lerer-Serfaty, N. Samara, A. Ben-Haroush, M. Shachar, O. Kossover, B. Fisch (Israel)11.00 o-115 dynamic perifusion culture initiates in vivo-like early follicular growth in prepubertal murineovarian tissueK. Winkler, V. Nederegger, S. Ayuandari, M. Salama, D. Rosenfellner, K.F. Murach,I. Zervomanolakis, S. Hofer, L. Wildt, S.C. Ziehr (Austria)11.15 o-116 a novel method for cryopreservation of very low count human spermatozoaA. Stein, S. Hadar, E. Kaisler, B. Fisch, H. Pinkas (Israel)TUESDAYProgramme book87

Tuesday 9 July 2013Selected oral communication session10.00 - 11.30 S8 - ASession 31: PGD/PGSChairman: C. Spits (Belgium)Chairman: J. Harper (United Kingdom)10.00 o-117 euploid embryos are far more likely to undergo blastulation than aneuploid embryos when basedon single blastomere array Comparative Genomic Hybridization (CGH)M. Vega, M. Keltz, A. Breborowicz (U.S.A.)10.15 o-118 preimplantation genetic screening on day 3 embryos using array comparative genomichybridization in patients with advanced maternal age: a prospective double blinded randomizedcontrolled trialF. Fiorentino, L. Rienzi, S. Bono, A. Capalbo, L. Spizzichino, E. Baroni, G. Harton, A. Biricik,F.M. Ubaldi (Italy)10.30 o-119 non-reciprocal errors and germinal mosaicism detected by the application of array-CGH tooocytes and polar bodies unexposed to spermH. Ghevaria, T. Mamas, T. Sabhnani, U. Sarna, P. Serhal, J.D.A. Delhanty (United Kingdom)10.45 o-120 analysis of gametes and embryos from translocation carriers reveals sex-specific differences inchromosome segregation patterns and the existence of an interchromosomal effectS. Alfarawati, K. Spath, P. Colls, D. Wells, E. Fragouli (United Kingdom)11.00 o-121 is cohort size of euploid blastocysts following comprehensive chromosomal screening predictiveof improved outcomes in single embryo transfer cyclesS. Morin, K. Melzer, J. Grifo, P. Colls, Z. Zheng, S. Munne (U.S.A.)11.15 o-122 re-analysis of whole day-5 embryos using the same arrayCGH platform used for day-3 diagnosisshowed a high confirmation rateP. Mir, L. Rodrigo, E. Mateu, V. Peinado, M. Milán-Sánchez, N. Al-Asmar, S. García-Herrero,I. Campos-Galindo, A. Mercader, M.E. Poo, C. Simón, C. Rubio (Spain)88

Tuesday 9 July 2013Selected oral communication session10.00 - 11.30 S8 - BSession 32: Stem cells and translational researchChairman: C. Eguizabal (Spain)Chairman: M. Stojkovic (Serbia)10.00 o-123 evaluation of oogonial stem cells and neo-oogenesis in ovaries of girls and women with TurnerSyndrome: a pilot studyR.A. Anderson, M. McLaughlin, D.C. Woods, J.L. Tilly, E.E. Telfer (United Kingdom)10.15 o-124 Borderline ovarian cancer: induced by small putative ovarian stem cells resembling very smallembryonic-like stem cells?I. Virant-Klun, M. Stimpfel, B. Cvjeticanin, E. Vrtacnik-Bokal, T. Skutella (Slovenia)10.30 o-125 successful hematopoietic stem cell transplantation (hsct) in 39 children from healthy siblingsconceived after preimplantation human leukocyte antigen (hla) typingC. Beyazyurek, C.G. Ekmekci, N. Gulum, H.A. Tac, S. Kahraman (Turkey)10.45 o-126 adipose-derived stem cells transplantation in rat rescues primary ovarian insufficiency inducedby tripterygium glycosidesJ. Cheng, J. Su, L.J. Ding, G.J. Yan, Y.L. Hu (China)11.00 o-127 perspectives of infertile men on future stem cell treatments for non-obstructive azoospermia(noa)S. Hendriks, E.A.F. Dancet, A. Meissner, F. van der Veen, M.H. Mochtar,S. Repping (The Netherlands)11.15 o-128 real-time analysis of the growth of human granulosa cells using an impedance-based signalprocessing system: a new technology for translational research in human reproductionO. Oktem, M. Muftuoglu, F. Senbabaoglu, B. Urman (Turkey)TUESDAYProgramme book89

Tuesday 9 July 2013Company symposium11.45 - 13.00 AuditoriumMerck-Serono Company Symposium: Breakthrough innovation in ART: Science and technologies beyond drugs tomaximize success for the benefit of the patients.Chairman: P. Braude (United Kingdom)90

TUESDAYTuesday 9 July 2013Invited session11.45 - 12.45 Capital Suite ASession 33: Chlamydia trachomatis and tubal infertility, modern insights and lessons from outsidereproductive medicineChairman: K. Diedrich (Germany)Chairman: A. Feki (Switzerland)11.45 o-129 How does Chlamydia trachomatis cause tubal infertility?J.A. Land (The Netherlands)12.15 o-130 Can screening programmes reduce the risk of tubal infertility?N. Low (Switzerland)Programme book91

Tuesday 9 July 2013Invited session11.45 - 12.45 Capital Hall BSession 34: Why sex is goodChairman: C.B. Lambalk (The Netherlands)Chairman: A. Salumets (Estonia)11.45 o-131 evolution of sexual reproductionS. Repping (The Netherlands)12.15 o-132 meiosis: A highly risky cell divisionJ. Turner (United Kingdom)92

TUESDAYTuesday 9 July 2013Selected oral communication session11.45 - 12.45 S8 - BSession 35: Paramedical selected oral session - NursingChairman: I.R. Joergensen (Denmark)Chairman: H. Birch (United Kingdom)11.45 o-133 Can a self-administered coping intervention reduce anxiety in women awaiting the outcome of IVFtreatment - a randomised controlled trialH. Ockhuijsen, J. Boivin, N. Macklon, A. van der Hoogen (The Netherlands)12.00 o-134 gaps in fertility patients' knowledge about the effect of age and lifestyle on pregnancy andmiscarriage rates after spontaneous and after medically assisted conceptionE. Dancet, L. Bunting, F. van Asseldonk, B.W. Mol, S. Repping, J. Boivin, T.M. D'Hooghe (Belgium)12.15 o-135 a study of the health-related quality of life in overweight and obese adult women with thepolycystic ovary syndrome during a lifestyle modification programV. De Frène, L. Verhofstadt, J. Lammertyn, A. Buysse, P. De Sutter (Belgium)12.30 o-136 women's experiences of antenatal services following In Vitro Fertilisation (IVF): a qualitative studyD. Barber, G. Mounce (United Kingdom)Programme book93

Tuesday 9 July 2013Company symposium14.00 - 15.15 AuditoriumIBSA Company Symposium: PROGESTERONE Support for the luteal phase: A new approachChairman: B. Imthurn (Switzerland)Chairman: P. G. Crosignani (Italy)14.00 welcome and introduction14.05 Luteal phase support: why, when, what and where?D. de Ziegler (France)14.25 a topical question with a parenteral answer? Sub-cut progesterone: the best of both worlds.G. M. Lockwood (United Kingdom)14.45 progesterone and endometrial receptivity.J. Garcia Velasco (Spain)15.05 discussion and conclusion15.15 end of session94

TUESDAYTuesday 9 July 2013Invited session14.00 - 15.00 Capital Hall ASession 36: Viral disease in reproductionChairman: A.E. Semprini (Italy)Chairman: E.V. Mocanu (Ireland)14.00 o-137 screening for CMV: fertility, prenatally, postnatallyS. Alain (France)14.30 o-138 HPV vaccine and reproductionD. Nardelli Haefliger (Switzerland)Programme book95

Tuesday 9 July 2013Invited session14.00 - 15.00 Capital Suite ASession 37: Historical lectureChairman: M. Kupka (Germany)14.00 o-139 the history of reproduction through ART - a visual journey from caves to chromosomesE.G. Hughes (Canada)96

TUESDAYTuesday 9 July 2013Invited session14.00 - 15.00 Capital Hall BSession 38: Managing relationship through infertility (Organised by Fertility Europe)Chairman: C. Lewis-Jones (United Kingdom)Chairman: D. Priadkova (Slovakia)Chairman: S. Rautakallio-Hokkanen (Finland)14.00 o-140 decision-making, ending treatment and the couple relationship: a counsellor's perspectiveS. Pike (United Kingdom)14.15 o-141 Love, sex and infertility. The art of growing as a couple when dealing with infertilityH. Sol Olafsdottir (Iceland)14.30 o-142 surviving Infertility: How I never became a dad, but still going strong with my wifeJ.F.J. Bor (The Netherlands)14.45 o-143 ending fertility treatment- when, why and how should clinicians advise our patients?T. Child (United Kingdom)Programme book97

Tuesday 9 July 2013Invited session14.00 - 15.00 S8 - BSession 39: Paramedical invited session - LaboratoryChairman: H. Bendtsen (Denmark)Chairman: B. Desmet (Belgium)14.00 o-144 Cumulus cells and gene expression, markers for oocyte competenceM. Groendahl, R. Borup (Denmark)14.30 o-145 is there a future for sperm morphology?A.M.M. Wetzels (The Netherlands)98

TUESDAYTuesday 9 July 2013Selected oral communication session15.15 - 16.30 AuditoriumSession 40: Embryo metabolismChairman: S. Ziebe (Denmark)Chairman: H.J. Leese (United Kingdom)15.15 o-146 metabolic profile of the human embryo and its association with chromosomal abnormalitiesK. Chatzimeletiou, G. Theodoridis, C. Virgiliou, N. Raikos, E. Kolibianakis, A. Sioga, L. Oikonomou,K.H. Nicolaides, B.C. Tarlatzis (Greece)15.30 o-147 the effect of GM-CSF on murine embryo development, aneuploidy, DNA fragmentation andmorphokinetic parameters analysed using EmbryoScopeA. Elaimi, A. Balasuriya, J. Harper (United Kingdom)15.45 o-148 ammonium accumulates in IVF culture medium but this does not affect the birth weight of thenewbornS.H.M. Kleijkers, A.P.A. Van Montfoort, O. Bekers, E. Coonen, J.G. Derhaag, I.E.L. Schreurs,J.L.H. Evers, J.C.M. Dumoulin (The Netherlands)16.00 o-149 BMP-15 supplementation to COCs during bovine IVM alters intra-oocyte metabolism by alteringthe source of NADPH productionJ. Thompson, R. Gilchrist, M. Sutton-McDowall (Australia)16.15 o-150 effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on pregnancy rates inpatients with multiple unsuccessful IVF attemptsI.A. Sfontouris, G.T. Lainas, K. Anagnostara, E.M. Kolibianakis, T.G. Lainas (Greece)Programme book99

Tuesday 9 July 2013Selected oral communication session15.15 - 16.30 Capital Hall ASession 41: Keys for success for embryo cryopreservationChairman: E. Van den Abbeel (Belgium)Chairman: R. Simons (United Kingdom)15.15 o-151 obstetric and perinatal outcomes of a defined embryo vitrification procedure with recombinanthuman albumin: a randomised studyM. Murakami, A. Egashira, K. Tanaka, C. Mine, T. Kuramoto (Japan)15.30 o-152 influence of cell loss after vitrification and slow-freezing on further in vitro development andimplantation of human day 3 embryosL. Van Landuyt, H. Van de Velde, A. De Vos, P. Haentjens, C. Blockeel, H. Tournaye, G. Verheyen (Belgium)15.45 o-153 fresh vs aseptic vitrified sibling embryo transfers in oocyte donation program: a prospective,observational, comparative studyA. Papatheodorou, Y. Panagiotidis, S. Petousis, E. Kasapi, M. Goudakou, T. Passadaki, N. Prapas,P. Vanderzwalmen, K. Zikopoulos, I. Georgiou, Y. Prapas (Greece)16.00 o-154 the implantation potential and pregnancy outcome of day 5 cryopreserved morula and earlyblastocyst in subsequent frozen-thawed cyclesM. Abuzeid, F.A. Ahmed, T. Abozaid, M. Urich, K. Ullah, H. Salem, M. Sasy, I. Khan (U.S.A.)16.15 o-155 novel automated instrument executing a standardised closed vitrification protocol yieldsequivalent outcomes with human blastocysts when compared with open manual vitrificationsystemT.K. Roy, S. Brandi, N.M. Tappe, E. Vom, T.T. Peura, S.J. McArthur, M.C. Bowman,T. Stojanov (Australia)100

TUESDAYTuesday 9 July 2013Selected oral communication session15.15 - 16.30 Capital Suite ASession 42: Ethical aspects of ARTChairman: W.J. Dondorp (The Netherlands)Chairman: F. Shenfield (United Kingdom)15.15 o-156 medical frontiers: debating mitochondria replacementH. Darby (United Kingdom)15.30 o-157 genetic relatedness as one step ahead: how lesbian couples deal with the presence of a singlegenetic linkI. Raes, E. Wyverkens, H. Van Parys, A. Ravelingien, V. Provoost, S. Somers, I. Stuyver, A. Buysse,P. De Sutter, G. Pennings (Belgium)15.45 o-158 redefining reproductionA. Smajdor (United Kingdom)16.00 o-159 the right to know your genetic parents: from open-identity gamete donation to universalpaternity testingA. Ravelingien, G. Pennings (Belgium)16.15 o-160 the voice of Dutch women with anticipated gamete exhaustion who consider oocyte freezing toincrease their chances on shared parenthoodM. De Groot, E.A.F. Dancet, S. Repping, D. Stoop, M. Goddijn, F. Van der Veen,T. Gerrits (The Netherlands)Programme book101

Tuesday 9 July 2013Selected oral communication session15.15 - 16.30 Capital Hall BSession 43: Spermatogenesis - the new knowledgeChairman: W. Ombelet (Belgium)Chairman: TBA15.15 o-161 results of ICSI with testicular sperms in cases of 88 non-mosaic azoospermic Klinefelter'ssyndromeA. Yoshida, T. Ishikawa, S. Koyama, H. Suzuki, M. Tanaka, K. Seida (Japan)15.30 o-162 dysfunctional spermatogenesis in sickle cell disease and thalassaemiaK. Wen, R. Bajoria, E. Williamson, B. Spreyer, R. Chatterjee (United Kingdom)15.45 o-163 origin of DNA fragmentation: pre- or post-spermiogenesisL. Harvey, Q.V. Neri, T. Fields, Z. Rosenwaks, G.D. Palermo (U.S.A.)16.00 o-164 sperm with large nuclear vacuoles negatively influence blastocyst formation, implantation,pregnancy and miscarriage rates in couples undergoing ICSIA.S. Setti, L. Vingris, D.P.A.F. Braga, R.C.S. Figueira, A. Iaconelli Jr., E. Borges Jr. (Brazil)16.15 o-165 is morphologically selected sperm injection with testicular spermatozoa useful?K. Sano, A. Yoshida, S. Tanigiwa, K. Seida, H. Suzuki, M. Tanaka (Japan)102

Tuesday 9 July 2013Selected oral communication session15.15 - 16.30 S8 - ASession 44: Long term outcome of ARTChairman: A. D'Angelo (United Kingdom)Chairman: J. Boivin (United Kingdom)15.15 o-166 perinatal mortality and cause of death in babies born in Australia. A population study of all birthsincluding those following assisted reproductive technologiesE. Sullivan, L. Hilder, Y.A. Wang (Australia)15.30 o-167 risk of cancer in children and young adults born after IVF - a Nordic cohort study from theCoNARTaS groupK. Jerhamre Sundh, C. Bergh, A.K.A. Henningsen, K. Källen, L.B. Romundstad, A. Pinborg,A. Nyboe-Andersen, R. Skjaerven, M. Gissler, A. Tiitinen, K.G. Nygren, U.B. Wennerholm (Sweden)15.45 o-168 Cancer risk in children born after assisted conceptionC.L. Williams, K.J. Kathryn Bunch, C.A. Stiller, M.F.G. Murphy, W.H. Wallce, M. Davies,B. Botting, A.G. Sutcliffe (United Kingdom)16.00 O-169 Psychological distress and involuntary childlessness in women: a register-based Swedish cohort studyC.E. Cesta, H. Olsson, S. Cnattingius, K.G. Nygren, V. Johansson, P. Lichtenstein,A.N. Iliadou (Sweden)16.15 o-170 Correlates of long-term psychosocial adjustment and mental-health care consumption of 7148women who did infertility treatmentS. Gameiro, A.W. van den Belt-Dusebout, E. Bleiker, D. Braat, F.E. van Leeuwen,C.M. Verhaak (United Kingdom)TUESDAYProgramme book103

Tuesday 9 July 2013Selected oral communication session15.15 - 16.30 S8 - BSession 45: Clinical female infertilityChairman: F. Petraglia (Italy)Chairman: I.D. Cooke (United Kingdom)15.15 o-171 an economic analysis comparing IVF with a single embryo transfer and IVF with a modified naturalcycle to IUI with hyperstimulation (the INeS trial)R.I. Tjon-Kon-Fat, A.J. Bensdorp, J. Maas, G.J.E. Oosterhuis, A. Hoek, P.G.A. Hompes,F.J. Broekmans, H.R. Verhoeve, J.P. de Bruin, S. Repping, B.J. Cohlen, H. Groen, B.W.J. Mol,F. van der Veen, M. Wely (The Netherlands)15.30 o-172 effect of controlled ovarian stimulation with low dose human menopausal gonadotrophin orclomiphene on reproductive outcome after intrauterine insemination: a prospective, multicenterrandomized trialK. Peeraer, S. Debrock, P. De Loecker, A. Laenen, M. Welkenhuyzen, C. Spiessens, D. De Neubourg,T.M. D'Hooghe (Belgium)15.45 o-173 the impact of Uterine Artery Embolization (UAE) on subsequent fertility when used as a substitutefor invasive operations like myomectomy and in obstetrical emergenciesS. Puri, B. Mohan (India)16.00 o-174 Clinical predictive criteria for live birth following elective single embryo transferC. Herbemont, E. Adda, J.N. Hugues, N. Sermondade, C. Dupont, I. Cedrin-Durnerin, C. Poncelet,R. Levy, C. Sifer (France)16.15 o-175 obesity and impaired uterine receptivity: clinical experience from 9,587 first cycles of ovumdonationJ. Bellver, A. Pellicer, J.A. García-Velasco, A. Ballesteros, J. Remohí, M. Meseguer (Spain)104

TUESDAYTuesday 9 July 2013Selected oral communication session17.00 - 18.00 AuditoriumSession 46: Epigenetics in reproductive healthChairman: U. Eichenlaub-Ritter (Germany)Chairman: A. van Montfoort (the Netherlands)17.00 o-176 time-lapse and array CGH evaluation of human embryos cultured in single versus sequentialmedia: a randomized pilot studyZ. Yang, J. Liu, Y. Kuang, S. Terigima, R. Salem (U.S.A.)17.15 o-177 aberrant DNA methylation of GRB10 gene in human spontaneous abortions after assistedreproduction techniques and natural conceptionY. Tang, J. Niu, P. Li, D.S. Ye, X. Chen, H.Y. Zheng, L. Li, F.H. Duan, S.L. Chen (China)17.30 o-178 maternal high fat diet during pregnancy impacts on markers of folliculogenesis in the offspringK. Sadek, K. Bruce, N. Macklon, Y. Cheong, F. Cagampang (United Kingdom)17.45 o-179 the effect of different ovarian stimulation protocols on imprinted gene expression and live birthrates in miceK. Swann, B.K. Campbell, N. Raine-Fenning, K. Jayaprakasan, W. Maalouf (United Kingdom)Programme book105

Tuesday 9 July 2013Selected oral communication session17.00 - 18.00 Capital Hall ASession 47: Reproductive surgeryChairman: G. Grimbizis (Greece)Chairman: E. Saridogan (United Kingdom)17.00 o-180 Long-term reproductive performance after surgery for ovarian endometriomaS. Amer, F. Raffi (United Kingdom)17.15 o-181 predictors for ovarian histological preservation after ovarian torsion, and the possible impact onfuture fertilityV. Asfour, R. Varma, A. Polson, P. Menon (United Kingdom)17.30 o-182 economic analysis of salpingotomy and salpingectomy in women with tubal ectopic pregnancy(the ESEP study)F. Mol, N.M. van Mello, W.M. Ankum, B.W. Mol, F. van der Veen, P.J. Hajenius,M. van Wely (The Netherlands)17.45 o-183 to lyse or not to lyse: results from a randomized controlled trial of adhesiolysis versus diagnosticlaparoscopy in women with chronic pelvic painY. Cheong, I. Reading, K. Sadek, W.L. Ledger, T.C. Li (United Kingdom)106

TUESDAYTuesday 9 July 2013Selected oral communication session17.00 - 18.00 Capital Suite ASession 48: Challenges of AMH studiesChairman: D. Dewailly (France)Chairman: D.T. Baird (United Kingdom)17.00 o-184 amH assays: a review of the literature on assay method comparabilityC. Fitzgerald, O. Rustamov, P. Pemberton, A. Smith, A. Yates, M. Krishnan, R. Russel,L. Nardo, S. Roberts (United Kingdom)17.15 o-185 pre-mixing samples with assay buffer is an essential pre-requisite for reproducible AntimullerianHormone (AMH) measurement using the Beckman Coulter Gen II assay (Gen II)X. Han, M. McShane, R. Sahertian, C. White, W. Ledger (Australia)17.30 o-186 the AMH generation ii assay: development and validation of age related reference range in13,275 infertility patientsM. Messow, A. McConnachie, C. Fifield, R. Fleming, V.T.N. Lan, H.M. Tuong,S.M. Nelson (United Kingdom)17.45 o-187 anti-mullerian hormone serum levels decrease in female to male transsexual women usingtestosterone as cross-sex therapyM. Caanen, R. Soleman, E. Kuijper, B. Kreukels, P. Hompes, M. Trotsenburg, F. Broekmans,C. Lambalk (The Netherlands)Programme book107

Tuesday 9 July 2013Selected oral communication session17.00 - 18.00 Capital Hall BSession 49: Protecting and choosing good spermChairman: M.C. Sanchez Pozo (Spain)Chairman: TBA17.00 o-188 treatment of bovine spermatozoa with antioxidants improves embryo production in vitroR. Gualtieri, V. Barbato, I. Fiorentino, S. Braun, S. Longobardi, R. Talevi (Italy)17.15 o-189 treatment with zinc, d-aspartate and coenzyme q10 protects human spermatozoa in vitroR. Talevi, V. Barbato, I. Fiorentino, S. Braun, S. Longobardi, R. Gualtieri (Italy)17.30 o-190 influence of temperature and preparation techniques on sperm qualityA. Thijssen, E. Klerkx, L. De Ryck, E. Bosmans, R. Campo, W. Ombelet (Belgium)17.45 o-191 the potential use of consecutive ejaculates for gaining better quality sperm during fertilitytreatmentR. Zeirideen Zaid, G. Bahadur, O. Almossaawi, A. Illahibuccus, A. Al-Habib,S. Okolo (United Kingdom)108

TUESDAYTuesday 9 July 2013Selected oral communication session17.00 - 18.00 S8 - ASession 50: Reproduction and societyChairman: TBAChairman: S. Bhattacharya (United Kingdom)17.00 o-192 Hospital utilisation, costs and mortality rates during the first 5 years of life: a population study ofART and spontaneously conceived singletonsG.M. Chambers, E. Lee, V.P. Hoang, M. Hansen, C. Bower, E.A. Sullivan (Australia)17.15 o-193 do working schedules influence early reproductive outcomes - a meta-analysisL.J. Stocker, S. Bewley, N.S. Macklon, Y. Cheong (United Kingdom)17.30 o-194 mortality among 42,915 women in Denmark treated with assisted reproductive technology -a register-based nationwide cohort studyG.L. Petersen, C.O. Hougaard, A. Pinborg, I.H. Pedersen, M. Kamper-Jørgensen,L. Schmidt (Denmark)17.45 o-195 do randomized clinical trials in reproductive medicine compare strategies or treatment cycles -a systematic sample reviewJ. Gianotten, I. Scholten, J. Limpens, P.G.A. Hompes, F. van der Veen, B.W.J. Mol (The Netherlands)Programme book109

Tuesday 9 July 2013Selected oral communication session17.00 - 18.00 S8 - BSession 51: Fertility awarenessChairman: C. Verhaak (The Netherlands)Chairman: S. Gameiro (United Kingdom)17.00 o-196 Comparison of US healthcare provider (HCP) perceptions of women's knowledge of infertilitytreatment options and outcomes: findings from the Fertility IQ 2012 HCP SurveyM. Mahony, B. Hayward, F. Velez (U.S.A.)17.15 o-197 "I wish I had known!" - supporting informed reproductive and childbearing-decisions for womenand menJ. Daniluk, E. Koert (Canada)17.30 o-198 the impact of personalising fertility risk information: double blind randomised control trialmeasuring attentional allocation and physiological reactions to presenting risk information toyoung womenL. Bunting, N. Kalebic, J. Boivin (United Kingdom)17.45 o-199 "I kinda thought it was something if you wanted to do, you could just do it":women's understanding of IVF efficacy - implications for clinical practiceI. Daly (United Kingdom)110

TUESDAYProgramme book111

Overview Wednesday, 10 July 201308.30 - 09.30Session 52: Future infertility management−−When will infertility be explained? - Robert W. Rebar (U.S.A.)−−The future of randomized clinical trials - P.M.M. Bossuyt (The Netherlands)Auditorium08.30 - 09.30Session 53: Are human embryonic stem cells ready for regenerativemedicine?−−hESC and iPSC as models for human development and disease -Rita Vassena (Spain)−−Cell therapy with pluripotent stem cells (hESC and iPS) -Benjamin Reubinoff (Israel)Capital Hall A08.30 - 09.30Session 54: New findings in reproductive oncology−−Ovarian cancer and the incessant menstruation hypothesis -Edgardo Somigliana (Italy)−−Obesity and breast cancer: role of inflammation and dysregulatedmetabolism? - Evan Simpson (Australia)Capital Suite A08.30 - 09.30Session 55: ASRM/Society of Reproductive Biologists and TechnologistsExchange Symposium: Optimizing the culture and selection of humanembryo in 2013−−Current status of non-invasive approaches for embryo assessmentand selection - Catherine Racowsky (U.S.A.)−−Evaluating media systems and day of transfer for human embryos:What are optimal? - Michael John Tucker (U.S.A.)Capital Hall B08.30 - 09.30Session 56: From experimental to established: ESHRE guidelines andposition papers−−The 2013 ESHRE guideline on the management of women withendometriosis. - Gerard A.J. Dunselman (The Netherlands)−−On the notion of the experimental - Veerle Provoost (Belgium)S8 - B09.30 - 10.00Coffee breakExhibit hall10.00 - 11.15Besins Healthcare Company Symposium - “Luteal phase support:Building on firm foundations”Auditorium10.00 - 11.45Session 57: Time lapse: the real revolution for embryo assessment?Capital Hall A10.00 - 11.30Session 58: Basics of reproductive endocrinologySession 59: EndometriumSession 60: Perinatal outcome after ARTSession 61: Effects of interventions on embryo qualityCapital Suite ACapital Hall BS8 - AS8 - B112

12.00 - 13.00Session 62: Quality management and regulation in the ART labAuditorium−−From quality control to total quality management in the IVF lab -Kelly Tilleman (Belgium)−−The European Tissue Directive: a curse or a blessing? -Basil C. Tarlatzis (Greece)12.00 - 13.00Session 63: New ART interventions may, under certain circumstances,Capital Hall Abe introduced without a clinical trial? (Debate)−−For - Simon Fishel (United Kingdom)−−Against - Sigrid Sterckx (Belgium)12.00 - 13.00Session 64: Endometriosis-associated pain−−Endometrium, nerves and endometriosis - Ian S. Fraser (Australia)−−Central nervous system (CNS) mechanisms of pain in endometriosis -Karen Berkley (U.S.A.)Capital Suite ACOMMITTEES12.00 - 13.00Session 65: Paramedical invited session - Nursing (Debate):S8 - BPatients have the right for an anonymous donor−−Pro - Lone Schmidt (Denmark)−−Con - Claes Gottlieb (Sweden)13.00 - 14.00Lunch break and Poster viewing and discussion at the Speakers' CornerExhibit hallin the poster area.14.00 - 15.15Session 66: Embryo quality: does it predict pregnancy?AuditoriumSession 67: Scientific challenges in early pregnancy achievementCapital Hall ASession 68: The impact of genetics in andrologyCapital Suite ASession 69: Clinical endocrinologyCapital Hall BSession 70: Challenges in cryopreservationS8 - ASession 71: SurgeryS8 - B15.30 - 16.30Session 72: Awards and closing ceremonyCapital Suite AWEDNESDAYProgramme book113

Wednesday 10 July 2013Invited session08.30 - 09.30 AuditoriumSession 52: Future infertility managementChairman: V. Vlaisavljevic (Slovenia)Chairman: TBA08.30 o-200 when will infertility be explained?R. Rebar (U.S.A.)09.00 o-201 the future of randomized clinical trialsP. Bossuyt (The Netherlands)114

WEDNESDAYWednesday 10 July 2013Invited session08.30 - 09.30 Capital Hall ASession 53: Are human embryonic stem cells ready for regenerative medicine?Chairman: O. Hovatta (Finland)Chairman: K. Sermon (Belgium)08.30 o-202 hESC and iPSC as models for human development and diseaseR. Vassena (Spain)09.00 o-203 Cell therapy with pluripotent stem cells (hESC and iPS)B. Reubinoff (Israel)Programme book115

Wednesday 10 July 2013Invited session08.30 - 09.30 Capital Suite ASession 54: New findings in reproductive oncologyChairman: M. von Wolff (Switzerland)Chairman: M. Davies (United Kingdom)08.30 o-204 ovarian cancer and the incessant menstruation hypothesisE. Somigliana (Italy)09.00 o-205 obesity and breast cancer: role of inflammation and dysregulated metabolism?E.R. Simpson, N.U. Samarajeewa, K.A. Brown (Australia)116

WEDNESDAYWednesday 10 July 2013Invited session08.30 - 09.30 Capital Hall BSession 55: ASRM/Society of Reproductive Biologists and Technologists Exchange Symposium: Optimizing the cultureand selection of human embryo in 2013Chairman: D.J. Lamb (U.S.A.)08.30 o-206 Current status of non-invasive approaches for embryo assessment and selectionC. Racowsky (U.S.A.)09.00 o-207 evaluating media systems and day of transfer for human embryos: What are optimal?M.J. Tucker (U.S.A.)Programme book117

Wednesday 10 July 2013Invited session08.30 - 09.30 S8 - BSession 56: From experimental to established: ESHRE guidelines and position papersChairman: W. Nelen (The Netherlands)Chairman: TBA08.30 o-208 the 2013 ESHRE guideline on the management of women with endometriosis.G. Dunselman, N. Vermeulen, W. Nelen (The Netherlands)09.00 o-209 on the notion of the experimentalV. Provoost, K. Tilleman, A. D'Angelo, P. De Sutter, G. De Wert, W. Dondorp, W. Nelen, G. Pennings,F. Shenfield (Belgium)118

WEDNESDAYWednesday 10 July 2013Company symposium10.00 - 11.15 AuditoriumBesins Healthcare Company Symposium - "Luteal phase support: Building on firm foundations"Chairman: W. Ledger (Australia)Chairman: N. Macklon (United Kingdom)10.00 Luteal phase defect (LPD): pathophysiology, diagnosis and optimal duration for LSPE. Bosch (Spain)10.20 strategies to improve the safety and success rate in ARTP. Devroey (Belgium)10.40 ivm: views and reviewsM. De Vos (Belgium)11.00 the use of vaginal natural progesterone for prevention of preterm birth in IVF/ICSI pregnanciesM. Aboulghar (Egypt)Programme book119

Wednesday 10 July 2013Selected oral communication session10.00 - 11.45 Capital Hall ASession 57: Time lapse: the real revolution for embryo assessment?Chairman: M.J. De Los Santos (Spain)Chairman: S. Fishel (United Kingdom)10.00 o-210 embryo oxygen consumption is directly related with exact timing of cell cleavages andimplantation ratesA. Tejera, J. Herrero, I. Rubio, D. Castelló, A. Pellicer, M. Meseguer (Spain)10.15 o-211 prospective analysis of the relationship between oocyte morphology and embryonic viability inhuman using time-lapse monitoring systemK. Iwata, K. Yumoto, M. Ueda, Y. Matoba, Y. Kamada, S. Furuyama, C. Mizoguchi, H.C. Sargent,Y. Kai, Y. Tsuchie, Y. Iba, Y. Mio (Japan)10.30 o-212 abnormal syngamy phenotypes observed with time-lapse imaging may allow early identificationof embryos with lower development potentialK. Athayde Wirka, K. Suraj, J. Conaghan, M. Gvakharia, K. Ivani, R. Murugesan, A.A. Chen,S. Shen (U.S.A.)10.45 o-213 inter and intra-observer variability of time-lapse annotationsL. Sundvall, H.J. Ingerslev., U.B. Knudsen, K. Kirkegaard (Denmark)11.00 o-214 does one model fit all? Testing a published embryo selection algorithm on independenttime-lapse dataL. Best, A. Campbell, S. Duffy, S. Montgomery, S. Fishel (United Kingdom)11.15 o-215 does oocyte activation influence morphokinetic parameters of embryos: a comparative analysisusing time-lapse imagingM. Montag, B. Toth, J. Weigert, T. Strowitzki (Germany)11.30 o-216 Blastocyst culture using time-lapse in good prognosis IVF patients and elective SET:a randomized pilot studyY. Kumtepe, S. Kahraman, M. Cetinkaya, C. Pirkevi, H. Yelke, M. Montag (Turkey)120

Wednesday 10 July 2013Selected oral communication session10.00 - 11.45 Capital Suite ASession 58: Basics of reproductive endocrinologyChairman: C. Yding Andersen (Denmark)Chairman: S.G. Hillier (United Kingdom)10.00 o-217 miR-181a promotes mouse granulosa cell apoptosis by suppressing sirt1-mediated foxo1deacetylationQ. Zhang, S. Wu, Y. Jiang, T. Fang, G. Yan, H. Sun, Y. Hu (China)10.15 o-218 gonadotropin treatments for IVF/ICSI affects apoptosis regulation of human cumulus cells:importance of miR-21A.L. Courjaud, S. Assou, D. Haouzi, A. Gala, H. Dechaud, S. Hamamah (France)10.30 o-219 Hedgehog signaling regulates steroid hormone production in human placentasC. Tang, Y.B. Pan, X.M. Wu, H.F. Ruan, Y.J. Wang, J.R. Wang (China)10.45 o-220 microRNA 132 promotes estradiol release from mouse granulosa cells by translational repressionof Nr4a2S. Wu, Q. Zhang, Y. Jiang, T. Fang, H. Sun, G. Yan, Y. Hu (Nanjing City)11.00 o-221 elucidating the role of natriuretic peptides (NPs) in the regulation of the key angiogenic mediator,vascular endothelial growth factor (VEGF)R. Alhamdan, P. Marsters, B. Campbell (United Kingdom)11.15 o-222 the role of the phosphatidylinositol-3'-kinase (PI3K) pathway in bovine primordial follicleactivation and the regulation of ovarian follicle growth in vitroS. Spence, R.A. Anderson, E.E. Telfer (United Kingdom)11.30 o-223 anti-mullerian hormone (AMH) has a direct regulatory role on theca cell functionA. Elfituri, P. Marsters, B.K. Campbell (United Kingdom)WEDNESDAYProgramme book121

Wednesday 10 July 2013Selected oral communication session10.00 - 11.45 Capital Hall BSession 59: EndometriumChairman: A. Makrigiannakis (Greece)Chairman: H. Critchley (United Kingdom)10.00 o-224 the endometrial stem cell markers Notch-1 and Numb are associated with endometriosisA. Schüring, L. Kiesel, M. Götte (Germany)10.15 o-225 Characterization of mouse endometrial labeling retaining cells after uterine remodelingM.Z. Cao, R.W.S. Chan, W.S.B. Yeung (Hong Kong)10.30 o-226 genome-wide DNA methylation profiling in cultured eutopic and ectopic endometrial stromal cellsY. Yamagata, H. Asada, H. Tamura, N. Sugino (Japan)10.45 o-227 nur77 cooperates with foXO1A to regulate decidual prolactin expression in human endometrialstromal cellsX. Jin, Y. Jiang, X. Shen, H. Liu, L. Zhu, H. Shan, Y. Hu, H. Sun, G. Yan (China)11.00 o-228 signal transduction pathways activated by human chorionic gonadotropin (hCG) in humanendometrial stromal cells (ESC)A. Tapia-Pizarro, S. Archiles, F. Argandoña, L. Devoto (Chile)11.15 o-229 novel decellularization and recellularization techniques for reconstruction and regeneration ofthe uterus in ratK. Miyazaki, T. Maruyama, H. Masuda, H. Oda, N. Hida, H. Uchida, Y. Yoshimura (Japan)11.30 o-230 mirna-21 is a novel regulator of NUR77 and KLF12 mediated decidual prolactin expression inhuman endometrial stromal cellsY. Jiang, X. Shen, H. Liu, X. Zhen, H. Sun, Y. Hu, G. Yan (China)122

Wednesday 10 July 2013Selected oral communication session10.00 - 11.45 S8 - ASession 60: Perinatal outcome after ARTChairman: P. De Sutter (Belgium)Chairman: S. Nelson (United Kingdom)10.00 O-231 Issue of assisted reproductive techniques in HIV-infected women: a case-control retrospective studyC. Stora, E. Devouche, L. Delaroche, C. Patrat, S. Matheron, F. Damond, C. Yazbeck, P. Longuet,M.A. Llabador, D. Luton, S. Epelboin (France)10.15 o-232 Birth-weight distribution of two large cohorts of singleton ART children resulting from two typesof culture media and compared to 107718 naturally conceived childrenJ. Lemmen, S. Rasmussen, S. Ziebe (Denmark)10.30 o-233 iCSI with non-ejaculated sperm is associated to higher perinatal risks than ICSI with ejaculatedsperm or IVFL. El Khattabi, E. Hafhouf, D. Royère, J.L. Pouly, J. De Mouzon, R. Levy, the FIVNAT group (France)10.45 o-234 obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome -a Nordic cohort studyA. Hagman, A. Loft, U.B. Wennerholm, A. Pinborg, C. Bergh, K. Aittomäki, K.G. Nygren,L.B. Romundstad, J. Hazekamp, V. Söderström-Anttila (Sweden)11.00 o-235 perinatal outcome of children born after vitrification of blastocysts (6467 cycles with 2059 babiesin 12 years experiences)T. Mukaida, T. Goto, T. Tajima, C. Oka, K. Takahashi (Japan)11.15 o-236 does embryo culture medium influence birthweight of the newborn - a randomised control trial.B. Carrasco, M. Boada, I. Rodríguez, B. Coroleu, P.N. Barri, A. Veiga (Spain)11.30 o-237 Birth weight in children born after frozen thawed embryo transfer - a Nordic cohort study fromthe CoNARTaS groupU.B. Wennerholm, A.K.A. Henningsen, L.B. Romundstad, C. Bergh, A. Pinborg, R. Skjaerven,J. Forman, M. Gissler, K.G. Nygren, A. Tiitinen (Sweden)WEDNESDAYProgramme book123

Wednesday 10 July 2013Selected oral communication session10.00 - 11.45 S8 - BSession 61: Effects of interventions on embryo qualityChairman: B. Balaban (Turkey)Chairman: B. Woodward (United Kingdom)10.00 o-238 impact of Hepatitis B and Hepatitis C infections on embryo quality during In-vitro fertilizationR. Naik, G. Bahadur, F. Olivier, A. Srikantharajah, J. Mehta, H. Joshi (United Kingdom)10.15 o-239 factors affecting success of blastocyst transfer into an artificially prepared uterine environmentdiffer from those affecting outcome of fresh autologous blastocyst transferB. Shapiro, S. Daneshmand, F. Garner, M. Aguirre, C. Hudson (U.S.A.)10.30 o-240 a randomized trial investigating the effectiveness and safety of three IVF laboratory disinfectantsS. Catt, E. Lingham, W. Lee, Y. Muthusamy, C. Kally, P. Chen, M. Pangestu, J. Catt,P. Temple-Smith (Australia)10.45 o-241 prospective study of the effect of early coasting on blastocyst development and outcome of fertilitytreatment in an IVF/ICSI programC. Kailasam, U.D. Gordon (United Kingdom)11.00 o-242 Clinical outcome following ICSI with assisted oocyte activation (ionomycin or electroporation)M. Kobayashi, A. Yoshida, S. Tanigiwa, K. Seida, H. Suzuki, M. Tanaka (Japan)11.15 o-243 the effect of developmental stage of embryos on human sex ratio at birth by assisted reproductivetechnologyS. Ogata, M. Matsu-ura, H. Ogata, A. Kajiwara, Y. Tokura, Y. Matsumoto, Y. Mizusawa, E. Okamoto,S. Yamada, S. Kokeguchi, M. Shiotani (Japan)11.30 o-244 oocyte versus embryo vitrification: searching the most efficient approach when preventing OHssafter agonist triggeringL. Herrero Grassa, S. Pareja Marín, S. Aragonés Barragán, J. Alonso Lorite, F. Bronet Campos,J.A. García-Velasco (Spain)124

WEDNESDAYWednesday 10 July 2013Invited session12.00 - 13.00 AuditoriumSession 62: Quality management and regulation in the ART labChairman: TBAChairman: TBA12.00 o-245 from quality control to total quality management in the IVF labK. Tilleman, K. Schepens, P. De Sutter (Belgium)12.30 o-246 the European Tissue Directive: a curse or a blessing?B. Tarlatzis (Greece)Programme book125

Wednesday 10 July 2013Invited session12.00 - 13.00 Capital Hall ASession 63: New ART interventions may, under certain circumstances, be introduced without a clinical trial? (Debate)Chairman: M. Van Wely (The Netherlands)Chairman: E. Somigliana (Italy)12.00 o-247 ForS. Fishel (United Kingdom)12.30 o-248 AgainstS. Sterckx (Belgium)126

WEDNESDAYWednesday 10 July 2013Invited session12.00 - 13.00 Capital Suite ASession 64: Endometriosis-associated painChairman: G.A.J. Dunselman (The Netherlands)Chairman: TBA12.00 o-249 endometrium, nerves and endometriosisI.S. Fraser (Australia)12.30 o-250 Central nervous system (CNS) mechanisms of pain in endometriosisK.J. Berkley (U.S.A.)Programme book127

Wednesday 10 July 2013Invited session12.00 - 13.00 S8 - BSession 65: Paramedical invited session - Nursing (Debate): Patients have the right for an anonymous donorChairman: TBAChairman: H.J. Kendrew (United Kingdom)12.00 o-251 ProL. Schmidt (Denmark)12.30 o-252 ConC. Gottlieb (Sweden)128

WEDNESDAYWednesday 10 July 2013Selected oral communication session14.00 - 15.15 AuditoriumSession 66: Embryo quality: does it predict pregnancy?Chairman: F. Prados Mondéjar (Spain)Chairman: A. Thornhill (United Kingdom)14.00 o-253 Human embryos release extracellular vesicles which may act as indicators of embryo qualityY.J. Ferreira, C. Gardiner, M. Poli, K. Turner, T. Child, I.L. Sargent (United Kingdom)14.15 o-254 research of circadian genes (Clock Bmal1, Per1, Per2, Cry1, Cry2) control over early embryodevelopment, ovaries and liver in vitroC. Theofanakis, V. Dinopoulou, D. Mavrogianni, E. Anagnostou, R. Bletsa, K. Kallianidis,D. Loutradis, A.A. Kiessling (Greece)14.30 o-255 assessment of nucleus dynamics and karyokinesis improves embryo selectionA. Azzarello, T. Hoest, A.L. Mikkelsen (Denmark)14.45 o-256 Use of trophectoderm quality versus use of inner cell mass quality to predict pregnancy after asingle blastocyst transfer in women of advanced maternal ageS. Ohgi, C. Hagiwara, C. Nakamura, H. Anakubo, A. Yanaihara (Japan)15.00 o-257 timing of pre- and post-compaction mouse embryo development is affected by media compositionand oxygen concentration: compositional analysis of seven commercially available culture mediaD. Morbeck, N. Bauman, J. Fredrickson, T. Moyer, D. Matern (U.S.A.)Programme book129

Wednesday 10 July 2013Selected oral communication session14.00 - 15.15 Capital Hall ASession 67: Scientific challenges in early pregnancy achievementChairman: S. Quenby (United Kingdom)Chairman: E. Kirk (United Kingdom)14.00 o-258 is hyaluronan essential for embryo implantation? Lesson from studies in sheepA. Fouladi-Nashta, W.F. Marei (United Kingdom)14.15 o-259 Could a novel, retrovirally-derived inhibitor of trophoblast syncytialization play a role in limitingcell fusion between extravillous trophoblast and maternal deciduaD. Schust, J. Sugimoto, T. Oda, Y. Jinno (U.S.A.)14.30 O-260 Genotyping analyses for polymorphisms of the ANXA5 gene in patients with recurrent pregnancy lossY. Hayashi, E. Mizutani, T. Kitaori, K. Katano, Y. Ozaki, N. Suzumori (Japan)14.45 o-261 Combination of laparoscopic uterine artery blockage and D&C to treat advanced cervical andcesarean section scar ectopic pregnanciesF. Kung, K.H. Huang, T.Y. Hsu (Taiwan R.O.C.)15.00 o-262 specific alleles of the PRDM9 gene are a risk factor for the production of chromosomallyabnormal embryos in humansJ. Sarasa, M. Enciso, L. Xanthopoulou, M. Bowles, J. Delhanty, D. Wells (United Kingdom)130

WEDNESDAYWednesday 10 July 2013Selected oral communication session14.00 - 15.15 Capital Suite ASession 68: The impact of genetics in andrologyChairman: TBAChairman: L.R. Fraser (United Kingdom)14.00 o-263 Clinical significance of sperm DNA damage on embryo implantation efficiency and spontaneouspregnancy loss after assisted reproductive therapyH. Asakura, Y. Nakahara, K. Nishio, Y. Araki (Japan)14.15 o-264 microRNA expression profile in spermatozoa from fertile donorsA. Salas-Huetos, J. Blanco, E. Anton (Spain)14.30 o-265 Comparative proteomic analysis coupled with conventional protein assay as a strategy toidentify predictors of successful testicular sperm extraction in patients with non-obstructiveazoospermia (noa)T. Freour, E. Com, P. Barrière, D. Masson, C. Pineau (France)14.45 o-266 molecular karyotyping of human single sperm by array- comparative genomic hybridizationA. Ferlin, C. Patassini, A. Garolla, A. Bottacin, M. Menegazzo, C. Foresta (Italy)15.00 o-267 a comparison of a newly developed round spermatid injection (rosi) and classical rosi -reproductive health study on 25 newborn babies-A. Tanaka, M. Nagayoshi, I. Tanaka (Japan)Programme book131

Wednesday 10 July 2013Selected oral communication session14.00 - 15.15 Capital Hall BSession 69: Clinical endocrinologyChairman: A.P. Ferraretti (Italy)Chairman: R. Anderson (United Kingdom)14.00 o-268 kisspeptin-54 administration stimulates pulsatile luteinising hormone secretion in women withhypothalamic amenorrheaC.N. Jayasena, A. Abbara, A.N. Comninos, R. Ratnasabapathy, J.D. Veldhuis, G.M.K. Nijher,Z. Ganiyu-Dada, A. Mehta, C. Todd, M.A. Ghatei, S.R. Bloom, W.S. Dhillo (United Kingdom)14.15 o-269 first birth achieved after in-vitro maturation of oocytes from a woman with resistant ovarysyndromeM. Grynberg, N. Frydman, R. Frydman, H. Peltoketo, P. Bouchard, R. Fanchin (France)14.30 o-270 Long-term effects of oxandrolone treatment in childhood on neurocognition, wellbeing andsocial-emotional functioning in young adults with Turner syndromeK. Freriks, C.M. Verhaak, T.C.J. Sas, L.A. Menke, B.J. Otten, S.M.P.F. de Muinck Keizer-Schrama,J.M. Wit, R.T. Netea-Maier, A.R.M.M. Hermus, R.P.C. Kessels, H.J.L.M. Timmers (The Netherlands)14.45 o-271 ivf outcome in treated hypothyroidismA. Busnelli, L. Benaglia, M. Leonardi, S. Faulisi, G. Ragni, E. Somigliana (Italy)15.00 o-272 differences in morphokinetic parameters between in-vitro maturation (IVM) and COS-ICSIanalysed by time-lapse imagingS. Roesner, B. Toth, J. Weigert, T. Strowitzki, M. Montag (Germany)132

WEDNESDAYWednesday 10 July 2013Selected oral communication session14.00 - 15.15 S8 - ASession 70: Challenges in cryopreservationChairman: G. Coticchio (Italy)Chairman: E.E. Telfer (United Kingdom)14.00 o-273 oocyte cryopreservation in the 21st century and post warming fertility outcomes: a systematicreview and meta-analysisN. Potdar, T.A. Gelbaya, L.G. Nardo (United Kingdom)14.15 o-274 metal cryovial: a new, promising system for clinical grade vitrification of ovarian tissueA. Bos-Mikich, D. Aquino, L. Danielli, P.S.L. Rigon, N. Lothhammer, N. Frantz (Brazil)14.30 o-275 the new Rapid i carrier is effective for human embryo vitrification at both the cleavage andblastocyst stage: preliminary clinical pregnancy and live birth outcomesN. Desai, C. Austin, J. Goldberg, T. Falcone (U.S.A.)14.45 o-276 maturation in presence of a glutathione donor protects spindle integrity and chromosomalalignment in vitrified mouse metaphase II oocytesT. Trapphoff, N. Staubach, T. Seidel, M. Heiligentag, U. Eichenlaub-Ritter (Germany)15.00 o-277 development of novel automated vitrification instrument; confirmation of ability to controlcritical parameters in a microfluidics consumable and software controlled instrument as part ofvitrificationE. Vom, T.K. Roy, S. Brandi, N.M. Tappe, T.T. Peura, S.J. McArthur, T. Stojanov (Australia)Programme book133

Wednesday 10 July 2013Selected oral communication session14.00 - 15.15 S8 - BSession 71: SurgeryChairman: C. Calhaz - Jorge (Portugal)Chairman: T. Li (United Kingdom)14.00 o-278 Clinical implications of congenital uterine anomalies: a systematic review and meta-analysis ofcomparative studiesS. Papadopoulos, C.A. Venetis, G. Grimbizis, B.C. Tarlatzis (Greece)14.15 o-279 reproductive surgery and ovarian reserveO. Rustamov, M. Krishnan, S. Roberts, C. Fitzgerald (United Kingdom)14.30 o-280 adnexal torsion in a rat model: does ischemia-reperfusion injury affect follicule cohort?P. Tokdemir Calis, L. Karakoc Sokmensuer, G. Bozdag (Turkey)14.45 o-281 fibroid volume reduction induced by ulipristal acetate (Upa) following fibroid characteristics atbaseline. post-hoc analyses of pearl i studyB. Fauser, J. Oliver, E. Loumaye (Switzerland)15.00 o-282 reproductive outcomes after hysteroscopic resection of the uterine septumI. Kozachenko, L. Adamyan, Z. Makyan (Russia C.I.S.)134

WEDNESDAYWednesday 10 July 2013Closing ceremony15.30 - 16.30 Capital Suite ASession 72: Awards and closing ceremonyProgramme book135

136

POSTER DISCUSSION SESSIONSEach day during lunch break, a number of posters will be discussed at the so called“Speakers’ Corner” in the poster area, which is located in the exhibit hall.The following posters have been pre-selected for discussion:Monday, 8 July13.00 P-047 Cross-border reproductive care among French patients eligible for ART funding in France –V. Rozée et al13.05 p-066 HCG may favor embryonic implantation and early growth by modulating endometrial cellreceptivity to major embryonic signals and targeting different cell types –A. Akoum et al13.10 p-119 abnormal distribution of type 1 Inositol 1,4,5 tri-phosphate receptor in fertilization failedhuman eggs –S. Yoon et al13.15 p-125 embryonic human chorionic gonadotropin (hCG) in spent culture medium may tellembryo viability in IVF-ET program: a multi-center study –J. Li et al13.20 p-360 Becoming a reflective ART practitioner: development of the professional trainingprogramme in infertility counseling for healthcare professionals in Hong Kong –C.H. Y. Chan et al13.25 p-390 psychological and social characteristics of single mothers by sperm donation –S. Zadeh et al13.30 p-392 prevalence of depressive disorders in infertile women and men up to 5 years afterundergoing in vitro fertilization treatment – a follow-up study –H. Volgsten et al13.35 p-581 Cumulative parenthood rates in 6,507 couples treated by in vitro fertilization –P. Troude et al13.40 p-517 Can anti-Müllerian hormone (AMH) predict the diagnosis of polycystic ovary syndrome (PCOS) -a systematic review and meta-analysis –S. Iliodromiti et alPOSTERS13.45 p-231 markers of human endometrial basal glandular epithelial cells: phenotypic and functionalcharacterisation and implications in the pathogenesis of endometriosis –D. Hapangama et alProgramme book137

Tuesday, 10 July13.00 P-050 Health related quality of life in women and their partners accessing infertility care at an urban,public tertiary referral centre in South Africa –M. Patel et al13.05 p-153 an additive model using morphokinetics to predict embryos of highest implantation potential –M. Cetinkaya et al13.10 p-210 Can completion of compaction predict implantation outcome? –E. Power et al13.15 p-269 what constitutes parenthood according to both genetically and non-genetically related mothers(lesbian parents) –V. Provoost et al13.20 p-395 parent-child relationships in assisted reproduction families: a follow-up at age 10 –L. Blake13.25 p-439 Highly multiplexed targeted single-nucleotide polymorphism (SNP) amplification And sequencingas a method for identifying fetal chromosomal disorders from maternal cell-free DNA –N. Chopra et al13.30 p-384 risk perception among patients undergoing fertility treatment –G. Weitzman et al13.35 P-602 The mouse embryonic stem (ES) cells assay could not replace the mouse embryo assay (MEA) fortesting the culture media in assisted reproduction technology (ART) –C. Schwarzer et al13.40 p-223 pale cells might be involved in the development of adenomyosis –M.G.S. Ibrahim et al13.45 p-311 aromatase inhibitors for subfertile women with PCOS –S. Franik et al138

POSTERSWednesday, 11 July13.00 P-111 Cleavage and blastocyst development rate is diminished and sex ratio is shifted by oocyteexposure to bisphenol A in Bos Taurus –F. Ferris et al13.05 p-234 a comparison of human papilloma virus infection and cervical cytology in women with copper andlevonorgestrel containing intrauterine devices –J. Lekovic et al13.10 p-317 analysis of the anti-STX5 autoantibody identified as a new serum marker for endometriosis -Nabeta, M.13.15 p-417 tubal factor infertility and perinatal risk after assisted reproductive technology -D. Session et al13.20 p-425 profiling of microRNAs in human preovulatory granulosa cells by deep sequencing reveals novelmiRNAs in fsH receptor and aromatase genes -A. Velthut – Meikas et al13.25 p-458 fisH on sperm to identify infertile male patients with higher aneuploidy risk -L. Rodrigo Vivo et al13.30 p-033 development and validation of CryoCocoons for the safe, aseptic storage of sperm cryovials –M. Schiewe13.35 P-323 Investigating the efficacy of the novel liquidus tracking method for ovarian tissue cryopreservation –F. Aljaser et al13.40 p-358 spanish gamete recipients: how do they feel? –M.D.M. Tirado et al13.45 p-048 is the world health organization assessing and monitoring global infertility prevalence:determining burden when addressing a poorly addressed global public health issue –S. van der PoelProgramme book139

POSTERSAndrologyP-001 Magnetic Activated Cell Sorting (MACS) is a useful technique to improved pregnancy rate in patientswith high level of sperm DNA fragmentationM. San Celestino Carchenilla, D. Agudo, S. Rubio, D. Becerra, F. Bronet, J.A. Garcia-Velasco, A. Pacheco (Spain)P-002 INSL3 gene expression is correlated with high levels of serum LH in patients with Sertoli cell-only syndromeM. Lardone, A. Piottante, A. Parada-Bustamante, F. Argandoña, M. Florez, A. Espinoza, M. Ebensperger,A. Castro (Chile)P-003 Cigarette smoking and sperm parameters. Analysis of a cohort of 4471 consecutive semen samplesM. Cohen-Bacrie, S. Belloc, A. Dalleac, E. Amar, V. Izard, A. Hazout, P. Cohen-Bacrie, J. de Mouzon (France)P-004 the relevance of aneuploidy assessment in normospermic samplesF. Muzzonigro, A.M. Crivello, I. Stanghellini, L. Bernardini, A.P. Ferraretti, M.C. Magli, L. Gianaroli (Italy)P-005 Increased reproductive outcome in oligospermic patients with abnormal sperm DNA damage after TESE-ICSIP. Sanchez Martin, M. Hebles Duvison, M. Dorado Silva, J. Gosalvez, F. Sanchez Martin (Spain)P-006 Correlation between sperm DNA fragmentation and aneuploidyA. Pomante, F. Muzzonigro, F. Colombo, M. Mattioli, B. Barboni, A.P. Ferraretti, M.C. Magli, L. Gianaroli (Italy)P-007 the effect of testicular sperm on the cycle outcome in blastocyst-stage single and double embryotransfer programmes: experience from two large centers in TurkeyO. Hacifazlioglu, N. Findikli, U. Goktolga, M. Bahceci (Turkey)P-008 sperm fertilization potential and chromosomal anomalies at decreased sperm concentration:differences between testicular cancer patients and infertile menA. Jakab, A. Mokánszki, A. Varga, M. Benyó, Z. Kassai, E. Oláh, Z. Molnár (Hungary)P-009 relation of infertility with fertilin-ß protein on the surface of human spermatozoaG.I. Gündogan, H.H. Bozkurt, T. Irez (Turkey)P-010 study of apoptosis in sperm samples: are we doing this test analysis correctlyA. Domingo, C. Anarte, N. Presilla, I. Calvo, O. Aguirre, A. Oroquieta, J.A. Agirregoikoa, J.L. De Pablo,G. Barrenetxea (Spain)P-011 magnetic cell sorting in frozen sperm samplesI. Moragues, M.L. Medrano, A. Montoya, B. Ramos, M.J. Gómez Torres, J. Aizpurua (Spain)P-012 meiotic segregation and sperm DNA fragmentation in men with dysplasia of the fibrous sheath (dfs)associated with head abnormalitiesS. Romdhane Ibala, H. Ghedir, A. Mehri, I. Zidi, S. Brahem, M. Mehdi, M. Ajina, A. Saad (Tunisia)P-013 sperm vitrification will replace slow freezingM.L. Medrano, I. Moragues, M.J. Gomez-Torres, A. Montoya, J. Aizpurua (Spain)140

P-014 "Fast food" may induce pre-diabetes impairing testicular function in ratsJ.E. Cavaco, L. Rato, M.G. Alves, T.R. Dias, G. Lopes, S. Socorro, P.F. Oliveira (Portugal)P-015 Can DNA damages depend on the mitochondrial potential membrane?A.M. Lobascio, M.G. Minasi, E. Greco (Italy)P-016 improvement of human sperm viability by using antioxidant supplementation during cryopreservationM. Bungum, A. Bungum, N. Silver (Sweden)P-017 CatSper gene expression after the transplantation of human spermatogonial stem cellsM. Zahiri, M. Movahedin, S.J. Mowla, M. Noruzinia (Iran)P-018 expression of macrophage migration inhibitory factor in sertoli cells; its possible role in spermatogonialstem cells migrationM. Huleihel, Y. Abarbanel, E. Piltcher Haber, M. Azab, D. Lan, E. Lunenfeld (Israel)P-019 antioxidant power of seminal plasma on male gamete competenceM.J. Smith, Q.V. Neri, L. Harvey, Z. Rosenwaks, G.D. Palermo (U.S.A.)P-020 High prevalence of Y-chromosome microdeletions in Middle Eastern patients with idiopathicnon-obstructive azoospermiaM. Alhalabi, S. Samawi, H. Droubi, M. Khalaf, A. Taha, R. Khatib (Syria)P-021 pregnancy outcome after magnetic activated cell sorting used during sperm preparation beforeintracytoplasmic sperm injection in men with a high rate of sperm DNA fragmentationA. Bednarowska-flisiak, M. Wcislo, J. Liss, A. Swider, J. Szczyglinska, M. Grzymkowska, A. Bruszczynska,J. Glowacka, K. Kitowska-Marszalkowska, M. Krapchev, A. Mirecka, K. Wisniewska, K. Lukaszuk (Poland)P-022 sperm DNA fragmentation (SDF) as assessed by TUNEL/PI: study of the intra individual variabilityI. Natali, L. Tamburrino, M. Cambi, S. Marchiani, I. Noci, M. Maggi, G. Forti, E. Baldi, M. Muratori (Italy)P-023 very short delay in intermittent HIV-1 RNA excretion in seminal plasma samples from HAART-treatedpatients with undetectable HIV-1 RNA in blood plasmaX. Ferraretto, B. Pasquet, F. Damond, S. Matheron, S. Epelboin, S. Yahi, P. Demailly, N. Rougier,C. Yazbeck, L. Delaroche, P. Longuet, M. Llabador, C. Estellat, C. Patrat (France)P-024 reduction of sperm DNA fragmentation using the magnetic activated cell sorting (MACS) withannexin V microbeads in assisted reproductionM. Wcislo, J. Liss, A. Swider, J. Szczyglinska, M. Grzymkowska, A. Bruszczynska, J. Glowacka,M. Krapchev, A. Mirecka, K. Kitowska-Marszalkowska, K. Wisniewska, K. Lukaszuk (Poland)P-025 the effect of Iranian traditional herb (calligonum) on sperm parameters and expression of catspergenes in aging male miceM. Askarijahromi, M. Movahedin, M. Amanlu, S.j. Mowla, Z. Mazaheri (Iran)POSTERSP-026 impact of sperm DNA fragmentation on reproductive outcome following IVF and ICSI: a retrospectiveanalysis of 406 casesP. Christensen, E.S. Sills, R. Fischer, O.G.J. Naether, D. Walsh, K. Rudolf, G. Coull, V. Baukloh,R. Labouriau, A. Birck (Denmark)P-027 HIV-1 seropositive males: quality of semenF. Parisi, B. Parrilla, M. Oneta, V. Savasi (Italy)Programme book141

P-028 Female age and number of retrieved oocytes in cases with oligoasthenozoospermiaL. Veleva, T. Milachich, I. Bochev, I. Antonova, A. Shterev (Bulgaria)P-029 Are classic semen analysis and sperm function tests all measuring the same cause of the male infertilityV. Vlaisavljevic, B. Pregl Breznik, B. Kovacic (Slovenia)P-030 Using STROBE and SEMQUA to evaluate the reporting quality of studies on semen quality and the impactof exposure to pesticidesM. Serrano, M.C. Gonzalvo, A. Clavero, M.F. Fernandez, J. Mozas, L. Martínez, J. Fontes, S. Carrillo,M.L. Lopez-Regalado, B. Lopez-Leria, I. Orozco, A. Mantilla, J.A. Castilla (Spain)P-031 Sperm retrieval techniques in patients with non-obstructive azoospermia: fertilization and pregnancy ratesG. Mskhalaya, E. Zakharova, V. Zaletova, E. Kasatonova, Y. Melnik, E. Efremov (Russia C.I.S.)P-032 are computer assisted semen analysis (CASA) motility parameters predictive for fertilization rate inconventional IVFB. Pregl Breznik, B. Kovacic, V. Vlaisavljevic (Slovenia)P-033 development and validation of CryoCocoons for the safe, aseptic storage of sperm cryovialsM.C. Schiewe, G. Verheyen, H. Tournaye, I. Phletincx, C.A. Sims, C. Rothman (U.S.A.)P-034 is the quality of sperm samples declining - findings from a 10 year gap longitudinal analysis of 2300sperm samples from BrazilE. Borges Jr., A.S. Setti, D.P.A.F. Braga, L. Vingris, A. Iaconelli Jr. (Brazil)P-036 association between male anthropometric data, metabolic status and semen parametersC. Dupont, C. Faure, N. Sermondade, B. Gautier, C. Herbemont, I. Aknin, J.P. Klein, I. Cedrin-Durnerin,J.P. Wolf, S. Czernichow, R. Lévy (France)P-037 expression of liver X receptors in testicular biopsies of patients with azoospermiaC. Rondanino, C. Chauffour, L. Ouchchane, C. Artonne, L. Janny, J.M. Lobaccaro, D.H. Volle, F. Brugnon (France)P-038 phase-II, multicentre, single-arm, open-label, prospective, interventional study to evaluate spermDNA-fragmentation in male idiopathic infertility before and after treatment with Gonal-f®PEN 900IU:an interim analysisN. Colacurci, P. Piomboni, G. Ruvolo, F. Lombardo, E. La Verde, V. De Leo, M. Lispi, E. Papaleo, R. De Palo,L. Gandini, S. Longobardi (Italy)P-039 effects of caffeine on embryo development and morphology in male mice under in vitro fertilizationY. Yokota, M. Yokota, H. Yokota, Y. Araki, Y. Araki (Japan)P-040 impact of world health organization new standards on the referral of infertile men for IUI and IVF/ICSIS. Alshahrani, D. Durairajanayagam, R. Sharma, E. Sabanegh, A. Agarwal (U.S.A.)P-041 Comparison of clinical results of fresh and vitrified oocytes by intracytoplasmic sperm injection withtesticular spermH. Hattori, Y. Nakajo, T. Ikeno, Y. Sato, T. Kyoya, K. Kyono (Japan)P-042 altered DNA methylation patterns of H19 differentially methylated region and the daZL gene promoterare associated with defective human spermB. Li, J.B. Li, X.F. Xiao, Y.F. Ma, J. Wang, X.X. Liang, H.X. Zhao, F. Jiang, Y.Q. Yao, X.H. Wang (China)142

P-043 Semen amyloids that enhance HIV-1 infection are conserved in great apes and play a role inreproduction by temporarily immobilizing spermatozoaN.R. Roan, H. Liu, J. Müller, A. Avila-Herrera, K.S. Pollard, P. Lishko, F. Kirchhoff, J. Münch,H.E. Witkowska, W.C. Greene (U.S.A.)P-044 specific sperm defects are differentially correlated with DNA fragmentation both in normozoospermicand teratozoospermic subjectsA. Mangiarini, A. Paffoni, L. Restelli, C. Guarneri, E. Somigliana, G. Ragni (Italy)P-045 proper dietary supplementation may improve fatty acid composition and semen quality: a prospective,randomized, double-blind trialC. Anarte, A. Domingo, I. Calvo, N. Presilla, O. Aguirre, R. Bou, M. Alemán, F. Guardiola, J.A. Agirregoikoa,J.L. De Pablo, G. Barrenetxea (Spain)P-046 effects of varicocele on sperm chromatin packaging, mitochondrial function and apoptosisC. Camargo, J.B.A. Oliveira, C.G. Petersen, A.L. Mauri, F.C. Massaro, A. Nicoletti, A.M. Nascimento,L.D. Vagnini, A.M.V.C. Martins, M. Cavagna, R.L.R. Baruffi, J.G. Franco Jr. (Brazil)Cross border reproductive careP-047 Cross-border reproductive care among French patients eligible for ART funding in FranceV. Rozée, E. de La Rochebrochard (France)Developing countries and infertilityP-048 Is the world health organization assessing and monitoring global infertility prevalence:determining burden when addressing a poorly addressed global public health issueS. van der Poel (Switzerland)P-049 HMG-only protocol for IVF, a practical and more affordable option for developing countriesH. Sallam, F. Ezzeldin, N. Sallam, A. Agameya, S. Sallam, A. Farrag (Egypt)P-050 Health related quality of life in women and their partners accessing infertility care at an urban,public tertiary referral centre in South AfricaM. Patel (South Africa)P-051 gender preference and demand for preconception sex selection: a survey among middle-class pregnantwomen in GhanaB.J. Woodward, M.A. Otoo, M.B. Yakass, E.K. Hiadzi (United Kingdom)Early pregnancyPOSTERSP-052 Biochemical pregnancy rate may be lower in subjects undergoing in-vitro fertilization with singleembryo transfer as compared to the fertile population, =42 years oldA. Zeadna, H. Holzer, W.Y. Son, E. Demirtas, S. Reinblatt, M.H. Dahan (Royal Victoria Hospital)P-053 How successful is the medical management of early pregnancy failure (EPF) in clinical practice?Retrospective analysis of a combined protocol of mifepristone and misoprostolV. Colleselli, E. D'Costa, L. Wildt, B. Seeber (Austria)Programme book143

P-054 Genomic rearrangements and CNVs detected by array CGH in blighted ovum pregnanciesA.A. Kashevarova, N.A. Skryabin, T.V. Nikitina, I.N. Lebedev (Russia C.I.S.)P-055 HLA-G+CD4+ T cells and HLA-G+ dendritic cells accumulate in the first trimester decidua of women withspontaneous abortionP. Panina Bordignon, A. Mugione, V.S. Vanni, P. Viganò, E. Papaleo, M. Candiani, E. Somigliana, G. Amodio,S. Gregori (Italy)P-056 effects of progesterone elevation in late follicular phase on the pregnancy outcomes of day 3 embryotransfer and day 5 blastocyst transferY.H. Guo, R. Li (China)P-057 analysis on reasons of misdiagnosis and delayed diagnosis for ectopic pregnancies and heterotopicpregnancies conceived with ART treatmentL.L. Wang, S.L. Chen, X. Chen, W. Guo, D.S. Ye, Y.D. Liu (China)P-058 Clinical efficiency and perinatal outcome of ART cycles following embryo culture in the presence ofGM-CSF in patients with miscarriage or early pregnancy loss historyM. Mignini Renzini, M. Dal Canto, G. Coticchio, R. Comi, C. Brigante, I. Caliari, F. Brambillasca, M. Merola,M. Lain, D. Turchi, G. Karagouga, M. Sottocornola, R. Fadini (Italy)P-059 randomised comparison of fertility outcome in women with ectopic pregnancy or pregnancy of unknownlocation treated with systemic methotrexate or expectant managementM.Z. Wekker, F. Mol, M. van Wely, W.M. Ankum, B.W. Mol, F. van der Veen, P.J. Hajenius, N.M. van Mello(The Netherlands)P-060 Chromosomal abnormalities in women with early miscarriage after natural conception or assistedreproductive techniquesC. Verlengia, E. Alviggi, M.R. Rampini, P. Alfano, I. Pergolini, D. Marconi, N. Iacobelli, M.C. Muzi, G. Gelli,C. Alviggi, A. Colicchia (Italy)P-061 Increasing prevalence of undiagnosed celiac disease in spanish women with recurrent reproductive failureL. Herráiz-Nicuesa, M. Tejera-Alhambra, A. García-Segovia, R. Ramos-Medina, B. Alonso, J. Gil-Pulido,L. Martín, M. Caballero, M. Rodríguez-Mahou, S. Sánchez-Ramón (Spain)P-062 aspirin or anticoagulants not effective for treating recurrent miscarriage in women withoutantiphospholipid syndrome: an updated systematic reviewP.G. de Jong, S.P. Kaandorp, M. Di Nisio, M. Goddijn, S. Middeldorp (The Netherlands)P-063 relevance of R72P p53 single nucleotide polymorphism in the outcome of IVF cycle in patients withrepeated implantation failure and pregnancy lossB. Lledo, A. Turienzo, J.A. Ortiz, R. Morales, J. Ten, J. Llacer, R. Bernabeu (Spain)P-064 new decision-tree model for defining the risk of recurrent reproductive failureR. Ramos-Medina, A. Garcia-Segovia, J. Gil, J.A. Leon, B. Alonso, M. Tejera-Alhambra, A. Seyfferth,A. Aguaron, J. Alonso, E. Carrillo de Albornoz, J. Carbone, P. Caballero, E. Fernandez-Cruz,L. Ortiz-Quintana, S. Sanchez-Ramon (Spain)P-065 down-regulation of the serum- and glucocorticoid-inducible kinase family in the decidua of women withspontaneous abortionY.Y. Lou, F. Jin, Y.M. Zheng, L.J. Li, F. Le, L.Y. Wang, S.Y. Liu, P.P. Pan, C.X. Hu (China)144

P-066 HCG may favor embryonic implantation and early growth by modulating endometrial cell receptivity tomajor embryonic signals and targeting different cell typesA. Akoum, A. Bourdiec, R. Shao, C.V. Rao (Canada)P-067 g-CSF treatment in the implantation failure with a fixed dose of 60mcg/day: preliminary data of acontrolled trialF. Scarpellini, M. Sbracia (Italy)P-068 predicting abnormal placentation with position of gestational sac in the uterine cavity after IVFprocedures and spontaneous conceptionN. Jancar, E. Vrtacnik Bokal, H. Ban-Frangez, S. Drobnic, S. Korosec, B. Pinter, V. Salamun (Slovenia)P-069 transvaginal methotrexate injection for cesarean scar pregnancy: efficacy and subsequent fecundityM. Yamaguchi, R. Honda, K. Uchino, T. Ohba, H. Katabuchi (Japan)P-070 prognostic value of serum CA 125 and beta hCG ratio to separate ectopics from IUPsO. Leylek, B. Tiras, A.Y.S.E. Saltik, C. Halicigil, N. Kavci (Turkey)P-071 effects of treatment of ectopic pregnancy with methotrexate or salpingectomy on subsequent in vitrofertilization cycleA. Wiser, A. Gilbert, R. Nahum, R. Orvieto, J. Hass, A. Hourvitz, A. Weissman, G. Younes, M. Dirnfeld,A. Hershko, A. Shulma, H. Holzer, E. Shalom-Paz, T. Tulandi (Canada)P-072 Caesarean section and time to next birth, ectopic pregnancy, miscarriage or stillbirth-a Danishregister-based studyS.M. O'Neill, E. Agerbo, L.C. Kenny, T.B. Henriksen, P.M. Kearney, R.A. Greene, P.B. Mortensen,A.S. Khashan (Ireland)P-073 differences in ultrastructure and protein profiles of extracellular matrix components in decidua basalisversus parietalis: implications for successful placentation in early human pregnancyV. Sinai Talaulikar, B.E. Bax, I. Manyonda (United Kingdom)P-074 randomised comparison of health-related quality of life in women with ectopic pregnancy or pregnancyof unknown location treated with systemic methotrexate or expectant managementN. Van Mello, F. Mol, P.J. Hajenius, W.M. Ankum, B.W. Mol, F. van der Veen, M. van Wely (The Netherlands)EmbryologyP-075 ACCU-VIT: a new strategy for managing poor respondersG. Gandhi, G. Allahbadia, S. Kagalwala, A. Allahbadia, S. Ramesh, K. Patel, R. Hinduja, V. Chipkar,M. Madne, R. Ramani (India)P-076 Sucrose needs not to be added in vitrification solution for freezing the artificial shrunken mouse blastocystsJ.K. Joo, J.E. Jeung, K.R. Go, K.S. Lee (Korea South)POSTERSP-077 atp contents in immature oocytes obtained from graafian follicles decreased compared with those fromsmall folliclesH. Goto, S. Hashimoto, A. Amo, T. Yamochi, H. Iwata, Y. Morimoto (Japan)P-078 is ICSI yielding better clinical outcome compared to IVF in poor responders with normal sperm analysis?M. Koifman, S. Lahav-Baratz, E. Blais, Z. Megnazi-Wiener, D. Ishai, R. Auslender, M. Dirnfeld (Israel)Programme book145

P-079 A modified cryotop vitrification protocol with polimer cryoprotectant agent ficoll in the cryopreservationof human oocytesV. Zaletova, E. Zakharova, I. Krivokharchenko, S. Zaletov (Russia C.I.S.)P-080 Cryopreservation of cleavage stage embryo or blastocyst: which option is betterL. Zhu, Y. Li, H. Zhang, J. Ai, L. Jin (China)P-081 Quantitative analysis of operator-dependent variability in blastocyst vitrification with a High SecurityVessel (HSV) vitrification systemX. Zhang, N. Rajan, A. Kovacs, C. Foley, J. Flanagan, J. O'Callaghan, J. Waterstone, T. Dineen (Ireland)P-082 for now, I would rather have the transfer of one fresh blastocyst. The surplus, please, vitrify them!E.M. Dahdouh, P. St-Michel, L. Granger, B. Carranza-Mamane, F. Faruqi, T.V. Kattygnarath,F.L.A. Ferreira Gomes (Canada)P-083 effectiveness of vitrification in women undergoing elective freezing of oocytes and/or embryos whenembryo transfer conditions are suboptimalN. Christoforidis, C. Ioakimidou, C. Papas, M. Moisidou, A. Chatziparasidou (Greece)P-084 Cleavage stage embryo versus blastocyst transfer in patients with 3 failed IVF/ ICSI cycles,a retrospective cohort studyM. Klaver, K. Tilleman, P. De Sutter (Belgium)P-085 effect of female underweight on embryo morphokinetic using time-lapseJ. Lammers, T. Freour, C. Splingart, P. Barriere (France)P-086 effect of oocyte activation by calcium ionophore A23187 or strontium chloride in patients with lowfertilization ratesT. Ikeno, Y. Nakajyo, Y. Sato, K. Hirata, T. Kyoya, K. Kyono (Japan)P-087 are there any differences in terms of kinetic parameters between male or female embryos -a time lapse analysisF. Bronet Campos, M. Meseguer, M. Nogales, E. Martinez, M. Ariza, D. Agudo, L. Rodrigo,J.A. Garcia-Velasco (Spain)P-088 Blastocyst survival, re-expansion, and % live cells following vitrification and warming using twocommercially-available vitrification systemsA.S. Lopes, V. Frederickx, G. Vankerkhoven, A. Serneels, P. Roziers, P. Puttermans, R. Campo,S. Gordts (Belgium)P-090 serum anti-Mullerian hormone measurements and human blastocyst development after IVFJ. Liss, K. Lukaszuk, J. Glowacka, A. Bruszczynska (Poland)P-091 Effect of sperm selection using hyaluronic acid binding on reproductive outcome with donated oocyte cyclesS. Cortés Gallego, L. Ortega López, E. Olaya Vila, M. Gago García, C. Luna Cañas, A. García Segovia,A. Guijarro Ponce, R. Núñez Calonge, P. Caballero Peregrín (Spain)P-092 does growth retardation in human blastocysts decrease implantation potential after embryo transferthrough an increase of the abnormal spindlesS. Hashimoto, A. Amo, K. Ito, Y. Nakaoka, Y. Morimoto (Japan)P-093 in vitro maturation of human oocytes selected by Brilliant Cresyl Blue stainingD.D. Alcoba, E.G. Valério, M. Conzatti, J. Tornquist, A.P. Kussler, A.M. Pimentel, H.E. Corleta, I.S. Brum (Brazil)146

P-094 Local evaluation and validation of open system oocyte vitrification methodP. Boyer, D. Montjean, P. Tourame, M. Gervoise-Boyer (France)P-095 oocyte ERM proteins play a crucial role in gamete adhesion/fusionJ. Cohen, B. Lefevre, C. Ialy Radio, J.P. Wolf, A. Ziyyat (France)P-096 Clinical outcome of vitrified single blastocyst transfer as related to blastocyst morphology before vitrificationI. De Croo, A. Tolpe, S. Degheselle, A. Van de Velde, K. Tilleman, P. De Sutter, E. Van den Abbeel (Belgium)P-097 a comparison of two different vitrification methods for cryopreservation of mature human oocytesS. Kagalwala, G. Gandhi, G. Allahbadia, M. Kuwayama, A. Allahbadia, V. Chipkar, A. Khatoon, R. Ramani,M. Madne, S. Alsule (India)P-098 influence of storage period of vitrified embryos on clinical outcomeM. Inaba, A. Ohgaki, A. Ohtani, H. Matsumoto, S. Mizuno, R. Mori, A. Fukuda, Y. Morimoto (Japan)P-099 outcome of blastocyst vitrification with cryoloops: clinical outcome of 2,924 cycles comparing with 2,003fresh blastocyst transfer cyclesY. Umekawa, A. Yoshida, S. Tanigiwa, K. Seida, H. Suzuki, M. Tanaka (Japan)P-100 Anthocyanin improves viability and maturation of sheep oocytes cultured In the presence of cAMP modulatorsZ. Vahabi, P. Eftekhari Yazdi, A. Dalman, B. Ebrahimi, F. Mostafaei, M. Rajabpour Niknam (Iran)P-101 Correlation of the duration of the first cleavage cycle of embryos with good quality blastocyst andimplantation rates in single frozen-thawed blastocyst transferS. Watanabe, M. Kamihata, T. Tanaka, R. Matsunaga, N. Yamanaka, C. Kani, T. Ishikawa, T. Wada,H. Morita, H. Miyamura, E. Nishio, M. Ito, A. Kuwahata, M. Ochi, T. Horiuchi (Japan)P-102 in vitro maturation does not affect the morphology of the metaphase II spindle in oocytes collected fromantral follicles in IVM cyclesM. Dal Canto, M.C. Guglielmo, R. Fadini, M. Mignini Renzini, D.F. Albertini, P. Novara, M. Lain,F. Brambillasca, D. Turchi, M. Sottocornola, G. Coticchio (Italy)P-103 effects of sperm concentration after swim-up on conventional in vitro fertilization rates: Analysis ofsperm motility using a sperm motility analysis systemM. Kato, N. Fukunaga, R. Nagai, H. Kitasaka, T. Yoshimura, F. Tamura, N. Hasegawa, K. Nakayama,M. Takeuchi, H. Ohno, N. Aoyagi, E. Kojima, F. Itoi, Y. Hashiba, Y. Asada (Japan)P-104 study of the most effective embryo transfer with blastocyst gradeH. Kikuchi, Y. Iwasa, T. Kamono, A. Suzuki, K. Yamada, H. Kanno, K. Sasaki, H. Murakawa, M. Matsubara,H. Yoshida (Japan)P-105 Comparison of four techniques for artificial shrinkage of the blastocoele cavity pre-vitrificationC. Valdespin, M. Elhelaly, P. Chen, M. Pangestu, S. Catt (Mexico)POSTERSP-106 morphokinetics of embryos acquired from poor responders aged 40 years and above:comparison between natural and stimulated cyclesN. Hojnik, B. Kovacic, P. Roglic, M. Taborin, M. Zafosnik, J. Knez, V. Vlaisavljevic (Slovenia)P-107 Hydroxypropyl Cellulose as a novel cryoprotectant for oocyte/embryo vitrificationC. Mori, A. Yabuuchi, K. Ezoe, Y. Takayama, F. Aono, K. Kato (Japan)P-108 morphokinetics and time-lapse technique as a predictor of embryo development to the blastocyst stageP. Radwan, R. Krasinski, K. Chorobik, M. Radwan (Poland)Programme book147

P-109 Effect of early blastomere multinucleation on pre-implantation developmental timings of human embryosM. Stoppa, R. Maggiulli, A. Capalbo, E. Ievoli, L. Dovere, C. Scarica, L. Albricci, S. Romano, F. Sanges,N. Barnocchi, L. Papini, A. Vivarelli, F.M. Ubaldi, L. Rienzi (Italy)P-110 Human embryo aneuploidies cannot be predicted by morphokinetic assessment during the first phasesof in vitro cultureL. Rienzi, S. Bono, A. Capalbo, L. Spizzichino, C. Rubio, F.M. Ubaldi, F. Fiorentino (Italy)P-111 Cleavage and blastocyst development rate is diminished and sex ratio is shifted by oocyte exposure tobisphenol A in Bos taurusJ. Ferris, L.A. Favetta, N. MacLusky, W.A. King (Canada)P-112 the impact of laser-assisted hatching (LAH) on clinical outcome of assisted reproduction technology andthe role of maternal ageT. Madani, N. Jahangiri, R. Aflatoonian (Iran)P-113 retrospective analysis of clinical outcome of vitrified blastocyst post thaw using time-lapse imaging andstandard incubationE. Cater, D. Hulme, K. Berrisford, L. Jenner, A. Campbell, S. Fishel (United Kingdom)P-114 minimal waste of healthy human embryos due to chromosomal mosaicismX.Y. Zhang, A. Yilmaz, H. Hananel, A. Ao (Canada)P-115 near-equilibrium rapid freezing versus cryotop vitrification of 2-cell mouse embryosT. Vutyavanich, W. Piromlertamorn, U. Saenganan, S. Samchimchom (Thailand)P-116 Aseptic oocyte vitrification to circumvent oocyte aging as strategy when semen sample production is delayedB. Wirleitner, B. Lejeune, N.H. Zech, P. Vanderzwalmen (Austria)P-117 sequential versus single step media in a time lapse system: is there a difference in pregnancy rate?E. Albani, V. Parini, A. Smeraldi, F. Menduni, R. Antonacci, A. Marras, S. Levi, G. Morreale, B. Pisano,A. Di Biase, A. Di Rosa, P.E. Levi Setti (Italy)P-118 reverse phase protein array (rppa): a new approach for the identification of cumulus cells biomarkersof oocyte qualityV. Puard, V. Cadoret, T. Tranchant, C. Gauthier, E. Reiter, F. Guérif, D. Royère (France)P-119 abnormal distribution of type 1 Inositol 1,4,5 tri-phosphate receptor in fertilization failed human eggsS.Y. Yoon, J.H. Eum, E.A. Park, T.Y. Kim, T.K. Yoon, D.R. Lee, W.S. Lee (Korea South)P-120 the shipment of oocytes or embryos vitrified in minimum volume by means of dry shipper containersdoes not impair the clinical outcomeA. Cobo Cabal, B. Vallejo, P. Campos, E. Sánchez, J. Serrano, J. Remohi (Spain)P-121 Cleavage timing of euploid embryo development is age-relatedV. Nagornyy, P. Mazur, D. Mykytenko, L. Semeniuk, V. Zukin (Ukraine)P-122 does the type of culture media or oxygen tension affect embryo fertilization and development - analysisof sibling o ocytesP. Guilherme, C. Madaschi, T.C.S. Bonetti, G. Fassolas, C.R. Izzo (Brazil)P-123 is intrafollicular retinoic acid associate with nuclear oocyte maturationM.J. De Los Santos, D. Beltrán, V. García-Láez, M.J. Escribá, N. Grau, L. Escrich, C. Albert,J.L. Zuzuarregui, A. Pellicer (Spain)148

P-124 Evaluation of calcium machinery in a meiosis defect mouse modelY. LU, D. Nikiforaki, F. Vanden Meerschaut, J. Neupane, W.H. De Vos, S. Lierman, T. Deroo, B. Heindryckx,P. De Sutter (Belgium)P-125 embryonic human chorionic gonadotropin (hCG) in spent culture medium may tell embryo viability inIVF-ET program: a multi-center studyJ. Li, X.Y. Chen, G. Lin, G.N. Huang, Z.Y. Sun, Y. Zhong, B. Zhang, T. Li, S.P. Zhang, H. Ye, S.B. Han,S.Y. Liu, J. Zhou, G.X. Lu, G.L. Zhuang (China)P-126 viability markers: optimal dynamic range for implantation in competent blastocystL. Muela, M. Roldan, B. Gadea, M. Martinez, I. Perez, M. Meseguer, M. Muñoz (Spain)P-127 impact of exposure to music during in vitro culture on embryo developmentC. Castelló, M. Asensio, P. Fernández, A. Farreras, S. Rovira, J.M. Capdevila, E. Velilla, M. López-Teijón (Spain)P-128 Can a composite score based on time lapse observation aid embryo selection for single embryo transfer- an interim reportP. Kovács, S.Z. Mátyás, V. Forgács, A. Reichart, F. Rárosi, A. Bernárd, A. Török, S.G. Kaáli, A. Sajgó,C.S. Pribenszky (Hungary)P-129 p38 MAPK signal activity is critical for GLUT1 and GLUT4 expressions, maintaining pluripotency andsurvival of early mouse embryosB. Sozen, S. Ozturk, A. Yaba-Ucar, N. Demir (Turkey)P-130 a prospective study evaluating the effect of high (21%) and low (5%) oxygen levels on the human embryodevelopmentN. Gelo, P. Stanic, V. Hlavati, Sˇ.ogoric, D. Pavicic-Baldani, M. [prem-Gold{tajn, B. Radakovic, M. Kasum,M. Strelec, T. Canic, V. ?imunic, H. Vrcic (Croatia)P-131 growth factors status in follicular fluid of patients undergoing ICSIM. Ajina, D. Negra, H. Ben-Ali, S. Jallad, I. Zidi, S. Meddeb, M. Bibi, H. Khairi, A. Saad (Tunisia)P-132 detailed kinetics and morphology analyis of human triplonucleated embryos: a comparison withcorrectly fertilized transferred embryosL. Escrich, N. Grau, M. Meseguer, P. Gámiz, T. Viloria, M.J. Escribá (Spain)P-133 embryo morphokinetic after artificial oocyte activation by using calcium ionophoreE. Taboas Lima, M. Pérez Fernández, J.A. Aguilar Prieto, M. Ojeda Varela, D. Kassa, E. Muñoz Muñoz (Spain)P-134 improvement of blastocyst culture by a time-lapse incubatorH. Morita, S. Watanabe, M. Kamihata, R. Matsunaga, T. Wada, K. Kani, T. Ishikawa, H. Miyamura,M. Ito, A. Kuwahata, M. Ochi, T. Horiuchi (Japan)P-135 the effect of piezo-assisted biopsy on preimplantation mouse embryo development and gene expressionM.N.K. Nor-Ashikin, J.M.Y. Norhazlin, S. Norita, W.J. Wan-Hafizah, M. Mohd-Fazirul, D. Razif, B.P. Hoh,S.H. Sheikh Abdul Kadir (Malaysia)POSTERSP-136 retrospective analysis of sperm incubation time pre IVF inseminationS. Dale, E. Cater, G. Woodhead, L. Jenner, S. Fishel (United Kingdom)P-137 the effect of CO 2levels in embryo culture on clinical outcomeS. Andronikou, G. Francis, S. Tailor, M. Vourliotis, P.A. Almeida (United Kingdom)Programme book149

P-138 Cyclin E1 as a new ICM marker identifies a discrete lineage in epiblast cells of the human blastocystM. Krivega, H. Van de Velde (Belgium)P-139 Correlation of prss35 and SERPINE2 gene expression levels in cumulus cells with oocyte maturationand the potential as a biomarker to predict embryo qualityR.K. Lee, Y.M. Hwu, C.H. Lu, S.H. Li (Taiwan R.O.C.)P-140 Biologic efficiency of fresh oocytes in a large Italian ART program in relation to InternationalbenchmarksA. Vaiarelli, R. Antonacci, A. Smeraldi, M. Desgro, E. Albani, A. Baggiani, E. Zannoni, P.E. Levi Setti (Italy)P-141 factors affecting the twin-delivery rate in sperm donation programmeL. Bacer Kermavner, I. Virant Klun, B. Pinter, E. Vrtacnik-Bokal (Slovenia)P-142 differentiation during early human embryogenesisC. De Paepe, G. Cauffman, G. Verheyen, D. Stoop, I. Liebaers, H. Van de Velde (Belgium)P-143 oocyte activation increases fertilization rate resulting in a higher final number of blastocysts withoutcompromising implantation potential per transferred embryo: a sibling prospective studyA. Stecher, B. Wirleitner, P. Vanderzwalmen, M. Zintz, A. Neyer, M. Bach, B. Baramsai, D. Schwerda,N.H. Zech (Austria)P-144 synchronized blastomere cleavage at cryopreservation: Effect on subsequent embryo survival,pregnancy and live birth ratesZ. Wiener-Megnazi, M. Fridman, M. Koifman, S. Lahav-Baratz, I. Blais, R. Auslender, M. Dirnfeld (Israel)P-145 Histidine-rich glycoprotein improves embryo developmentH. Åkerud, K. Lindgren, K. Kårehed, K. Wånggren, J. Hreinsson (Sweden)P-146 the efficacy of hyaluronate (HA): a comparative study to evaluate the selection of mature sperm inICSI-IMSI cyclesS. Rovira, J.M. Capdevila, B. Freijomil, C. Castelló, A. Farreras, P. Fernández, M. Asensio, M. López-Teijón,E. Velilla (Spain)P-147 oocyte maturity rate as function of time from ovulation trigger to oocyte aspiration in IVF-ICSI cyclesA. Weiss, R. Neril, J. Geslevich, R. Beck-Fruchter, M. Lavee, J. Golan, A. Ermoshkin, E. Shalev (Israel)P-148 factors related to clinical pregnancy of vitrified-warmed embryo transfer: a retrospective andmultivariate logistic regression analysis of 2313 transfer cyclesW. Shi, S. Zhang, W. Zhao, X.I.A. Xue, M.I.N. Wang, H. Bai, J. Shi (China)P-149 Understanding the impact of Assisted Reproductive Technologies (ART) on embryo health, child healthand disease and longevity in later lifeH.L. Smith, L. Shaw, S. Kimber, D. Brison (United Kingdom)P-150 developmental regulation of apoptosis related-genes during early embryonic development:a comparison between human and mouse speciesI. Boumela, S. Assou, D. Haouzi, O. Ait Ahmed, H. Dechaud, S. Hamamah (France)P-151 Ultrastructural alterations in different developmental stages of in vivo and in vitro preimplantationmurine embryos exposed to cryopreservationR. Dasiman, A.R. Nor-Shahida, W.J. Wan-Hafizah, J.M.Y. Norhazlin, M. Mohd-Fazirul, O. Salina,R.A.F. Gabriele, M.N.K. Nor-Ashikin (Malaysia)150

P-152 Time-lapse microscopic analysis for exploring the dynamics of embryonic cell cycles followingblastomere biopsyD. Ben-Yosef, T. Shwartz, T. Cohen, A. Carmon, N. Mey Raz, M. Malcov, T. Frumkin, B. Almog, I. Vagman,R. Kapustiansky, A. Reches, F. Azem, A. Amit (Israel)P-153 an additive model using morphokinetics to predict embryos of highest implantation potentialM. Cetinkaya, C. Pirkevi, H. Yelke, Y. Kumtepe, Z. Atayurt, S. Kahraman (Turkey)P-154 safespeed technology - the myth of ultrahigh cooling rates: a close device and a serum-free media forthe vitrification human oocytes/embryos with the highest recovery ratesR. Risco, M. Hebles, A.M. Saa, M.A. Vilches-Ferron, P. Sanchez-Martin, E. Lucena, M. Lucena (Spain)P-155 vitrification: a useful tool in IVF lab when fresh embryo transfer can not be performedM. De Las Heras, J.A. Agirregoikoa, E. Martinez, G. Barrenetxea, J.L. De Pablo (Spain)P-156 embryo density in group culture of human embryos may influence embryo qualityA. Lehner, C. Pribenszky, A. Murber, J. Rigó Jr., J. Urbancsek, P. Fancsovits (Hungary)P-157 effect of oil density in donor oocyte IVF cyclesD. Gumbao Baño, A. Sánchez-León, J. Marcos, M. Mollá, B. Amorocho, M. Nicolás, L. Fernández,J. Landeras (Spain)P-158 a comparative gene expression analysis of slow frozen and vitrified metaphase II human oocytesO.A. Adeniyi, S.M. Ehbish, D.R. Brison (Manchester Academic Health Science Centre)P-159 Comparison of two different cryo-devices for vitrified-warmed single blastocyst transfer usingchemically defined vitrification/warming solutions supplemented with recombinant human albuminA. Egashira, M. Murakami, E. Nagafuchi, K. Tanaka, A. Tomohara, C. Mine, H. Otsubo, A. Nakashima,M. Otsuka, N. Yoshioka, T. Kuramoto (Japan)P-160 fresh embryo transfer versus frozen embryo transfer with GnRH-antagonist protocol in ARTD. Choi, H.I. Yang, J.H. Park, J.H. Jung, H.G. Hwang, J.H. Lee, J.E. Lee, A.S. Kang, J.H. Yoo, H.C. Kwon,S.J. Lee (Korea South)P-161 induction of autophagy in the vitrified-warmed mouse oocytesS. Bang, H. Shin, H.J. Lim (Korea South)P-162 forced blastocoele collapse of the blastocoel improves developmental potential in cryopreserved bovineblastocysts by vitrification and slow-rate freezing methodsS.H. Min, J.Y. Yeon, D.B. Koo (Korea South)P-163 effect of Hydroxypropyl cellulose on survival of bovine and human oocytes after vitrificationM. Kuwayama, S. Higo, L. Ruvalcaba (Japan)POSTERSP-164 restoration of developmental competence of oxidatively damaged oocytes by meiotic spindle transferM. Kobayashi, T. Takeuchi, A. Yoshida (Japan)P-165 avoiding the occurrence of smooth endoplasmic reticulum clusters in oocytes improves ART outcomesA. Miwa, Y. Nagai, Y. Momma, K. Takahashi, M. Chuko, A. Nagai, J. Otsuki (Japan)P-166 Thawing in the day of embryo transfer had improved pregnancy rate in HRT cycles, but not in the natural cyclesS.G. Kim, J.H. Lee, Y.Y. Kim, H.J. Kim, I.H. Park, H.G. Sun, K.H. Lee, H.J. Song (Korea South)Programme book151

P-167 Single medium culture in a time-lapse incubator until the blastocyst stage with or without mediumrenewal on Day-3: a prospective randomised study with donor oocytesN. Costa-Borges, M. Belles, J. Herreros, J. Teruel, A. Ballesteros, A. Pellicer, G. Calderón (Spain)P-168 regulation of inositol 1,4,5-trisphosphate receptor during human oocyte maturation and fertilizationD. Nikiforaki, L. Vossaert, F. Vanden Meerschaut, C. Qian, Y. Lu, J.B. Parys, W.H. De Vos, D. Deforce,T. Deroo, E. Van den Abbeel, L. Leybaert, B. Heindryckx, P. De Sutter (Belgium)P-169 Exosomes as bioactive messengers in a critical time for preimplantation embryos - an ultrastructural studyL. Surlan, V. Otasevic, K. Velickovic, I. Golic, M. Vucetic, V. Stankovic, J. Stojnic, N. Radunovic, I. Tulic,B. Korac, A. Korac (Serbia)P-170 prospective randomized study comparing human embryo culture in group in the Well-of-the-Well dishor individually in droplets. Results from an intermediate analysisP. Fancsovits, C. Pribenszky, A. Lehner, A. Murber, J. Rigo Jr., J. Urbancsek (Hungary)P-171 origin and role of transient DNA strand breaks during spermiogenesisR. Elias, Q.V. Neri, T. Fields, P.N. Schlegel, Z. Rosenwaks, G.D. Palermo (U.S.A.)P-172 Clinical outcomes following the transfer of vitrified blastocysts derived from a single or sequentialculture mediumA. Gilson, N. Piront, B. Heens, C. Vastersaegher, A. Vansteenbrugge, P.C.P. Pauwels (Belgium)P-173 embryo culture under two different incubator temperature: a double blind randomized clinical trialM.F. Abdel-Raheem, M.Y. Abdel-Rahman, H.M. Abdel-Gaffar, M. Sabry, H. Kasem, S.M. Rasheed,M. Amin, A. Abdelmonem, A.S. Ait-Allah (Egypt)P-174 an uninterrupted culture medium protocol in conjunction with a non-humidified incubation environmentcan provide more patient treatment options for IVF programsM. VerMilyea, J. Anthony, J. Bucci, S. Croly, C. Coutifaris (U.S.A.)P-175 efficiency of biopsy strategy and vitrification procedure in PGS cyclesR. Maggiulli, L. Rienzi, D. Cimadomo, A. Capalbo, L. Dusi, S. Colamaria, E. Baroni, M. Giuliani, A. Vaiarelli,F. Sapienza, L. Buffo, F.M. Ubaldi (Italy)P-176 Use of culture media amino acid mass spectrometry / liquid chromotography (LCMS) measurments inidentifing the embryo with the best implantation potentialE. Zivi, E. Aizenman, D. Barash, D. Gibson, Y. Shufaro (Israel)P-177 Pronuclear score does not predict embryo implantaion. Retrospective study on different checkpoint timesM. Pérez, J. Aguilar, E. Táboas, M. Ojeda, L. Suárez, E. Muñoz (Spain)P-178 time laps monitoring of embryo development in patients with testicular or ejaculated sperm:a comparative studyV. Casciani, M.G. Minasi, F. Scarselli, M. Terribile, D. Zavaglia, A. Colasante, G. Franco, E. Greco (Italy)P-179 time affects time: increased maternal age delays embryo morphokineticsC. Hickman, C. Cook, D. Gwinnett, G. Trew, A. Carby, S. Lavery (United Kingdom)P-180 the effect of Sildenafil Citrate (Viagra ® ) in vivo on endometrial receptivity, ovulation and embryodevelopment in miceL. Asgari, D. Paouneskou, K. Jayaprakasan, W. Maalouf, B.K. Campbell (United Kingdom)152

P-181 Binucleation versus multinucleation in 2-cells embryos. how do they affect to implantation rate?J. Aguilar, E. Taboas, M. Perez, E. Muñoz, M. Ojeda, J. Remohi (Spain)P-182 improvement in blastocysts formation by selecting hyaluronic acid binding spermE. Rega, A. Alteri, R.P. Cotarelo, P. Rubino, A. Colicchia, P. Giannini, C. Piscitelli (Italy)P-183 embryo quality predictive models based on cumulus cells gene expression for clinical applicationR. Devjak, T. Burnik Papler, K. Fon Tacer, I. Verdenik, E. Vrtacnik Bokal (Slovenia)P-184 pronuclear behavior and timing of embryo development: a time-lapse point of viewC. Scarica, F.M. Ubaldi, M. Stoppa, R. Maggiulli, A. Capalbo, E. Ievoli, L. Dovere, L. Albricci, S. Romano,F. Sanges, A. Vaiarelli, B. Iussig, L. Rienzi (Italy)P-185 artificial collapse of blastocoelic cavity improves clinical outcome of closed blastocyst vitrification:a randomized controlled trialA. Gala, A. Ferrières, S. Assou, C. Vincens, S. Bringer-Deutsch, C. Brunet, S. Hamamah (France)P-186 dynamic assessment of early embryo fragmentation by time-lapse analysis may improve cell cycletiming-based embryo selectionJ. Conaghan, L. Tan, M. Gvakharia, K. Ivani, A. Chen, R. Reijo Pera (U.S.A.)P-187 Comparison of clinical results, between standard and uninterrupted embryo culture, when there are noembryos to select betweenN. Bowman, S. Montgomery, L. Best, A. Campbell, S. Duffy, S. Fishel (United Kingdom)P-188 the zona pellucida thickness of a human embryo is associated with implantation potential in freshblastocyst transfer but not in day 3 transferR. Hirata, Y. Aoi, T. Habara, N. Hayashi (Japan)P-189 a novel biological role of embryo derived oxytocin in early stages of embryo development in miceV. Dinopoulou, G.A. Partsinevelos, R. Bletsa, D. Mavrogianni, E. Anagnostou, K. Stefanidis, P. Drakakis,D. Loutradis (Greece)P-190 incidence of live birth using hyaluronic acid (HA) for sperm selectionJ. Hernandez, C. Lorenzo León, M. Puopolo, A. Palumbo (Spain)P-191 impact of seminal trace elements and glutathione levels on sperm DNA fragmentation and assistedreproductive techniques outcomeF. Atig, A. Kerkeni, A. Saad, M. Ajina (Tunisia)P-192 matured human oocytes with cumulus cells and assisted reproduction techniquesG. D'Ommar, A.K. Herrera, L. Lozano, M. Majerfeld (Venezuela)P-193 direct unequal cleavages: Cell stage onsets, embryo developmental potential and chromosomalabnormalitiesZ. Ye, N. Zaninovic, R. Clarke, R. Bodine, Z. Rosenwaks (U.S.A.)POSTERSP-194 Can timing of post-cleavage embryo development stages reveal ploidy or implantation potential?P. Mazur, V. Nagorny, D. Mykytenko, L. Semeniuk, V. Zukin (Ukraine)P-195 prospective trial of vitrification of all embryos in cycles of ART: implantation and pregnancy rateA. Zabala, T. Pessino, S. Outeda, L. Blanco, F. Leocata, R. Asch (Argentina)Programme book153

P-196 Early cleaving mouse embryos are better candidates for vitrificationW.J. Wan-Hafizah, M.H. Rajikin, A.S. Nuraliza, M. Mohd-Fazirul, J.M.Y. Norhazlin, D. Razif,M.N.K. Nor-Ashikin (Malaysia)P-198 is embryo quality affected by different approaches to stimulation in IVF?T. Pehlivan Budak, O. Oliana Membrado, E. Sevillano Martinez, P. Wilson, A. McClure,G. Nargund (United Kingdom)P-199 accumulation of vitrified oocyte: a successful strategy to achieve an elective embryo transfer in younglow responders patientsD. Raso, M.F. Insua, B. Lotti, S. Giordana, C. Baldi, J. Barattini, M. Cogorno, N. Fernandez Peri,F. Neuspiller (Argentina)P-200 Cryopreserved versus fresh blastocyst transfer: a way to improve implantation rateS. Resta, A. Filannino, E. Maggi, G. Cafueri, A.P. Ferraretti, M.C. Magli, L. Gianaroli (Italy)P-201 vitrification of cleavage and morula stage mouse embryos with DMSO/ EG and PROH/ EG:effects on blastomere viability, cytoskeleton and developmentA. Sioga, Z. Oikonomou, K. Chatzimeletiou, L. Oikonomou, E. Kolibianakis, B.C. Tarlatzis (Greece)P-202 impact of oxygen concentration on early human embryo development in vitroM. Roychoudhury Sarkar, D. Ray, J. Bhattacharya (India)P-203 randomised assisted localised hatching in cryopreserved blastocyst transfersJ. Marcos Alises, D. Gumbao, A. Sánchez-León, B. Amorocho, M. Mollá, M. Nicolás, L. Fernández,J. Landeras (Spain)P-204 does gender affect pre-implantation embryonic developmental rates?- looking back at the baby picturesS. Duffy, A. Campbell, S. Montgomery, C.F.L. Hickman, S. Fishel (United Kingdom)P-205 Bovine embryo development in vitro: a sensitive assay to evaluate plga peg nanoparticle toxicityI. Fiorentino, R. Gualtieri, V. Barbato, S. Braun, V. Mollo, P. Netti, R. Talevi (Italy)P-206 the relationship of morphokinetic events and euploidy in human cleavage-stage embryosA. Bayram, N. Findikli, M. Serdarogullari, O. Sahin, U. Ulug, S.B. Tosun, M. Bahceci (Turkey)P-207 vitrification effect on the oocyte morphometry and the hardening of zona pellucidaA. Sanchez Leon, D. Gumbao, J. Marcos, M. Mollá, B. Amorocho, M. Nicolás, L. Fernández, J. Landeras (Spain)P-208 the influence of sequential scoring in determining the best embryo classification for transfer when notusing time lapse technologyM.C.A. Cardoso, A.P.S. Aguiar, C. Sartorio, A. Evangelista, P. Gallo-Sá, M.C. Erthal-Martins (Brazil)P-209 factors affecting the transcriptome of human preimplantation embryosE. Mantikou, M.J. Jonker, M. de Jong, K.M. Wong, A.P.A. van Montfoort, T.M. Breit, S. Repping,S. Mastenbroek (The Netherlands)P-210 Can completion of compaction predict implantation outcome?E. Power, S. Montgomery, S. Duffy, K. Jordan, A. Campbell, S. Fishel (United Kingdom)P-211 vitrification/warming before embryo biopsy can positively contribute to clinical outcome inPreimplantation Genetic Screening casesN. Findikli, T. Aksoy, M. Gultomruk, A. Aktan, C. Goktas, U. Ulug, M. Bahceci (Turkey)154

P-212 Impact of HIV infection in women submitted to ICSI cyclesR. Petracco, L. Okada, R. Azambuja, F. Badalotti, J. Michelon, V. Reig, D. Kvitko, A. Tagliani-Ribeiro,M. Badalotti, A. Petracco (Brazil)P-213 synchronicity of cleavage cycles predicts blastocyst formation and qualityC. Pirkevi, M. Cetinkaya, H. Yelke, Y. Kumtepe, Z. Atayurt, S. Kahraman (Turkey)P-214 the relationship between homocysteine, embryo quality and pregnancy in embryo culture medium inassisted reproductive techniquesB. Aydin, I. Cepni (Turkey)P-215 Comparison of gender-specific human embryo development characteristics by time lapse technologyM. Serdarogullari, N. Findikli, A. Bayram, C. Goktas, O. Sahin, U. Ulug, M. Bahceci (Turkey)P-216 final outcome of embryo transfers on day 3, 4 and 5 using own and donated oocytesD. Rodríguez-Arnedo, J. Ten, J. Guerrero, I. Ochando, M. Pérez, R. Bernabeu (Spain)P-217 pregnancy rates comparison between fresh versus frozen blastocyst transfersL. Okada, R. Petracco, R. Azambuja, F. Badalotti, J. Michelon, V. Reig, A. Tagliani-Ribeiro, D. Kvitko,M. Badalotti, A. Petracco (Brazil)P-218 Transfer of frozen/thawed embryos: pregnancy comparison between blastocysts and cleavage stage embryosV. Reig, D. Kvitko, A. Tagliani-Ribeiro, L. Okada, R. Azambuja, R. Petracco, J. Michelon, F. Badalotti,A. Petracco, M. Badalotti (Brazil)Endometriosis, endometrium, implantation and fallopian tubeP-219 Down-regulation of dipeptidyl peptidase 4 under hypoxia could enhance endometrial stromal cellmigration in endometriosisC.W. Tan, Y.H. Lee, M. Choolani, H.H. Tan, L. Griffith, J. Chan (Singapore Rep. of)P-220 inhibition of annexin A2 by prostaglandin E2 results in reduced phagocytic ability of peritonealmacrophages and contributes to the development of endometriosisP.C. Chuang, M.H. Wu, Y.J. Lin, S.J. Tsai (Taiwan R.O.C.)P-221 effects of granulocyte-colony stimulating factor on human endometrium: target genes selected from alarge scale microarray and pathways tested on an ex-vivo modelM. Rahmati, M. Petitbarat, S. Dubanchet, A. Bensussan, G. Chaouat, N. Lédée (France)P-222 functional analyses of biomarkers of human endometrial receptivity under natural cycleL. Bissonnette, D. Haouzi, C. Monzo, S. Traver, S. Bringer, J. Faidherbe, H. Perrochia, O. Ait-Ahmed,H. Dechaud, S. Hamamah (France)POSTERSP-223 pale cells might be involved in the development of adenomyosisM. Gamaleldin Ibrahim, M.L. Barcena de Arellano, M. Sachtleben, V. Chiantera, S. Frangini, S. Younes,A. Schneider, J. Plendl, S. Mechsner (Germany)P-224 the frozen-thawed blastocyst transfer at 4 days after ovulation present an effective method in thenatural cyclesM. Ono, H. Hamai, A. Chikawa, S. Teramura, R. Takata, T. Sugimoto, K. Iwahashi, N. Ohhama, R. Nakahira,M. Shigeta (Japan)Programme book155

P-225 Luteal phase support has a beneficial effect on natural frozen-thawed embryo transfer cyclesI.H. Park, K.H. Lee, H.G. Sun, S.G. Kim, J.H. Lee, Y.Y. Kim, H.J. Kim, G.H. Jeon, C.M. Kim (Korea South)P-226 the interaction between decidualized stromal cells and trophoblast stimulates expression ofmetalloproteinases to regulate trophoblast invasion in a novel three dimensional (3D) humanimplantation modelS. Bocca, H. Wang, S. Anderson, L. Yu, J. Horcajadas, S. Oehninger (U.S.A.)P-227 Comparison of GnRH agonist and antagonist protocols in stage III-IV endometriosis patients whounderwent endometrioma resection surgeryE. Bastu, M.F. Mutlu, C. Celik, C. Yasa, O. Dural, F. Buyru (Turkey)P-228 a previous cesarean section does not impair IVF or intrauterine insemination resultsF. Quintana, A. Cobo, J. Remohí, M. Ferrando, R. Matorras (Spain)P-229 impact of oral contraceptive pill (OCP) for cycle scheduling on gene expression related to endometrialreceptivityA. Bermejo, C. Iglesias, M. Cerrillo, M. Ruiz, D. Blesa, C. Simon, J.A. García-Velasco (Spain)P-230 prevalence and pelvic distribution of deeply infiltrative endometriosis (DIE) in 1141 consecutive infertileBrazilian women evaluated with transvaginal ultrasound after bowel preparationL. Chamié, D.M.F. Ribeiro, M. Riboldi, R. Pereira, M.B. Rosa, C. Gomes, P. Homem de Mello, P. Fettback,T. Domingues, A. Cambiaghi, A.C.P. Soares, C. Kimati, E.L.A. Motta, P. Serafini (Brazil)P-231 markers of human endometrial basal glandular epithelial cells: phenotypic and functionalcharacterisation and implications in the pathogenesis of endometriosisD.K. Hapangama, A.J. Valentijn, H. Al-Lamee, K. Palial, J.A. Drury, T. von Zglinicki, G. Saretzki,C.E. Gargett (United Kingdom)P-232 soluble fibronectin enhances trophoblast cell migration by epithelial-mesenchymal transition ina trophoblast stem cell model: possible applications in improving implantation rate in assistedreproductive technologyC.Y. Liao, K.H. Lee, Y.J. Sung, H.Y. Li (Taiwan R.O.C.)P-233 progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of painsymptoms caused by rectovaginal endometriosis in patients with migraine without auraM. Morotti, V. Remorgida, P.L. Venturini, S. Ferrero (Italy)P-234 analysis of the anti-STX5 autoantibody identified as a new serum marker for endometriosisM. Nabeta, A. Iki, H. Hashimoto, M. Koizumi, Y. Matsubara, K. Hamada, T. Fujioka, K. Matsubara,Y. Kusanagi, A. Nawa (Japan)P-235 progesterone receptor isoform (PR-B) is strongly expressed in rectosigmoid endometriosis andassociated to HOXA-10 expression in the lesionA. Zanatta, M. Riboldi, A.M. da Rocha, J.L. Guerra, B. Cogliati, R. Pereira, E.L.A. Motta, P. Serafini (Brazil)P-236 estrogen receptor beta (ER-ß) is strongly expressed in rectosigmoid endometriosis and its adjacentmuscular tissue independently of the phase of the menstrual cycleP. de Mello Bianchi, A. Zanatta, M. Riboldi, A.M. da Rocha, B. Cogliati, J.L. Guerra, R. Pereira, E.L.A. Motta,P. Serafini (Brazil)P-237 impact of endometriosis and endometriomas on pelvic inflammatory disease after follicular aspirationB. Prieto, A. Exposito, R. Mendoza, A. Rabanal, R. Matorras (Spain)156

P-238 Abundance and localization of progesterone receptor isoforms in endometrium, peritonealendometriosis and endometrioma cyst wallM. Bedaiwy, L. Yi, W. Dahoud, J. Liu, W. Hurd, T. Falcone, C. Biscotti, S. Mesiano (U.S.A.)P-239 the role of salpingoscopy in assessing the inner fallopian tubes of infertility patients with ovarianendometrioma(s)R. Sugiyama, K. Nakagawa, Y. Nishi, Y. Kuribayashi, S. Akira (Japan)P-240 intrauterine application of diluted seminal plasma in in vitro fertilization does not improve pregnancyrates - a placebo controlled double blinded randomized trialA. Germeyer, S. Rösner, J. Jauckus, T. Strowitzki, M. von Wolff (Germany)P-241 involvement of hepatocyte growth factor-induced epithelial-mesenchymal transition in adenomyosisK.N. Khan, M. Kitajima, A. Fujishita, M. Nakashima, H. Masuzaki (Japan)P-242 androgens modulate the morphological and biological characteristics of human endometrial stromalcells decidualized in vitroT. Kajihara, O. Ishihara, J. Brosens (Japan)P-243 the identification of specific immune endometrial profiles in patients with previous implantation failuresafter IVF-ET increases dramatically subsequent pregnancy ratesN. Lédée, M. Petitbarat, M. Rahmati, K. Vezmar, V. Savournin, S. Dubanchet, G. Chaouat, R. Balet,A. Bensussan, G. Chaouat (France)P-244 dysregulated sphingolipid metabolism promotes cell growth in endometriosisY.H. Lee, S.F. Loh, S.R. Tannenbaum, J.K.Y. Chan (Singapore Rep. of)P-245 transvaginal ultrasound for diagnosis of deeply infiltrating endometriosisA. Scarella, V. Chamy, L. Devoto, M. Abrao, H. Sovino (Chile)P-246 ivf infertility treatment outcomes are negatively influenced by the severity of diffuse adenomyosisestablished by ultrasound examinationK. Krasnopolskaya, A. Popov, D. Kabanova, A. Beketova, V. Ivakhnenko (Russia C.I.S.)P-247 is dienogest effective in postoperative management of endometriosis compared to GnRH aA. Shohayeb, A. Wahba, A. Abousetta, H. al-inany (Egypt)P-248 adopt: a new surgical classification for endometriosis - associated infertility: can we adopt it -a pilot studyA. Wahba, A. El Daly, M. Zayed (Egypt)P-249 Use of tanning beds, sun exposure and the incidence of endometriosisM. Kvaskoff, J. Han, S.A. Missmer (U.S.A.)POSTERSP-250 expression of genes SOD1, SOD2 and GPX4 in cumulus oophorus cells of infertile women with andwithout endometriosis undergoing ovarian stimulation for ICSIP. Navarro, J. Meola, C.P. Ribas, C.P. Paz, R.A. Ferriani, F.C. Donabela (Brazil)P-251 radiological long-term follow-up of patients with histologically infiltrated resection margins atcolorectal resection for endometriosisE. Tafi, U. Leone Roberti Maggiore, C. Scala, V. Remorgida, P.L. Venturini, S. Ferrero (Italy)Programme book157

P-252 Correlation of histomorpholgy and clinicopathology of peritoneal ednometriosisJ. Hackl, J. Strehl, D. Wachter, R. Dittrich, S. Cupisti, T. Hildebrandt, L. Lotz, M. Attig, I. Hoffmann,S. Renner, A. Hartmann, M.W. Beckmann (Germany)P-253 endometrial differential biomarkers of recurrent spontaneous abortionF. Urquiza, C. Ferrer, E. Incera, A. Azpiroz, G. Junovich, C. Pappalardo, G. Guerrero, S. Pasqualini,G. Gutiérrez (Argentina)P-254 the presence of an ovarian endometrioma affects iron metabolism in the developing follicleL. Corti, A.M. Sanchez, P. Panina Bordignon, P. Santambrogio, S. Levi, P. Persico, P. Viganò, E. Papaleo,S. Ferrari, M. Candiani (Italy)P-255 efficacy and safety of intrauterine insemination in patients with moderate to severe endometriosis;a 5 year cohortstudy, systematic review and meta-analysisL.E.E. van der Houwen, A.M.F. Schreurs, C.B. Lambalk, R. Schats, P.G.A. Hompes, V. Mijatovic (The Netherlands)P-256 The preliminary study on the regulation of StAR, Annexin IV and VEGF by LH/hCG-R in human endometriumS.Y. Xu, J. Li, X.Y. Chen, S.Q. Chen, L.Y. Guo (China)P-257 an in silico approach to biomarker and drug discovery in the endometriumD. Mathew, Q. Nunes, B. Lane, D. Fernig, D. Hapangama (United Kingdom)P-258 patients with endometriosis both with and without ovarian surgery present with a progressive reductionof AMH levels. A prospective controlled study.T. Lind, M. Hammarström, D. Golmann, K. Rodriguez-Wallberg (Sweden)P-259 the present of unmyelinated sensory C nerve fibers in menstrual blood tissues is useful for noninvasivediagnosis of endometriosisA. Hestiantoro, A. Cakra, A. Aulia (Indonesia)P-260 postoperative application of LNG-IUD for symptomatic endometriosisH. Al-Inany, B. Houston, C. Farquhar, A. Abousetta (Egypt)P-261 follow-up of patients undergoing surgery for ovarian endometriosis: evaluation of ovarian reserveV. Tagliaferri, D. Gagliano, V. Immediata, C. Tartaglia, A. Zumpano, G. Campagna, A. Lanzone, M. Guido (Italy)P-262 the Wnt/ß-catenin signaling pathway might be involved in mechanisms regulating fibrosis inendometriosis: a study of in vitro and in vivoS. Matsuzaki, C. Darcha, R. Botchorishvili, J.L. Pouly, G. Mage, M. Canis (France)P-263 new insights into the mechanisms underlying menorrhagia: roles of smoothelin and calponinS. Biwas Shivhare, J.N. Bulmer, B.A. Innes, D.K. Hapangama, G.E. Lash (United Kingdom)P-264 women with endometriosis have significantly more pain during intercourse than controls resulting in aseverely impaired sexual functioningA.A. de Graaff, H. Zandstra, L.J. Smits, J.J. Van Beek, G.A.J. Dunselman (The Netherlands)P-265 non-invasive diagnosis of endometriosis: examination of cervical fluid with infrared spectroscopyG. Bozdag, P. Tokdemir Calis, D. Ozel Demiralp, B. Ayhan, N. Igci, H. Yarali (Turkey)P-266 expressions of proliferating cell nuclear antigen (PCNA), cyclin D3, p27, p57 proteins and determinationapoptotic cells in normal and dexamethasone-induced intrauterine growth restricted rat placentasN. Acar, H. Er, A. Ozmen, I. Ustunel, E.T. Korgun (Turkey)158

P-267 Histological assessment of impact of ovarian endometrioma and laparoscopic cystectomy on ovarian reserveK. Kuroda, M. Kuroda, A. Arakawa, M. Kitade, A.I. Brosens, J.J. Brosens, S. Takeda, T. Yao (Japan)Ethics and lawP-268 Surrogate mothers: background and motivationsK. Svitnev (Russia C.I.S.)P-269 what constitutes parenthood according to both genetically and non-genetically related mothers(lesbian parents)V. Provoost, E. Wyverkens, H. Van Parys, A. Ravelingien, I. Raes, S. Somers, I. Stuyver, P. De Sutter,A. Buysse, G. Pennings (Belgium)P-270 revisiting the fourteen-day limit for human embryo-researchW. Dondorp, G. De Wert (The Netherlands)P-272 Comprehensive embryo screening and selection in preimplantation genetic diagnosis (PGD) andpreimplantation genetic screening (PGS) and the right of the child to an open futureK. Hens, W.J. Dondorp, G.M. de Wert (The Netherlands)P-273 Cross-border reproductive care in Europe and medical liability litigations: which court is competent andwhich law is applicableS. Tack, T. Balthazar, K. Osmanagaoglu, G. Pennings (Belgium)Female (in)fertilityP-274 Immune profile of Sudanese women with conception disorders: possible role for T-helper CytokinesH. Saad, E. Khalil (Sudan)P-275 One-to-one donor egg recipients and egg sharer recipients: a comparison study in IVF/ICSI success ratesS.A. Bora, J. Parikh, H. Abdalla, M.Y. Thum (United Kingdom)P-277 Comparison of clinical pregnancy outcome for endometrial preparation in vitrified frozen thawed cycleswith GnRH + Estradiol and only EstradiolV. Bina, P. Roopa, S. Shyamala, A. Anupama (India)P-278 predictors of ovarian response in women treated with corifollitropin alfa for IVF/ICSIH. Tournaye, N.P. Polyzos, L. Guzman, S.M. Nelson (Belgium)P-279 simple parameters monitored in cumulus cells: relevant correlations with oocyte status, fertilizationand patient ageB. Lourenço, A.P. Sousa, T. Almeida-Santos, J. Ramalho-Santos (Portugal)POSTERSP-280 follicle size does not reflect oocyte competencyJ. Okhowat, B. Wirleitner, T. Neyer, M. Bach, M. Murtinger, N.H. Zech (Austria)P-281 Live birth rates in "Bologna" poor responders treated with intensified ovarian stimulation for IVF/ICSIN.P. Polyzos, M. Nwoye, R. Corona, C. Blockeel, D. Stoop, M. Camus, H. Tournaye (Belgium)P-282 gamma-tocotrienol supplementation improves embryo development and fetal survival rate innicotine-treated pregnant miceM.H. Rajikin, Y.S. Kamsani, A. Chatterjee, M.N.K. Nor-Ashikin, A.S. Nuraliza (Malaysia)Programme book159

P-283 Homologous intrauterine insemination (iui-h): six years of data (2005-2010) collection from the ItalianAssisted Reproductive Technologies (ART) registerG. Scaravelli, P. D'Aloja, S. Bolli, R. De Luca, R. Spoletini, S. Fiaccavento, L. Speziale, V. Vigiliano (Italy)P-284 a randomised controlled trial of fallopian tube sperm perfusion compared with standard intrauterineinsemination for women with non-tubal infertilityC. Farquhar, J. Brown, N. Arroll, D. Gupta, C. Boothroyd, M. Al Bassam, J. Moir, N. Johnson (New Zealand)P-285 relationship between serum and follicular levels of glucose and lipids, oocyte lipids and in vitrofertilisation (IVF) outcomeT. Pantasri, R.L. Robker, L.L. Wu, R.J. Norman (Thailand)P-286 endometrial thickness is a predictor of success in modified natural cycle IVF (mnIVF)K. Buzaglo, M. Velez, T. Shaulov, C. Sylvestre, I.J. Kadoch (Canada)P-287 prediction of total fertilization failure - a case-control study of 304 consecutive couples with fertilizationfailure after IVF compared with 304 controlsM. Krog, M. Prior, E. Carlsen, A. Loft, A. Pinborg, A. Nyboe Andersen (Denmark)P-288 Title: AMH is affected by smoking and oral contraceptive use: results from a large population based studyM. Dolleman, W.M.M. Verschuren, M.J.C. Eijkemans, M.E.T. Dolle, E.H.J.M. Jansen, F.J.M. Broekmans,Y.T. Van der Schouw (The Netherlands)P-289 myeloid cell population alterations within the ovary occur in a gonadotropin dose dependent manner in amurine model of ovarian hyperstimulation syndromeO. Fainaru, N. Pencovich, S. Hantisteanu, I. Barzilay, A. Ellenbogen, M. Hallak (Israel)P-290 predicting pregnancy outcomes after IVF/ICSI cycles using the vascular endothelial growth factor(VEGF) gene polymorphismM. Cavagna, R.L.R. Baruffi, C.G. Petersen, A.L. Mauri, F.C. Massaro, J. Ricci, A.M. Nascimento,L.D. Vagnini, A. Pontes, J.B.A. Oliveira, J.G. Franco Jr. (Brazil)P-291 a prospective evaluation of the effect of herpesvirus-associated ubiquitin-specific protease (HAUSP)gene polymorphism genotypes on implantation failureM.C.T. Canas, L.D. Vagnini, A.M. Nascimento, C.G. Petersen, A.L. Mauri, F.C. Massaro, A. Nicoletti,A.M.V.C. Martins, M. Cavagna, J.B.A. Oliveira, R.L.R. Baruffi, J.G. Franco Jr. (Brazil)P-292 Low serum basal AMH level is not always of poor prognostic in ART. Analysis of 10753 consecutive cyclesI. Lichtblau, F. Olivennes, F.A. Aubriot, A.M. Junca, S. Belloc, M. Cohen-Bacrie, P. Cohen-Bacrie,J. de Mouzon (France)P-293 what affects total dose of gonadotrophins and how does the total dose used affect the outcome ofIVF/ICSI treatmentT. Nandy, A. Caragia, S. Balestrini, A. Zosmer, L. Sabatini, T. Al-Shawaf (United Kingdom)P-294 role of thrombophilia in female fertility: a systematic review and meta-analysisS. Seshadri, Y. Khalaf, S.K. Sunkara (United Kingdom)P-295 efficiency and cost effectiveness analysis of hepatitis b core antibody testing in assisted conceptionJ. Joy, M. Lambe, D. Lutton (United Kingdom)160

P-296 High serum progesterone levels on the day of hCG administration are associated with low pregnancyrates in women treated with GnRH-antagonist IVF cyclesJ. Nicopoullos, S.A. Bora, J. Parikh, R. Faris, H. Abdalla, M.Y. Thum (United Kingdom)P-297 Luteinizing hormone supplementation from Day 1 versus 6 of ovarian stimulation in women aged36-40 years: results from an open-label, randomized, multicentre, multinational trialH.M. Behre, C.M. Howles, S. Longobardi (Germany)P-298 B-hcg level on day 7 of spontaneously hatched blastocyst transfer (shbt) can predict pregnancy outcomein terms of live birth rate in ivf cyclesN. Chimote, B. Mehta, N. Nath, N.M. Chimote (India)P-299 follicular-fluid dehydroepiandrosterone-sulphate (FF DHEAS) is a poignantly credible biomarker ofoocyte fertilization potential and pregnancy outcome in conventional IVF cycles of non-PCOS womenB. Mehta, N. Nath, N. Chimote, N.M. Chimote (India)P-300 risk factors of recurrent pregnancy loss do not affect in-vitro fertilization successK. Mine, A. Yoshida, M. Yonezawa, S. Ono, T. Abe, T. Ichikawa, R. Tomiyama, Y. Nishi, Y. Kuwabara,S. Akira, T. Takeshita (Japan)P-301 egr-3 exhibits a unique subcellular localization in mouse oocytes during meiotic maturationH. Shin, H.S. Song, H.J. Lim (Korea South)P-302 Comparison of embryo transfer in egg donation recipients with transvaginal and transabdominalultrasound: a randomized pilot studyE. Hauzman, G. Kohls, A. Barrio, J. Martínez-Salazar, C. Iglesias, J.A. García Velasco (Spain)P-303 study of triple CGG repeats (FMR1 gene) in 41 patients with a reduced ovarian response to gonadotropinstimulation: no correlation found with four ovarian parametersM.I. Tejada, H. Maortua, R. Mendoza, B. Prieto, C. Martinez-Bouzas, M. Díez-Zapirain, N. Martínez-Zilloniz,R. Matorras (Spain)P-304 impact of estradiol and homocysteine concentrations from follicular fluid and peripheral blood on theoutcome of assisted reproduction treatmentA. Amaro, B. Bianco, J. Christofolini, F.A. Mafra, C.P. Barbosa, D.M. Christofolini (Brazil)P-305 Hysterosalpingography plus ultrasound versus hysteroscopy plus ultrasound in the work-up of donoroocyte recipients: a diagnostic accuracy studyR. Pesce, S. Gogorza, C. Ochoa, S. Gil, A. Saavedra, S. Ciarmatori, G. Perman (Argentina)P-306 Use of partial AUC to evaluate progesterone elevation on the day of HCG administration reveals basalprogesterone as the main prognostic factorL. Pagliardini, E. Papaleo, L. Corti, V.S. Vanni, J. Ottolina, F. de Michele, A. La Marca, P. Viganò,M. Candiani (Italy)POSTERSP-307 fsH receptor gene polymorphisms are associated with ovarian response in Chinese IVF/ICSI patientsL. Li, Q. Yin, L. Huang, J. Huang, Z. He, D. Yang (China)P-308 ivf success rates in egg sharers compared to women having self-funded IVFJ. Parikh, S.A. Bora, H. Abdalla, M.Y. Thum (United Kingdom)P-309 detection of two urinary hormones by a new home ovulation test to identify the wider fertile window:a randomised comparative laboratory study of home ovulation testsS. Tiplady, W. Ledger, S. Godbert, S. Hart, S. Johnson (Australia)Programme book161

P-310 Uterine contraction after embryo transfer and outcome of in-vitro fertilization and embryo transfer cyclesA.W.Y. Wong, G.W.S. Kong, C.J. Haines (Hong Kong)P-311 aromatase inhibitors for subfertile women with PCOSS. Franik, W. Nelen, J. Kremer, C. Farquhar (The Netherlands)P-312 effect of severity of endometriosis on prioritisation for infertility treatment in New ZealandW.R. Gillett, J.M. Lamont, J.C. Peek, G.P. Herbison (New Zealand)P-313 the fate of implanted embryo which showed low early serum ß- hCG level in IVF-ETN.Y. Sung, Y.I. Hwang, M.H. Choi, I.O. Song, I.S. Kang, M.K. Koong, J.S. Lee, K.M. Yang (Korea South)P-314 follicular fluid anti-Mullerian hormone, inhibin-A, progesterone and estradiol levels in patients withdifferent ovarian responseM.B. Celtemen, P. Telli, C. Karakaya, N. Bozkurt, R.H. Gursoy (Turkey)P-315 protein c global assay in the evaluation of infertile women undergoing ivf-et treatment - implications toperinatal risksJ.S. Younis, M. Ben-Ami (Israel)P-316 outpatient hysteroscopy prior to the first IVF cycle - a systematic review and meta-analysisJ. Pundir, V. Pundir, K. Omanwa, Y. Khalaf, T. El-Toukhy (United Kingdom)Male and female contraceptionP-317 A comparison of human papilloma virus infection and cervical cytology in women with copper andlevonorgestrel containing intrauterine devicesJ. Lekovic, M.K. Frey, M. Pangasa, M. Manaku, A. Varrey, K. Holcomb (U.S.A.)P-318 a comparison of bleeding patterns, cycle control, and pharmacokinetic analyses using two transdermalcontraceptive systems: a multicenter, open-label, randomized studyD. Gruber, A. Skrivanek, M. Serrani, V. Lanius, C. Zurth, M. Merz (Austria)Male and female fertility preservationP-319 Genotoxicity assessment of three vitrification protocols by comet assay on mouse oocytesA. Berthelot-ricou, J. Perrin, A. Roustan, C. Di Giorgio, M. De Meo, A. Botta, T. Orsiere,B. Courbiere (Ile de la Réunion)P-320 Comparison of different protocols to improve oocyte in vitro maturation and its implications for fertilitypreservation in women with cancerJ. Gómez Martínez, I. Molina Botella, I. Peinado Casas, E. Novella-Maestre, P.J. Fernández Colom,J.M. Rubio, A. Pellicer Martínez (Spain)P-321 pre-pubertal status does not protect against follicle depletion induced by cyclophosphamide in mice.A randomized studyK.A. Rodriguez-Wallberg, S. Alonso de Mena, E. Malm, A. Larsson, R. Kuiper, M. Hassan (Sweden)P-322 Cryopreservation of primordial follicles from human ovarian tissue after slow-rate freezing orvitrification and xenograftingS. Herraiz, E. Novella-Maestre, B. Rodriguez-Iglesias, C. Díaz-García, V. Mirabet, A. Pellicer (Spain)162

P-323 Investigating the efficacy of the novel liquidus tracking method for ovarian tissue cryopreservationF.S. Aljaser, J. Hernandez Medrano, S. Rhodes, M.J. Tomlinson, B.K. Campbell (United Kingdom)P-324 the effects of the two-step mechanical isolation and fibrin-alginate three-dimensional culture systemon the isolated human preantral follicles in vitro developmentF. Dong, S. Shi, S. Dai, X. Liu, Y. Su, Y. Guo, F. Wang, Z. Xin, W. Song, H. Jin, H. Jin, Y. Sun (China)P-325 the efficiency of a "freeze-all" embryo strategy after in vitro maturation (IVM): a potential tool forfertility preservation in women with polycystic ovaries (PCO)?C. Ortega-Hrepich, D. Stoop, L. Guzmán, L. Van Landuyt, H. Tournaye, J. Smitz, M. De Vos (Belgium)P-326 safety assessment of ovarian cryopreservation by molecular techniques in breast cancer patientsB. Rodriguez-Iglesias, S. Herraiz, E. Novella-Maestre, C. Díaz, F. Vera, A. Pellicer (Spain)P-327 activation of primordial follicles in vitro preserves the follicular viability and restores theantimüllerian-hormone levels in cryopreserved ovarian tissueE. Novella-Maestre, S. Herraiz, B. Rodriguez-Iglesias, C. Díaz-García, A. Pellicer (Spain)P-328 optimal vitrification protocol for ovarian tissue cryopreservation: the effect of cryoprotective agents andin vitro culture on vitrified-warmed ovarian tissue survivalH. Youm, J. Lee, J.r. Lee, J.y. Lee, B.c. Jee, C.s. Suh, S.h. Kim (Korea South)P-329 reproductive outcome after transplantation of cryopreserved ovarian tissue into 14 patientsL. Lotz, I. Hoffmann, A. Müller, J. Hackl, C. Schulz, C. Reißmann, S. Cupisti, P.G. Oppelt, K. Heusinger,T. Hildebrandt, M.W. Beckmann, R. Dittrich (Germany)P-330 development of a predictive in vitro assay for prevention of chemiotherapic effect on the oocytes of theovarian reserveF. Klinger, V. Rossi, M. Lispi, S. Longobardi, M. De Felici (Italy)P-331 morphological, ultrastructure and functional assessment of cryopreserved human ovarian tissueretrieved from oncological patientsR. Fabbri, R. Vicenti, N.A. Martino, I. Parazza, M. Macciocca, V. Magnani, G. Pasquinelli, M.E. Dell'Aquila,S. Venturoli (Italy)P-332 needle immersed vitrification, slow freezing and their improved grafting protocols for human ovariancryopreservationB. Fisch, R. Orvieto, N. Fisher, A. Ben-Haroush, A. Stein, R. Abir (Israel)P-333 passive immunization against bone morphogenetic protein signalling system is an effective model toincrease female fertility reserveS. Al-Samerria, J. McFarlane, G. Almahbobi (Australia)P-334 the effects of interim storage at supra-zero temperature of human ovarian cortex before vitrificationS. Klocke, C. Tappehorn, G. Griesinger (Germany)POSTERSProgramme book163

Paramedical - laboratoryP-335 To endure as an IVF technician in a developing country - a critical overviewN. Lukic, A. Miric, I. Cvetic, Z. Tomic, M. Podgorac, J.D. Micic, L. Surlan (Serbia)P-336 importance of sperm aneuploidy assessment on embryo implantationS. Cheung, Q.V. Neri, T. Fields, Z. Rosenwaks, G.D. Palermo (U.S.A.)P-337 retrospective analysis of the effects of embryo culture temperature on IVF-outcomeJ. Speksnijder, A.J.A.M. Dons, G.W. van der Heijden, J.S.E. Laven, E.B. Baart, J.H. Doorninck (The Netherlands)P-338 immediate retrial with rigid catheter after failed soft catheter trial in ET does not affect pregnancy ratesS.k. Kim, K.h. Lee, I.h. Park, H.g. Sun, J.h. Lee, Y.y. Kim, H.j. Kim (Korea South)P-339 sperm selection reduces bacterial growth in cryopreserved semen specimens to be used for ARTR. Manzo, T. Fields, Q.V. Neri, Z. Rosenwaks, G.D. Palermo (U.S.A.)P-340 extreme ICSIT. Fields, Q.V. Neri, Z. Rosenwaks, G.D. Palermo (U.S.A.)Paramedical - nursingP-341 The process of deciding who will be the biological mother in lesbian couplesS. Somers, V. Provoost, H. Van Parys, A. Ravelingien, E. Wyverkens, I. Raes, I. Stuyver, A. Buysse,G. Pennings, P. De Sutter (Belgium)P-342 attitudes towards motherhood, assisted reproductive technologies and fertility preservation amonghealth professionalsL. Bergman, G. Pe'er, D. Carmeli, M. Dirnfeld (Israel)P-343 midwife-led information sessions prior to starting ART-treatment: a pilot study indicating that groupinformation sessions might be less patient-centered than individual information sessionsK. Eelen, S. Verschueren, U. Van den Broeck, E. Bakelants, S. Repping, E. Dancet, T. D'Hooghe (Belgium)P-344 the role of nurses and midwives in fertility clinics offering in vitro fertilization in Dutch speaking EuropeT. De Vries, S.M. Michon, T.M. D'Hooghe, F. Van der Veen, S. Repping, E.A.F. Dancet (The Netherlands)P-345 Understanding preference formation among young women with cancer surrounding the decision toundergo fertility preservation: findings from a qualitative study in the United StatesP.E. Hershberger, L. Finnegan, J. Hirshfeld-Cytron (U.S.A.)P-346 patient satisfaction in a randomized trial comparing natural versus hormone replacement therapy (HRT)frozen embryo replacement (FER) treatmentG. Mounce, J. Birks, C. Bradley, T. Child (United Kingdom)Psychology and counsellingP-347 The process of talking about donor conception in lesbian families: a qualitative studyH. Van Parys, E. Wyverkens, V. Provoost, A. Ravelingien, I. Raes, S. Somers, I. Stuyver, P. De Sutter,G. Pennings, A. Buysse (Belgium)164

P-348 Attitudes and disclosure decisions of Finnish parents with children born after donor insemination anddonorIVF treatmentV. Söderström - Anttila, M. Sälevaara, A.M. Suikkari (Finland)P-349 A comparative analysis of post-partum maternal mental health in women conceiving with ART or naturallyD.R. Listijono, S. Mooney, M.G. Chapman (Australia)P-350 the impact of sex and previous in vitro fertilization treatment experience on the infertility patients'understanding of their infertility problemU. Res Muravec, S. Pusica, M. Lomsek, M. Cisek Sajko (Slovenia)P-351 what makes a difference in accepting egg-sharing?S. Parames, L. Semião-Francisco, H. Sato, J. Ueno (Brazil)P-352 womens' preference for a twin or a singleton pregnancy - a discrete choice experimentL. van den Wijngaard, M.H. Mochtar, H. van Dam, F. van der Veen, M. van Wely (The Netherlands)P-353 Decision making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for BRCA couplesI.A.P. Derks-Smeets, J.J.G. Habets, A. Tibben, V.C.G. Tjan-Heijnen, M. Meijer-Hoogeveen, J.P.M. Geraedts,R. van Golde, E. Gomez-Garcia, C.E.M. de Die-Smulders, L.A.D.M. van Osch (The Netherlands)P-354 awareness and acceptability of preimplantation genetic diagnosis (PGD) as a reproductive option amongBRCA carrier couplesJ.J.G. Habets, I.A.P. Derks-Smeets, A. Tibben, V.C.G. Tjan-Heijnen, J.P.M. Geraedts, R. van Golde,E. Gomez-Garcia, C.M. Kets, C.E.M. de Die-Smulders, L.A.D.M. van Osch (The Netherlands)P-355 the fertility problem inventory (FPI): a validation study of the italian versionS. Gullo, Z. Donarelli, G. Lo Coco, A. Marino, A. Volpes, F. Sammartano, A. Allegra (Italy)P-356 the profile of a pioneer cohort of 225 women with anticipated gamete exhaustion (age) opting for oocytecryopreservationJ. Nekkebroeck, H. Tournaye, D. Stoop (Belgium)P-357 analysis of attachment and anxiety in couples experiencing infertility using the Actor PartnerInterdependence Model (APIM)Z. Donarelli, G. Lo Coco, S. Gullo, A. Marino, A. Volpes, F. Coffaro, A. Allegra (Italy)P-358 spanish gamete recipients: how do they feel?D. Guerra Diaz, M.A. Gonzalez, M. Tirado, S. Chamorro, P. Dolz, M.A. Gil, A. Ballesteros (Spain)P-359 watching embryo development in real time and online: the emotional impact of these images onpatients with infertilityE. Velilla, C. Castelló, N. Moina, M. López-Teijón (Spain)POSTERSP-360 Becoming a reflective ART practitioner: development of the professional training programme ininfertility counseling for healthcare professionals in hong kongC.H.Y. Chan, C.L.W. Chan, M.K.H. Leong, I.K.M. Cheung, T.H.Y. Chan, B.N.L. Hui (China)P-361 psychosocial predictors of dropout in in vitro fertilizationA.J.C.M. van Dongen, A.G. Huppelschoten, J.A.M. Kremer, W.L.D.M. Nelen, C.M. Verhaak (The Netherlands)P-362 the impact of positive thinking on IVF outcomesH.G. Sun, K.H. Lee, I.H. Park, S.G. Kim, J.H. Lee, Y.Y. Kim, H.J. Kim, J.D. Cho, Y.J. Yoo (Korea South)Programme book165

P-363 Effects of pharmacologically induced sex-hormone downregulation on depressive symptoms and brainserotonin transporter binding in healthy womenV. Frokjaer, A. Pinborg, E.C. Larsen, M. Heede, D.S. Stenbæk, S. Henningsson, A.P. Nielsen, C. Svarer,K.K. Holst, G.M. Knudsen (Denmark)P-364 male sexual function in relation to infertility: an exploratory cross sectional studyM. Emery, L. DeJonckheere, S. Rothen, M. Wisard, M. Germond (Switzerland)P-365 a comparison of changes in mental distress in women undergoing short versus long in vitro fertilizationprotocol: a clinical prospective randomized trialD.S. Stenbæk, M. Toftager, L.V. Hjordt, P.S. Jensen, K. Holst, T. Holland, T. Bryndorf, J. Bogstad,P. Hornnes, V.G. Frokjaer (Denmark)P-366 "Living each week as unique": maternal fears in Assisted Reproductive Technology pregnanciesL.M. Netto Dornelles, F. MacCallum, R.C. Sobreira Lopes, C.A. Piccinini, E.P. Passos (Brazil)P-367 sharing information in donor insemination - from intention to practiceC. Bruegge, P. Thorn, K. Daniels (Germany)P-368 surrogate mothers: contact and relationships with families created through surrogacyS. Imrie, V. Jadva, S. Golombok (United Kingdom)P-369 who chooses PGD? Do clinical characteristics of recurrent miscarriage couples with a chromosomalabnormality influence their reproductive choice?Y. Arens, G. De Krom, R.J.T. Van Golde, E. Coonen, C.M.A. Van Ravenswaaij-Arts, M. Meijer-Hoogeveen,J.L.H. Evers, J.P.M. Geraedts, C.E.M. De Die-Smulders (The Netherlands)P-370 Anxiety, cognitive and depressive assessment in adolescents with polycystic ovary syndrome: a pilot studyG. Ghazeeri, J. Awwad, A. Fakih, H. Abbas, S. Harajly, L. Tawidian, F. Maalouf (Lebanon)P-371 the interaction of personal and partner's correlates of fertility-related quality of lifeD. Ajdukovic, M. Pibernik-Okanovic, M.S. Alebic (Croatia)P-372 reasons for discontinuing fertility treatments in SpainG. Baccino, C. Calatayud, E. Ricciarelli, E.R. Hernández de Miguel (Spain)P-373 acceptance for treatment and disclosure intentions of transsexual men and their female partnerscompared to heterosexual couples using anonymous sperm donationI. Stuyver, K. Wierckx, H. Verstraelen, L. Van Glabeke, E. Van den Abbeel, J. Gerris, G. T'Sjoen,P. De Sutter (Belgium)P-374 importance of psychological assessment in the welfare of egg donorsB. Monica, R. Nuñez Calonge, P. Caballero Peregrin (Spain)P-375 Connections between fertiqol and fertility problem inventory (FPI) in a hungarian sample of couplesfacing involuntary childlessnessR. Cserepes, J. Kollár, T. Wischmann, A. Bugán (Hungary)P-376 what are the barriers to equality and diversity in childbearing? A systematic review of reproductivedecision-making in groups that cannot conceive spontaneouslyC. Pinkard, C. Harrison, L. Bunting, J. Boivin (United Kingdom)P-377 feeling immune to risk may explain poor adherence to periconceptional health guidelinesB. Fulford, J. Boivin (United Kingdom)166

P-378 Why do couples refrain from preimplantation genetic diagnosis - results of a questionnaire among 37patients and their partnersN. Theusink-Kirchhoff, C.M.A. van Ravenswaaij-Arts, M.K. Bakker (The Netherlands)P-379 a qualitative exploration of couples facing HIV and infertility in an assisted reproduction clinic in capetown, south africa: recommendations for health policy.C. Volks (South Africa)P-380 the experiences of Greek individuals in families created through gestational surrogacy arrangements:a preliminary studyZ. Papaligoura, D. Papadatou, T.H. Bellali (Greece)P-381 infertility counselling in Germany - an invisible counselling field and area of expertiseP. Thorn, T. Wischmann (Germany)P-382 infertility counselling in Germany - divergent and convergent perspectives regarding future needsT. Wischmann, P. Thorn (Germany)P-383 planning for pre-implantation genetic diagnosis (pgd), a decision related to myself, the child and thesurroundings A qualitative study among men and women currently eligible for pgdS. Järvholm, M. Broberg, A. Thurin-Kjellberg (Sweden)P-384 risk perception among patients undergoing fertility treatmentG. Weitzman, T.m. Van Der Putten-Landau, S. Chudnoff (Israel)P-385 stress, and success of ARTs: Identifying the missing link (s)E. Panagopoulou, B. Tarlatzis (Greece)P-386 investigation of the impact of emotional health on pregnancy rates after assisted conceptionV. Tamhankar, G.L. Jones, P. Magill, J.D. Skull, W. Ledger (United Kingdom)P-387 demographic characteristics and fertility status of women consulting a newly established FertilityAssessment and Counseling Clinic - an initiative to prevent infertilityH.W. Hvidman, I.O. Specht, A. Pinborg, K.T. Schmidt, E.C. Larsen, A. Nyboe Andersen (Denmark)P-388 disclosure decisions of heterosexual mothers by donor insemination in single- and two-parent families:a comparison of anonymous and identity-release sperm donationT. Freeman, S. Zadeh, V. Smith, S. Golombok (United Kingdom)P-389 diagnosing neuropathic pain in women with chronic pelvic pain: a pilot studyL.H.R. Whitaker, J. Reid, J. Wilson, H.O.D. Critchley, A.W. Horne (United Kingdom)P-390 psychological and social characteristics of single mothers by sperm donationS. Zadeh, T. Freeman, V. Smith, S. Golombok (United Kingdom)POSTERSP-391 a typology of coping in couples undergoing infertility treatmentB. Peterson, M. Pirritano, L. Schmidt (U.S.A.)P-392 prevalence of depressive disorders in infertile women and men up to 5 years after undergoing in vitrofertilization treatment - a follow-up studyH. Volgsten (Sweden)Programme book167

P-393 "It is not his child, it is our child with his sperm.": the (de-)involvement of the anonymous donor inlesbian family buildingE. Wyverkens, H. Van Parys, V. Provoost, A. Ravelingien, I. Raes, S. Somers, I. Stuyver, G. Pennings,P. De Sutter, A. Buysse (Belgium)P-394 improving the wellbeing of couples living with endometriosisN. Hudson, L. Culley, C. Law, E. Denny, H. Mitchell, M. Baumgarten, N. Raine-Fenning (United Kingdom)P-395 parent-child relationships in assisted reproduction families: a follow-up at age 10L. Blake, V. Jadva, S. Golombok (United Kingdom)P-396 the impact of life stress and IVF procedure-related stress on IVF outcomesK.H. Lee, H.G. Sun, I.H. Park, S.G. Kim, J.H. Lee, Y.Y. Kim, H.J. Kim, K.H. Kim (Korea South)Quality and safety of ART therapiesP-397 Incidence of monozygotic twinning and perinatal outcomes following either blastocyst or cleavage stageembryo transferA. Thornhill, Z. Al - Dibouni, T. Shah, S. Wheat (United Kingdom)P-398 CARTRPlus: The evolution of a national fertility registry, linking existing independent databases of ART,perinatal and childhood outcomesM. Teitelbaum, M. Walker, F. Bissonette, A.L. Yuzpe, M.C. Leveille, M. Gysler, M. Johnson, A. Sprague (Canada)P-399 dropout evaluation during egg donor screeningJ. Guerrero Villena, J. Llácer Aparicio, J. Giménez, J. Ten, R. Bernabeu Pérez (Spain)P-400 the impact of assisted reproductive technologies on the incidence of multiple pregnancies from apopulation perspectiveI. Scholten, G.M. Chambers, L. van Loendersloot, F. van der Veen, S. Repping, J. Gianotten, P.G.A. Hompes,W. Ledger, B.W.J. Mol (The Netherlands)P-401 the risk of preeclampsia in pregnancies after the age of 45: a comparison between natural and oocytedonation conceptionsU.P. Dior, N. Laufer, S. Granovsky-Grisaru, S. Yagel, H. Yaffe, Y. Gielchinsky (Israel)P-402 towards more patient-centred fertility care: what does it costW.L.D.M. Nelen, A.G. Huppelschoten, E.W. Verkerk, E.M.M. Adang, J.A.M. Kremer (The Netherlands)P-403 sex variation in perinatal outcomes by infertility treatment modality in a population cohortM. Davies, A. Rumbold, J. Marino, K. Willson, V. Moore, L. Giles (Australia)P-404 possibilities of predicting pregnancy and multiple pregnancy in a two embryo transfer setting in anIVF/ICSI trialO. Shebl, T. Ebner, G. Tews, D. Haas, P. Oppelt, R.B. Mayer (Austria)P-405 implementing an electronic witnessing system into a busy IVF clinic - one clinic's experienceF. Sanges, R. Maggiulli, L. Albricci, S. Romano, C. Scarica, M. Schimberni, A. Giallonardo, G. Vettraino,F. Ubaldi, L. Rienzi (Italy)P-406 the transfer of an extra low quality embryo significantly increases the risk of multiple pregnanciesR.C.S. Figueira, D.P.A.F. Braga, A.S. Setti, A. Iaconelli Jr., E. Borges Jr. (Brazil)168

P-407 Obstetric and perinatal follow-up in an oocyte donation program: why should we transfer only one embryoE. Clua Obradó, D. Rodríguez Barredo, L. Latre Navarro, A. Vázquez Rodríguez, P.N. Barri Ragué,B. Coroleu Lletget, R. Tur Padró (Spain)P-408 effects of embryo quality on pregnancy and perinatal outcomeG. Oron, T. Sokal-Arnon, A. Zeadna, W.Y. Son, H. Holzer, T. Tulandi (Canada)P-409 follow-up of child growth regarding new technologies: testicular sperm extraction (TESE),invitro maturation (IVM), and assisted oocytes activation (aoa)Y. Nakamura, H. Hattori, Y. Sato, M. Kuchiki, E. Sakamoto, M. Doshida, M. Toya, K. Kyono (Japan)P-410 pregnancy and neonatal outcome following ovulation induction with aromatase inhibitor letrozole andclomiphene citrateY. Nakajo, Y. Nakamura, K. Hirata, M. Doshida, M. Toya, K. Kyono (Japan)P-411 pregnancy outcomes of day 5 blastocyst transfer in the patients with high risk ovarian hyper-stimulationsyndrome and analysis of blastocyst formation related factorsZ.M. Xin, H. Zhu, Y.P. Sun, H.X. Jin, W.Y. Song (China)P-412 Cumulative summation: a tool to monitor training in folliculometry during controlled ovarian stimulationwith three-dimensional ultrasoundA. Rodriguez, F. Poisot, F. Rodriguez, O. Coll, R. Vassena, V. Vernaeve (Spain)P-413 altered expression of genes related to male reproduction in the testes of intracytoplasmic sperminjection miceY. Ye, L. Wang, N. Wang, F. Le, F. Jin (China)P-414 mismatch repair gene promoter methylation and expression in human placenta from singleton ARToffspringY. Zheng, F. Jin, Y. Lou (China)P-415 assisted reproductive technologies increase the risk of cardiometabolic diseases related to the aberranthepatic expression of insig-scap-srebf and their epigenetic mechanisms in the elder miceF. Le, P.P. Pan, N. Wang, L.Y. Wang, C.X. Hu, S.Y. Liu, Y.M. Zheng, L.J. Li, X.Z. Liu, X.R. Xu, H.F. Huang, F. Jin (China)P-416 effect of in vitro culture of human embryos on birthweight and birthlength of newbornsS.L. Lin, M. Li, Y. Lian, L.X. Chen, P. Liu (China)P-417 tubal factor infertility and perinatal risk after assisted reproductive technologyJ.F. Kawwass, S. Crawford, D.M. Kissin, D.R. Session, S. Boulet, D.J. Jamieson (U.S.A.)Reproductive (epi)geneticsPOSTERSP-418 Application of aCGH for pre-implantation genetic diagnosis of chromosome rearragements andadditional unrelated chromosome aneuploidyC. Lynch, N. Tee, H. Rouse, A. Gordon (United Kingdom)P-419 expression of boris, a testis-cancer gene, related to vascular malformations and hemorrhage in miceand humansL. Sati, C. Zeiss, B. Soygur, I. Bassorgun, E. Goksu, R. Demir, J. McGrath (Turkey)Programme book169

P-420 Differences in somatic cell gene expression in the pre-ovulatory follicle after controlled ovarianstimulation with rfsH supplemented with increasing doses of hCGM.L. Groendahl, L. Thuesen, A. Nybo Andersen, A. Loft, J. Smitz, T. Adriaenssens, J. Vikeså,R. Borup (Denmark)P-422 maternal age affects angiogenic factors and insulin signaling pathway of human cumulus cells isolatedfrom mature MII oocyteT. Aledani, S. Assou, S. Traver, O. Aït-ahmed, H. Dechaud, S. Hamamah (France)P-423 synaptonemal complex protein 3 mutation is not necessarily associated with female infertilityE. Mizutani, N. Suzumori, C. Sugiyama, Y. Hattori, T. Sato, H. Ando, Y. Ozaki, M. Sugiura-Ogasawara (Japan)P-424 Comparing the transcriptome of human granulosa cells before and after hCG triggering in the samestimulation cycle reveals significant and unique differencesM. Wissing, S.G. Kristensen, C.Y. Andersen, A.L. Mikkelsen, T. Hoest, R. Borup, M.L. Groendahl (Denmark)P-425 profiling of microRNAs in human preovulatory granulosa cells by deep sequencing reveals novelmiRNAs in fsH receptor and aromatase genesA. Velthut-Meikas, J. Simm, M. Metsis, A. Salumets (Estonia)P-426 preliminary study on DNA present in Blastocoele FluidS. Palini, L. Galluzzi, S. De Stefani, M. Primiterra, D. Wells, M. Magnani, C. Bulletti (Italy)P-427 gonadoblastoma Y (GBY) locus expression in females with primary amenorrhoea and 46,XY karyotypecan visualize risk for gonadal tumour developmentP.H. Vogt, P. Frank-Herrmann, U. Bender, T. Strowitzki, B. Besikoglu, P. Heidemann, L. Wünsch,M. Bettendorf (Germany)P-428 predictive power of early cleavage morphokinetics in relation to euploidy/aneuploidy of resultedembryosL. Jelinkova, S. Vilímová, M. Kosarová, P. Sebek, E. Volemanová, M. Kruzelová, J. Civisová, L. Svobodová,V. Sobotka, T. Mardesic (Czech Republic)P-429 Chromosome segregation regulation in human preimplantation embryos: altered histone modificationdynamics and centromeric targeting of the chromosomal passenger complexC. van de Werken, M. Avo Santos, C. Eleveld, J.S.E. Laven, E.B. Baart (The Netherlands)P-430 meiotic segregation of chromosomes involved in balanced translocations in sperm of infertile menL.Y. Pylyp, L.A. Spinenko, V.D. Zukin (Ukraine)P-431 p27kip1 mutant mice displays an increased number of multioocyte follicles(mofs):presumable role of granulosa cellsJ. Pérez-Sanz, R. Matorras, J. Arluzea, J. Bilbao, N. González-Santiago, N. Yeh, A. Koff, A. Barlas,Y. Romin, K. Manova-Todorova, C. De la Hoz (Spain)P-432 relationship between pregnancy outcomes in couples with recurrent implantation failure and TP53polymorphism genotypes of embryosA.L. Mauri, A.M. Nascimento, L.D. Vagnini, C.G. Petersen, J. Ricci, F.C. Massaro, M. Cavagna, A. Pontes,J.B.A. Oliveira, R.L.R. Baruffi, J.G. Franco Jr. (Brazil)P-434 oocyte accumulation strategy for preimplantation genetic diagnosis/screening in cases of low responseM. Parriego, M. Solé, M. Boada, B. Coroleu, A. Veiga (Spain)170

P-435 Triple-factor PGD for beta-thalassaemia, sideroblastic anaemia, combined with HLA-typing, employingthree different molecular approaches in a single blastomere: real-time nested-PCR, high-resolutionmelting (HRM) and fragment analysisG. Kakourou, M. Poulou, C. Vrettou, A. Destouni, J. Traeger-Synodinos, E. Kanavakis (Greece)P-436 multiple mutations discovered in a familial case of azoospermia using whole exome sequencing (WES)A.N. Yatsenko, A.P. Georgiadis, M.M. McGuire, M. Zorrilla, K.D. Bunce, D. Peters, A. Rajkovic,M. Olszewska, M. Kurpisz (U.S.A.)P-437 Clinical outcome assessment from pre-implantation genetic screening using array comparativegenomic hybridisation of polar bodies and blastomeres for embryo transfer selectionA.Z.A. Gilbertson, C.S. Ottolini, M.C. Summers, K. Sage, A.H. Handyside, A.R. Thornhill,D.K. Griffin (United Kingdom)P-438 positive clinical outcome after preimplantation genetic screening (PGS) using newly developed wholegenome array CGH platform after trophectoderm biopsyM.K. Chung, J.W. Kim, J.H. Lee, H.J. Jeong, M.H. Kim, M.J. Ryu, S.J. Park, H.Y. Kang, H.S. Lee (Korea South)P-439 Highly multiplexed targeted single-nucleotide polymorphism (SNP) amplification and sequencing as amethod for identifying fetal chromosomal disorders from maternal cell-free DNAB. Zimmermann, M. Banjevic, M. Hill, P. Lacroute, M. Dodd, S. Sigurjonsson, P. Lau, D. Prosen, N. Chopra,A. Ryan, M. Hall, S. McAdoo, Z. Demko, B. Levy, M. Rabinowitz (U.S.A.)P-440 introducing preimplantation genetic screening by array comparative genome hybridization in hungary:improving outcome of in vitro fertilizationA. Vereczeky, Z.S. Kósa, S. Sávay, M. Csenki, L. Nánássy, B. Dudás, Z.S. Dömötör, D. Debreceni (Hungary)P-441 frequency and characterization of blastocyst aneuplodyies after CGH-array analysis and its relationwith maternal ageA. Rossi, J.R. Alegretti, J. Cuzzi, M. Bonavita, M. Tanada, P. Matunaga, P. Fettback, M.B. Rosa, V. Maia,P. Hassun, E.L.A. Motta (Brazil)P-442 is morphological development of blastocysts correlated to chromosomal analysis by cgh-array aftertrophectoderm biopsy?M. Piccolomini, C. Gomes, B. Barros, M. Nicoliello, P. Matunaga, T. Criscuolo, M. Bonavita, J.R. Alegretti,E. Miyadahira, J. Cuzzi, P. Hassun, E.L.A. Motta (Brazil)P-443 dna methylation, genetic variants and ART outcome in oligozoospermiaD. Montjean, M. Benkhalifa, I. Berthaut, J.F. Griveau, K. Morcel, A. Bashamboo, K. McElreavey,C. Ravel (France)P-444 array-CGH versus FISH for PGS in recurrent miscarriage couplesC. Rubio, L. Rodrigo, E. Mateu, A. Mercader, V. Peinado, P. Buendia, M. Milán, A. Delgado, N. Al-Asmar,L. Escrich, I. Campos-Galindo, S. Garcia-Herrero, M.E. Poo, P. Mir, C. Simón (Spain)POSTERSP-445 single nucleotide polymorphisms (SNPs) related to neurotransmission associated with sperm qualityin infertile menA. Reyes-Engel, M. Cortes-Rodriguez, A. Lendinez, B. Perez-Nevot, A.R. Palomares, M. Ruiz Galdon (Spain)Programme book171

P-446 Comparison between fresh or vitrified-warmed blastocyst transfer performed after trophectodermbiopsy in preimplantation genetic diagnosis cyclesA. Ruberti, M.G. Minasi, A. Biricik, A. Colasante, D. Zavaglia, E. Iammarrone, F. Fiorentino, E. Greco (Italy)P-447 Epab and Pabpc1 genes exhibit different expressions and cellular localizations in postnatal mouse ovariesN. Demir, S. Ozturk, B. Sozen (Turkey)P-448 Effect of chromosome polymorphic variants in the infertility and their relationship with the IVF cycles outcomeR. Morales, B. Lledo, J.A. Ortiz, J. Ten, J. Llacer, R. Bernabeu (Spain)P-449 pgd or natural conception - recommendations for couples with recurrent miscarriages caused bytranslocation chromosomal aberrationsM. Nagayoshi, A. Tanaka, I. Tanaka, H. Kusunoki, S. Watanabe (Japan)P-450 preimplantation genetic diagnosis (PGD) for inversion carriersS.G. Temel, C. Beyazyurek, G.C. Ekmekci, F. Aybar, C. Cinar, S. Kahraman (Turkey)P-451 ivf treatment is affected by Histidine-rich glycoprotein (HRG) polymorphismS. Nordqvist, K. Kårehed, H. Åkerud (Sweden)P-453 poor preimplantation genetic diagnosis outcomes of translocations involving chromosome 10:do we blame on genetics?M. Gultomruk, P. Tulay, N. Findikli, E. Yagmur, G. Karlikaya, U. Ulug, M. Bahceci (Turkey)P-454 embryo morphology does not predict euploidy in advanced maternal age (= 40 years old) patientsM. Florensa Bargalló, M. Riqueros Arévalo, M. Martín Salat, I. Vanrell Barbat, J. Teruel López,M. Esbert Algam, A. Ballesteros Boluda, G. Calderon de Oya (Spain)P-455 epigenetic effects of trisomy 16 on first-trimester pregnancy lossE.N. Tolmacheva, A.A. Kashevarova, N.A. Skryabin, I.N. Lebedev (Russia C.I.S.)P-456 is high semen DNA fragmentation from infertile men a cause for increased specific embryonicchromosomal deletions and duplications detected by CGH-array?E. Semaco, A. Belo, M. Riboldi, J. Cuzzi, B. Barros, L. Luz, T. Criscuolo, N. Nobrega, P. Matunaga,R. Mazetto, J.A. Alegretti, M. Bibancos, P. Hassun, E.L.A. Motta, P. Serafini (Brazil)P-457 nuclear transfer can prevent mitochondrial DNA carry-over without compromising embryonicdevelopment potential in miceJ. Neupane, M. Vandewoestyne, B. Heindryckx, T. Deroo, Y. Lu, S. Ghimire, S. Lierman, C. Qian,D. Deforce, P. De Sutter (Belgium)P-458 fisH on sperm to identify infertile male patients with higher aneuploidy riskL. Rodrigo, C. Rubio, E. Mateu, V. Peinado, M. Milán, T. Viloria, N. Al-Asmar, A. Mercader, P. Buendía,A. Delgado, L. Escrich, J.M. Martínez-Jabaloyas, C. Simón, M. Gil-Salóm (Spain)P-459 preliminary comparison of quantitative real-time (q)PCR and array comparative genomic hybridization(aCGH) based 24 chromosome aneuploidy screening in human blastocystsA. Capalbo, N. Treff, D. Cimadomo, X. Tao, K. Ferry, F.M. Ubaldi, L. Rienzi, R.T. Scott (Italy)P-460 Diagnostic value of serum anti-müllerian hormone levels in women with premature ovarian failure syndromeN. Katzorke, T. Strowitzki, H.P. Vogt (Germany)172

P-461 PGD for monogenic disorders on polar bodies (PBD) - impact of clinical parameters on PBD outcomeA. Hehr, C. Gassner, B. Paulmann, Z. Kowalzyk, M. Klatt, S. Krauß, D. Seifert, B. Seifert, U. Hehr (Germany)P-462 performing PGD+PGS at blastocyst stage rather than only PGD on day-3 does not affect clinical resultsM.G. Minasi, A. Ruberti, A. Biricik, M. Lobascio, D. Zavaglia, M.T. Varricchio, F. Fiorentino, E. Greco (Italy)P-463 does preimplantation genetic screening (PGS) really improve implantation rate? Comparison offrozen-thawed embryo transfers between patients undergoing PGS and those without genetic screeningP. Rubino, S. Bono, R.P. Cotarelo, L. Spizzichino, A. Biricik, A. Colicchia, P. Giannini, F. Fiorentino (Italy)P-464 the potential role of dioxin analogues in prostate cancer and male infertility - preliminary study usingLNCaP cell lineM. Suhorutshenko, K. Rosenstein-Tamm, J. Simm, A. Salumets, M. Metsis (Estonia)Reproductive endocrinologyP-465 rLH supplementation to rfsH during induced ovarian stimulation in the GnRh antagonist protocolimproves implantation and pregnancy ratesA. Nazzaro, A. Salerno, L. Di Iorio, G. Landino, S. Marino, E. Pastore (Italy)P-466 ivf results following transdermal testosterone in poor responders according bologna criteriaF. Fabregues, A. Iraola, G. Casals, M. Creus, S. Peralta, J. Peñarrubia, D. Manau, S. Civico, J. Balasch (Spain)P-467 effects of fsH receptor polymorphismsI. Lindgren, Y. Lundberg Giwercman (Sweden)P-468 Lipid features of polycystic ovary syndrome under different diagnostic criteriaE. Celik, I. Turkcuoglu, B. Ata, A. Karaer, P. Kirici, B. Berker (Turkey)P-469 Comparison of serum Anti-Müllerian hormone levels and affecting factors in polycystic ovary syndromewith and without hyperandrogenismJ. Park, J. Kim, J. Rhee (Korea South)P-470 the role of ethnicity and body weight in determination of AMH levels in women diagnosed withsubfertilityM. Krishnan, O. Rustamov, R. Russel, C. Fitzgerald, S. Roberts (United Kingdom)P-471 Current practice of assessment of ovarian reserve in the UKS. Hapuarachi, B.K. Tan, R.S. Mathur (United Kingdom)P-472 the role of gonadotrophin releasing hormone agonist downregulation in artificially prepared frozenembryo transfer cyclesA. van de Vijver, C. Blockeel, M. Camus, N. Polyzos, L. Van Landuyt, H. Tournaye (Belgium)POSTERSP-473 Combined oral contraceptive use increases serum prostate-specific antigen levels in patients withpolycystic ovary syndromeN. Öztürk Turhan, D. Hizli, Z. Kamalak, A. Kösüs, N. Kösüs, H. Kafali (Turkey)P-474 probability of live birth in women with extremely low anti-Müllerian hormone levelsA. Lukaszuk, M. Kunicki, J. Liss, A. Bednarowska, G. Jakiel, K. Lukaszuk, M. Lukaszuk,B. Olszak-Sokolowska (Poland)Programme book173

P-475 Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilizationK. Lukaszuk, M. Kunicki, J. Liss, G. Jakiel, A. Bednarowska, T. Wasniewski, M. Neuberg, M. Lukaszuk (Poland)P-476 mtHFR gene polymorphisms and the correlation with estradiol serum levels and assisted reproductionoutcomesV. Cavalcanti, C. Peluso, B.L. Lechado, E.B. Cordts, D.M. Christofolini, C.P. Barbosa, B. Bianco (Brazil)P-477 progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis ofover 60,000 cyclesC.A. Venetis, E.M. Kolibianakis, J. Bosdou, B.C. Tarlatzis (Greece)P-478 pregnancy outcomes according to endometrial thickness in ovulation induction cycles with clomiphenecitrateM. Onal, D.N. Gungor, M. Acet, S. Kahraman (Turkey)P-479 mid-pregnancy and perinatal reproductive endocrinology in singletons and twinsE. Kuijper, J. Twisk, M. Caanen, T. Korsen, P. Hompes, M. Kushnir, A. Rockwood, W. Meikle,C.B. Lambalk (The Netherlands)P-480 does combined oral contraceptive use change serum 25-hydroxy vitamin D levels in patients withpolycystic ovary syndrome?D. Hizli, Z. Kamalak, A. Kosus, N. Kosus, N.O. Turhan, H. Kafali (Turkey)P-481 prenatal androgen excess programs metabolic derangements in pubertal female ratsX. Yan, X. Dai, J. Wang, N. Zhao, Y. Cui, J. Liu (China)P-482 serum AMH levels in women with a history of early onset preeclampsia indicate a role for vascularfactors in ovarian ageingF. Yarde, A.H.E.M. Maas, A. Franx, M.J.C. Eijkemans, J.T. Drost, B.B. van Rijn, J. van Eyck,Y.T. van der Schouw, F.J.M. Broekmans (The Netherlands)P-483 should all young women have their AMH level checked and at what age?F. Martyn, B. Anglim, M. Wingfield (Ireland)P-484 dehydroepiandrosterone (DHEA) as a Holy Grail in the treatment of Premature Ovarian Failure (POF)patients; hype or hope?T. Fang, G.J. Yan, H.X. Sun, Y.L. Hu (China)P-485 the prevalence of insLQ, Asn291Ser and Ser312Asn polymorphisms of luteinizing hormone receptorgene in Czech population and patients with ovarian hyperstimulation syndromeJ. Chrudimská, P. Krenková, M. Macek jr., M. Macek sr. (Czech Republic)P-486 Low-dose human chorionic gonadotropin at oocyte retrieval after gonadotropin-releasing hormoneagonist triggering: retrospective studyJ. Teixeira da Silva, M. Cunha, J. Silva, P. Viana, A. Gonçalves, N. Barros, C. Oliveira, M. Sousa,A. Barros (Portugal)P-487 prediction of live birth from IVF: enhanced discrimination and calibration with inclusion of AMH in theIVFpredict modelS.M. Nelson, S.M. Lloyd, A. McConnachie, A. Khader, R. Fleming, D.A. Lawlor (United Kingdom)P-488 intrafollicular endocrine milieu after addition of different doses of hCG to rfsH throughout controlledovarian stimulation for IVFL. Thuesen, A. Nyboe Andersen, A. Loft, J. Smitz (Denmark)174

P-489 Accuracy of glycated hemoglobin (HbA1c) in detecting abnormal glucose metabolism in women with PCOSM. Abdel-Rahman, S. Ismail, J. Silk, M. Abdellah, A.H. Abdellah (Egypt)P-490 endocrine profile during controlled ovarian stimulation with recombinant versus urinarygonadotropins (fsH+LH)F. Ruiz, M. Cruz, M. Piro, D. Collado, J.A. Garcia-Velasco, A. Requena (Spain)P-491 fsH-responsiveness as well as Anti-Mullerian hormone secretion is higher in granulosa cells in vitrofrom naturally matured follicles than from gonadotropin stimulated folliclesZ. Kollmann, N.A. Bersinger, B. McKinnon, S. Schneider, M.D. Mueller, M. von Wolff (Switzerland)P-492 gonoadotropin stimulation in In vitro fertilization (IVF) significantly alters the hormone concentrations infollicular fluid - a comparative study between Natural Cycle and conventional IVFA. Vaucher, Z. Kollmann, N.A. Bersinger, B. Weiss, P. Stute, U. Marti, M. von Wolff (Switzerland)P-493 The live-birth rates of women with thyroid autoimmunity and/or subclinical hypothyroidism following IVFJ. Chai, W.Y.T. Yeung, C.Y.V. Lee, W.H.R. Li, P.C. Ho, H.Y.E. Ng (Hong Kong)P-494 increased femoral bone mineral density according to increase of skeletal muscle mass in 547 Koreanwomen; a retrospective cohort study over 2.7-year periodS.M. Kim, S.H. Kim, B.C. Jee, S. Ku, C.S. Suh, Y.M. Choi, J.G. Kim, S.Y. Moon (Korea South)P-495 the effect of additional low dose hCG with vaginal progesterone gel in luteal phase of IVF cyclesJ.H. Lee, S.G. Kim, Y.Y. Kim, H.J. Kim, K.H. Lee, I.H. Park, H.G. Sun (Korea South)P-496 is fertility sustained until the late reproductive age in the IVF-ET cycles of PCOS patients?Y.I. Hwang, N.Y. Sung, M.H. Choi, S.H. Cha, C.W. Park, J.Y. Kim, K.M. Yang, I.O. Song, M.K. Koong,I.S. Kang, H.O. Kim (Korea South)P-497 Hormone replacement therapy versus combined oral contraceptives for prevention of osteoporosis inyoung hypoestrogenic women: a prospective randomized trialC. Haines, W.Y. Wong, W.S. Kong, L.P. Cheung, T.K. Choy, P.C. Leung (Hong Kong)P-498 expression and effects of amphiregulin on the maturation of human cumulus cell-oocyte complexesrecovered from antral follicles in IVM cyclesR. Fadini, G. Coticchio, M. Mignini Renzini, M.C. Guglielmo, F. Brambillasca, A. Hourvitz, D.F. Albertini,P. Novara, M. Merola, M. Dal Canto (Italy)P-499 AMH vs fsH blood determination: which one is the most decisive and comfortable? It is time to be pragmaticJ.A. Agirregoikoa Iza, J.L. DePablo, C. Anarte, A. Domingo, E. Abanto, G. Barrenetxea (Spain)P-500 patient- and cycle-related prognostic factors affecting the outcome of mild IVF: a multivariate analysisof 2876 treatment cycles from a single centreR. Kato, S. Kawachiya, D. Bodri, M. Kondo, T. Matsumoto (Japan)POSTERSP-501 Cost-effectiveness comparison between pituitary downregulation with a GnRH agonist short regimen inalternate days and an antagonist protocol for assisted fertilization treatmentsL.G.L. Maldonado, A.S. Setti, D.P.A.F. Braga, A. Iaconelli Jr., E. Borges Jr. (Brazil)P-502 supplementation with hCG microdoses brings costs and effectiveness together resulting in higheroocyte quality and blastocyst formation in young women undergoing controlled ovarian stimulationC. Iaconelli, A.S. Setti, D.P.A.F. Braga, R.C.S. Figueira, A. Iaconelli Jr., E. Borges Jr. (Brazil)Programme book175

P-503 Low follicular fluid tyrosine concentration in infertile patients with ovarian hyperstimulation syndromeK. Kitaya, S. Taguchi, M. Funabiki, Y. Tada, T. Hayashi, Y. Nakamura (Japan)P-504 sexual development in girls with central precocious puberty during 5 years after completion oflong-term treatment with GnRH agonistM. Snajderova, D. Zemkova, V. Lanska, L. Teslik (Czech Republic)P-505 Luteal hormonal profile of the same oocyte donors stimulated with either GnRH antagonist or agonistcompared with natural cyclesR. Nunez - Calonge, L. Ortega, A. Garcia, S. Cortes, A. Guijarro, P. Caballero Peregrin (Spain)P-506 Impact of ovarian hyperstimulation syndrome on thyroid function after assisted reproductive technologiesM. Bellavia, M.H. Pesant, D. Wirthner, L. Portman, D. de Ziegler, D. Wunder (Switzerland)P-507 the reproductive outcome in women with premature ovarian failureX. Chen, S.H.L. Chen, Y.D. Liu, T. Tao, L.J. Xu, X.L. Tian, D.S.H. Ye, Y.X. He (China)P-508 antagonist cycles using GnRH trigger without hCG luteal phase support achieve similar clinicalpregnancy rates to standard hCG trigger protocols in PCO patients undergoing IVF/ICSIA. Carby, E. Barsoum, S. El-Shawarby, G. Trew, S. Lavery (United Kingdom)P-509 three day pre-treatment with GnRH antagonists prior to beginning of controlled ovarian stimulation inIVF/ICSI: efficacy from a clinical and embryological perspectiveN. Mishieva, N. Barkalina, I. Korneeva, T. Ivanets, A. Abubakirov (Russia C.I.S.)P-510 regulation of hyaluronan (HA) synthesis and signalling systems in ovine granulosa cellsR. Chavoshinejad, G.m. Hartshorne, W. Marei, A.a. Fouladi-nashta (United Kingdom)P-511 Randomize study: the prevalence of the metabolic syndrome in Greek women with polycystic ovary syndromeG. Kyrkou, E. Trakakis, C.H. Chrelias, E. Alexiou, K. Lykeridou, G. Mastorakos (Greece)P-512 exogenous gonadotropins have little impact on follicular but considerable effect on serum cytokineconcentrations - a comparison between natural cycle and stimulated IVFN. Bersinger, Z. Kollmann, M.D. Mueller, A. Vaucher, M. von Wolff (Switzerland)P-513 dopamine receptor D2 agonist (D2-ag) post-transcripitonally inhibits VEGF production and secretion bylutein granulosa cells through non classical D2 transduction pathwaysH. Ferrero, R. Gómez, C.M. García-Pascual, C. Simón, A. Pellicer (Spain)P-514 effect of follicle-stimulating hormone receptor N680S polymorphism in the efficacy of folliclestimulating hormone stimulation on donor ovarian responseA. Turienzo, B. Lledo, J. Guerrero, J.A. Ortiz, R. Morales, J. Ten, J. Llacer, R. Bernabeu (Spain)P-515 oxidative stress status in follicular fluid and oocyte quality in women with polycystic ovary syndrometreated with inositolV. De Leo, R. Focarelli, A. Capaldo, A. Stendardi, L. Gambera, A. La Marca, P. Piomboni (Italy)P-516 Carotid intima-media thickness in women with polycystic ovary syndrome and matched controlsJ.J. Kim, Y.M. Choi, J.H. Kang, K.R. Hwang, S.J. Chae, S.M. Kim, S.H. Yoon, S.Y. Ku, S.H. Kim, J.G. Kim,S.Y. Moon (Korea South)P-517 Can anti-Müllerian hormone (AMH) predict the diagnosis of polycystic ovary syndrome (PCOS) -a systematic review and meta-analysisS. Iliodromiti, T.W. Kelsey, R.A. Anderson, S.M. Nelson (United Kingdom)176

P-518 Is androgen production in association with immune system activation potential evidence for theexistence of a functional adrenal/ovarian autoimmune system in women?H.J. Lee, A. Weghofer, V.A. Kushnir, A. Shohat-Tal, E. Lazzaroni, H.J. Lee, D.H. Barad, N.N. Gleicher (U.S.A.)P-519 a comparison of in-vitro maturation versus antagonist protocols for in-vitro fertilization in women withpolycystic ovarian syndromeT. Shavit, E. Shalom-Paz, O. Fainaru, M. Michaeli, E. Kartchovsky, A. Ellenbogen (Israel)P-520 self-operated endo-vaginal tele-monitoring (SOET) as an alternative for traditional monitoring of thestimulation phase of IVF/ICSI cyclesPreliminary results of a randomized comparisonJ. Gerris, F. Vandekerckhove, A. Delvigne, N. Dhont, B. Madoc, J. Neyskens, M. Buyle, E. Vansteenkiste,E. De Schepper, L. Pil, N. Van Keirsbilck, W. Verpoest, D. Debacquer, L. Annemans, P. De Sutter (Belgium)P-521 amH, a putative follicular fluid marker of oocyte quality, is concentrated around 3-fold higher infollicular fluid of Natural Cycle-IVF than in gonadotropin stimulated IVFM. Von Wolff, Z. Kollmann, A. Vaucher, B. Weiss, N.a. Bersinger (Switzerland)P-522 pregnancy outcomes in poor responders after ICSI cyclesF.F. Verit, S. Keskin, A.K. Sargin, S. Karahuseyinoglu, O. Yucel, S. Yalcinkaya (Turkey)P-523 Chronic kisspeptin administration advances the menstrual cycle in healthy womenA.N. Comninos, C.N. Jayasena, G.M.K. Nijher, A. Abbara, A. De Silva, J.D. Veldhuis, R. Ratnasabapathy,C. Izzi-Engbeaya, A. Lim, D.A. Patel, M.A. Ghatei, S.R. Bloom, W.S. Dhillo (United Kingdom)P-524 triggering of final oocyte maturation with triptorelin 0.3 mg increases pregnancy rates in oocytedonation cyclesM. Colodron, J.J. Guillén, D. García, O. Coll, R. Vassena, V. Vernaeve (Spain)P-525 Comparing the effects of aerobic exercise and fennel (foeniculum vulgare) on pre-menstrualsyndrome(PMS) in high school young girlsH. Pazoki, G. Bolouri, F. Farokhi, M.A. Azarbayjani (Iran)P-526 should serum anti-Müllerian hormone (AMH) or antral follicle count (AFC) be used for prediction ofoocyte yield in patients with AMH-AFC discordancesM.S. Alebic, N. Stojanovic (Croatia)P-527 decreased ovarian reserve in female Sprague -Dawley rats induced by isotretinoin exposureR. Abali, A. Yuksel, C. Aktas, C. Celik, S. Guzel, G. Erfan, O. Sahin (Turkey)P-528 expression of transforming growth factor-ß1 in ovarian follicular fluid from women with polycystic ovarysyndrome and its effect on miR-224 in ovarian luteinized granulosa cellsH. Zhongying, L. Shangwei, M. Qianhong, F. Wei, L. Lei, X. Zhun, W. Yan (China)P-529 a randomized controlled trial to evaluate the effect on oocyte yield of prolongating the follicular phasein IVF/ICSI cycles with not-elevated progesteroneF. Vandekerckhove, A. De Baerdemaeker, J. Gerris, K. Tilleman, S. Vansteelandt, P. Pr. De Sutter (Belgium)POSTERSP-530 evaluation of a new ovarian response prediction index (ORPI) for individualised controlled ovarianstimulationJ.B.A. Oliveira, R.L.R. Baruffi, C.G. Petersen, A.L. Mauri, A.M. Nascimento, L. Vagnini, J. Ricci, M. Cavagna,F.C. Massaro, A. Pontes, J.G. Franco Jr. (Brazil)Programme book177

P-531 Addition of luteal estradiol pre-treatment in women treated with GnRH antagonist for in vitrofertilization: a systematic review and meta-analysisW. El-khayat, M. Elsadek (Egypt)P-532 pregnancy rate following luteal phase support in polycystic ovarian syndrome using combinationtherapies for ovulation induction: a randomized clinical trialF. Foroozanfard, H. Saberi, A. Moravvegi, M. Kazemi (Iran)P-533 gnRH agonist for triggering final oocyte maturation versus IVM in patients at risk of OHssY.S. Gidoni, A. Raziel, S. Friedler, D. Strassburger, D. Hadari, E. Kasterstein, I. Ben-Ami, D. Komarovsky,B. Maslansky, O. Bern, R. Ron-El (Israel)P-534 should testosterone be used for more patients than only low ovarian respondersM. Pérez Izquierdo, J. Ten, J. Guerrero, F. Araico, J. Llácer, R. Bernabeu (Spain)P-535 ivf outcomes and embryo morphokinetics in women with polycystic ovarian syndromeO. Somova, O. Feskov, I. Feskova, I. Bezpechnaya, I. Zhylkova, O. Tishchenko (Ukraine)P-536 is anti-mullerian hormone (amh) significantly related with hyperandrogenemia or insulin resistance inwomen with pcosS. Kralik Oguic, D. Pavicic Baldani, L. Skrgatic, V. Simunic, H. Vrcic, D. Rogic, J. Juras,M. Sprem Goldstein (Croatia)P-537 experience on the use of Corifollitropin-alfa (Elonva) for controlled ovarian hyperstimulation in ovumdonor cyclesL. Garcia De Miguel, M. Caballero Campo, A. Gurria, J. Alonso, A. Serrano, E. Marbán,P. Caballero Peregrín (Spain)P-538 dysregulation of gene expression in cumulus cells of in vitro matured oocytesA. Hourvitz, L. Shalev, Y. Yung, G. Yerushalmi, C. Giovanni, M. Dal Canto, R. Fadini, J. Has,E. Maman (Israel)P-539 molecular expression of androgen and fsH receptors after follicular priming prior to ICSI cycles -an interim analysis of the "foLLPRIM" randomized controlled trialM. Monterde, R. Gómez, A. Marzal, O. Vega, J.m. Rubio, C. Diaz-Garcia, A. Pellicer (Spain)P-540 Comparison of two strategies to prevent ovarian hyperstimulation syndrome in high-risk patients:GnRH agonist trigger and a 'mild stimulation' regimenA. Eapen, A. Datta, A. Kurinchi-selvan, H. Birch, G.M. Lockwood (United Kingdom)P-541 Clinical preganancy rates of late HCG administration to trigger ovulation in clomiphene citrate induced cylesM.C. Ornek, U. Ates, T. Usta, C.P. Goksedef (Turkey)P-542 the value of I generation AMH measurements kits for prediction of live birth in women undergoingassisted reproductive technologyA. Bruszczynska, J. Glowacka, M. Kunicki, G. Jakiel, T. Wasniewski, K. Jaguszewska, J. Liss,K. Lukaszuk (Poland)P-543 predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlledovarian stimulationS. Oehninger, S. Nelson, P. Verweij, B. Stegmann (U.S.A.)178

P-544 Impact of ovarian endometrioma on oocyte retrieval, fertilisation, and first embryonic cleavage divisionin assisted reproductive technologyH. Ando, T. Takayanagi, H. Minamoto, N. Suzuki (Japan)P-545 anti Mullerian hormone receptor type II expression and regulation in human granulosa cells in latefollicular development and the correlation to clinical outcomeE. Maman, N. Rubinshtein, Y. Yung, L. Shalev, G. Yerushalmi, A. Hourvitz (Israel)P-546 assesment of relationships between the HMW Adiponectin and insulin resistance in normal weightadolescents with PCOSS. Saltek, B. Demir, B. Dilbaz, C. Demirtas, U. Goktolga (Turkey)P-547 elevated progesterone (>1.5 ng/mL) during the late follicular phase of ovarian stimulation withcorifollitropin alfa or rfsH does not compromise pregnancy rates in older womenW. Kutteh, B. Shapiro, H. Witjes, K. Gordon (U.S.A.)P-548 failure to shorten the stimulation period and induce monoovulation in women with anovulatoryinfertility using an individualized gonadotrophin dosage regimen. A prospective clinical trialM.P. Lauritsen, A. Loft, A. Pinborg, N.L. Freiesleben, A.L. Mikkelsen, M.R. Bjerge,A. Nyboe Andersen (Denmark)P-549 attenuated Wnt4 action impacts the fate of ovarian maturation by impeding Anti-Mullerian hormone inpolycystic ovary syndromeP. Chakraborty, S.K. Goswami, B.N. Chakravarty (India)P-550 the evaluation of ovarian reserve in women with a haemoglobinopathy and iron overload using adynamic fsH stress test (dfst)M. Mittal, R. Bajoria, N. Narvekar, R. Chatterjee (United Kingdom)P-551 advantages of reporting plasma anti-Müllerian hormone (AMH) levels as multiples of the median (MoM)in women of reproductive ageJ.G. Bentzen, T. Holm Johannsen, T. Scheike, A. Nyboe Andersen, L. Friis-Hansen (Denmark)P-552 effectiveness of the GnRH agonist long, GnRH agonist short and GnRH antagonist regimens in poorresponders undergoing IVF treatment: a three arm randomised controlled trialS. Sunkara, A. Coomarasamy, R. Faris, P. Braude, Y. Khalaf (United Kingdom)P-553 Triggering of final oocyte maturation with GnRH agonist in patients with polycystic ovaries undergoing IVFA. Makedos, E.M. Kolibianakis, C.A. Venetis, S. Masouridou, K. Chatzimeletiou, L. Zepiridis, A. Mitsoli,G. Lainas, I. Sfontouris, A. Tzamtzoglou, D. Kyrou, T. Lainas, B.C. Tarlatzis (Greece)P-554 influence of the fsh/lh ratio in ovarian stimulation in ivf results in women aged over 35 years:a randomized studyA. Fermin, L. Crisol, A. Expósito, B. Prieto, R. Mendoza, R. Matorras (Spain)POSTERSP-555 inferred genetic ancestry versus reported ethnicity in polycystic ovary syndrome (PCOS)Y. Louwers, O. Lao, M. Kayser, J.S.E. Laven (The Netherlands)P-556 gnRH agonist (GnRHa) trigger in antagonist protocol cycles: incidence of failed trigger and impact ofdifferent GnRH agonist dosesA. Palumbo, V. Sanabria, J.P. Rouleau, M. Puopolo, M.J. Hernandez (Spain)Programme book179

P-557 Altered sensitivity rather than decreased amounts of FSH (FSHR) and androgen receptors (AR) ingranulosa cells might be beneath the development of diminished ovarian responseC. Díaz-García, M. Monterde, A. Marzal, O. Vega, J.M. Rubio, R. Gómez, A. Pellicer (Reproductive Medicine)P-558 superovulation influences epab and pabpc1 gene expressions in mouse oocytes and earlypreimplantation embryosS. Ozturk, B. Sozen, A. Yaba-Ucar, D. Mutlu, N. Demir (Turkey)P-559 a randomised, double-blind, active-controlled, multiple-dose trial investigating the pharmacokineticsand pharmacodynamics of a novel recombinant fsH (FE 999049) derived from a human cell lineH. Olsson, R. Sandström, L. Grundemar (Denmark)P-560 Blastocyst transfer as a clinical strategy to overcome progesterone elevation on the day of hCGadministrationE. Papaleo, L. Corti, E. Rabellotti, V.S. Vanni, M. Potenza, M. Molgora, P. Viganò, M. Candiani (Italy)P-562 different pharmacokinetic properties between a novel recombinant fsH (FE 999049) derived froma human cell line and follitropin alfaR. Sandström, H. Olsson, L. Grundemar (Denmark)P-563 the evaluation of AMH and AMHR2 genes polymorphisms in infertile women and the correlation withAMH, fsH and estradiol serum levels and assisted reproduction outcomesP. Peluso, C.M. Trevisan, E.B. Cordts, V. Cavalcanti, D.M. Christofolini, F.A. Fonseca, C.P. Barbosa,B. Bianco (Brazil)P-564 premature luteinization in IVF or ICSI cycles using GnRH antagonists for pituitary downregulationP. Bakas, N. Vlahos, D. Hassiakos, D. Tzanakaki, O. Gregoriou, A. Liapis, G. Creatsas (Greece)P-565 impact of FMR1 mutation on follicle responsiveness to exogenous fsH as measured by the FollicleOutput RaTe (fort)E. Adda-Herzog, J. Steffann, S. Sebag-Peyrelevade, M. Poulain, A. Benachi, R. Fanchin (France)P-566 does delayed endometrial shedding post OC pretreatment increase pregnancy rates in womenundergoing COS with rfsH in a GnRH antagonist regimenK. Gordon, D. Zhang, A. Nyboe Andersen (U.S.A.)P-567 decreased estradiol level after hcg administration can be used as a predictor for poor ivf outcomeF. Aybar, S. Temel, S. Kahraman (Turkey)P-568 simultaneous initiation of GnRH antagonist co-treatment and recfsH for ovarian hyperstimulation in IVFdoes not affect clinical outcome: a randomized controlled trialO. Hamdine, N.S. Macklon, M.J.C. Eijkemans, J.S. Laven, B.J. Cohlen, A. Verhoeff, P.A. van Dop,R.E. Bernardus, C.B. Lambalk, G.J.E. Oosterhuis, C.A.G. Holleboom, G.C. van den Dool-Maasland,H.J. Verburg, P.F.M. van der Heijden, A. Blankhart, B.C.J.M. Fauser, F.J. Broekmans (The Netherlands)P-569 a comparative study of antral follicle count with fsH and AMH in an IVF programmeJ. Bhattacharya, A. Mitra, G.B. Dutta, A. Kundu, M. Bhattacharya, S. Kundu (India)P-570 Comparative analysis of two widely-used immunoassays for the measurement of serum AMH in womenP. Pigny, A. Dassonneville, S. Catteau-Jonard, C. Decanter, D. Dewailly (France)180

P-571 Acceptability and utility of the CONSORT algorithm for calculating recombinant human folliclestimulatinghormone starting doses for ovarian stimulation in assisted reproductive technology: anobservational studyJ. Pouly, F. Olivennes, N. Massin, M. Celle, N. Caizergues (France)P-572 values of anti-Mullerian hormone within individual women show high consistency relative to age relatedpopulations over time, and can inform fertility planning adviceR. Fleming, M. Gaudoin, M. Messow, A. McConnachie, S.M. Nelson (United Kingdom)P-573 pulsatile GnRH administration in women with functional hypothalamic anovulation in presence ofpolycystic ovary-like anomaliesD. Dewailly, L. Vanhove, M. Peigné, P. Thomas, G. Robin, S. Catteau-Jonard (France)Reproductive epidemiology and health economyP-575 Fertility treatment and the risk of childhood and adolescent mental disorders: a register-based cohort studyB. Bay, E.L. Mortensen, U.S. Kesmodel (Denmark)P-576 endocrine screening in women with amenorrhea or oligomenorrhea before starting clomiphene citrate:cost-effectiveS.C. Braam, N. Weiss, J.P. de Bruin, P.G.A. Hompes, F. van der Veen, M. van Wely, B.W. Mol (The Netherlands)P-577 maternal obesity increases risk of congenital anomalies: a population-based studyM.A.Q. Mutsaerts, L. Tromp, S. Scholtens, W.S. Kerstjens-Frederikse, A. Hoek, H.E.K. De Walle (The Netherlands)P-578 effect of ethnicity on IVF/ ICSI outcomeK. Jayaprakasan, D. Pandian, J. Hopkisson, B. Campbell, W. Maalouf (United Kingdom)P-579 reproductive outcome of HIV infected women undergoing assisted conception in EuropeS. Fiore, on behalf of CREAThe network, and the ESHRE TF on viral diseases in reproduction (Italy)P-580 willingness-to-pay for patient-centred and effective fertility care; preferences of patients andhealthcare insurersJ. Kremer, A.G. Huppelschoten, I.W.H. van Empel, E.M.M. Adang, H. Groenewoud,W.L.D.M. Nelen (The Netherlands)P-581 Cumulative parenthood rates in 6,507 couples treated by in vitro fertilizationP. Troude, G. Santin, J. Bouyer, E. de La Rochebrochard (France)Reproductive surgeryP-582 Hysteroscopic metroplasty for uterine septum; analysis of 414 casesE. Simsek, E.B. Kilicdag, B. Haydardedeoglu, G. Coban, C. Iskender, S. Yuksel Simsek, H.B. Zeyneloglu (Turkey)POSTERSP-583 Can skin scar characteristics help predict the degree of pelvic adhesions at laparoscopy?J.E. Glazebrook, L.J. Stocker, Y. Cheong (United Kingdom)P-584 Use of a 16 French resectoscope as an alternative device in the treatment of uterine lesions: arandomized controlled trialC. Di Florio, V. Immediata, D. Gagliano, A. Zumpano, C. Tartaglia, L. Selvaggi, A. Lanzone, M. Guido (Italy)Programme book181

P-585 A late presentation of obstructed hemivagina and ipsilateral renal anomaly with pyocolpos and it issurgical managementG. Kanmaz, A. Kahraman, B. Varli, E. Çetinkaya, S. Taskin, B. Özmen (Turkey)P-586 ruptured ectopic pregnancy and routine 'Laparoscopic Management' in shock.shocking?P. Vij, T.K. Cherian (India)P-587 Comparison of the anti-adhesive effect of clarithromycin and tetracyclineM. Simsek, R. Atilgan, Z.S. Ozkan, B. Kavak, D. Deveci, I. Demirel, E. Sapmaz (Turkey)P-588 Reproductive outcome following hysteroscopic division of uterine septum in women with primary infertilityM. Ashraf, G. Ghourab, O. Abuzeid, M.F. Mitwally, M.P. Diamond, M. Abuzeid (U.S.A.)P-589 experience with outpatient transvaginal hydrolaparoscopy in the NetherlandsR. Coenders-Tros, M.A. Van Kessel, G.J.E. Oosterhuis, E. Vernooy, W.K.H. Kuchenbecker, B.W.J. Mol,C. Koks (The Netherlands)P-590 Correlation of sonohysterographic findings of endometrial polyps in infertile patients andhistopathological diagnosisH. Al Rabiah, M. Karins, M. Faghih (Saudi Arabia)P-591 robot-assisted single-incision laparoscopic myomectomy: first case seriesS. Choussein, A.P. Bailey, S.S. Srouji, A.R. Gargiulo (U.S.A.)P-592 the effectiveness of anti-adhesion therapy following operative hysteroscopy for treating femaleinfertility: a systematic review and meta-analysisJ. Bosteels, S. Pelckmans, S. Weyers, B.W.J. Mol, T. D'Hooghe (Belgium)P-593 Laparoscopic tubal sterilisation reversal and fertility outcomesK. Dr K Jayakrishnan, B. Dr Sumeeth Baheti (India)P-594 single port laparoscopic myomectomy versus conventional laparoscopic myomectomy: a comparison ofoperative outcomesJ.H. Lee, J.R. Lee, J.Y. Lee, B.C. Jee, C.S. Suh, S.H. Kim (Korea South)P-595 argon beam coagulator versus cystectomy for endometrioma treatment in subfertile women and theimpact on ovarian reserve - a case control studyS. Aboeighait, M.A.F. Youssef, A.N. Hosny, M.S. Yassin, M.A. Shokry, S. Gemei (Egypt)P-596 reproductive outcome after hysteroscopic myomectomies for infertile patients with submucous fibroidA. Sanad (Egypt)P-597 Comparison of sublingual misoprostol versus lidocaine spray for pain relief in office hysteroscopy:a randomized, double blind, placebo-controlled trialS. Esin, E. Baser, E. Okuyan, T. Kucukozkan (Turkey)Stem cellsP-598 Maternal exposure of bisphenol A may increase the risks of fetal origins of Parkinson's disease byup-regulating of the IGF-1 expression in the offspringB. Huang, C. Jiang, L. Qin, Y. Cui, J. Liu (China)182

POSTERSP-599 Mesenchymal stem cells expressing some markers of pluripotency from adult human ovariesM. Stimpfel, B. Cvjeticanin, I. Virant-Klun (Slovenia)P-600 promoting angiogenesis via transplantation of adipose derived mesenchymal stem cells in damagedovariesA. Yabuuchi, K. Ezoe, T. Kuroda, N. Aoyama, F. Aono, Y. Takehara, O. Kato, K. Kato (Japan)P-601 Comparison of pluripotent and germline stem cell-specific markers in ovarian surface epitheliumaccording to the female age in a mouse modelD.S. Oh, K.S. Lee, J.K. Joo, J.E. Jeong, B.S. Joo (Korea South)P-602 the mouse embryonic stem (ES) cells assay could not replace the mouse embryo assay (MEA) fortesting the culture media in assisted reproduction technology (ART)M. Boiani, V. Nordhoff, S. Schlatt, C. Schwarzer (Germany)Translational researchP-603 Hyperhomocysteinemia mediated recurrent pregnancy loss: plausible role of bone morphogenetic proteinS. Kanta Goswami, P. Chakraborty, S.N. Kabir, B.N. Chakravarty (India)P-604 everolimus, heparin, montelukast and gnrh antagonist effect on ovarian weight and vascularpermeability in an ohss model: a preclinical randomized controlled studyI.P. Kosmas, X. Kitsou, L. Lazaros, A. Euaggelou, H. Tournaye, N. Prapas, Y. Prapas, K. Zikopoulos,I. Georgiou (Greece)P-605 Characterisation of human blastocoel protein contents by mass spectrometryM. Poli, A. Ori, T. Child, K. Turner, D. Wells (United Kingdom)P-606 mesoporous silica nanoparticles as a delivery platform to mammalian gametes: development of novelresearch tools and techniques for the transfer of therapeutic compoundsN. Barkalina, J. Kashir, C. Jones, H. Townley, K. Coward (United Kingdom)Programme book183

184

author indexAAguilar J. 152, 153Alemán M. 143Abali R. 177Aguilar Prieto J.A. 149Alexiou E. 176Abanto E. 175Aguirre M. 124Alfano P. 59, 144Abarbanel Y. 141Aguirre O. 140, 143Alfarawati S. 84Abbara A. 86, 132, 177Ahlstrom A. 54Alhalabi M. 141Abbas H. 166Ahmed F.A. 100Alhamdan R. 121Abdalla H. 159, 161Ai J. 146Aljaser F.S. 163Abdel-Gaffar H.M. 152Aït-ahmed O. 150, 155,170Allahbadia A. 145, 147Abdel-Raheem M.F. 152Ait-Allah A.S. 152Allahbadia G. 145, 147Abdel-Rahman M. 152, 175Aittomäki K. 123Allegra A. 165Abdellah A.H. 175Aizenman E. 152Almahbobi G. 163Abdellah M. 175Aizpurua J. 71, 140Almeida P.A. 149Abdelmonem A. 152Ajdukovic D. 166Almeida Santos T. 60, 159Abe T. 161Ajina M. 140, 149, 153Almog B. 151Abir R. 87, 163Åkerud H. 150, 172Almossaawi O. 108Aboeighait S. 182Akira S. 157, 161Alonso B. 144Aboulghar M. 119Aknin I. 142Alonso de Mena S. 162Abousetta A. 157, 158Akoum A. 145Alonso J. 144, 178Abozaid T. 100Aksoy T. 154Alonso Lorite J. 124Abraham M. 69Aktan A. 154Alonzo T. 56Abrao M. 157Aktas C. 177Alshahrani S. 142Abrão M.S. 59Al - Dibouni 168Alsomait H. 58Abubakirov A. 176Al azemi M. 75Alsule S. 147Abuzeid M. 100, 182Al Bassam M. 160Alteri A. 153Abuzeid O. 182Al Rabiah H. 182Alves M.G. 141Acar N. 158Al-Asmar N. 88, 171, 172Alviggi C. 144Acet M. 73, 174Al-Habib A. 108Alviggi E. 59, 144Adamson D. 80Al-Inany H. 157, 158Alvigi E. 59Adamyan L. 134Al-Lamee H. 156Amanlu M. 141Adang E.M.M. 168, 181Al-Samerria S. 163Amar E. 140Adda E. 104Al-Shawaf T. 160Amaro A. 161Adda-Herzog E. 180Alain S. 95Amer S. 106Adeniyi O.A. 151Adriaenssens T. 170Aflatoonian R. 148Agameya A. 143Alasmari W. 67Albani E. 148, 150Albert C. 148Albertini D.F. 175Amicarelli F. 60Amin M. 152Amit A. 151Amo A. 145, 146AUTHOR INDEXAgarwal A. 142Albricci L. 148, 153, 168Amodio G. 144Agerbo E. 145Alcoba D.D. 146Amorocho B. 151, 154Agirregoikoa J.A. 140, 143, 151, 175Alebic M.S. 166, 177Anagnostara K. 99Aguaron A. 144Aledani T. 170Anagnostou E. 129, 153Agudo D. 84, 140, 146Alegretti J.A. 172Anakubo H. 129Aguiar A.P.S. 154Alegretti J.R. 171Anarte C. 140, 143, 175Programme book185

Anastácio A. 60Andersen A.N. 80Andersen C.Y. 170Anderson E. 72Anderson R.A. 89, 121, 176Anderson S. 71, 156Ando H. 170, 179Andrea Borini A.B. 84Andronikou S. 149Anglim B. 174Ankum W.M. 106, 144, 145Annemans L. 177Anserini P. 55Anthony J. 152Anton E. 131Antonacci R. 148, 150Antonova I. 142Anupama A. 159Ao A. 148Aoi Y. 153Aono F. 147, 183Aoyagi N. 147Aoyama N. 183Aquino D. 133Aragonés Barragán S. 124Araico F. 178Arakawa A. 159Araki Y. 131, 142Archiles S. 122Arens Y. 166Argandoña F. 122, 140Ariza M. 84, 146Arluzea J. 170Arnone A. 87Arroll N. 160Artonne C. 142Asada H. 122Asada Y. 147Asakura H. 131Asch R. 153Asensio M. 149, 150Asfour V. 106Asgari L. 152Ashby D. 86Ashraf M. 182Askarijahromi M. 141Assou S. 84, 121, 150, 153, 170Astruc K. 70Ata B. 173Atayurt Z. 151, 155Ates U. 178Athayde Wirka K. 120Atig F. 153Atilgan R. 182Attig M. 158Aubriot F.A. 160Aulia A. 158Auslender R. 145, 150Austin C. 133Avila-Herrera A. 143Avo Santos M. 170Awwad J. 166Aybar F. 172, 180Aydin B. 155Ayhan B. 158Ayuandari S. 87Azab M. 141Azambuja R. 155Azarbayjani M.A. 177Azem F. 151Azpiroz A. 158Azzarello A. 129BBaart E.B. 164, 170Baccino G. 166Bacer Kermavner L. 150Bach M. 150, 159Badalotti F. 155Badalotti M. 155Baggiani A. 150Bahadur G. 108, 124Bahceci M. 140, 154, 155, 172Bai H. 150Bailey A.P. 182Bajoria R. 102, 179Bakas P. 180Bakelants E. 164Baker S. 72Bakker M.K. 167Balasch J. 173Balasuriya A. 99Baldi C. 154Baldi E. 141Balestrini S. 160Balet R. 157Ballesteros A. 104, 152, 165Ballesteros Boluda A. 172Balthazar T. 159Ban-Frangez H. 145Bang S. 151Banjevic M. 71, 171Banker M. 80Barad D.H. 177Baramsai B. 150Barash D. 152Barattini J. 154Barbato V. 108, 154Barber D. 93Barboni B. 140Barbosa C.P. 161, 174, 180Barcena de Arellano M.L. 155Barkalina N. 176, 183Barlas A. 170Barnocchi N. 148Baroni E. 88, 152Barratt C. 67Barraud-Lange V. 58Barrenetxea G. 140, 143, 151, 175Barri P.N. 123Barri Ragué P.N. 169Barrière P. 131, 146Barrio A. 161Barrios L. 55Barros A. 174Barros B. 171, 172Barros N. 174Barsoum E. 176Barth J.H. 76Baruffi R.L.R. 58, 73, 143, 160, 170, 177Barzilay I. 160Basar M. 73Baser E. 182Bashamboo A. 171Basile N. 84Bassorgun I. 169Bastings L. 74Bastu E. 156186

Baukloh V. 141Bernardi S. 87Blockeel Ch. 66Bauman N. 129Bernardini L. 140Bloigu A. 57, 72Baumann N. 70Bernardu R.E. 180Bloom S.R. 86, 132, 177Baumgarten M. 168Berrisford K. 148Boada M. 123, 170Bax B.E. 145Bersinger N. 176Bocca S. 156Bay B. 181Bersinger N.A. 175, 177Bochev I. 142Bayram A. 154, 155Berthaut I. 171Bodine R. 153Becerra D. 140Berthelot-ricou A. 162Bodri D. 86, 175Beck-Fruchter R. 150Bertoldo A. 73Bogstad J. 166Beckmann M.W. 158, 163Besikoglu B. 170Boiani M. 183Bedaiwy M. 157Best L. 120, 153Boivin J. 93, 110, 166Bednarowska A. 173, 174Bettendorf M. 170Bolli S. 160Bednarowska-flisiak A. 141Bewley S. 109Bolouri G. 177Behre H.M. 161Beyazyurek C. 89, 172Bonavita M. 171Bekers O. 99Bezpechnaya I. 178Bonduelle M. 86Beketova A. 157Bhattacharya J. 154, 180Bonetti T.C.S. 148Bellali T.H. 167Bhattacharya M. 180Bono S. 88, 148, 173Bellavia M. 176Bhattacharya S. 80Boostanfar R. 66Belles M. 152Bhide P. 57Boothroyd C. 160Belloc S. 75, 140, 160Bianchi V. 84Bor J.F.J. 97Bellver J. 104Bianco B. 161, 174, 180Bora S.A. 159, 161Belo A. 172Bibancos M. 172Borg P. 55Beltrán D. 148Bibi M. 149Borges Jr E. 142Bemfola E. 86Bider D. 60Borges Jr. E. 55, 102, 168, 175Ben-Ali H. 149biesemanns S. 75Borup R. 98, 170Ben-Ami I. 178Bilbao J. 170Bos-Mikich A. 133Ben-Ami M. 162Bina V. 159Bosch E. 119Ben-Haroush A. 87, 163Birch H. 178Bosdou J. 174Ben-Yosef D. 151Birck A. 141Bose G. 59Benachi A. 180Biricik A. 88, 172, 173Bosmans E. 108Benaglia L. 132Birks J. 164Bossuyt P. 114Bender U. 170Biscotti C. 157Bosteels J. 182Benkhalifa M. 171Bissonette F. 168Botchorishvili R. 158Bensdorp A.J. 60, 104Bissonnette L. 155Botta A. 162Bensussan A. 155, 157Biwas Shivhare S. 158Bottacin A. 131Bentzen J.G. 179Bjerge M.R. 179Botting B. 103Benyó M. 140Blais E. 145Bou R. 143Bergh C. 103, 123Bergman L. 164Berker B. 173Berkley K.J. 127Blais I. 150Blake L. 168Blanco J. 131Blanco L. 153Bouchard, P. 132Boulet S. 169Boumela I. 150Bourdiec A. 145AUTHOR INDEXBermejo A. 156Blankhart A. 180Bourroul F. 58Bern O. 178Bleiker E. 103Bouyer J. 181Bernabeu Pérez R. 168Blesa D. 156Bower C. 109Bernabeu R. 144, 155, 172, 176, 178Bletsa R. 129, 153Bowles M. 130Bernárd A. 149Blockeel C. 86, 100, 159, 173Bowman M.C. 100Programme book187

Bowman N. 55, 153Boyer P. 147Bozdag G. 134, 158Bozkurt H.H. 140Bozkurt N. 162Braam S. 86Braam S.C. 181Braat D. 103Braat D.D.M. 58, 69, 74Bradley C. 164Braga D.P.A.F. 55, 102, 142, 168, 175Brahem S. 140Brambillasca F. 144, 147, 175Brandi S. 100, 133Braude P. 179Braun S. 108, 154Breborowicz A. 88Breit T.M. 154Brigante C. 144Bringer S. 155Bringer-Deutsch S. 153Brison D. 150Brison D.R. 81, 151Broberg M. 167Broderick P. 73Broekmans F. 107Broekmans F.J. 60, 72, 104, 180Broekmans F.J.M. 160, 174Bronet Campos F. 124, 146Bronet F. 84, 140Brosens A.I. 159Brosens J. 157Brosens J.J. 56, 159Brown J. 160Bruce K. 105Bruegge C. 166Brugnon F. 142Brum I.S. 146Brunet C. 153Bruszczynska A. 141, 146, 178Bryndorf T. 166Bucci J. 152Buchanan P. 56Buendia P. 171Buendía P. 172Buffo L. 152Bugán A. 166Bulletti C. 170Bulmer J.N. 158Bunce K.D. 171Bungum A. 141Bungum M. 77, 141Bunting L. 93, 110, 166Burnik Papler T. 153Busnelli A. 132Buyle M. 177Buyru F. 156Buysse A. 93, 101, 159, 164, 168Buzaglo K. 160Byerley S. 84CCaanen M. 107, 174Caballero Campo M. 178Caballero M. 144Caballero P. 144Caballero Peregrín P. 146, 166, 176, 178Cadoret V. 148Cafueri G. 154Cagampang F. 105Caizergues N. 181Cakra A. 158Calatayud C. 166Calderon de Oya G. 172Calderón G. 152Caliari I. 144Calvo I. 140, 143Camargo C. 143Cambi M. 141Cambiaghi A. 156Campagna G. 158Campbell A. 55, 120, 148, 153, 154Campbell B. 121, 181Campbell B.K. 56, 105, 121, 152, 163Campo R. 56, 108, 146Campos P. 148Campos-Galindo I. 88, 171Camus M. 159, 173Canas M.C.T. 160Candiani M. 144, 158, 161, 180Canic T. 149Canis M. 158Cao M.Z. 122Capalbo A. 88, 148, 152, 153, 172Capaldo A. 176Capdevila J.M. 149, 150Caragia A. 160Carbone J. 144Carby A. 86, 152, 176Cardoso M.C.A. 154Carlsen E. 160Carmeli D. 164Carmely A. 87Carmon A. 151Carranza-Mamane B. 146Carrasco B. 123Carrillo de Albornoz E. 144Carrillo S. 142Carvalho L.F. 59Casals G. 173Casciani V. 152Castelló C. 149, 150, 165Castelló D. 120Castilla J.A. 80, 142Castro A. 140Cater E. 148, 149Catt J. 124Catt S. 75, 124, 147Catteau-Jonard S. 180, 181Cauffman G. 150Cavaco J.E. 141Cavagna M. 58, 73, 143, 160, 170, 177Cavalcanti V. 174, 180Cedrin-Durnerin I. 104, 142Celik C. 156, 177Celik E. 173Celle M. 181Celtemen M.B. 162Cepni I. 155Cerrillo M. 156Cesta C.E. 103Çetinkaya E. 182Cetinkaya M. 120, 151, 155Cha S.H. 175Chae S.J. 176Chai J. 175Chakraborty P. 179, 183Chakravarty B.N. 59, 179, 183188

Chakravarty M. 59Cho J.D. 165Cohlen B.J. 60, 104, 180Chambers G.M. 109, 168Choi D. 151Colacurci N. 142Chamié L. 156Choi M.H. 162, 175Colamaria S. 152Chamorro S. 165Choi Y.M. 175, 176Colasante A. 152, 172Chamy V. 157Choolani M. 155Colicchia A. 59, 144, 153, 173Chan C.H.Y. 165Chopra N. 171Coll O. 169, 177Chan C.L.W. 165Chorobik K. 147Collado D. 175Chan J. 155Choussein S. 182Colledge W.H. 60Chan J.K.Y. 157Choy T.K. 175Colleselli V. 143Chan R.W.S. 122Chrelias C.H. 176Colls P. 88Chan T.H.Y. 165Christensen L.P. 58Colodron M. 177Chaouat G. 155, 157Christensen P. 141Colombo F. 140Chapman M. 56Christofolini D.M. 161, 174, 180Com E. 131Chapman M.G. 165Christofolini J. 161Comi R. 144Chardonnet S. 60Christoforidis N. 146Comninos A.N. 86, 132, 177Chatterjee A. 159Christopoulos G. 86Conaghan J. 64, 120, 153Chatterjee R. 102, 179Chrudimská J. 174Conzatti M. 146Chattopadhyay R. 59Chuang P.C. 155Cook C. 152Chatzimeletiou K. 99, 154, 179Chudnoff S. 167Coomarasamy A. 179Chatziparasidou A. 146Chuko M. 151Coonen E. 63, 99, 166Chaudhury K. 59Chung M.K. 171Cordts E.B. 174, 180Chauffour C. 142Ciarmatori S. 161Corleta H.E. 146Chausiaux O. 72Cimadomo D. 152, 172Coroleu B. 123, 170Chavoshinejad R. 176Cinar C. 172Coroleu Lletget B. 169Chen A. 153Cirella E. 57Corona R. 159Chen A.A. 120Cisek Sajko M. 165Correia J. 67Chen F. 71Civico S. 173Correia K.F. 59Chen L.X. 169Civisová J. 170Cortés Gallego S. 146Chen P. 124, 147Clapham E. 84Cortes S. 176Chen S.H.L. 176Clarke R. 153Cortes-Rodriguez M. 171Chen S.L. 105, 144Clavero A. 142Corti L. 158, 161, 180Chen S.Q. 158Clua Obradó E. 169Costa M.E. 74Chen X. 105, 144, 176Cnattingius S. 103Costa P. 74Chen X.Y. 149, 158Coban G. 181Costa-Borges N. 152Cheng J. 89Cobo A. 156Cotarelo R.P. 153, 173Cheong Y. 105, 106, 109, 181Cobo Cabal A. 148Coticchio G. 144, 147, 175Cherian T.K. 182Coenders-Tros R. 182Coull G. 141Cheung I.K.M. 165Cheung L.P. 175Cheung S. 164Chiantera V. 155Coffaro F. 165Cogliati B. 156Cognigni G.E. 87Cogorno M. 154Courbiere B. 162Courjaud A.L. 121Coutifaris C. 152Coward K. 183AUTHOR INDEXChikawa A. 155Cohen J. 147Crawford S. 169Child T. 97, 129, 164, 183Cohen T. 151Creatsas G. 180Chimote N. 161Cohen-Bacrie M. 75, 140, 160Creus M. 173Chimote N.M. 161Cohen-Bacrie P. 75, 140, 160Criscuolo T. 171, 172Chipkar V. 145, 147Cohen-Kettenis P.T. 57Crisol L. 179Programme book189

Critchley H.O.D. 167Crivello A.M. 140Croly S. 152Cruz F. 75Cruz M. 175Csenki M. 171Cserepes R. 166Cui Y. 174, 182Culley L. 168Cunha M. 174Cupisti S. 158, 163Cuzzi J. 171, 172Cvetic I. 164Cvjeticanin B. 89, 183Czernichow S. 142DD’Aloja P. 160D’Angelo A. 118D’Costa E. 143d’Hauwers K.W.M. 58, 69D’Hooghe T. 74, 164, 182D’Hooghe T.M. 93, 104, 164D’Hoore A. 74D’Ommar G. 153da Rocha A.M. 156Dagan Wells D.W. 84Dahan M.H. 143Dahdouh E.M. 146Dahoud W. 157Dai S. 163Dai X. 174Dain L. 60Dal Canto M. 144, 147, 175, 178Dale S. 149Dalleac A. 75, 140Dalman A. 147Daly I. 110Damond F. 123, 141Dancet E. 93, 164Dancet E.A.F. 89, 101, 164Daneshmand S. 124Danielli L. 133Daniels K. 166Daniluk J. 110Darby H. 101Darcha C. 158Dasiman R. 150Dassonneville A. 180Datta A. 178Davies M. 103, 168De Baerdemaeker A. 177de Bruin J.P. 60, 104, 181De Cicco S. 57De Croo I. 147de Die-Smulders C.E.M. 165, 166De Felici M. 163De Frène V. 93de Graaff A.A. 158De Groot M. 101de Jong M. 154de Jong P.G. 144de Kat A.C. 72De Krom G. 166De la Hoz C. 170de La Rochebrochard E. 143, 181De Las Heras M. 151De Leo V. 142, 176De Loecker P. 104De Los Santos M.J. 148De Luca R. 160de Mello Bianchi P. 156De Meo M. 162de Michele F. 161De Mouzon J. 63, 75, 123de Mouzon J. 63, 80, 140, 160de Muinck Keizer-Schrama S.M.P.F. 132De Neubourg D. 104De Pablo J.L. 140, 143, 151De Paepe C. 150De Palo R. 142De Ryck L. 108De Rycke M. 86De Schepper E. 177De Silva A. 177De Stefani S. 170De Sutter P. 69, 93, 101, 118, 125, 147, 149,152, 159, 164, 166, 168, 172, 177De Vos A. 69, 100De Vos M. 119, 163De Vos W.H. 69, 149, 152De Vries T. 164De Walle H.E.K. 181De Wert G. 118, 159de Ziegler D. 94, 176Debacquer D. 177Debreceni D. 171Debrock S. 104Decanter C. 180Dechaud H. 84, 121, 150, 155, 170Deforce D. 152, 172Degheselle S. 147DeJonckheere L. 166Delaroche L. 123, 141Delgado A. 171, 172Delhanty J. 130Delhanty J.D.A. 88Dell’Aquila M.E. 163Delvigne A. 177Demailly P. 141Demir B. 179Demir N. 149, 172, 180Demir R. 169Demirel I. 182Demirtas C. 179Demirtas E. 143Demko Z. 71, 171Denny E. 168DePablo J.L. 175Derhaag J.G. 99Derks-Smeets I.A.P. 165Deroo T. 149, 152, 172Desai N. 133Desgro M. 150Desmet B. 69Destouni A. 171Deveci D. 182Devjak R. 153Devos A. 86Devoto L. 122, 157Devouche E. 123Devroey P. 119Dewailly D. 76, 180, 181Dhillo W.S. 86, 132, 177Dhont N. 177Di Biase A. 148Di Emidio G. 60, 87Di Florio C. 181190

Di Giorgio C. 162Drouineaud V. 70Elfituri A. 121Di Iorio L. 173Drury J.A. 156Elhelaly M. 147Di Nisio M. 144Drury S.L. 70Elias R. 152Di Pietro C. 60Duan F.H. 105Ellenbogen A. 160, 177Di Rosa A. 148Dubanchet S. 155, 157Ellery S. 75Diamond M.P. 182Duch M. 55Elpida Fragouli E.F. 84Dias T.R. 141Dudás B. 171Elsadek M. 178Díaz C. 163Duffy S. 55, 120, 153, 154Emery M. 166Díaz-García C. 162, 163, 178, 180Dumoulin J.C.M. 99Enciso M. 130Dickinson H. 75Dunger D.B. 72Enzlin P. 74Díez-Zapirain M. 161Dunkley E. 84Epelboin S. 123, 141Dilair Baban D.B. 84Dunselman G. 118Er H. 158Dilbaz B. 179Dunselman G.A.J. 158Erfan G. 177Dineen T. 146Dupont C. 58, 104, 142Ermoshkin A. 150Ding L.J. 89Durairajanayagam D. 142Erthal-Martins M.C. 154Dinopoulou V. 129, 153Dural O. 156Esbert Algam M. 172Diop H. 57Dusi L. 152Escribá M.J. 148, 149Dior U.P. 168Dutta G.B. 180Escrich L. 148, 149, 171, 172Dirnfeld M. 60, 145, 150, 164Duvillard L. 70Esin S. 182Dittrich R. 158, 163Dyer S. 80Espinoza A. 140Dodd M. 71, 171Dyer S.J. 80Estellat C. 141Doherty D.A. 73Dokuzeylül N. 73EEuaggelou A. 183Eum J.H. 148Dolle M.E.T. 160Eapen A. 178Evangelista A. 154Dolleman M. 160Ebensperger M. 140Evers J.L.H. 99, 166Dolz P. 165Ebner T. 168Exposito A. 156Domingo A. 140, 143, 175Ebrahimi B. 147Expósito A. 179Domingues T. 156Edgar D.H. 70Ezoe K. 147, 183Dömötör Z.S. 171Eelen K. 164Ezzeldin F. 143Donabela F.C. 157Donarelli Z. 165Efremov E. 142Eftekhari Yazdi P. 147FDondorp W. 118, 159Egashira A. 100, 151Fabbri R. 163Dondorp W.J. 159Ehbish S.M. 151Fabregues F. 173Dong F. 163Ehrlich S. 75Fadini R. 144, 175, 178Dons A.J.A.M. 164Eichenlaub-Ritter U. 133Faghih M. 182Doorninck J.H. 164Eijkemans M.J.C. 160, 174, 180Faidherbe J. 155Dorado Silva M. 140Ekmekci C.G. 89Fainaru O. 160, 177Doshida M. 169Dovere L. 148, 153Dr K Jayakrishnan K. 182Dr Sumeeth Baheti B. 182Ekmekci G.C. 172El Daly A. 157El Khattabi L. 123El Toukhy T. 58Fakih A. 166Falcone T. 133, 157Falone S. 60Fanchin R. 132, 180AUTHOR INDEXDrakakis P. 153El-khayat W. 178Fancsovits P. 151, 152Drent M.L. 57El-Shawarby S. 176Fang T. 121, 174Drobnic S. 145El-Toukhy T. 162Faris R. 161, 179Drost J.T. 174Elaimi A. 99Farokhi F. 177Droubi H. 141Eleveld C. 170Farquhar C. 158, 160, 162Programme book191

Farrag A. 143Farreras A. 149, 150Faruqi F. 146Fassolas G. 148Fatemi H. 75Faulisi S. 132Faure C. 142Fauser B. 134Fauser B.C.J.M. 180Favetta L.A. 148Fedder J. 58Fenwick J. 84Ferlin A. 131Fermin A. 179Fernandes L.F.C. 59Fernández Colom P.J. 162Fernández L. 151, 154Fernandez M.F. 142Fernández P. 149, 150Fernandez Peri N. 154Fernandez-Cruz E. 144Fernig D. 158Ferrando M. 156Ferraretti A. 80Ferraretti A.P. 63, 140, 154Ferraretto X. 141Ferrari S. 158Ferreira Gomes F.L.A. 146Ferreira R.C. 55Ferreira Y.J. 129Ferrer C. 158Ferrero H. 176Ferrero S. 59, 156, 157Ferriani R.A. 157Ferrières A. 153Ferrieres A. 84Ferris J. 148Ferry K. 172Feskov O. 178Feskova I. 178Fettback P. 156, 171Fiaccavento S. 160Fields T. 102, 152, 164Fifield C. 107Figueira R.C.S. 55, 102, 168, 175Filannino A. 154Filicori M. 87Findikli N. 140, 154, 155, 172Finnegan L. 164Fiore S. 181Fiorentino F. 88, 148, 172, 173Fiorentino I. 108, 154Fisch B. 87, 163Fischer R. 141Fishel S. 55, 120, 126, 148, 149, 153, 154Fishel-Bartal M. 87Fisher N. 163Fitzgerald C. 107, 134, 173Flanagan J. 146Fleischer K. 69Fleming R. 72, 107, 174, 181Florensa Bargalló M. 172Florensa M. 84Florez M. 140Focarelli R. 176Foley C. 146Fon Tacer K. 153Fonseca F.A. 180Fontes J. 142Foresta C. 73, 131Forgács V. 149Forman J. 123Forman J.L. 60Foroozanfard F. 178Forti G. 141Fouladi-Nashta A. 130Fouladi-nashta A.a. 176Fragouli E. 71, 84Franceus N. 69Francis G. 149Franco G. 152Franco Jr. J.G. 58, 73, 143, 160, 170, 177Frangini S. 155Franik S. 162Frank-Herrmann P. 170Franks S. 57, 72Frantz N. 133Franx A. 174Fraser A. 72Fraser I.S. 127Frederickx V. 146Fredrickson J. 70, 129Freeman T. 167Freiesleben N.L. 179Freijomil B. 150Freour T. 131, 146Freriks K. 132Frey M.K. 162Fridman M. 150Friedler S. 178Friis-Hansen L. 179Frokjaer V. 166Frokjaer V.G. 166Frumkin T. 151Frydman N. 132Frydman R. 132Fujioka T. 156Fujishita A. 157Fukuda A. 147Fukunaga N. 147Fulford B. 166Funabiki M. 176Furuyama S. 120GGabriele R.A.F. 150Gadd S.C. 70Gadea B. 149Gagliano D. 57, 158, 181Gago García M. 146Gala A. 121, 153Gallo C. 75Gallo-Sá P. 154Galluzzi L. 170Gamaleldin Ibrahim M. 155Gambera L. 176Gameiro S. 103Gámiz P. 149Gandhi G. 145, 147Gandini L. 142Ganiyu-Dada Z. 132Ganyani R. 72Garcia A. 176García D. 177Garcia De Miguel L. 178Garcia Velasco J. 94García Velasco J.A. 161Garcia-Herrero S. 171192

García-Herrero S. 88Giglio B. 59Gonçalves A. 174García-Láez V. 148Gil J. 144Gonzalez M.A. 165García-Pascual C.M. 176Gil M.A. 165González-Santiago N. 170García-Segovia A. 144, 146Gil S. 161Gonzalvo M.C. 142García-Velasco J.A. 104, 124, 156Gil-Pulido J. 144Gook D.A. 70Garcia-Velasco J.A. 140, 146, 175Gil-Salóm M. 172Goossens V. 63, 80Gardiner C. 129Gilbert A. 145Gordon A. 169Gardner D.K. 70Gilbertson A.Z.A. 171Gordon K. 179, 180Gargett C.E. 156Gilchrist R. 99Gordon U.D. 124Gargiulo A.R. 182Giles J. 75Gordts S. 146Garner F. 124Giles L. 168Gosalvez J. 140Garolla A. 73, 131Gilio B. 59Goswami S.K. 179Garrido N. 75Gillett W.R. 162Goto H. 145Gassner C. 173Gilson A. 152Goto T. 123Gaudoin M. 181Giménez J. 168Götte M. 122Gauthier C. 148Giordana S. 154Gottlieb C. 128Gautier B. 142Giovanni C. 178Goudakou M. 100Gautier T. 70Girod S. 70Granger L. 146Gelbaya T.A. 133Gissler M. 60, 103, 123Granovsky-Grisaru S. 168Gelli G. 144Giuliani M. 152Grau N. 148, 149Gelo N. 149Giversen I. 58Gravotta E. 59Gemei S. 182Giwercman A. 77Grayson K. 57Georgiadis A.P. 171Glazebrook J.E. 181Greco E. 141, 152, 172, 173Georgiou I. 100, 183Gleicher N.N. 177Greene R.A. 145Geraedts J.P.M. 165, 166Glowacka J. 141, 146, 178Greene W.C. 143Germeyer A. 157Go K.R. 145Gregori S. 144Germond M. 166Godbert S. 56, 161Gregoriou O. 180Gerris J. 166, 177Goddijn M. 101, 144Gremmels H. 72Gerrits T. 101Gogorza S. 161Griesinger G. 163Gervoise-Boyer M. 147Goksedef C.P. 178Griffin D.K. 171Geslevich J. 150Goksu E. 169Griffith L. 155Ghatei M.A. 86, 132, 177Goktas C. 154, 155Grifo J. 71, 88Ghazeeri G. 166Goktolga U. 140, 179Grigorescu V. 57Ghedir H. 140Golan J. 150Grimbizis G. 134Ghevaria H. 88Goldberg J. 133Griveau J.F. 171Ghezzi M. 73Golic I. 152Groen H. 104Ghimire S. 172Golmann D. 158Groendahl M. 98Ghosh S. 59Ghourab G. 182Giallonardo A. 168Gianaroli L. 140, 154Golombok S. 74, 166, 167, 168Gomel V. 54Gomes C. 156, 171Gómez Martínez J. 162Groendahl M.L. 170Groeneveld E. 86Groenewoud H. 181Gruber D. 162AUTHOR INDEXGiannini P. 153, 173Gómez R. 176, 178, 180Grundemar L. 180Gianotten J. 109, 168Gómez Torres M.J. 140Grynberg M. 132Gibson D. 152Gomez-Garcia E. 165Grzymkowska M. 141Gidoni Y.S. 178Gómez-Martínez R. 55Gualtieri R. 108, 154Gielchinsky Y. 168Gomez-Torres M.J. 140Guardiola F. 143Programme book193

Guarneri C. 143Gudi A. 57Guérif F. 148Guerra Diaz D. 165Guerra J.L. 156Guerrero G. 158Guerrero J. 155, 176, 178Guerrero Villena J. 168Guglielmo M.C. 175Guido M. 57, 158, 181Guijarro A. 176Guijarro Ponce A. 146Guilherme P. 148Guillén J.J. 177Gullo S. 165Gultomruk M. 154, 172Gulum N. 89Gumbao Baño D. 151Gumbao D. 154Gündogan G.I. 140Gungor D.N. 174Guo L.Y. 158Guo W. 144Guo Y. 163Guo Y.H. 144Gupta D. 160Gurria A. 178Gursoy R.H. 162Gutermuth J. 75Gutiérrez G. 158Guzel S. 177Guzman L. 159Guzmán L. 163Gvakharia M. 120, 153Gwinnett D. 152Gysler M. 168HHaas D. 168Habara T. 153Habets J.J.G. 165Hacifazlioglu O. 140Hackl J. 158, 163Hadar S. 87Hadari D. 178Haentjens P. 69, 100Hafhouf E. 123Hagiwara C. 129Hagman A. 123Haines C. 175Haines C.J. 162Hajenius P.J. 106, 144, 145Halicigil C. 145Hall M. 171Hall M.P. 71Hallak M. 160Hamada K. 156Hamai H. 155Hamamah S. 84, 121, 150, 153, 155, 170Hamdine O. 180Hamilton C.J. 86Hamilton C.J.C.M. 74Hammarström M. 158Han J. 157Han S.B. 149Han X. 107Hananel H. 148Handelsman D.J. 73Handyside A.H. 171Hansen M. 109Hantisteanu S. 160Haouzi D. 84, 121, 150, 155Hapangama D. 158Hapangama D.K. 156, 158Hapuarachi S. 173Harajly S. 166Hardarson T. 54Harper J. 99Harris H. 59Harrison C. 166Hart R. 73Hart S. 161Hartmann A. 158Harton G. 88Hartshorne G.m. 176Hartshorne G.M. 70Harvey L. 102, 141Has J. 178Hasegawa N. 147Hashiba Y. 147Hashimoto H. 156Hashimoto S. 145, 146Hass J. 145Hassan M. 162Hassiakos D. 180Hassun P. 171, 172Hattori H. 142, 169Hattori Y. 170Hauptmann M. 86Hauser R. 75Hauzman E. 161Hayashi N. 153Hayashi T. 176Hayashi Y. 130Haydardedeoglu B. 181Hayes J. 72Hayward B. 110Hazekamp J. 123Hazout A. 75, 140He Y.X. 176He Z. 161Hebles Duvison M. 140Hebles M. 151Heede M. 166Heens B. 152Hehr A. 173Hehr U. 173Heidemann P. 170Heiligentag M. 133Heilikman I. 58Heindryckx B. 149, 152, 172Heinrich J. 75Hendriks M.L. 57, 86Hendriks S. 89Henningsen A.A. 60Henningsen A.K.A. 103, 123Henningsson S. 166Henriksen T.B. 145Hens K. 159Herbemont C. 104, 142Herbert M. 84Herbison G.P. 162Hermus A.R.M.M. 132Hernández de Miguel E.R. 166Hernandez J. 153Hernandez M.J. 179Hernandez Medrano J. 163Herraiz S. 162, 163194

Herráiz-Nicuesa L. 144109, 158, 168, 181IHerreboudt A. 60Honda R. 145Iacobelli N. 144Herrera A.K. 153Hopkisson J. 181Iaconelli C. 175Herrero Grassa L. 124Horcajadas J. 156Iaconelli Jr. A. 55, 102, 142, 168, 175Herrero J. 120Horiuchi T. 147, 149Ialy Radio C. 147Herreros J. 152Horne A.W. 167Iammarrone E. 172Hershberger P.E. 164Hornnes P. 166Iba Y. 120Hershko A. 145Hosny A.N. 182Ibáñez E. 55Hessel M. 58, 69Hougaard C.O. 109Ichikawa T. 161Hestiantoro A. 158Hourvitz A. 145, 175, 178, 179Ievoli E. 148, 153Heusinger K. 163Houston B. 158Igci N. 158Hiadzi E.K. 143Howles C.M. 161Iglesias C. 156, 161Hickman C. 152Hreinsson J. 150Ikeno T. 142, 146Hickman C.F.L. 154Hsu T.Y. 130Iki A. 156Hida N. 122Hu C.X. 144, 169Iliadou A.N. 103Higo S. 151Hu Y. 121, 122Iliodromiti S. 176Hildebrandt T. 158, 163Hu Y.L. 89, 174Illahibuccus A. 108Hilder L. 103Huang B. 182Immediata V. 57, 158, 181Hill M. 71, 171Huang G.N. 149Imrie S. 74, 166Hindkjær J.J. 70Huang H.F. 169Imthurn B. 86Hinduja R. 145Huang J. 161Inaba M. 147Hirata K. 146, 169Huang K.H. 130Incera E. 158Hirata R. 153Huang L. 161Ingerslev H.J. 70, 120Hirshfeld-Cytron J. 164Huang X. 55Innes B.A. 158Hizli D. 173, 174Hudson C. 124Inoue N. 58Hjordt L.V. 166Hudson N. 168Insua M.F. 154Hlavati V. 149Hughes E.G. 96Ioakimidou C. 146Ho P.C. 175Hugues J.N. 104Iraola A. 173Hoang B. 71Hui B.N.L. 165Irez T. 140Hoang V.P. 109Huleihel M. 141Ishai D. 145Hoek A. 60, 104, 181Hulme D. 148Ishihara O. 80, 157Hoest T. 129, 170Hulsbergen A.F.C. 58Ishikawa T. 102, 147, 149Hofer S. 87Hulsbergen-van de Kaa C.A. 58Iskender C. 181Hoffmann I. 158, 163Huot M.N. 70Ismail S. 175Hoh B.P. 149Huppelschoten A.G. 74, 165, 168, 181Ito K. 146Hojnik N. 147Hurd W. 157Ito M. 147, 149Holcomb K. 162Husheer S. 72Itoi F. 147Holland T. 166Holleboom C.A.G. 180Holm Johannsen T. 179Holst K. 166Hvidman H.W. 65, 167Hwang H.G. 151Hwang K.R. 176Hwang Y.I. 162, 175Iussig B. 153Ivakhnenko V. 157Ivanets T. 176Ivani K. 120, 153AUTHOR INDEXHolzer H. 143, 145, 169Hwu Y.M. 150Iwahashi K. 155Homburg R. 57Hyslop L. 84Iwasa Y. 147Homem de Mello P. 156Iwata H. 145Hompes P. 107, 174Iwata K. 120Hompes P.G.A. 57, 60, 86, 104,Izard V. 140Programme book195

Izzi-Engbeaya C. 177Izzo C.R. 148JJadva V. 74, 166, 168Jaguszewska K. 178Jahangiri N. 148Jakab A. 140Jakiel G. 173, 174, 178Jakobsen H.B. 58Jallad S. 149Jamieson D. 57Jamieson D.J. 169Jancar N. 145Janny L. 142Jansen E.H.J.M. 160Janssen M. 56Jaroudi S. 84Järvelin M.R. 57, 72Järvholm S. 167Jauckus J. 157Jayaprakasan K. 105, 152, 181Jayasena C.N. 86, 132, 177Jee B.c. 163Jee B.C. 175, 182Jelinkova L. 170Jenner L. 148, 149Jensen P.S. 166Jeon G.H. 156Jeong H.J. 171Jeong J.E. 183Jerhamre Sundh K. 103Jeung J.E. 145Jiang C. 182Jiang F. 142Jiang H. 71Jiang Y. 121, 122Jimenez C. 70Jin F. 144, 169Jin H. 163Jin H.X. 169Jin L. 146Jin X. 122Jinno Y. 130Johansson V. 103Johnson M. 168Johnson N. 160Johnson S. 56, 161Jonard S. 76Jones C. 183Jones G.L. 167Jonker M.J. 154Joo B.S. 183Joo J.K. 145, 183Jordan C. 73Jordan K. 154Joshi H. 124Joy J. 160Junca A.M. 160Jung J.H. 151Junovich G. 158Juras J. 178Jurkovic D. 68KKaaijk E.M. 57, 86Kaáli S.G. 149Kaandorp S.P. 144Kabanova D. 157Kabir S.N. 183Kadoch I.J. 160Kafali H. 173, 174Kagalwala S. 145, 147Kahraman A. 182Kahraman S. 73, 89, 120, 151,155, 172, 174, 180Kai Y. 120Kailasam C. 124Kaisler E. 87Kajihara T. 157Kajiwara A. 124Kakourou G. 171Kalebic N. 110Kalich-Philosoph L. 87Källen K. 103Kallianidis K. 129Kally C. 124Kamada Y. 120Kamalak Z. 173, 174Kamihata M. 147, 149Kamin G. 56Kamono T. 147Kamper-Jørgensen M. 109Kamsani Y.S. 159Kanavakis E. 171Kanety H. 87Kang A.S. 151Kang H.Y. 171Kang I.S. 162, 175Kang J.H. 176Kani C. 147Kani K. 149Kanmaz G. 182Kanno H. 147Kanta Goswami S. 183Kapustiansky R. 151Karaer A. 173Karagouga G. 144Karahuseyinoglu S. 177Karakaya C. 162Karakoc Sokmensuer L. 134Kårehed K. 150, 172Karins M. 182Karlikaya G. 172Kartchovsky E. 177Kasapi E. 100Kasatonova E. 142Kasem H. 152Kashevarova A.A. 144, 172Kashir J. 183Kaspersen M.D. 58Kassa D. 149Kassai Z. 140Kasterstein E. 178Kasum M. 149Katabuchi H. 145Katano K. 130Kathryn Bunch K.J. 103Kato K. 147, 183Kato M. 147Kato O. 183Kato R. 86, 175Kattygnarath T.V. 146Katzorke N. 172Kaupp U.B. 67Kaur K. 71Kavak B. 182Kavci N. 145196

Kawachiya S. 86, 175Kim Y.Y. 151, 156, 165, 168, 175König T.E. 86Kawwass J.F. 169Kim Y.y. 164Konstantinidis M. 71, 84Kayser M. 179Kimati C. 156Koo D.B. 151Kazemi M. 178Kimber S. 150Koong M.K. 162, 175Kearney P.M. 145King W.A. 148Korac A. 152Keelan J.A. 73Kirby R. 57Korac B. 152Kelsey T.W. 176Kirchhoff F. 143Korevaar J.C. 84Keltz M. 88Kirici P. 173Korgun E.T. 158Kenny L.C. 145Kirkegaard K. 70, 120Korneeva I. 176Kerkeni A. 153Kissin D. 57Korosec S. 145Kerstjens-Frederikse W.S. 181Kissin D.M. 169Korsak V. 80Keskin S. 177Kitade M. 159Korsen T. 57, 174Kesmodel U.S. 181Kitajima M. 157Kósa Z.S. 171Kessels R.P.C. 132Kitaori T. 130Kosarová M. 170Kets C.M. 165Kitasaka H. 147Kosmas I.P. 183Khader A. 174Kitaya K. 176Kossover O. 87Khairi H. 149Kitowska-Marszalkowska K. 141Kösüs A. 173Khalaf M. 141Kitsou X. 183Kosus A. 174Khalaf Y. 58, 160, 162, 179Klatt M. 173Kösüs N. 173Khalil E. 159Kleijkers S.H.M. 99Kosus N. 174Khan I. 100Klein J.P. 142Kovacic B. 142, 147Khan K.N. 157Klerkx E. 108Kovacs A. 146Khashan A.S. 145Klerkx E.P.F. 56Kovács P. 149Khatib R. 141Klinger F. 163Kowalzyk Z. 173Khatoon A. 147Klocke S. 163Koyama S. 102Kiesel L. 122Knez J. 147Kozachenko I. 134Kiessling A.A. 129Knudsen G.M. 166Kralik Oguic S. 178Kikuchi H. 147Knudsen U.B. 120Krapchev M. 141Kilicdag E.B. 181Kobayashi M. 124, 151Krasinski R. 147Kim C.M. 156Koert E. 110Krasnopolskaya K. 157Kim H.J. 151, 156, 165, 168, 175Koff A. 170Krauß S. 173Kim H.j. 164Kohls G. 161Kremer J. 162, 181Kim H.O. 175Koifman M. 145, 150Kremer J.A.M. 74, 165, 168Kim J. 173Koizumi M. 156Krenková P. 174Kim J.G. 175, 176Kojima E. 147Kreukels B. 107Kim J.J. 176Kokeguchi S. 124Kreukels B.P.C. 57Kim J.W. 171Koks C. 60, 86, 182Krishnan M. 107, 134, 173Kim J.Y. 175Kim K.H. 168Kim M.H. 171Kim S.G. 151, 156, 165, 168, 175Kolibianakis E. 99, 154Kolibianakis E.M. 99, 174, 179Kollár J. 166Kollmann Z. 175, 176, 177Kristensen S.G. 170Krivega M. 150Krivokharchenko I. 146Krog M. 160AUTHOR INDEXKim S.h. 163Komarovsky D. 178Krul I.M. 86Kim S.H. 175, 176, 182Kondo M. 86, 175Kruzelová M. 170Kim S.k. 164Kong G.W.S. 162Ku S. 175Kim S.M. 175, 176Kong W.S. 175Ku S.Y. 176Kim T.Y. 148König T. 57Kuang Y. 105Programme book197

Kuchenbecker W.K.H. 182Kuchiki M. 169Kucukozkan T. 182Kuijper E. 107, 174Kuiper R. 162Kumtepe Y. 120, 151, 155Kundu A. 180Kundu S. 180Kung F. 130Kunicki M. 173, 174, 178Kupka M. 80Kuramoto T. 100, 151Kuribayashi Y. 157Kurinchi-selvan A. 178Kuroda K. 56, 159Kuroda M. 159Kuroda T. 183Kurpisz M. 171Kusanagi Y. 156Kushnir M. 174Kushnir V.A. 177Kussler A.P. 146Kusunoki H. 172Kutteh W. 179Kuwabara Y. 161Kuwahata A. 147, 149Kuwayama M. 147, 151Kvaskoff M. 157Kvitko D. 155Kwon H.C. 151Kyono K. 142, 146, 169Kyoya T. 142, 146Kyrkou G. 176Kyrou D. 179LLa Marca A. 161, 176La Verde E. 142Labouriau R. 141Lacroute P. 71, 171Laenen A. 104Lagrost L. 70Lahav-Baratz S. 145, 150Lain M. 144Lainas G. 179Lainas G.T. 99Lainas T. 179Lainas T.G. 99Lalitkumar P.G.L. 55Lamb D. 82Lambalk C. 107Lambalk C.B. 57, 86, 158, 174, 180Lambe M. 160Lambers M.J. 86Lammers J. 146Lammertyn J. 93Lamont J.M. 162Lan D. 141Lan V.T.N. 107Land J.A. 91Landeras J. 151, 154Landino G. 173Lane B. 158Lanius V. 162Lanska V. 176Lanzilotti S. 87Lanzone A. 57, 158, 181Lao O. 179Lardone M. 140LaRosa D. 75Larsen E.C. 166, 167Larsen J. 56Larsson A. 162Lash G.E. 158Lashen H. 57, 72Latre Navarro L. 169Lau P. 171Laufer N. 168Lauritsen M.P. 179Lavee M. 150Laven J.S. 180Laven J.S.E. 164, 170, 179Lavery S. 152, 176Law C. 168Lawlor D.A. 72, 174Lazaros L. 183Lazzaroni E. 177Le F. 144, 169Lebedev I.N. 144, 172Lechado B.L. 174Lédée N. 155, 157Ledger W. 107, 161, 167, 168Ledger, W.L. 106Lee C.Y.V. 175Lee D.R. 148Lee E. 109Lee H. 168Lee H.J. 177Lee H.S. 171Lee J. 163Lee J.E. 151Lee J.H. 151, 156, 165, 171, 175, 182Lee J.h. 164Lee J.r. 163Lee J.R. 182Lee J.S. 162Lee J.y. 163Lee J.Y. 182Lee K.H. 151, 156, 165, 168, 175Lee K.h. 164Lee K.S. 145, 183Lee R.K. 150Lee S.J. 151Lee W. 124Lee W.S. 148Lee Y.H. 155, 157Lefevre B. 147Lehner A. 151, 152Lei L. 177Lejeune B. 148Lekovic J. 162Lemmen J. 123Lendinez A. 171Leocata F. 153Leon J.A. 144Leonardi M. 132Leone Roberti Maggiore U. 59, 157Leong M.K.H. 165Lerer-Serfaty G. 87Leung P.C. 175Leveille M.C. 168Levi S. 148, 158Levi Setti P.E. 148, 150Levron J. 60Levy B. 71, 171Levy R. 104, 123Lévy R. 142Leybaert L. 152198

Leylek O. 145Liu Y.D. 144, 176Lukaszuk K. 141, 146, 173, 174, 178Li B. 142Llabador M. 141Lukaszuk M. 173, 174Li H.Y. 156Llabador M.A. 123Lukic N. 164Li J. 71, 149, 158Llácer Aparicio J. 168Luna Cañas C. 146Li J.B. 142Llacer J. 144, 172, 176Lundberg Giwercman Y. 173Li L. 105, 161Llácer J. 178Lunenfeld E. 141Li L.J. 144, 169Lledo B. 144, 172, 176Luton D. 123Li M. 169Lloyd S.M. 174Lutton D. 160Li P. 105Lo Coco G. 165Luz L. 172Li R. 144Lobaccaro J.M. 142Lykeridou K. 176Li S.H. 150Lobascio A.M. 141Lynch C. 169Li T. 149Li T.C. 106Lobascio M. 173Lobo R. 82MLi W.H.R. 175Lockwood G.M. 178M. Lockwood G. 94Li Y. 146Loft A. 123, 160, 170, 174, 179Ma Y.F. 142Lian Y. 169Loh S.F. 157Ma, X. Liang W. 55Liang X.X. 142Lombardo F. 142Maalouf F. 166Liao C.Y. 156Lomsek M. 165Maalouf W. 105, 152, 181Liapis A. 180Long C. 72Maas A.H.E.M. 174Lichtblau I. 160Longobardi S. 108, 142, 161, 163Maas J. 104Lichtenstein P. 103Longuet P. 123, 141MacCallum F. 166Lidegaard O. 60Lopes A.S. 146Maccarini A.M. 87Liebaers I. 150Lopes G. 141Macciocca M. 163Lierman S. 69, 149, 172Lopez-Leria B. 142Macek jr. M. 174Ligumsky H. 87Lopez-Regalado M.L. 142Macek sr. M. 174Lim A. 177López-Teijón M. 149, 150, 165Macgregor S. 59Lim H.J. 151, 161Lorenzo León C. 153Macklon N. 66, 83, 93, 105Limpens J. 109Lothhammer N. 133Macklon N.S. 109, 180Lin G. 71, 149Lotti B. 154MacLusky N. 148Lin S.L. 169Lotz L. 158, 163Madani T. 148Lin Y.J. 155Lou Y. 169Madaschi C. 148Lind T. 158Lou Y.Y. 144Madne M. 145, 147Lindgren C.M. 59Loumaye E. 134Madoc B. 177Lindgren I. 173Lourenço B. 159Maes E. 87Lindgren K. 150Loutradis D. 129, 153Mafra F.A. 161Lingham E. 124Louwers Y. 179Mage G. 158Lishko P. 143Low N. 91Maggi E. 154Lispi M. 142, 163Liss J. 141, 146, 173, 174, 178Listijono D.R. 165Liu H. 122, 143Lowndes Stevenson E. 65Lozano L. 153Lu C.H. 150Lu G.X. 149Maggi M. 141Maggiulli R. 148, 152, 153, 168Magill P. 167Magli M.C. 140, 154AUTHOR INDEXLiu J. 105, 157, 174, 182LU Y. 149Magnani M. 170Liu P. 169Lu Y. 152, 172Magnani V. 163Liu S.Y. 144, 149, 169Lucena E. 151Mahony M. 110Liu X. 163Lucena M. 151Maia V. 171Liu X.Z. 169Lukaszuk A. 173Majerfeld M. 153Programme book199

Makedos A. 179Makyan Z. 134Malcov M. 151Maldonado L.G.L. 175Malm E. 162Maman E. 178, 179Mamas T. 88Manaku M. 162Manau D. 173Mangiarini A. 143Manova-Todorova K. 170Mansour R. 80Mantikou E. 154Mantilla A. 142Manyonda I. 145Manzo R. 164Maortua H. 161Marbán E. 178Marchiani S. 141Marconi D. 59, 144Marcos Alises J. 154Marcos J. 151, 154Mardesic T. 63, 170Marei W. 176Marei W.F. 130Marino A. 165Marino J. 168Marino S. 173Marras A. 148Marsters P. 121Marti U. 175Martín L. 144Martín Salat M. 172Martinez E. 146, 151Martínez E. 84Martínez L. 142Martinez M. 149Martinez-Bouzas C. 161Martínez-Jabaloyas J.M. 172Martínez-Salazar J. 161Martínez-Zilloniz N. 161Martino N.A. 163Martins A.M.V.C. 73, 143, 160Martins M. 74Martyn F. 174Maruyama T. 122Marzal A. 178, 180Maslansky B. 178Masouridou S. 179Massaro F.C. 58, 73, 143, 160, 170, 177Massin N. 181Masson D. 131Mastenbroek S. 84, 154Mastorakos G. 176Masuda H. 122Masuzaki H. 157Matern D. 70, 129Mateu E. 88, 171, 172Matheron S. 123, 141Mathew D. 158Mathur R.S. 173Matoba Y. 120Matorras R. 156, 161, 170, 179Matsu-ura M. 124Matsubara K. 156Matsubara M. 147Matsubara Y. 156Matsumoto H. 147Matsumoto T. 86, 175Matsumoto Y. 124Matsunaga R. 147, 149Matsuzaki S. 158Mattioli M. 140Matunaga P. 171, 172Mátyás S.Z. 149Mauri A.L. 58, 73, 143, 160, 170, 177Mavrogianni D. 129, 153Mayer R.B. 168Mazaheri Z. 141Mazetto R. 172Mazur P. 148, 153McAdoo S. 171McArthur S.J. 100, 133McClure A. 154McConnachie A. 107, 174, 181McEleny K. 77McElreavey K. 171McFarlane J. 163McGrath J. 169McGuire M.M. 171McKane P. 57McLachlan R. 73McLaughlin M. 89McNally W. 72McShane M. 107Mechsner S. 155Meddeb S. 149Medrano M.L. 140Megnazi-Wiener Z. 145Mehdi M. 140Mehri A. 140Mehta A. 132Mehta B. 161Mehta J. 124Meijer-Hoogeveen M. 165, 166Meikle W. 174Meirow D. 62, 87Meissner A. 89Melnik Y. 142Melzer K. 88Mendoza R. 156, 161, 179Menduni F. 148Menegazzo M. 73, 131Menezes J. 55Menke L.A. 132Menon P. 106Meola J. 157Mercader A. 88, 171, 172Merola M. 144, 175Merz M. 162Meseguer M. 84, 104, 120, 146, 149Mesiano S. 157Messow M. 107, 181Metsis M. 170, 173Meul W. 69Meuleman C. 74Mey Raz N. 151Michaeli M. 177Michelon J. 155Michon S.M. 164Micic J.D. 164Middeldorp S. 144Mignini Renzini M. 144, 175Mijatovic V. 158Mikkelsen A.L. 129, 170, 179Milachich T. 142Milán M. 171, 172Milán-Sánchez M. 88200

Min S.H. 151Montjean D. 147, 171Murakami M. 100, 151Minamoto H. 179Montoya A. 140Murakawa H. 147Minasi M.G. 141, 152, 172, 173Monzo C. 155Muratori M. 141Mine C. 100, 151Mooij T.M. 86Murber A. 151, 152Mine K. 161Moon S.Y. 175, 176Murdoch A. 84Mio Y. 120Mooney S. 165Murphy M.F.G. 103Mir P. 88, 171Moore V. 168Murtinger M. 159Mirabet V. 162Moragues I. 71, 140Murugesan, R. 120Mirecka A. 141Morales R. 144, 172, 176Muthusamy Y. 124Miric A. 164Moravvegi A. 178Mutlu D. 180Mishieva N. 176Morbeck D. 70, 129Mutlu M.F. 156Missmer S.A. 59, 157Morcel K. 171Mutsaerts M.A.Q. 181Mitchell H. 168Mori C. 147Muzi M.C. 144Mitra A. 180Mori R. 147Muzzonigro F. 140Mitsoli A. 179Morimoto Y. 145, 146, 147Mykytenko D. 148, 153Mittal M. 179Mitwally M.F. 182Morin - Papunen L. 57Morin S. 88NMiwa A. 151Morin-Papunen L. 72Nabeta M. 156Miyadahira E. 171Morita H. 147, 149Naether O.G.J. 141Miyamura H. 147, 149Morotti M. 156Nagafuchi E. 151Miyazaki K. 122Morreale G. 148Nagai A. 151Mizoguchi C. 120Morris S. 72Nagai R. 147Mizuno S. 147Mortensen E.L. 181Nagai Y. 151Mizusawa Y. 124Mortensen P.B. 145Nagayoshi M. 131, 172Mizutani E. 130, 170Mostafaei F. 147Nagorny V. 153Mochtar M.H. 89, 165Motta E.L.A. 156, 171, 172Nagornyy V. 148Mohan B. 104Mounce G. 93, 164Nahum R. 145Mohd-Fazirul M. 149, 150, 154Movahedin M. 141Naik R. 124Moina N. 165Mowla S.j. 141Nakagawa K. 157Moir J. 160Mowla S.J. 141Nakahara Y. 131Moisidou M. 146Moyer T. 70, 129Nakahira R. 155Mokánszki A. 140Mozas J. 142Nakajo Y. 142, 169Mol B.W. 86, 93, 106, 144, 145, 181Mskhalaya G. 142Nakajyo Y. 146Mol B.W.J. 60, 104, 109, 168, 182Muela L. 149Nakamura C. 129Mol F. 106, 144, 145Mueller M.D. 175, 176Nakamura Y. 169, 176Molgora M. 180Muftuoglu M. 89Nakaoka Y. 146Molina Botella I. 162Mugione A. 144Nakashima A. 151Mollá M. 151, 154Mollo V. 154Molnár Z. 140Momma Y. 151Mukaida T. 123Müller A. 163Müller J. 143Münch J. 143Nakashima M. 157Nakayama K. 147Nánássy L. 171Nandy T. 160AUTHOR INDEXMonica B. 166Munne S. 71, 88Nardelli Haefliger D. 95Montag M. 120, 132Muñoz E. 152, 153Nardo L. 107Monterde M. 178, 180Muñoz M. 149Nardo L.G. 133Montgomery G.W. 59Muñoz Muñoz E. 149Nargund G. 154Montgomery S. 55, 120, 153, 154Murach K.F. 87Narvekar N. 179Programme book201

Nascimento A.M. 58, 73, 143,160, 170, 177Natali I. 141Nath N. 161Navarro P. 157Nawa A. 156Nazzaro A. 173Nederegger V. 87Negra D. 149Nekkebroeck J. 87, 165Nelen W. 118, 162Nelen W.L.D.M. 74, 165, 168, 181Nelson S. 178Nelson S.M. 72, 107, 159, 174, 176, 181Neri Q.V. 102, 141, 152, 164Neril R. 150Netea-Maier R.T. 132Netti P. 154Netto Dornelles L.M. 166Neuberg M. 174Neupane J. 149, 172Neuspiller F. 154Neyer A. 150Neyer T. 159Neyskens J. 177Ng H.Y.E. 175Nicolaides K.H. 99Nicolás M. 151, 154Nicoletti A. 58, 73, 143, 160Nicoliello M. 171Nicopoullos J. 161Nielsen A.P. 166Nielsen N.C. 70Nijher G.M. 86Nijher G.M.K. 132, 177Nikiforaki D. 149, 152Nikitina T.V. 144Nishi Y. 157, 161Nishio E. 147Nishio K. 131Niu J. 105Nobrega N. 172Noci I. 141Nogales M. 146Nogales M.C. 84Nogués C. 55Nor-Ashikin M.N.K. 149, 150, 154, 159Nor-Shahida A.R. 150Nordhoff V. 183Nordqvist S. 172Norhazlin J.M.Y. 149, 150, 154Norita S. 149Norman R.J. 73, 160Noruzinia M. 141Novara P. 175Novella-Maestre E. 162, 163Novo S. 55Nowak L. 84Nunes Q. 158Nunez - Calonge R. 176Núñez Calonge R. 146Nuñez Calonge R. 166Nuraliza A.S. 154, 159Nwoye M. 159Nybo Andersen A. 170Nyboe Andersen A. 60, 65, 160,174, 179, 180Nyboe-Andersen A. 103Nygren K.G. 60, 80, 103, 123OO’Callaghan J. 146O’Neill S.M. 145Ochando I. 155Ochi M. 147, 149Ochoa C. 161Ockhuijsen H. 93Oda H. 122Oda T. 130Oehninger S. 156, 178Ogata H. 124Ogata S. 124Oh D.S. 183Ohba T. 145Ohgaki A. 147Ohgi S. 129Ohhama N. 155Ohno H. 147Ohtani A. 147Oikonomou L. 99, 154Oikonomou Z. 154Ojeda M. 152, 153Ojeda Varela M. 149Oka C. 123Okada L. 155Okamoto E. 124Okhowat J. 159Okolo S. 108Oktem O. 89Okuyan E. 182Oláh E. 140Olaya Vila E. 146Oleszczuk K. 77Oliana Membrado O. 154Oliveira C. 174Oliveira J.B.A. 58, 73, 143, 160, 170, 177Oliveira P.F. 141Olivennes F. 75, 160, 181Oliver J. 134Olivier F. 124Olsson H. 103, 180Olszak-Sokolowska B. 173Olszewska M. 171Omanwa K. 162Ombele W. 56Ombelet W. 108Onal M. 73, 174Oneta M. 141Ong K. 72Ono M. 155Ono S. 161Oosterhui G.J.E. 180Oosterhuis G.J.E. 60, 104, 182Oppelt P. 168Oppelt P.G. 163Ori A. 183Ornek M.C. 178Oron G. 169Oroquieta A. 140Orozco I. 142Orsiere T. 162Ortega L. 176Ortega López L. 146Ortega-Hrepich C. 163Ortiz J.A. 144, 172, 176Ortiz-Quintana L. 144Orvieto R. 145, 163Osman A. 58202

Osmanagaoglu K. 159Pappalardo C. 158Peinado V. 88, 171, 172Otasevic V. 152Par I.H. 151Pelckmans S. 182Otoo M.A. 143Parada-Bustamante A. 140Pellicer A. 75, 104, 120, 148,Otsubo H. 151Parames S. 165152, 162, 163, 176, 178, 180Otsuka M. 151Parazza I. 163Pellicer Martínez A. 162Otsuki J. 151Pareja Marín S. 124Peltoketo H. 132Otten B.J. 132Parikh J. 159, 161Peluso C. 174Ottolina J. 161Parini V. 148Peluso, C.M. Trevisan P. 180Ottolini C.S. 171Parisi F. 141Pemberton P. 107Ouchchane L. 142Park C.W. 175Peñarrubia J. 173Outeda S. 153Park E.A. 148Pencovich N. 160Ozaki Y. 130, 170Park I.H. 156, 165, 168, 175Penninckx F. 74Ozel Demiralp D. 158Park I.h. 164Pennings G. 63, 101, 118, 159, 164, 168Ozkan Z.S. 182Park J. 173Penon O. 55Ozmen A. 158Park J.H. 151Peralta S. 173Özmen B. 182Park S.J. 171Pereira R. 156Ozturk S. 149, 172, 180Parmegiani L. 87Pereleshina E. 75Öztürk Turhan N. 173Parriego M. 170Pérez Fernández M. 149PParrilla B. 141Partsinevelos G.A. 153Perez I. 149Pérez Izquierdo M. 178Pacheco A. 140Parys J.B. 152Pérez M. 152, 155Paffoni A. 143Pasqualini S. 158Perez M. 153Pagliardini L. 161Pasquet B. 141Pérez-García L. 55Paglin S. 87Pasquinelli G. 163Perez-Nevot B. 171Palermo G.D. 102, 141, 152, 164Passadaki T. 100Pérez-Sanz J. 170Palial K. 156Passos E.P. 166Pergolini I. 59, 144Palini S. 170Pastore E. 173Perman G. 161Palomares A.R. 171Patassini C. 131Perrin J. 162Palumbo A. 153, 179Patel D.A. 177Perrochia H. 155Pan P.P. 144, 169Patel K. 145Persico P. 158Pan Y.B. 121Patel M. 143Pesant M.H. 176Panagiotidis Y. 100Patrat C. 123, 141Pesce R. 161Panagopoulou E. 167Paulmann B. 173Pessino T. 153Pandian D. 181Pauwels P.C.P. 152Peters D. 171Pangasa M. 162Pavicic Baldani D. 178Petersen C.G. 58, 73, 143, 160, 170, 177Pangestu M. 124, 147Pavicic-Baldani D. 149Petersen G.L. 109Panina Bordignon P. 144, 158Paz C.P. 157Peterson B. 167Pantasri T. 160Paouneskou D. 152Papadatou D. 167Papadopoulos S. 134Pazoki H. 177Pe’er G. 164Pedersen I.H. 109Pedroso D.C.C. 73Peterson B.D. 74Petitbarat M. 155, 157Petousis S. 100Petracco A. 155AUTHOR INDEXPapaleo E. 142, 144, 158, 161, 180Peek J.C. 162Petracco R. 155Papaligoura Z. 167Peeraer K. 104Peura T.T. 100, 133Papas C. 146Pehlivan Budak T. 154Philipse I.C.P. 74Papatheodorou A. 100Peigné M. 181Phletincx I. 142Papini L. 148Peinado Casas I. 162Pibernik-Okanovic M. 166Programme book203

Piccinini C.A. 166Piccolomini M. 171Pigny P. 180Pike S. 97Pil L. 177Piltcher Haber E. 141Pimentel A.M. 146Pinborg A. 60, 103, 109, 123,160, 166, 167, 179Pineau C. 131Pinkard C. 166Pinkas H. 87Pinola P. 57, 72Pinter B. 145, 150Piomboni P. 142, 176Pionneau C. 60Piottante A. 140Pirkevi C. 120, 151, 155Piro M. 175Piromlertamorn W. 148Piront N. 152Pirritano M. 167Pisano B. 148Piscitelli C. 153Pizzol D. 73Plaza J.A. 55Plendl J. 155Pocate K. 58Podgorac M. 164Poirot C. 60Poisot F. 169Poli M. 71, 129, 183Pollard K.S. 143Polson A. 106Polyzos N. 173Polyzos N.P. 87, 159Pomante A. 140Poncelet C. 104Pontes A. 58, 160, 170, 177Poo M.E. 88, 171Popov A. 157Porcher R. 58Portman L. 176Potdar, N. 133Potenza M. 180Poulain M. 180Poulou M. 171Pouly J. 181Pouly J.L. 123, 158Pouta A. 57, 72Power E. 154Pr. De Sutter P. 177Prapas N. 100, 183Prapas Y. 100, 183Prathalingam N. 84Pregl Breznik B. 142Presilla N. 140, 143Pribenszky C. 151, 152Pribenszky C.S. 149Prieto B. 156, 161, 179Primiterra M. 170Prior M. 160Prosen D. 171Provoost V. 101, 118, 159, 164, 168Puard V. 148Publicover S. 67Pundir J. 162Pundir V. 162Puopolo M. 153, 179Puri S. 104Pusica S. 165Puttermans P. 146Pylyp L.Y. 170QQian C. 152, 172Qianhong M. 177Qin L. 182Quenby S. 56, 68Quintana F. 156RRabanal A. 156Rabellotti E. 180Rabinowitz M. 71, 171Racca A. 59Racowsky C. 117Radakovic B. 149Radunovic N. 152Radwan M. 147Radwan P. 147Raes I. 101, 159, 164, 168Raffi F. 106Ragni G. 132, 143Rahmati M. 155, 157Rahmioglu N. 59Raikos N. 99Raine-Fenning N. 105, 168Raine-Fenning N.J. 56Rajabpour Niknam M. 147Rajan N. 146Rajikin M.H. 154, 159Rajkovic A. 171Ramalho-Santos J. 159Ramani R. 145, 147Ramesh S. 145Ramos B. 71, 140Ramos L. 58, 69Ramos-Medina R. 144Rampini M.R. 59, 144Rao C.V. 145Rárosi F. 149Rasheed S.M. 152Rasmussen S. 123Raso D. 154Rastellini A. 87Ratnasabapathy R. 132, 177Rato L. 141Ravel C. 171Ravelingien A. 101, 159, 164, 168Ray A. 57Ray D. 154Raziel A. 178Razif D. 149, 154Reading I. 106Rebar R. 114Reches A. 151Rega E. 153Reichart A. 149Reid J. 167Reig V. 155Reijo Pera R. 153Reinblatt S. 143Reißmann C. 163Reiter E. 148Remohí J. 104, 156Remohi J. 148, 153Remorgida V. 59, 156, 157Renner S. 158204

Repping S. 60, 84, 89, 92, 93,Roldan M. 149Rustamov O. 107, 134, 173101, 104, 154, 164, 168Romano S. 148, 153, 168Ruvalcaba L. 151Requena A. 175Romdhane Ibala S. 140Ruvolo G. 142Res Muravec U. 165Romin Y. 170Ryan A. 71, 171Resta S. 154Romualdi D. 57Ryu M.J. 171Restelli L. 143Rettenbacher M. 86Romundstad L.B. 60, 103, 123Ron-El R. 178SReubinoff B. 115Rondanino C. 142Saa A.M. 151Reyes-Engel A. 171Roness H. 87Saad A. 140, 149, 153Rhee J. 173Roopa P. 159Saad H. 159Rhodes S. 163Rosa M.B. 156, 171Saavedra A. 161Ribas C.P. 157Rosenfellner D. 87Sabanegh E. 142Ribeiro D.M.F. 156Rosenstein-Tamm K. 173Sabatini L. 160Riboldi M. 156, 172Rosenwaks Z. 102, 141, 152, 153, 164Saberi H. 178Ricci J. 160, 170, 177Rösner S. 157Sabhnani T. 88Ricciarelli E. 166Rossi A. 171Sabry M. 152Rienzi L. 88, 148, 152, 153, 168, 172Rossi V. 163Sachtleben M. 155Rigó Jr J. 151Rothen S. 166Sadek K. 105, 106Rigo Jr. J. 152Rothman C. 142Saenganan U. 148Rigon P.S.L. 133Rougier N. 141Sage K. 171Rikkert J.M.T. 69Rouleau J.P. 179Sagot P. 70Riordan K. 70Rouse H. 169Sahertian R. 107Riqueros Arévalo M. 172Roustan A. 162Sahin O. 154, 155, 177Riqueros M. 84Rovira S. 149, 150Sajgó A. 149Risco R. 151Roy T.K. 100, 133Sakamoto E. 169Roan N.R. 143Roychoudhury S. 59Salama M. 87Robben J. 69Roychoudhury Sarkar M. 154Salamun V. 145Roberts S. 107, 134, 173Royère D. 123, 148Salas-Huetos A. 131Robin G. 181Rozée V. 143Salem H. 100Robker R.L. 160Roziers P. 146Salem R. 105Rockwood A. 174Ruan H.F. 121Salerno A. 173Rodrigo L. 88, 146, 171, 172Ruberti A. 172, 173Sälevaara M. 165Rodriguez A. 169Rubino P. 153, 173Salina O. 150Rodríguez Barredo D. 169Rubinshtein N. 179Sallam H. 143Rodriguez F. 169Rubio C. 75, 88, 148, 171, 172Sallam N. 143Rodríguez I. 123Rubio I. 120Sallam S. 143Rodríguez-Arnedo D. 155Rubio J.M. 162, 180Saltek S. 179Rodriguez-Iglesias B. 162, 163Rodríguez-Mahou M. 144Rodriguez-Wallberg K. 158Rodriguez-Wallberg K.A. 162Rubio J.m. 178Rubio S. 140Rudolf K. 141Ruiz A. 63Saltik A.Y.S.E. 145Salumets A. 170, 173Samantha Knight S.K. 84Samara N. 87AUTHOR INDEXRoesner S. 132Ruiz F. 175Samawi S. 141Rogel S. 71Ruiz Galdon M. 171Samchimchom S. 148Rogenhofer N. 56Ruiz M. 156Sammartano F. 165Rogic D. 178Rumbold A. 168San Celestino Carchenilla M. 140Roglic P. 147Russel R. 107, 173Sanabria V. 179Programme book205

Sanad A. 182Sanchez A.M. 158Sánchez E. 148Sanchez Leon A. 154Sanchez Martin F. 140Sanchez Martin P. 140Sánchez-León A. 151, 154Sanchez-Martin P. 151Sanchez-Ramon S. 144Sánchez-Ramón S. 144Sandström R. 180Sanges F. 148, 153, 168Sano K. 102Santaló J. 55Santambrogio P. 158Santin G. 181Santonocito M. 60Sapienza F. 152Sapmaz E. 182Sarasa J. 130Saretzki G. 156Sargent H.C. 120Sargent I.L. 129Sargin A.K. 177Sarna U. 88Sartorio C. 154Sas T.C.J. 132Sasaki K. 147Sasy M. 100Sati L. 169Sato H. 165Sato T. 170Sato Y. 142, 146, 169Sattar N. 72Sauber-Schatz E. 57Savasi V. 141Sávay S. 171Savournin V. 157Sbracia M. 59, 145Scala C. 59, 157Scalici E. 70Scaravelli G. 160Scarella A. 157Scarica C. 148, 153, 168Scarpellini F. 145Scarselli F. 152Scaruffi, P. 55Schats R. 57, 158Scheike T. 179Schepens K. 125Schiewe M.C. 142Schimberni M. 168Schlatt S. 62, 183Schlegel P.N. 152Schleussner E. 56Schmidt K.T. 167Schmidt L. 74, 109, 128, 167Schmutz E. 70Schneider A. 155Schneider S. 175Scholten I. 109, 168Scholtens S. 181Schreurs A.M.F. 158Schreurs I.E.L. 99Schulz C. 163Schüring A. 122Schust D. 130Schwarzer C. 183Schwerda D. 150Scott R.T. 172Sebag-Peyrelevade S. 180Sebek P. 170Sedler M. 55Seeber B. 143Seeliger G. 56seher T. 75Seida K. 58, 102, 124, 147Seidel T. 133Seifert B. 173Seifert D. 173Selice R. 73Selvaggi L. 181Semaco E. 172Semeniuk L. 148, 153Semião-Francisco L. 165Senbabaoglu F. 89Serafini P. 156, 172Serdarogullari M. 154, 155Serhal P. 88Sermondade N. 58, 104, 142Serneels A. 146Serrani M. 162Serrano A. 178Serrano J. 148Serrano M. 142Seshadri S. 58, 160Session D.R. 169Setti A.S. 55, 102, 142, 168, 175Sevillano Martinez E. 154Seyfferth A. 144Sfontouris I. 179Sfontouris I.A. 99Shachar M. 87Shah A. 57Shah T. 168Shalev E. 150Shalev L. 178, 179Shalom-Paz E. 145, 177Shan H. 122Shangwei L. 177Shao R. 145Shapiro B. 124, 179Sharma R. 142Shaulov T. 160Shavit T. 177Shaw L. 150Shebl O. 168Sheedy J.R. 70Sheikh Abdul Kadir S.H. 149Shen S. 120Shen X. 122Shenfield F. 63, 118Shi J. 150Shi S. 163Shi W. 150Shiget M. 155Shin H. 151, 161Shiotani M. 124Shohat-Tal A. 177Shohayeb A. 157Shokry M.A. 182Shterev A. 142Shufaro Y. 152Shulma A. 145Shwartz T. 151Shyamala S. 159Sifer C. 58, 104Sigurjonsson S. 71, 171206

Silk J. 175Somova O. 178Stigliani S. 55Sills E.S. 141Son W.Y. 143, 169Stiller C.A. 103Silva J. 174Song H.J. 151Stimpfel M. 89, 183Silver N. 141Song H.S. 161Stocker L.J. 109, 181Simm J. 170, 173Song I.O. 162, 175Stojanov T. 100, 133Simon C. 156Song W. 163Stojanovic N. 177Simón C. 88, 171, 172, 176Song W.Y. 169Stojnic J. 152Simpson E.R. 116Sottocornola M. 144, 147Stoop D. 87, 101, 150, 159, 163, 165Sims C.A. 142Souraya Jaroudi S.J. 84Stoppa M. 148, 153Simsek E. 181Sousa A.P. 159Stora C. 123Simsek M. 182Sousa M. 174Strassburger D. 178Simunic V. 178Souter I. 75Strehl J. 158Sinai Talaulikar V. 145Sovino H. 157Strelec M. 149Singh A.K. 59Soygur B. 169Strowitzki T. 120, 132, 157, 170, 172Sioga A. 99, 154Sozen B. 149, 172, 180Stute P. 175Skakkebaek N.E. 73Spaan M. 86Stuyver I. 101, 159, 164, 166, 168Skjaerven R. 60, 103, 123Spath K. 71Su J. 89Skrgatic L. 178Specht I.O. 167Su Y. 163Skrivanek A. 162Speksnijder J. 164Suárez L. 152Skryabin N.A. 144, 172Spence S. 121Sucurovic S. 56Skull J.D. 167Speziale L. 160Sugimoto J. 130Skutella T. 89Spiessens C. 104Sugimoto T. 155Smajdor A. 101Spinenko L.A. 170Sugino N. 122Smeenk J.M.J. 74Spizzichino L. 88, 148, 173Sugiura-Ogasawara M. 170Smeraldi A. 148, 150Splingart C. 146Sugiyama C. 170Smith A. 107Spoletini R. 160Sugiyama R. 157Smith H.L. 150Sprague A. 168Suh C.S. 163, 175, 182Smith K.W. 75Sprem Goldstein M. 178Suhorutshenko M. 173Smith M.J. 141Spreyer B. 102Suikkari A.M. 165Smith V. 167Sredni B. 87Sullivan E. 80, 103Smits L.J. 158Srikantharajah A. 124Sullivan E.A. 56, 109Smitz J. 163, 170, 174Srouji S.S. 182Summers M.C. 171Snajderova M. 176St-Michel P. 146Sun H. 121, 122Snow R. 75Staessen C. 86Sun H.G. 151, 156, 164, 165, 168, 175Soares A.C.P. 156Stanghellini I. 140Sun H.X. 174Sobotka V. 170Stanic P. 149Sun Y. 163Sobreira Lopes R.C. 166Stankovic V. 152Sun Y.P. 169Socorro S. 141Söderström - Anttila V. 165Söderström-Anttila V. 123Sokal-Arnon T. 169Staubach N. 133Stecher A. 150Stefanidis K. 153Steffann J. 180Sun Z.Y. 149Sunderam M. 57Sundvall L. 120Sung N.Y. 162, 175AUTHOR INDEXSol Olafsdottir H. 97Stegmann B. 178Sung Y.J. 156Solé M. 170Stein A. 87, 163Sunkara S. 179Soleman R. 57, 107Stenbæk D.S. 166Sunkara S.K. 160Somers S. 101, 159, 164, 168Stendardi A. 176Sur S.D. 56Somigliana E. 116, 132, 143, 144Sterckx S. 126Suraj K. 120Programme book207

Surlan L. 152, 164Sutcliffe A.G. 103Sutton-McDowall M. 99Suzuki A. 147Suzuki H. 58, 102, 124, 147Suzuki N. 179Suzumori N. 130Svane A.S.P. 70Svarer C. 166Svitnev K. 159Svobodová L. 170Swann K. 105Swider A. 141Sylvestre C. 160Szczyglinska J. 141Szlarb N. 71TT’Sjoen G. 166Táboas E. 152Taboas E. 153Taboas Lima E. 149Taborin M. 147Tac H.A. 89Tack S. 159Tada Y. 176Tafi E. 59, 157Tagliaferri V. 158Tagliani-Ribeiro A. 155Taguchi S. 176Taha A. 141Tailor S. 149Tajima T. 123Takahashi K. 123, 151Takata R. 155Takayama Y. 147Takayanagi T. 179Takeda S. 159Takehara Y. 183Takeshita T. 161Takeuchi M. 147Takeuchi T. 151Talevi R. 108, 154Tamburrino L. 141Tamhankar V. 167Tamura F. 147Tamura H. 122Tan B.K. 173Tan C.W. 155Tan H.H. 155Tan K. 71Tan L. 153Tan Y.Q. 71Tanada M. 171Tanaka A. 131, 172Tanaka I. 131, 172Tanaka K. 100, 151Tanaka M. 58, 102, 124, 147Tanaka T. 147Tang C. 121Tang Y. 105Tanigiwa S. 58, 102, 124, 147Tannenbaum S.R. 157Tao T. 176Tao X. 172Tapanainen J.S. 57, 72Tapia-Pizarro A. 122Tappe N.M. 100, 133Tappehorn C. 163Tarlatzis B. 125, 167Tarlatzis B.C. 99, 134, 154, 174, 179Tartaglia C. 57, 158, 181Taskin S. 182Tatone C. 60, 87Tawidian L. 166Taylor D. 70Taylor J. 71Tee N. 169Teitelbaum M. 168Teixeira da Silva J. 174Tejada M.I. 161Tejera A. 120Tejera-Alhambra M. 144Telfer E.E. 89, 121Telli P. 162Temel S. 180Temel S.G. 172Temple-Smith P. 75, 124Ten J. 144, 155, 168, 172, 176, 178Teramura S. 155Terigima S. 105Terribile M. 152Teruel J. 152Teruel López J. 172Teslik L. 176Tews G. 168Theodoridis G. 99Theofanakis C. 129Theusink-Kirchhoff N. 167Thiering E. 75Thijssen A. 108Thomas P. 181Thompson J. 99Thorn P. 166, 167Thornhill A. 168Thornhill A.R. 171Thuesen L. 170, 174Thum M.Y. 159, 161Thurin-Kjellberg A. 167Tian X.L. 176Tibben A. 165Tiitinen A. 60, 103, 123Tilleman K. 69, 118, 125, 147, 177Tilly J.L. 89Timmers H.J.L.M. 132Timms P. 57Tiplady S. 161Tirado M. 165Tiras B. 145Tishchenko O. 178Tjan-Heijnen V.C.G. 165Tjon-Kon-Fat R.I. 60, 104Todd C. 132Toftager M. 166Tokdemir Calis P. 134, 158Tokura Y. 124Tolmacheva E.N. 172Tolpe A. 147Tomassetti C. 74Tomic Z. 164Tomiyama R. 161Tomlinson M.J. 163Tomohara A. 151Tong J. 71Tornquist J. 146Török A. 149Tosun S.B. 154Toth B. 56, 120, 132208

Tourame P. 147Urich M. 100Van Glabeke L. 166Tournaye H. 69, 86, 87, 100,Urman B. 89van Golde R. 60, 165142, 159, 163, 165, 173, 183Urquiza F. 158Van Golde R.J.T. 166Townley H. 183Usta T. 178Van Keirsbilck N. 177Toya M. 169Ustunel I. 158Van Kessel M.A. 182Traeger-Synodinos J. 63, 171Trakakis E. 176VVan Landuyt L. 69, 100, 163, 173van Leeuwen F.E. 86, 103Tranchant T. 148Vaegter K. 55van Loendersloot L. 168Trapphoff T. 133Vagman I. 151Van Mello N. 145Traver S. 155, 170Vagnini L. 177van Mello N.M. 106, 144Treff N. 172Vagnini L.D. 58, 73, 143, 160, 170Van Montfoort A.P.A. 81, 99, 154Trew G. 86, 152, 176Vahabi Z. 147van Osch L.A.D.M. 165Troilo E. 87Vaiarelli A. 150, 152, 153Van Parys H. 101, 159, 164, 168Tromp L. 181Valdespin C. 147Van Ravenswaaij-Arts C.M.A. 166, 167Trotsenburg M. 107Valentijn A.J. 156van Rijn B.B. 174Troude P. 181Valério E.G. 146van Wely M. 86, 106, 144, 145, 165, 181Tsai S.J. 155Vallejo B. 148Vandekerckhove F. 177Tsuchie Y. 120van Asseldonk F. 93Vanden Meerschaut F. 149, 152Tucker M.J. 117Van Beek J.J. 158Vanderzwalmen P. 100, 148, 150Tulandi T. 145, 169van Blerkom J. 56Vandewoestyne M. 172Tulay P. 172Van Cleynenbreugel B. 74Vanhove L. 181Tulic I. 152van Dam H. 165Vankerkhoven G. 146Tuong H.M. 107Van de Velde A. 147Vanni V.S. 144, 161, 180Tur Padró R. 169Van de Velde H. 69, 83, 100, 150Vanrell Barbat I. 172Turchi D. 144, 147van de Vijver A. 173Vansteelandt S. 177Turhan N.O. 174van de Werken C. 170Vansteenbrugge A. 152Turienzo A. 144, 176Van den Abbeel E. 147, 152, 166Vansteenkiste E. 177Turkcuoglu I. 173van den Belt-Dusebout A.W. 86, 103Varga A. 140Turner J. 92Van den Broeck U. 74, 164Varli B. 182Turner K. 129, 183van den Dool-Maasland G.C. 180Varma R. 106Twisk J. 174van den Wijngaard L. 165Varre A. 162Twisk J.W.R. 57, 86van der Heijden G.W. 164Varricchio M.T. 173Tzamtzoglou A. 179van der Heijden P.F.M. 180Vassena R. 115, 169, 177Tzanakaki D. 180van der Hoogen A. 93Vastersaegher C. 152Uvan der Houwen L.E.E. 158van der Poel S. 143Vaucher A. 175, 176, 177Vázquez Rodríguez A. 169Ubaldi F. 168Van Der Putten-Landau T.m. 167Veen van der F. 60Ubaldi F.M. 88, 148, 152, 153, 172Uchida H. 122Uchino K. 145Ueda M. 120Van der Schouw 160, 174Van der Veen F. 101, 164van der Veen F. 84, 89, 104, 106,109, 144, 145, 165, 168, 181Vega M. 88Vega O. 178, 180Veiga A. 123, 170Veldhuis J.D. 132, 177AUTHOR INDEXUeno J. 165van Dongen A.J.C.M. 74, 165Veleva L. 142Ullah K. 100van Dop P.A. 180Velez F. 110Ulug U. 154, 155, 172Van Echten-Arends J. 84Velez M. 160Umekawa Y. 147van Empel I.W.H. 181Velickovic K. 152Urbancsek J. 151, 152van Eyck J. 174Velilla E. 149, 150, 165Programme book209

Velthut-Meikas A. 170Veltman D.J. 57Venetis C.A. 134, 174, 179Venkatakrishnan R. 56Vento M. 60Venturini P.L. 55, 59, 156, 157Venturoli S. 163Vera F. 163Verburg H.J. 180Verdenik I. 153Vereczeky A. 171Vergote I. 74Verhaak C. 74Verhaak C.M. 74, 103, 132, 165Verhaar M.C. 72Verheyen G. 69, 87, 100, 142, 150Verhoeff A. 180Verhoeve H.R. 60, 104Verhofstadt L. 93Verit F.F. 177Verkerk E.W. 168Verlengia C. 59, 144Vermeulen N. 118VerMilyea M. 152Vernaeve V. 169, 177Vernooy E. 182Verpoest W. 86, 177Verschueren S. 164Verschuren W.M.M. 160Verstraelen H. 166Verweij P. 178Vettraino G. 168Vezmar K. 157Viana P. 174Vicenti R. 163Vidal C. 75Viganò P. 144, 158, 161, 180Vigiliano V. 160Vij P. 182Vikeså J. 170Vilches-Ferron M.A. 151Vilímová S. 170Viloria T. 149, 172Vincens C. 153Vingris L. 102, 142Virant Klun I. 150Virant-Klun I. 89, 183Virgiliou C. 99Vitrier S. 69Vitti M. 60, 87Vivarelli A. 148Vlahos N. 180Vlaisavljevic V. 142, 147Vloeberghs V. 86Vogt H.P. 172Vogt P.H. 170Volemanová E. 170Volgsten H. 167Volks C. 167Volle D.H. 142Volpes A. 165Vom E. 100, 133von Wolff M. 157, 175, 176Von Wolff M. 177von Zglinicki T. 156Vossaert L. 152Vourliotis M. 149Vrcic H. 149, 178Vrettou C. 171Vrtacnik Bokal E. 145, 153Vrtacnik-Bokal E. 89, 150Vu P. 71Vucetic M. 152Vutyavanich T. 148WWachter D. 158Wada T. 147, 149Wahba A. 157Walker D. 75Walker M. 168Wallce W.H. 103Walsh D. 141Wan-Hafizah W.J. 149, 150, 154Wang F. 163Wang H. 156Wang J. 142, 174Wang J.R. 121Wang L.L. 144Wang L.Y. 144, 169Wang M.I.N. 150Wang N. 169Wang W. 71Wang X.H. 142Wang Y.A. 56, 103Wang Y.J. 121Wånggren K. 150Wasniewski T. 174, 178Watanabe S. 147, 149, 172Waterstone J. 146Wayham N. 71Wcislo M. 141Weghofer A. 177Wei F. 177Wei L. 55Weigert J. 120, 132Weiss A. 150Weiss B. 175, 177Weiss N. 181Weiss N.S. 86Weissman A. 145Weitzman G. 167Wekker M.Z. 144Welkenhuyzen M. 104Wells D. 71, 84, 130, 170, 183Wely M. 104Wely van M. 60Wen K. 102Wennerholm U.B. 60, 103, 123West S. 57Westin C. 54Westler S. 60Wetzels A.M.M. 98Weyers S. 182Wheat S. 168Whitaker L.H.R. 167White C. 107Wiener-Megnazi Z. 150Wierckx K. 166Wikland M. 54Wildt L. 87, 143Williams C.L. 103Williams G. 72Williams P.L. 75Williamson E. 102Willson K. 168Wilson J. 167Wilson P. 154210

Wingfield M. 174Yagel S. 168Yokota Y. 142Winkler K. 87Yagmur E. 172Yonezawa M. 161Wirleitner B. 148, 150, 159Yahi S. 141Yoo J.H. 151Wirthner D. 176Yakass M.B. 143Yoo Y.J. 165Wisard M. 166Yalcinkaya S. 177Yoon S.H. 176Wischmann T. 166, 167Yamada K. 147Yoon S.Y. 148Wiser A. 145Yamada S. 124Yoon T.K. 148Wisniewska K. 141Yamagata Y. 122Yoshida A. 58, 102, 124, 147, 151, 161Wissing M. 170Yamaguchi M. 145Yoshida H. 147Wit J.M. 132Yamanaka N. 147Yoshimura T. 147Witjes H. 179Yamochi T. 145Yoshimura Y. 122Witkowska H.E. 143Yan G. 121, 122Yoshioka N. 151Wolf I. 87Yan G.J. 89, 174Youm H. 163Wolf J.P. 58, 142, 147Yan W. 177Younes G. 145Wolff H. 70Yan X. 174Younes S. 155Wolthuis A. 74Yanaihara A. 129Younis J.S. 162Wong A.W.Y. 162Yang D. 161Youssef M.A.F. 182Wong K.M. 84, 154Yang H.I. 151Yu L. 156Wong W.Y. 175Yang K.M. 162, 175Yucel O. 177Woodhead G. 149Yang X. 55Yuksel A. 177Woods D.C. 89Yang Z. 105Yuksel Simsek S. 181Woodward B.J. 143Yao T. 159Yumoto K. 120Wramsby H. 55Yao Y.Q. 142Yung Y. 178, 179Wramsby M. 55Yarali H. 158Yuzpe A.L. 168Wu L.L. 160Wu M.H. 155Yarde F. 72, 174Yasa C. 156ZWu S. 121Yassin M.S. 182Zabala A. 153Wu X.M. 121Yates A. 107Zadeh S. 167Wunder D. 176Yatsenko A.N. 171Zafosnik M. 147Wünsch L. 170Yazbeck C. 123, 141Zahiri M. 141Wyverkens E. 101, 159, 164, 168Ye D.S. 105, 144Zakharova E. 142, 146XYe D.S.H. 176Ye H. 149Zaletov S. 146Zaletova V. 142, 146Xanthopoulou L. 130Ye Z. 153Zanatta A. 156Xiao X.F. 142Yeh N. 170Zandstra H. 158Xin Z. 163Yelke H. 120, 151, 155Zaninovic N. 153Xin Z.M. 169Yeon J.Y. 151Zannoni E. 150Xu L.J. 176Xu S.Y. 158Xu X.R. 169Xue X.I.A. 150Yerushalmi G. 178, 179Yeung W.S.B. 122Yeung W.Y.T. 175Yi L. 157Zavaglia D. 152, 172, 173Zayed M. 157Zeadna A. 143, 169Zech N.H. 148, 150, 159AUTHOR INDEXYYilmaz A. 148Yin Q. 161Zegers-Hochschild F. 80Zeirideen Zaid R. 108Yaba-Ucar A. 149, 180Yin X.Y. 71Zeiss C. 169Yabuuchi A. 147, 183Yokota H. 142Zemkova D. 176Yaffe H. 168Yokota M. 142Zepiridis L. 179Programme book211

Zervomanolakis I. 87Zeyneloglu H.B. 181Zhang B. 149Zhang D. 180Zhang H. 146Zhang L.E.I. 71Zhang Q. 121Zhang S. 150Zhang S.P. 149Zhang X. 146Zhang X.Y. 148Zhang Y. 57Zhao H.X. 142Zhao N. 174Zhao W. 150Zhen X. 122Zheng H.Y. 105Zheng Y.M. 144, 169Zheng Z. 88Zhong Y. 149Zhongying H. 177Zhou J. 149Zhu H. 169Zhu L. 122, 146Zhuang G.L. 149Zhun X. 177Zhylkova I. 178Zidi I. 140, 149Ziebe S. 123Ziehr S.C. 87Zikopoulos K. 100, 183Zimmermann B. 71, 171Zinaman M. 56Zinchenko V. 60Zintz M. 150Zitoun P. 75Zivi E. 152Ziyyat A. 147Zondervan K.T. 59Zorrilla M. 171Zosmer A. 160Zukin V. 148, 153Zukin V.D. 170Zumpano A. 57, 158, 181Zurth C. 162Zuzuarregui J.L. 148212

LIST OF ADVERTISERSCCD INTERNATIONAL ...........................................................................Inset in front of page 18FINOX BIOTECH AG.....................................................................................Inside front of coverIBSA INSTITUT BIOCHIMIQUE SA .........................................................Inside back of cover & 3IVF SPAIN .............................................................................................................................3IVFONLINE.....................................................................................Inset in front of page 9 & 13KARL STORZ GMBH...............................................................................................................2LG LIFE SCIENCES...............................................................................................Back of coverMTG MEDICAL TECHNOLOGY VERTRIEBS-GMBH ....................................................................2NARISHIGE INTERNATIONAL LTD............................................................Inset in front of page 8ORIGIO A/S............................................................................................................................1PLANER ..............................................................................................................................12RESEARCH INSTRUMENTS LTD ............................................................Inset in front of page 26SUTTER INSTRUMENT .........................................................................Inset in front of page 19LIST OF ADVERTISERSProgramme book213

Achevé d’imprimer par :